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ABSTRACT 
Schistosomiasis and visceral leishmaniasis, each responsible for serious morbidity 
and mortality, also have overlapping endemicities e. g. in the Sudan. Both cause 
granulomatous responses in the liver. Leishmania donovani amastigotes are killed by Thl- 
dependent macrophage activation whereas schistosome eggs induce Th. 2 dependent 
granulomas which protect the liver tissue from toxic products and from Thl dependent 
inflammatory responses. In view of the reciprocal counter-regulation of Thl and Th-2 
responses it was hypothesized that co-infection would lead to altered immune responses 
and exacerbation of disease. This was modelled in the mouse using Schistosoma mansoni 
and L. donovani. When C57BL/6 mice were infected with 25 cercariae of S. mansoni and 
superinfected, 8 weeks later with L. donovani the co-infected mice (CO-INFECT) suffered 
increased morbidity and mortality and elevation of serum liver enzymes, ALVAST 
(aspartate/alanine aminotransaminase) compared with mice given the single infections 
(LEISH or SCHISTO). Schistosome worm and egg burdens and egg granulomatous 
responses were comparable in CO-INFECT and SCHISTO mice. In contrast, CO-INFECT 
and LEISH mice showed comparable L. donovani infection (Leishman Donovan units 
[LDUs]) in both liver and spleen at +2 weeks but the CO-INFECT mice showed 
progressively increased LDU up to +8weeks post Leishmania infection compared to 
declining LDUs in the LEISH group. 
The S. mansoni infection induced significant IL-4 and IL-10 but not IFN-^y 
splenocyte and liver lymphocyte recall responses to schistosome antigens and mitogen 
whereas the LEISH infection induced specific IFN--y production but not IL-4 to Leishmania 
antigen (Formalin fixed Leishmania amastigote antigen, FLAA). This IFN--y response was 
markedly lower at +2 and +8 weeks post infection in the CO-INFECT mice but FLAA- 
specific IL- 10 responses were higher. Since B-cells have been reported to be a major source 
of IL-10 in S. mansoni infected mice, co-infection experiments were carried out in ItMT 
mice which lack B cells. Indeed there was lower IL-10 production in the CO-INFECT ftMT 
mice and also a lower fold increase in LDU in the liver of CO-INFECT vs. LEISH mice 
compared with the wild-type (WT, C57BL/6) mice. However, the JtMT mice were also 
much less susceptible to infection with L. donovani alone than the WT mice so it is difficult 
to interpret the significance of these results. Administration of anti-IL-10 receptor antibody 
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(anti-IL-10R) between weeks 6-8 after super-infection reduced the high L. donovani LDU 
in the CO-INFECT mice but the significance of this was uncertain since anti-IL- 1 OR treated 
LEISH mice also had lower LDUs. 
Morphologically mature L. donovani granulomas are associated with leishmanicidal 
activity. Histology and immuno-histology showed an increasing proportion of 
morphologically mature granulomas in the hepatic parenchyma of LEISH mice as the 
infection resolved (i. e. between weeks +2 and +8) but in the CO-INFECT mice this 
proportion did not change. Higher mean amastigote numbers in L. donovani granulomas in 
the parenchyma of CO-INFECT mice suggested reduced leishmanicidal activity. 
Throughout the time course 60% of the foci of L. donovani infection were seen in various 
locations within the egg granulomatous response, most commonly in a ring around the 
outside of the granulomas but occasionally within giant cells in egg shells at the centre of 
the granulomas. Typical hepatic L. donovani granulomas did not form around such foci and 
the amastigotes appeared partly contained. 
The data suggests that in LEISH mice mature granulomas effectively kill the 
contained amastigotes limiting new infections so that by +8 weeks the granulomas are all 
mature or fully resolved. In contrast although morphologically normal mature L. donovani 
granulomas form in the parenchyma of CO-INFECT mice these show reduced 
leishmanicidal activity resulting in spread and establishment of new infections. It is 
concluded that raised Th2 responses to S. mansoni results in lowered Leishmania specific 
IFN-, y responses and raised levels of IL-10, both of which would reduce Thl mediated 
macrophage activation required for killing of L. donovani amastigotes. The effects of IL- 10 
plus the failure of Leishmania granulomas to develop around foci within the egg 
granulomas suggests very poor leishmanicidal activity in such foci. 
The final section of these studies was concerned with the effects of an established L. 
donovani . infection on a S. mansoni infection superimposed 2 weeks later. At 8 weeks post 
super-infection, there was no effect on the schistosome worm or egg burdens or the 
immunological and pathological response to the eggs i. e. a strong Th2 response still 
developed. However, lower L. donovani LDUs were seen in the CO-INFECT mice than in 
the LEISH alone and it is suggested that the early phase of the schistosome infection which 
is characterised by Thl responses may have promoted the protective anti-leishmanial 
response. 
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Thl T helper cell-typel 
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CMI Cell mediated immunity 
MLN Mesenteric Lymph node 
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gMT B-cell. deficient mice 
T Transgenic mice 
KO, Knock out mice 
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Chapter 1 
INTRODUCTION 
1.1 Introduction to Schistosoma mansoni: 
1.1.1 General Introduction: 
Schistosomiasis is considered one of the most important public health problems in the 
tropics and subtropics, affecting 4% of the world's population, an estimated 200 million 
people in 74 countries (WHO, 1985; Doumenge and Mott, 1984; Bergquist, 2002). The 
most affected areas are: Africa and the Middle East especially the Nile delta (Egypt); parts 
of the Far East and South-East Asia; and in the New World, notably the Amazon Basin. For 
example, a total of 2.5 million individuals are estimated to be infected by Schistosoma 
mansoni in Brazil despite years of attempted control (Passos and Amaral, 1998). Globally, 
schistosomiasis is recognised as being the most important human helminth infection, 
ranking second to malaria among parasitic causes of human 111-health. The estimated 
mortality due to Schistosoma mansoni and Schistosoma haematobium in sub-Saharan 
Africa is 280,000 per year (van der Werf et al., 2003). Schistosomiasis is an important issue 
for travel medicine with an increased incidence of prolonged unexplained pyrexia among 
tourists travelling to endemic areas thought to be due to acute Katayama fever (van 
Lieshout et al., t997; Elliott, 1996). The infection is transmitted by water snails and surface 
waters such as irrigation canals, rivers, streams, ponds or lakes are the usual source of 
infection but water piped or carried from rural areas to towns may be a source of infection 
too. 
The outcome of schistosome infection is influenced by many factors, such as the species of 
infecting parasite (there are three major human species, S. mansoni, S. haematobium and S. 
japonicum), the intensity and duration of infection, and genetic makeup of the human host. 
In many endemic areas, the prevalence of infection is often very high among young 
individuals but even so, most infections are light, and only in the case of a heavily infected 
minority does significant disease occur (Salam et al., 1979; Kojima et al., 1984; Kamel et 
al., 1984; Ohta et al., 1990; Hafez et al., 1991; Marquet et al., 1996; Abel et al., 2000). 
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Schistosomiasis is curable but, if left untreated, can persist for 30 years even though the 
parasite cannot reproduce in the human host (Lucey and Maguire, 1993). In longstanding S. 
mansoni and S. japonicum infections constant egg deposition causes extensive liver fibrosis 
and may give rise to irreversible calcification of the portal vessels, leading to increased 
portal blood pressure and periportal fibrosis (Symmer's clay pipe-stem fibrosis). However, 
fibrosis and collateral circulation development may progress insidiously and fatal 
haematemesis may occur without warning. Also some patients develop liver failure, 
perhaps caused by concomitant infection with hepatitis viruses (Dean et al., 1987). Chronic 
S. haematobium infections cause fibrosis and dysfunction of the bladder and urinary tract. 
The infection has also been associated with bladder cancer mostly in endemic areas (Dean 
et al., 1987; Wilkins et al., 1987; Farid et al., 1990) and S. haematobium has now been 
officially classified as a carcinogen (Vainio and Kleihues, 1994). Schistosomiasis has 
serious health consequences ranging from reversible growth faltering, permanent growth 
retardation, clinically overt symptoms (e. g. nausea, diarrhoea, dysentery, and fever). 
Malnutrition caused by loss of appetite, nutritional loss, malabsorption, and decreased 
nutrient utilization also occur (Crompton et al., 2000; Stephenson et al., 2000; O'Lorcain et 
al., 2000). In severe intense infection, schistosomiasis can lead to a decrease in working 
capacity (Parker, 1992; 1993), and there is increasing evidence that S. japonicum 
(McGarvey et al., 1993), S. haematobium (Stephenson et al., 1986; 1989) and S. mansoni 
(Jordan and Randall. 1962; Costa et al., 1988; Corbett et al., 1992) can each adversely 
affect child growth and nutritional status. It has also been reported (Kimura et al., 1992) 
that S. haematobium infection depresses cognitive function in children. 
There is at present only one widely available schistosomicide, praziquantel. This is safe, 
effective and now relatively cheap. However, there are concerns about the possible 
development of drug resistance. Recently, Cioli et al. (2000) demonstrated that 
schistosomiasis cure rates using praziquantel are worse than those a decade ago and other 
treatment failures have been reported (Ismail et al., 1994a; 1994b; 1999). Also 
praziquantel -resistant strains of S. mansoni have been generated experimentally (Fallon and 
Doenhoff, 1994) although this does not appear to be widespread as yet in the field. 
Given its distribution in the developing world, which is burdened by many other disease 
agents, schistosome infection is frequently found together with other infectious organisms, 
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viruses, bacteria, protozoa and other worms. The significance of the interplay between 
these different organisms has only recently been appreciated and attention focussed on the 
interplay between microparasites, which tend to induce Thl type responses, and the worrns 
which tend to induce Th2 responses (Scott, 199 1 a). The influence that the immune response 
induced by infectious agents may have on the Th2-dominated allergic reactions including 
asthma is also the subject of great interest (Yazdanbakhsh et al., 2001) 
1.1.2 Life cycle: 
Adult schistosomes are about lcm long and the male has a deep ventral groove or 'Schist' 
in which the female worm resides in copulo. The adult parasites reside in the smaller 
venules of the gastrointestinal or genitourinary tract where they ingest red blood cells and 
break down haemoglobin enzymatically to obtain amino acids for protein synthesis but 
elicit no significant pathology. The female deposits eggs in the smallest venules of the 
intestine or the bladder wall, near the superficial layer of the mucosa. The eggs mature after 
about one week in the tissues to contain the large ciliated 'miracidium' larvae, which infect 
the snail host. 
Eggs are the main cause of clinical disease (Warren, 1978) and when trapped in tissue elicit 
a marked inflammatory reaction with both mononuclear and polymorphonuclear cellular 
infiltrates and formation of a microabscess or granuloma. Granulomas in the gut or bladder 
wall usually rupture into the lumen allowing the eggs to be excreted in faeces or urine. The 
eggs move through the tissues perhaps aided by lytic enzymes which are secreted by the 
miracidium and diffuse through the rough microspores in the egg shell. After reaching fresh 
water, eggs hatch and the swimming miracidium larvae must find an appropriate freshwater 
snail to act as intennediate host. In the snail, they divide asexually into cercariae which are 
released into the water. If they contact susceptible hosts, they actively penetrate through the 
skin losing their tails and becoming schistosomula which undergo morphological and 
biochemical alterations of their membrane. After 2-4 days in the skin, schistosomula 
penetrate into blood and lymphatic vessels and reach the lungs. Crossing the capillary bed 
into the systemic circulation they eventually reach the liver and develop further into male 
and female worms before pairing and migrating to the mesenteric or vesical veins (Jordan 
and Webbe, 1993). 
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1.1.3 Pathology 
A proportion of the eggs pass through the wall of the intestine or bladder and so find their 
way into the environment to complete the life cycle but a significant proportion are retained 
in the intestine or bladder wall or in the case of S. mansoni5 the species used In this study, 
are swept by the blood stream to the liver. Here leakage of soluble egg antigens from 
microspores in the egg shell stimulate a host response to contain the organism but this 
results in immuno-pathology notably in longstanding infections with constant egg 
deposition. Extensive fibrosis occurs and may give rise to irreversible calcification of the 
portal vessels, with major complications being upper digestive tract haemorrhage secondary 
to portal hypertension (Bina, 1987; Prata, 1982; Andrade and Azevedo, 1987; Raia et al., 
1994; Strickland, 1994). The immuno-pathological basis of the schistosome granuloma will 
be considered below in the section on murine schistosomiasis (1.1 -9). 
1.1.4 The general immune response, schistosome development, and immune evasion. 
All stages of schistosome infection induce varying degrees of immune response, however, 
the schistosome eggs induces the strongest response. In the course of an infection, the 
immune response progresses through at least three phases (Pearce and Macdonald, 2002). 
In the first phase (at 3-5 weeks), during which the host is exposed to migrating immature 
parasites, the dominant response is T helper 1 (Thl)-like. In phase two the schistosome 
worms mature, mate and begin to produce eggs at weeks 5-6 (300 to 5000 eggs per day for 
S. mansoni, and S. haematobium respectively) and these result in the emergence of a strong 
Th2 response with a parallel decrease of the Thl response. During the chronic phase of 
infection (at 8-16 weeks) the Th2 response is modulated and granulomas that forni around 
newly deposited eggs are smaller than at earlier times during infection. 
The adult worms survive for many years in the blood stream in spite of strong humoral and 
cell-mediated immune responses induced by the infected host to adult wonn antigens. 
Within minutes of penetrating the skin of the host, a series of adaptations are initiated 
which enable the developing schistosomula to survive attack first by components of the 
innate immune system and then by components of acquired immunity. The trilaminate 
plasma membrane of the cercariae loses its outer glycocalyx coating followed by the 
formation of a double outer plasma membrane which appears heptalaminate (from the two 
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apposed trilaminate plasma membrane plus the space between them). This is due to the 
deployment of preformed membranous bodies at the larval surface and these persist in the 
adult tegument allowing constant repair (Smithers et al., 1977; Ramalho-Pinto et al., 1978). 
Complement activation and action is inhibited by anti-complement factors notably decay 
accelerating factor (DAF) which is derived from the cells of the host and which inhibits C3 
deposition at the surface and SCIP- 1 (schistosome C-inhibitory protein), which is expressed 
by the worms and which inhibits the formation of the membrane attack complex (Pearce 
and Sher, 1987). The uptake of cholesterol and triglycerides increases membrane rigidity 
and the surface acquisition of host-derived antigens is believed to cover the foreign 
antigens of the worm, so preventing antibody binding to the worm surface. These host 
antigens include blood group glycolipids, MHC glycoprotein, fibronectin and 
immunoglobulin (Smithers et al., 1969). 
The intrinsic tegumental resistance to attack varies between the different parasite stages. So 
the skin stage schistosomula are highly susceptible to membrane attack and killing in vitro 
by eosinophil degranulation and the adults are also susceptible (Racoosin et al., 1999; 
Pearce and MacDonald, 1986) but the lung stage is highly resistant to this attack (Bickle 
and Ford, 1982). Even if the lung stage parasite is made antigenic by conjugation of the 
hapten TNP (trinitrophenyl) to its surface and incubated in anti-TNP antibody plus 
eosinophils, these will degranulate onto the larval surface but the larvae are completely 
unaffected by the toxic products released (Bickle and Ford, 1982; Moser et al., 1980). 
Other immune evasion strategies are directed at subverting the immune response. 
Schistosomula have been shown to produce prostaglandin D2 (PGD2) which inhibits the 
migration of epidermal antigen-presenting Langerhans cells from the site of infection 
(Angeli et al., 2001), thereby downregulating the innate response leading to Thl activation 
and inflammation which might otherwise interfere with larval migration. Significant 
quantities of PGE(2) were also produced by cercariae of Schistosoma mansoni following 
incubation with linoleic acid. Cyclooxygenase (COX) 2 inhibitors failed to block this 
PGE(2) production, suggesting that a different biochemical pathway may be involved in the 
production of PGE(2) by the parasite. In addition, the parasites were also able to induce 
PGE(2) and IL-10 from human and mouse keratinocytes. COX2 inhibitors blocked the 
parasite-induced PGE(2) and IL-10 from keratinocytes. This effect could be blocked by 
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anti-IL-10 treatment. The significance of IL-10 in host immuno-regulation by skin stage 
schistosomula of S. mansoni was further confirmed by using IL-10-deficient mice. 
Compared with the wild type (WT) mice, a prominent cellular reaction occurred around the 
parasites, and there was considerable delay in parasitic migration through the skin. Thus 
these results suggest a key role for parasite-induced PGE(2) in IL-10-dependent down- 
regulation of host immune responses in the skin. (Ramaswamy et al., 2000). 
Not only is the worm able to inhibit immune activation but it also seems to have evolved to 
respond to immune components of the host. Certain studies have provided evidence that 
TNF-alpha induces worm fecundity and initiates granuloma formation around the parasites 
eggs (Amiri et al., 1992; Cheever et al., 1999; Davies and McKerrow, 200 1). Davies et al. 
(2001) reported that parasite development was delayed in RAG -/- mice (which lack both T 
cell and B cells) and detailed analyses have shown that a previously unrecognised subset of 
CD4+ T cells lacking both MHC class I and II molecules and localized primarily within the 
liver is likely to have an important in promoting schistosome maturation. It is possible that 
the hepatic T cells produce, or are dependent on, IL-7, because the phenotype that is 
described for schistosomes in Rag-/- mice is similar to that described for parasites that grow 
in IL-7-/- mice (Wolowczuk et al., 1999). A recent study Beall and Pearce, (2001), 
demonstrated that schistosomes express a receptor, SmRKl (S. mansoni receptor kinase-1), 
on their surface that can bind the cytokine TGF-0, which indicate that host cytokines can 
have effects on these parasites. 
1.1.5. Human immunity 
In areas where schistosomiasis is endemic, there is an obvious pattern of age-dependent 
intensity of infection; individuals who are below the age of puberty carry most of the 
parasites, and those in older age brackets are generally less heavily infected (Butterworth et 
al., 1994). For many years the high intensity in children was attributed to their increased 
water contact (Warren, 1973) but studies of reinfection following chemotherapy in which 
rates of water contact were monitored reached a different conclusion. Such studies on S 
mansoni in Kenya (Butterworth et al., 1984; 1985) identified a group of children classed as 
"resistant" because they had high water contact but low rates of reinfection and a group of 
susceptible children which become heavily reinfected following treatment. Comparison of the 
data for these two cohorts demonstrated that the average age of the resistant group was 13 and 
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that of the susceptible group 11 which indicated the operation of age-dependent factors that 
prevent reinfection. Demeure et al. (1993) took a similar approach and concluded that 
although water contact was a major factor in intensity of infection it, alone, could not explain 
the patterns adequately. 
More recent studies of populations in which the infection had been recently introduced 
(reviewed by Gryseels, 1994) demonstrate that similar age-intensity profiles develop 
relatively soon after the start of community exposure indicating that it is age per se more 
than duration of exposure that is responsible for the lower infection intensities in the adults 
(Polman et al., 1995; van Dam et al., 1996). Fulford et al. (1996) looked at data from a 
number of studies and showed that the peak in intensity of re-infection occurred at a very 
consistent age followed by a sharp decline. The data on water contact for several areas 
showed generally higher contact for the younger age groups but the distribution was much 
more spread and clearly did not mirror the age intensity pattern. Furthermore, in a study of 
a fishing community in Uganda, the pattern of observed contact with water known to 
contain infected snails was greater in adults than in children (Fulford et al., 1996). Despite 
this, six months after treatment, the Ugandan community showed a peak of reinfection 
intensity at about ten years of age, which fell away to a much lower level by the age of 
twenty (Kabateriene et al., 1999). As infection levels begin to decline around the early teen 
years, it has been considered that this may be due to anatomical and physiological changes 
associated with puberty e. g. increased skin thickness or fat deposition which may affect 
skin penetration, or to hormonal changes associated with the onset of puberty (e. g. adrenal 
androgen; dihydroepiandrostrone [DHEA]) (Fallon et al., 1998; Abebe et al., 2003). 
It should be appreciated that these various studies on human immunity have looked at 
reinfection after treatment and the finding that multiple reinfection episodes (and cures) 
correspond with increased time to subsequent reinfections for some people led to the 
hypothesis that the treatment itself and the consequent worin death and antigen release may 
result in priming and boosting of the immune response to resist reinfection (Woolhouse and 
Hagan, 1999). 
Hagan et al. (1991) provided the first insight into the possible immune mechanisms 
responsible for the human immunity. They found a correlation between high specific anti- 
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worm immunoglobulin E (IgE) antibody levels which increased up to the teenage years and 
apparent resistance to reinfection following chemotherapy but there was also a correlation 
with lowered specific anti-worm IgG4 which also increased up to early teenage and then 
declined. The positive influence of specific IgE and the negative reciprocal effect of IgG4 
in immunity to S. mansoni reinfection have also been reported in several independent 
investigations carried out in Africa and Brazil (Dunne et al., 1992a and 1992b; Demeure et 
al., 1993; Rihet et al., 1991; Caldas et al., 2000). The slow development of appropriate 
immune responses to worm antigens might be linked to the fact that schistosomes are very 
long-lived-parasites and the host becomes exposed to these antigens only after the parasites 
die (Woolhouse and Hagan, 1999), either as a result of ageing or drug intervention. The 
implication of high IgE and lowered IgG4 led to the notion that IgE was an effector isotype 
and IgG4 a blocking isotype. Despite the current acceptance that immunity does operate in 
humans Mwanakasale et al. (2003) demonstrated that resistance to reinfection with S. 
haematobium after treatment with praziquantel is not altered in subjects co-infected with 
HIV but this was prior to the development of symptoms and signs of AIDS/HIV disease 
and so the level of immuno-compromise was not severe. 
Other studies have implicated eosinophils in human immunity. Hagan et al. (1985) reported 
that resistance to S. haematobium in humans was related to high eosinophil counts. A 
longitudinal study of cellular responses of S. mansoni-infected individuals in Kenya before 
and after treatment showed a negative association between the proliferative responses to 
adult worm- and schi stosomulum- stage antigens and subsequent reinfection intensity in 
older individuals (the resistant group), who also had significantly higher levels of IL-5 in 
tissue culture supernatants of in vitro-stimulated cells than did younger individuals (the 
susceptible group) (Roberts et al., 1993). IL-5 is produced by Th2 cells and as it is 
responsible for eosinophil production/action this also suggested a role for eosinophils in 
human immunity in vivo. 
So IgE and eosinophils have been implicated but it is not known if or how this might 
operate in vivo. In vitro, however, human effector cells, eosinophils, macrophages and 
platelets are able to kill freshly transformed schistosomula in the presence of complement 
and/or antibody (Butterworth et al., 1975; Joseph et al., 1985). Regarding antibody-mediated 
cellular cytoxicity both the IgG (Anwar et al., 1979) and IgE (Capron et al., 1984) fractions 
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of human infection sera have been shown to be capable of opsonising the schistosomula for 
killing but IgE/eosinophils is a particularly potent combination (Dunne et aL, 1993). 
The ability of antibodies to block in vitro ADCC was initially described by Grzych et aL, ( 
1982,1984) using rat monoclonal antibodies. Mouse monoclonal antibodies of the IgM 
isotype directed at larval surface antigens were later shown to block in vitro killing of 
schistosomula by immune human serum and eosinophils (Dunne et al., 1987). Evidence that 
blocking antibodies are raised during a natural infection of humans was provided by Khalife et 
al. (1986) who demonstrated that the in vitro killing of schistosomula by the IgG fraction of 
sera taken from infected individuals was abolished by prior incubation of the larvae with the 
IgM fraction which unlike IgG does not have Fc receptors on eosinophils but can compete 
with the IgG for opsonization of the larvae. In regard to the IgE/IgG4 relation with human 
immunity it is suggested that IgG4 which also does -not have Fc receptors on eosinophils may 
similarly block IgE mediated larval killing (Nutten et al., 1997; Capron et al., 200 1). 
The above implication of specific IgE and eosinophils suggested the importance of Th2 
responses in human immunity (Hagan et al., 1991; Roberts et al., 1993; Grogan et al., 
1997; Medhat et al., 1998). Supporting evidence comes from a number of studies. Karanja 
et al. (2002) demonstrated an increased risk of reinfection among HIV-1 positive 
individuals with decreased CD4+ T cell count and a marked decrease in levels of Th2 
immune response in HIV-1 positive schistosomiasis patients. Immuno- epidemiological 
studies in Brazil demonstrated that the increased intensity of infection is influenced by a 
major gene (Sml) that maps to a region of chromosome 5 (5q3 1-q33) that encodes the Th2 
cytokines (Marquet et al., 1996). Cells from homozygous individuals for the resistant allele 
generated Th2 skewed T-cell clones (TCC) which secreted 10-1000 fold more IL-4 and IL- 
5 and a much higher IL-4/IFN or IL-5/IFN ratio than TCC from homozygous sensitive 
individuals when stimulated with parasite antigens (Rodrigues et al., 1999). This indicates 
that the SI locus controls the differentiation of Th2 lymphocytes and further implicates Th2 
mediated effector mechanisms in resistance to schistosomes. 
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1.1.6 Evidence for resistance to reinfection in experimental animals-"concomitant 
immunity" 
There are no good animal models for the slow build up of infection which occurs in 
humans, but rodents, such as mice and rats and, to a lesser extent, primates such as the 
rhesus monkey and the baboon have all been used in experimental infections with S. 
mansoni. Studies in rhesus monkeys (Smithers and Terry, 1969) showed that primary light 
infections could be established giving rise to low level egg production in the faeces, but that 
following challenge infection with large numbers of cercariae, egg output was unaltered 
although in challenge control monkeys faecal output rose dramatically. This was termed 
"concomitant immunity" as the primary worm burden was apparently unaffected by the 
response which eliminated the challenge infection. It has been suggested that a similar 
phenomenon may operate in naturally acquired immunity in humans. Unfortunately nothing 
is known of the mechanism of the resistance in rhesus monkeys. 
In mice, resistance to challenge arises within 8 weeks of a single unattenuated infection (Dean, 
1983) and resembles concomitant immunity in that the primary infection persists but the 
incoming larvae appear to succumb. However, it now accepted that the apparent resistance 
seen in this model is due to the pathological response of the host to parasite eggs deposited 
within the tissues (Wilson et al., 1983; McHugh et al., 1987) or with factors related to egg- 
associated pathology, such as the degree of portal hypertension (Harrison et al., 1982) or 
formation of portal shunts which allow the migrating larvae to bypass the liver and die in other 
organs (Wilson et al., 1983). This has limited the use of the mouse to mimic human immunity 
despite the widespread use of mice for most schistosome research. 
1.1.7 Prevention and control 
The most practical way of controlling schistosomiasis at present is through eradication of 
the adult worms using chemotherapy; eliminating the snail intermediate hosts by habitat 
modification or chemical attack; by changing human behaviour through health education 
and by providing safe water supplies and sanitation so that excreta containing live eggs do 
not reach water containing snails (Webbe and Jordan, 1993). There are problems with all of 
these approaches notably rapid re-infection after treatment and recurrent costs of 
chemotherapy and the costs provision and maintenance of sanitation and safe water. 
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1.1.8 Prospects for vaccination 
There has been intensive research effort to develop a schistosome vaccine (Bergquist, 
1995). High level of resistance can be induced in a range of experimental hosts ranging 
from rodents to baboons by exposure to relatively large number of schistosome larvae 
which have been irradiated with -y-, X- or ultra-violet- radiation in order to make them die 
out before the egg-laying adult stage (Taylor, 1994). The live attenuated vaccines are not 
suitable for human use because of the logistical difficulties of producing and preserving 
such a vaccine and for safety reasons. However, analysis of the immunity they induce may 
contribute to development of defined antigen vaccines although it is unknown if the 
immunity induced is in any way comparable to naturally acquired resistance in man. 
The mechanism of live attenuated vaccine immunity in mice and rats operates during larval 
migration through the lungs where there is an accelerated and enhanced cellular reaction 
around the migrating lung schistosomula which seems to trap the parasites in immune 
animals (Coulson, 1997). In rats this reaction can be transferred with antibody but in the 
. protection is dependent on CD4+ve T cells (Vignali et al., 1989) and IFN--y (Smythies et 
al., 1992; 1999). Consistent with this Thl requirement following single vaccination, IL-12 
and bacterial CpG motifs (which can induce the production of IL-12 by dendritic cells and 
macrophages) can be used as adjuvants to boost attenuated vaccine immunity (Wynn et al., 
1996; Chiaramonte et al., 2000). However, when mice are repeatedly exposed to 
attenuated larvae Th2 cytokines increase (Caulada-Benedetti et al., 1991), the requirement 
for CD4 +ve Tcells disappears (Kelly and Colley, 1988) and antibody assumes a major role 
as shown by the ability of the serum to transfer protection (Mangold and Dean, 1992). In 
the once vaccinated mouse the macrophages in the inflammatory lung reactions are in the 
activated state and show NO synthase activity but immunity is not dependent on NO 
production as iNOS-knockout mice show comparable protection to wild-type mice 
(Coulson et al., 1998). Vaccinated IL-10-/- mice develop exaggerated Thl and Th2 
responses and are almost entirely resistant to infection (Hoffmann et al., 1999), which 
indicates that a high-magnitude immune response involving both antibody and Thl 
responses might be the best option for induced resistance to schistosome infection. 
With the advent of recombinant DNA technology numerous schistosome protein genes 
have been cloned. Possible candidates for recombinant antigen vaccines includes: (i) Larval 
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surface antigens which might mediate ADCC or (ii) antigens secreted from the lung stage 
larvae which might mediate antibody or T cell mediated inflammatory reactions in the lung 
as seen with the irradiated vaccine. Numerous recombinant antigens representing both 
soluble and larval surface antigens have been tested and some reported to induce protection 
but none have proved reliable in independent testing (Bergquist, 1998). Only one such 
antigen, the 28kDa glutathione S-transferase of S. haematobium has entered phase I human 
clinical trials (BILVAX rP28), and the main protective effect of this vaccine may be to 
reduce egg production and thus reducing the pathology (anti-pathology vaccine) (Hagan et 
al., 2000). 
1.1.9 The Murine model of S. mansoni infection 
The murine response to S. rnansoni mimics what happens in man in terms of the full 
development of the infection and the pathological conditions. The egg stage is the most 
immunogenic and immuno-dominant phase of the infection and the immune response to the 
eggs causes the pathology in S. mansoni infection and involves granulomatous reactions 
around the eggs in the liver and gut (Pearce et al., 199 1; Grzych et al., 199 1). By contrast, 
the worms themselves do not induce significant pathology. At the 5th wk post-infection, the 
mature female worms begin to produce large numbers of eggs many of which lodge in the 
liver and intestinal tissue. The nature of the granulomatous response has been studied in the 
livers of infected mice and also in the "synchronous pulmonary granuloma" model (Wynn 
et al., 1993; 1997) in which eggs which had been purified are injected into the lungs of 
recipient mice. 
In both mice and humans the granuloma is composed of lymphocytes, macrophages, 
epithelioid cells, giant cells, eosinophils and fibroblasts although the relative proportion of 
these cell types changes as the miracidium dies and the granuloma ages such that eventually 
the empty egg shell surrounded by a small fibrotic reaction is left (Dunne and Pearce, 1999; 
Davies and McKerrow, 2001). During the course of infection of mice granulomas reach a 
maximum size at 8-10 weeks post-infection but are then markedly modulated or reduced in 
size by 12 weeks and thereafter (von Lichtenberg et al., 1962, Boros et al., 1975). 
The granulornatous reaction is considered to be a T-cell mediated immune response 
(Domingo and Warren, 1968, Boros et al., 1975), as evidenced by the suppression of 
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hepatic granuloma formation in anti-CD4 treated mice (Mathew and Boros, 1987; Phillips 
et al., 1987) and the formation of small granulomas in athymic mice (Phillips et al., 1977). 
In humans, a study of CD4+ T cell-deficient humans (HIV co-infected) also suggested that 
CD4+ve T cells are involved in granuloma formation Karanja et al. (1997). Thus it had 
previously been shown that T-cell deprived mice showed reduced faecal egg output and it 
was reasoned that the granuloma formation was necessary for this excretion (Doenhoff et 
al., 198 1; Cheever et al., 1999). Similarly the HIV and schistosome co-infected individuals 
had a significant defect in egg excretion in comparison to HIV negative, schistosome 
positive individuals suggesting that they also had impaired granuloma formation (Karanja et 
al., 1997). In T-cell deprived mice (Dunne and Doenhoff, 1983) or mice which are tolerized 
against S. mansoni egg antigen, granuloma development does not occur during infection 
and the animals have severe hepatotoxic liver damage, which was evident as microvesicular 
lipid accumulations (or steatoses) with hepatocytes (Fallon and Dunne, 1999). This is 
thought to be mediated by hepatotoxins that are secreted from the eggs, and the 
granulomas, together with egg- antigen- specific antibodies which might act in a neutralizing 
capacity, are envisaged as sequestering these toxins away from hepatocytes (Dunne and 
Doenhoff, 1983). So, the granulornatous response around schistosome ova is seen as a host 
protective tissue response which plays an integral role in host defence against this parasite 
eggs (von Lichtenberg, 1964, Dunne et al., 198 1) and facilitates their destruction (Warren, 
1978). From the parasite perspective the granuloma seems to facilitates egg excretion and 
so represents a balanced response of some benefit to both the host and the parasite 
1.1.9.1. The cytokine response 
A number of studies in mice have demonstrated that down-regulation of the production of Th I 
type cytokines e. g. IFN--y and IL-2 and an up-regulation in Th2 cytoldnes such as IIL-4, IL-5 
and IL-10 (although not exclusively a Th2 cytokine), occurs at the onset of egg production 
(Pearce et al., 1991; Sher et al., 1991; Grzych et al., 1991). A Th2 biased response similarly 
develops in human infections (Parra et al., 1992; Williams et al., 1994; El Ridi et al., 
1997), although Montenegro et al. (1999) reported that in chronically infected individuals a 
mixed type-1/type-2 anti-egg cytokine response can be observed. 
That the Th2 response is central to granuloma formation is shown by numerous studies. IL- 
4 is crucial for the development of Th2 responses and for the counter-regulation of Thl 
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responses. Thus IL-4 depletion with anti-IL-4 monoclonal antibody in schistosome-infected 
mice or intravenously egg-injected mice reduced egg-induced granuloma inflammation by 
50%, reduced the production of the type-2 cytokines IL-5 and IL-13 and reduced fibrosis 
(Yamashita and Boros, 1992; Wynn et al., 1993; Cheever et al., 1994). Conversely, 
administration of recombinant IL-4 to chronically infected animals reversed the down- 
regulated granulomatous response typically observed in later stages of infection (Yamashita 
and Boros, 1992). These studies show that IL-4 is, at least in part, responsible for the 
generation and maintenance of the type-2 immune responses. 
Various studies show, however, that IL-13 also plays a role in granuloma fori-nation. 
Granuloma size is diminished in IL-4-/- mice but not as much as in STAT6 [signal 
transduction and activator of transcription 6-] deficient mice (Kaplan et al., 1998). Such 
infected mice, which lack Th2 cells as STAT-6 is responsible for signalling by both IL-4 
and IL-13, produced high levels of the Thl cytokines, IFN--y and IL-2, minimal IL-4 and 
greatly reduced IL-5 and IL-10. Furthermore, IL-4/IL-13 double knockout (KO) mice 
barely develop granulomas at all (McKenzie et al., 1999). The contribution of IL-13 to 
granuloma formation was confirmed by conducting IL-13 blocking experiments using the 
soluble decoy receptor, IL-URc2, in IL-4-deficient mice, which resulted in a more 
significant (almost complete) abrogation of granuloma formation than in the IL-4- deficient 
mice alone (Chiaramonte et al., 1999a). These findings demonstrate that IL-4 and IL-13 are 
both necessary and sufficient to mediate granuloma development, and formally explain the 
maintenance of granulomatous inflammation in infected IL-4-deficient mice. 
Although Th2 cytokines predominate, both Th2 and Thl cells are involved in the formation 
of granuloma as discussed below (section 1.1.11). 
1.1.9.2. Production of profibrogenic cytoldnes, IL-4 and, IL-13 
Several studies have now demonstrated that IL-13 rather than IL-4, plays the major role in 
the development of egg-induced liver fibrosis. In a study by Fallon et al. (2000) IL-13 KO 
mice did not show a reduced granulornatous response but did show a dramatic reduction in 
collagen deposition whereas this was unaffected in IL-4-/- mice but was ablated along with 
granuloma formation in IL-4/IL-13 KO (Fallon et al., 1999). Chiaramonte et al. (2001) 
reported that administration of the IL-13 decoy receptor, IL-13RcO--Fc protein, to infected 
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mice led to significantly reduced collagen mRNA expression and so this could become a 
useful therapy for fibrotic disease. This receptor, which is present in a soluble form, will 
bind IL-13, preventing its binding to IL-4Ru/IL- 13 Roil which is the functional IL-13 
receptor responsible for signal transduction leading to fibrosis. The level of soluble serum 
IL- 13 Ra was recently demonstrated to correlate with infection intensity in infected humans 
which suggested that it may have important anti-pathology effects in vivo (Mentink-Kane et 
al., 2004). 
The fibrogenic role of interleukin-13 (IL-13) seems to stem from its ability, together with 
IL-4, to induce the expression of arginase which has been demonstrated in macrophages 
(Hesse et al., 2001). Arginase uses L-arginine as a substrate to make L-ornithine, which is 
converted to proline by omithine aminotransferase. Proline is an essential amino acid that is 
involved in collagen production and therefore, in the development of fibrosis. Arginase 
activity is abundant within the S. mansoni egg granulomas (Hesse et al., 2001). It was 
initially suggested that the granuloma macrophages were likely to be responsible for the 
collagen production and fibrosis in schistosomiasis but recent studies have shown that mice 
with a selective deletion of IL-4Ra expression in macrophages (and neutrophils) display 
normal levels of liver fibrosis (Herbert et al., 2004). This led these authors to suggest that 
the likely source are the abundant granuloma fibroblasts. These have receptors for IL-13 
(Murata et al., 1998) and both IL- 13 and IL-4 are capable of promoting collagen production 
in fibroblasts (Chiaramonte et al., 1999; Murata et al., 1999). However, the fact that 
cultured lymph node cells from S. mansoni infected mice produce nearly 100-fold more IL- 
13 than IL-4 would explain the greater role that IL-13 has in schistosome fibrosis 
(Chiaramonte et al., 1999). 
IL- 13 plays other important roles in the immune response to schistosomiasis. IL- 13 exhibits 
chemotactic activity for human eosinophils and may play a role in their survival by 
stimulating the production of IL-13 and granulocyte-macrophage colony-stimulating factor 
(GM-CSF) (Horie et al., 1997). In addition, a novel IL-4-independent pathway for IgE 
switching in the mouse has been described (Morawetz et al., 1996) which appears to be 
controlled by IL- 13 (Emson et al., 1998) explaining the ability of IL- 13 to induce IgG4 and 
IgE synthesis and direct IgE isotypes switching in human B cells (Punnonen et al., 1993). 
Also, IL-13 has been shown to regulate adhesion molecule expression on human 
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endothelial cells (Bochner et aL, 1995), and the expression of ICAM-1 in particular is 
important to granuloma development (Ritter and McKerrow, 1996). 
Origin of the Th2 response to schistosome eggs. 
Using the ELISPOT technique King et al. (2001) reported that the dynamics of IL-4, IL-5 
and IFN--y secreting splenocytes preceded by two weeks the cytokine production in the 
hepatic granulomas which peaked at 10 weeks and exceeded that observed in splenocytes 
by 5-10-fold. At 8 week post infýction, the principle source of IL-4, IL-5 and IFN-'y 
secreting splenocytes were CD4+ T cells whereas only approximately half of the IL-4 and 
IL-5 secreting granuloma cells were CD4+ve T cells. These observations are consistent 
with the production of IL-4 and IL-5 by cells other than CD4+ T cells present in the 
granulomas, including NK cells (Mountford et al., 1996), CD8+ T cells (Pedras- 
Vasconcelos and Pearce, 1996), -yb T- cells cells (Raziuddin et al., 1992), activated 
eosinophils (Rumbley et al., 1999), basophils (Gibbs et al., 1996) and non-B, non-T cells 
(Sabin and Pearce, 1995). Eosinophils represent a dominant source of IL-4 in the 
granulomas (Rumbley et al., 1999) and show greatest activation at the time of maximum 
granuloma formation, i. e. 10-12wk after initial cercarial exposure. 
This suggests that the initial development and activation of SEA-reactive lymphocytes 
occur in peripheral lymphoid tissues. The earlier occurrence but lower frequency of egg 
antigen-reactive splenocytes compared to granuloma cells and their increased cytokine 
production in response to exogenous SEA is consistent with the presence in the spleen of 
low concentrations of SEA which partially activate, but do not terminally differentiate, 
SEA reactive CD4+ memory T cells. King et aL (2001) speculate that low concentrations 
of egg antigen reach the spleen and other peripheral tissues and there induce SEA-specific 
cells which migrate into the granuloma where they become fully activated by high local 
concentrations of endogenous antigen released by the viable ova. There they secrete 
specific cytokines such as IL-4, IL-5 and IFN--y that mediate specific antibody responses, 
induce tissue eosinophilia and activate macrophages and multinucleated giant cells, 
respectively, that are thought to participate in ova destruction and local containment of 
parasite products. This explanation is supported by findings that activation antigens, such 
as CD69 and IL-2R, are more highly expressed in granuloma than splenic lymphocytes 
(Rumbley et al., 1998). 
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1.1.10.3 Which egg components stimulate the Th2 response? 
An area of current intense research interest is focused on how Th2 responses are 
induced. As for certain other helminth products, it is generally accepted that 
schistosome eggs induce an intense Th2 response without the need for additional 
adjuvant and that this is principally responsible for the shift from a Thl response in the 
prepatent period to a strong Th2 response as the eggs are produced (Pearce et al., 1991; 
Vella and Pearce., 1992). Much of this analysis has been based on splenocytes 
responses and Hayashi et al. (1999) reported that hepatic T cells deviated into type2 
cytokine production without showing any typel shift in the prepatent period. Unlike 
splenocytes, hepatic lymphocytes from infected mice during the prepatent period 
already produced a huge amount of IL-4, IL-13, and IL-5 and a lesser amount of IFN--y 
in response to soluble worm Ag preparation (SWAP). These results suggests the prompt 
type 2 deviation in the liver after the infection might be due to the alteration of Kdpffer 
cells that induces soluble worm antigen preparation (SWAP)-mediated type2- 
development of hepatic T cells (Hayashi et al., 1999). 
Nevertheless it is now clear that egg products promote a marked Th2 skewed response 
and that this largely controls the nature of the granulomatous response around the eggs. 
Various soluble egg antigen components e. g. proteins, glycans and lipoconjugates can 
all induce Th2 cells. One recombinant protein, IPSE, which is a prominent secreted egg 
product, can stimulate the release of IL-4 by human basophils (Schramm et al., 2003). 
IPSE seems to bind to 19E present on the cell surface of basophils, irrespective of 
antigen specificity, and activates cells by cross-linking. A second recombinant protein, 
TCTP, also activates basophils in terms of histamine release (Rao et al., 2002). 
Recent work has shown that carbohydrates on egg antigens are integral to this process 
(Okano et al., 1999; 2001; Williams et al., 2001) and, specifically, that a 
polylactosamine sugar (lacto-N-fucopentaose 111) acts as a Th2 adjuvant (Okano et al., 
2001) eliciting strong Th2-cell recall responses (IL-4, IL-5, IL-10, and IgE) in mice 
when conjugated to human serum albumin (Okano et al., 2001). The most 
immunoreactive components are glycoproteins found in the eggs and schistosomula. 
Egg glycoproteins were found to stimulate production of B-1 cells (CD5+ B220+) 
which appeared in the peritoneal cavity of mice at the time of egg production (Ham et 
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al., 1989). B-1 cells, distinct from the conventional B cells, are characterized as a self- 
replenishing lineage of B cells which produce autoreactive immunoglobulin M (IgM) 
antibodies and are capable of producing large amounts of IL-10 (O'Garra et al., 1992; 
Velupillai et al., 1997; Palanivel et al., 1996). Two immunoreactive oligosaccharides 
from the egg antigens were found to be involved (Ham et al., 1989): (i) Lacto-N- 
fucopentaose III (LNFP-III) which contains the Lewis-X trisaccharide. Lewis-X is a 
weak ligand for P-selectin (Larsen et al., 1992; Stoolman, 1989) and is also found on 
lymphocyte function-associated molecule- 1, which is a ligand for intercellular adhesion 
molecules I (Larsen et al., 1992). (ii) the non-fucosylated homologue, lacto-N- 
neotetraose (LNT). LNFP-III and related sugars (LNT) were found to be lympho- 
stimulatory and induced proliferation of splenic non-T cells, B220+, CD4-, CD8- cells 
(B cells) of schistosome infected and naYve mice. LNFP-111 induced spleen cells to 
produce large amounts of IL-10 and prostaglandin E2, two molecules known to 
downregulate Thl CD4+ T cells and so contribute to Th2-subset dominance. 
Interestingly, LNFP-III did not induce the production of IL-4 (Velupillai and Ham, 
1994). Thus, a specific carbohydrate ligand has been identified that stimulates B cells to 
proliferate and produce factors that downregulate Thl T cells (Velupillai and Ham, 
1994). The emerging role of carbohydrates as factors that are important for the 
induction of the immune response during schistosomiasis opens up the possibility that 
innate pattern recognition receptors that identify carbohydrates might have a crucial 
role in the induction of a Th. 2 response. Notably, the host-like glycans, such as the 
Lewis-x related carbohydrate lacto-N-fucopentose III, which when conjugated to 
human serum albumin, elicits strong Th2-cell recall responses (IL-4, IL-5, IL-10, and 
IgE) in mice (Okano et al., 2001). 
Recently, lipid fractions from the eggs have been shown to induce Th2-cell 
differentiation, in a manner that is distinct from the stimulation of Treg cells, as only 
the latter depends on TLR2 (van der Kleij et al., 2002; 2004). 
1.1.10.4 The role of DC in inducing Th2 responses. 
Recent elegant studies have focused on detennining how SEA interacts with dendritic 
cells (DCs) to induce Th2 responses (MacDonald et al., 2001; 1982). There is general 
acceptance that DCs are able to activate Thl cells during primary antigen exposure by 
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delivering (at least) three signals (Banchereau et al., 2003; Moser, 2001): antigen 
presentation via MHC-class II (major histocompatibility complex molecules-II); 
costimulatory signals by upregulation of costimulatory molecules such as CD80 and 
CD86; and a third signal, candidates for which include DC produced IL-12 (Macatonia 
et al., 1989) and CD40 (on DC) and CD 154 (on T cell) interactions (Cella et al., 1996). 
Triggering of the DC for such functions is believed to arise from PAMPS (pathogen 
associated molecular pattern molecules) interaction with Toll-like receptors (TLR) on 
the DCs (Trinchieri, 2003). MacDonald et al. (2001) showed that DC exposed to 
antigen of the bacterium Proprionibacterium acnes (Pa), show this typical pro-Thl 
activation and when transferred in vivo into naYve mice induce Thl responses. In 
contrast, DC exposed to SEA failed to show upregulation of costimulatory molecules or 
detectable cytokine production (McDonald et al., 2001) but were able to induce Th2 
responses (IL-4, IL-5, IL-13) but not IFN--y when transferred into naYve mice and this 
was shown to depend on CD40 expression by the DC. One suggestion is that Th2 
responses reflect a default which occurs when antigen fails to induce DC maturation. It 
has also been suggested that there are different populations of DC able to respond to 
either Thl or Th2 stimuli. These possibilities were investigated by stimulating DC with 
both Pa and SEA (Cervi et al., 2004) and these studies argued against there being DC I 
and DC2 by showing that the same DCs took up both antigens but could direct discrete 
Thl or Th2 responses to Pa and SEA respectively when transferred to naYve mice. The 
Pa and SEA however, entered different intracellular compartments in the DC with 
different predicted antigen processing capabilities. This led the authors to suggest that 
molecular motifs on the different antigens led to them being directed into different 
compartments resulting in differential processing perhaps resulting in a higher density 
expression of Pa compared with SEA and that this may ultimately be a key trigger to 
Th 1 or Th2 signalling. Carbohydrate components of the SEA have been implicated in DC 
priming because LN cells of mice that received periodate-treated SEA-pulsed DCs 
produced 6-to 10-fold less Th2 cytokines (IL-4, IL-5 and JIL-10) upon in vitro stimulation 
with SEA (Faveeuw et al., 2002). 
Studies with human myeloid DCs have shown the upregulation of OX40L expression (a 
factor known to be expressed by the peripheral blood DC and involved in Th. 2 cell 
development [Brocker et aL, 19991), and production of poor levels of IL-12p7O, TNF-(x 
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and IIL-6 following interaction with SEA upon CD40 ligation (Kalinski et aL, 2000). 
Interestingly, glycan moieties present on egg glycoproteins or glycolipids have also been 
implicated in this DC priming for Th2 response. 
1.1.11 Counter regulation between the Thl and Th2 responses 
In spite of this focus on Th2 responses it is clear that Thl responses are induced in 
schistosomiasis and are crucial for immunoregulation of disease. The underlying Thl 
response is revealed, for example, following treatment with anti-IL-4 monoclonal 
antibody (mAb) when antigen specific IFN--y and IL-2 responses are increased 
(Yamashita and Boros, 1992). Treatment with recombinant IL-12 (rIL-12) alone or 
combined with neutralization of Th2 type cytokine production also suppressed Th2 cell 
development and profoundly inhibited pulmonary and early hepatic granuloma 
formation during infection (Wynn et al., 1994; Boros and Whitfield, 1999). Conversely, 
administration of anti-IFN--y (Luckacs and Boros, 1993) or anti-IL-12 mAb (Wynn et 
al., 1994) promoted pulmonary granuloma formation due to enhanced Th2 cell 
expansion. Similar findings were reported in gene targeted KO mice models. IL-12-/- or 
IFN-Y/- mice also developed severe disease, with excessive Th2 responses, and marked 
mortality associated with increased granuloma size and fibrosis (Hoffinann et al., 
2000). Conversely, STAT6-deficient mice (Kaplan et al., 1998) produced high levels 
of Thl cytokines IFN--y and IL-2, minimal IL-4 and greatly reduced IL-5 and IL-10. 
They developed decreased size of (smaller) both pulmonary and hepatic granulomas 
with very sparse eosinophils, and decreased amounts of liver hydroxyproline content as 
a measure of collagen deposition. The balanced nature of the response in normal mice 
was shown by the fact that several of these treatments to promote Thl or Th2 responses 
led to increased mortality, on the one hand due to reduced granuloma formation and on 
the other to increased responses. 
The influence of IL-4 has been studied in several experiments in IL-4-/- mice. These 
show greatly impaired granuloma formation and impaired Th2 cytokine responses but 
somewhat different levels of mortality (Pearce et al., 1996; Metwali et al., 1996; 
Kaplan et al., 1998). In the studies of Brunet et al. (1997) and Fallon et al. (2000) the S. 
mansoni infection led to cachexia, with evidence of hepatotoxicity and significant 
mortality. This process was accompanied by detectable levels of lipopolysaccharide in 
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the plasma, perhaps owing to the translocation of intestinal bacteria (Fallon et al., 
2000). This severe intestinal inflammation resulted in endotoxemia and death (Fallon 
and Dunne, 1999; Fallon, 2000, Patton et al., 2001). Analyses of the immune system of 
the infected IL-4 -/- mice showed there were an increase in production of pro- 
inflammatory cytokines i. e. IFN--y and TNF-a (Fallon and Dunne, 1999; Hoffinann et 
al., 2000), and there was a correlation between elevated levels of nitric oxide (NO) and 
disease severity (Brunet et al., 1997). Treatment with uric acid, which is a 
peroxyradical scavenger, had marked ameliorative effects (La Flamme et al., 2001). 
However, Metwali et al. (1996) conclude that the increase in IFN--y expression was 
only slight and suggested that IL-4-deficient mice failed to default to a robust Thl 
response because they maintained a significant non-T-cell-derived immuno- suppressive 
IL-10 response. Several studies have shown that the Th2 cytokine responses can 
develop in vivo in the absence of IL-4 or IL-4 receptor alpha, which is consistent with 
the findings in the schistosomiasis model (Jankovic et al., 1999; 2000). 
Consistent with this, animals deficient in both IL-4 and IL- 10 did develop highly 
polarized Thl responses with dramatic increases in IFN--y and simultaneous reductions 
in Th2-type cytokines both in vitro and in vivo (Wynn et al., 1997; Hoffmann et al., 
2000). The IL- I O/IL-4- deficient mice, developed an acute wasting condition at the 
onset of egg-laying leading to 100% mortality, and showing strong evidence of 
increased hepatotoxicity that seemed to be an exaggerated form of the disease that is 
observed in infected IL-4-/- animals (HofErnann et al., 2000). This acute mortality was 
linked to the over-expression of the pro-inflammatory mediators IFN--y, TNF-Cý both of 
which increase the expression of inducible nitric oxide synthase (iNOS) which converts 
the L-arginine to L-hydroxy-arginine eventually leading to excessive production of NO 
and citrulline but diverting L-arginine from the collagen pathway leading to non- 
fibrotic granulomas (Hesse et al., 2001). 
Together these results demonstrate that the early production of IL-4 and EL-10 are 
equally important to Th. 2 response polarization in vivo, with IL-4 driving Th2 
development and IL- 10 polarizing the response by downregulating IL- 12 and Th 1 -type 
cytokine expression. IL-10 KO mice develop large granulomas with elevated Thl and 
Th2 cytokines but with no significant increase in hepatic fibrosis compared to WT mice 
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showing that IL-10 modulates both the Thl and Th2 components of the granulomatous 
response (Metwali et al., 1996; Wynn et al., 1997; Hoffmann et al., 2000). IL-10 
modulation of the developing Thl response would explain the marked reduction which 
occurs in IL-12 production soon after egg injection in the pulmonary granulomatous 
model (Wynn et al., 1994) further indicating the importance of rapidly inducing IL-10 
response against S. mansoni eggs. 
Studies in humans demonstrate a role for inflammatory cytokines and their regulation 
by IL-10 in urinary tract morbidity during S. haematobium infection (King et al., 2001). 
IL-10 (and TNF-cc) release from egg-stimulated PBMC cultures was compared in age- 
and sex-matched infected children and adolescents suffering from moderate to severe 
bladder wall pathology. A significantly lower ratio of egg-specific IL-10: TNF-oc 
production from PBMC cultures obtained from the patients with severe bladder wall 
pathology, suggesting that low IL-10 and high TNF-a can correlate with an increased 
risk of developing severe disease during schistosomiasis. A recent study examining the 
correlates of developing severe fibrosis in adult male populations living in Uganda who 
were chronically infected with S. mansoni, also demonstrated that a deficiency in IL- 10 
was partly responsible (Hoffmann et al., 2002). 
Despite the serious inflammatory disease associated with uncontrolled Thl responses to 
the eggs it is clear that the Thl response serves an important function in modulating the 
Th2 response. Th2 polarized, IL- I O/IL- 12 -deficient, mice developed increased hepatic 
fibrosis, formation of large eosinophil-rich granulomas, a 10-fold increase in IL-4 and 
IL- 13, and significant mortality during the chronic stages of infection (Hoffinann et al., 
1999; 2000). It is thus important that the Th2 response to eggs is controlled and this is 
fulfilled by the counterbalancing Thl response. Egg-injected IL-10-deficient mice 
treated with anti-IL-12 mAb showed more than a 10-fold increase in lymph node or 
spleen cell production of IL-4 and IL-5 upon in vitro activation (Wynn et al., 1997). 
The highly polarized and exacerbated Th2 response in these mice was not seen in wild 
type mice treated with anti-IL-12mAb, which suggests that endogenous IL-10 in these 
animals serves as a potent inhibitory signal not only for Thl cytokine expression as was 
previously demonstrated, but for Th2 responses as well. Thus, two main pathways for 
suppressing Th2 responses have been demonstrated; the counteregulatory Thl-type 
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IFN--y response and IL-10, with the latter mechanism being better demonstrated in 
animals only after elimination of both inhibitory pathways 
Although a highly polarized Thl response is particularly damaging, studies in inbred 
mice show that there is some scope to amplify the Th-2-regulating Thl response and so 
reduce fibrosis. This is accomplished by sensitizing mice to soluble egg-antigens in the 
presence of Thl adjuvants, like IL-12 (Wynn et al., 1995) or CpG oligonucleotides 
(Chiaramonte et al., 2000), before schistosome infection to provoke the development of 
an egg-antigen-specific Thl response (Wynn et al., 1995), which was characterized by 
reduced granuloma size and fibrosis and reduced mortality. This was contrary to the 
effects of immunizing with egg antigen in complete Freund's adjuvant (CFA) which 
also induced a strong Thl response but led to a acute lethal hepatotoxicity on 
subsequent infection (Rutitzky et al., 200 1). One possible explanation is that IL- 12, but 
not CFA, promotes the production of high levels of IL- 10 (Wynn et al., 1994; Morris et 
al., 1994), which, in turn, is needed for protection against potentially lethal pro- 
inflammatory mechanisms. 
These findings show that the anti-egg response which has evolved represents a finely 
regulated balance between Thl and Th2 responses with IL-10 playing a central 
regulatory role and induction of excessive typel and type 2 cytokine responses 
triggering distinct, but equally detrimental, fonns of pathology following infection. 
1.1.11.1 Anti-fibrotic effects of Thl in macrophages. 
Therefore, Th. 2-driven production of arginase might be a critical component in the 
development of schistosome-egg induced liver pathology (Hesse et al., 2001). Blocking 
the arginase activity in aaMo with L-hydroxy-arginine (LOHA), a product of NOS 
activity, impairs the production of proline. It has been proposed that aaMo, by 
promoting the synthesis of polyamines through the arginase, increased collagen deposit 
and fibrotic reaction in the liver (Hesse et al., 2001). In addition, the increased 
synthesis of polyamines through arginase activity in aaMo might favour the growth of 
helminths that are thought to relay on the host for the uptake of polyamines (Abdallahi 
et al., 200 1). 
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Arginase uses L-arginine as a substrate to make L-ornithine, which is converted to 
proline by ornithine aminotransferase. Proline is an essential amino acid that is 
involved in collagen production and therefore, in the development of fibrosis. Fibrosis 
is inhibited in mice that are immunized with egg antigens plus IL-12; cytokines are 
produced a components of the induced Thl response (such as IFN--y, and TNF-a) that 
prevents Th2 response development (and, so, IL-13 production) and also activate the 
macrophages to express inducible nitric oxide synthase (iNOS), rather than arginase 
(Modolell et al., 1995). Concomitantly, arginase-positive aaMo and the liver fibrosis is 
strongly decrease. However, this immunization protocol is ineffective in iNOS- 
knockout mice, despite the induction of an excellent Thl response in these animals 
(Hesse et al., 2000). This seems to be due to the fact that iNOS uses arginine to make 
nitric oxide (NO) and citrulline-an intermediate pathway is the L-hydroxyarginine, 
which inhibits arginase effectively reducing the amount of proline that is available for 
collagen synthesis. This phenomenon depends on the NO secretion because iNOS-/- 
mice induced inflammation despite developing a Thl cytokine response. Thus, Thl 
mediators such as IFN-7, IL-12, TNF-cý TGF-0 (Lee et al., 2001), and NO can prevent 
IL-13 mediated fibrosis in the schistosome granuloma (Hesse et al., 2001). Taken 
together, these data indicate that arginase-positive aaMo contribute to the granuloma 
pathology during schistosoma infection. 
1.1.11.2 Immuno-regulation - Regulation of fibrosis 
In schistosomiasiS, several studies have shown that IFN--y can directly down-regulate 
the synthesis of extracellular matrix components (Stephenson et al., 1985). The mice 
which developed the most severe fibrosis displayed the highest IL-13 to IFN--y ratio 
(Chiaramonte et al., 2001). Using a model of carbon tetrachloride-induced liver injury, 
Thompson et al. (1998) demonstrated increased fibrosis in the EL-10-deficient mice. A 
marked increased fibrosis among S. mansoni infected mice that were deficient for both 
IL-10 and IL-12 (Hoffmann et al., 2000). These mice, in contrast to single knockout IL- 
10-deficient animals fail to develop an IFN--y response and consequently developed 
much more fibrosis. The production of IL-13 was also increased more than 10-fold in 
these mice, providing an additional mechanistic explanation for their altered fibrotic 
response. Together, these data strongly suggest that the magnitude of fibrosis is 
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controlled, at least in part, by the pro-fibrogenic activities and anti-fibrotic effects of 
IFN--y and IL- 10. 
1.1.11.3 Regulatory cells induced in schistosomiasis- Modulated macrophage 
function in schistosomiasis 
Macrophages count among the most pleiotropic cells of the both innate and acquired 
immune system, exhibiting a wide range of biological functions. They act as effector 
cells by their specialized lysosomal enzymes and cytotoxic molecules, such as nitric 
oxide, oxygen radicals, and TNF--y, and also play an important role as APCs in the 
acquired immune system (MacMicking et al., 1997; Sprent and Schaefer, 1990). The 
degree of activation of macrophages defines the fate of the infection, either to control 
the infection (remission) or persistence of the inflammatory status and progression to 
chronic infection. Thus, macrophages play a crucial role as mediators of many chronic 
inflammatory diseases (Allen and Loke, 2001; Kiefer et al., 2001; Kinne et al., 2000). 
Depending on the cytokine environment, macrophages can differentiate into distinct 
subsets that perform specific immunological roles (Gordon, 2002). Macrophages 
activated by interferon--y, referred to as "classically activated macrophages" (caMo), 
have been extensively studied and shown to play an essential role in the protection 
against intracellular pathogens by means of increased oxidative burst and NO release, 
and to exert anti-proliferative and cytotoxic activities, and consequent production of 
pro-inflammatory cytokines (IL-10, TNF-cý IL-6). Such caMo are responsible for 
control of many micro-organisms which live inside cells including L. donovani. 
Macrophages activated in the presence of IL-4 and IL-13 are known as "alternatively 
activated" (aaMo) and have powerful immuno- suppressive properties (Stein et al., 
1992; Goerdt and Orfanos, 1999). Most recently, a new phenotype of macrophages 
exerting anti-inflammatory activity were called type 2-activated macrophages, which 
exhibit functional similarity to both caMo and aaMo. Like caMo, they produce pro- 
inflammatory cytokines TNF-cý IL-10 and IL-6. However, type2 activated 
macrophages do not produce IL-12, but secrete IL-10 and drive preferentially a Th2- 
like immune response. This phenotype is reminiscent of alternative activation. Yet in 
contrast to aaMo, type2-activated macrophages do not exert arginase activity (Mosser, 
2003). 
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There is increasing evidence that aamO are abundant in helminth infections. This was 
first demonstrated in mice in response to implanting the filarial worrn Brugia malayii in 
mice peritoneal cavity (Allen et al., 1996; MacDonald et al., 1998) and these cells have 
been extensively studied. The implantation induced profound Th2 responses with 
recruitment of high numbers of eosinophils and macrophages to the site of parasite 
infection (Falcone et al., 2001), paralleled with suppression in the proliferative 
response (Loke et al., 2000). These alternatively activated macrophages actively 
blocked proliferation in vitro of peripheral blood lymphocytes, CD4+ T cells and many 
other cell types by cell-to-cell contact, implicating a receptor mediated mechanism 
(Loke et al., 2000; Schebesch et al., 1997, Allen et al., 1996). Furthermore, the 
proliferative block was reversible and not a result of apoptosis. The suppressed cells 
accumulate in the G1 and G2/M phase of the cell cycle, suggesting a mechanism that 
affects degradation of cell cycle proteins. The suppressive function is dependent on IL- 
4, since macrophages recruited in IL-4-deficient mice are not suppressive (Loke et al., 
2000; MacDonald et al., 1998) and not IL-10 (MacDonald et al., 1998). Interestingly, 
when these macrophages are used as antigen presenting cells to stimulate naive T cells 
from TCR transgenic mice, they induce the differentiation of IL-4 producing Th2 cells 
(Loke et al., 2000). Recent studies have focused on differential gene expression in 
aaMo activated with IL-4 (Welch et al., 2002; Loke et al., 2002). As expected arginase 
is highly upregulated but 10% of the transcripts, not previously associated with 
macrophage function, encoded a recently recognized eosinophil chemotactic factor 
termed Yml/ECF-L, which explains why the recruitment of the aaMO in the Brugia 
model is accompanied by a localized infiltration of eosinophils and this may also play a 
role in the eosinophil recruitment to the schistosome egg granuloma (see below). 
It is clear that there is also profoundly altered macrophage function in schistosomiasis. 
Splenocytes from S. mansoni infected mice when stimulated with SEA were able to 
produce a factor in supernatants which would suppress APC mediated proliferation of 
SEA specific Thl cell clones (Flores Villanueva et al., 1993). This activity was first 
seen at 5 weeks post infection peaked at 8 weeks and then increased (a little) but was 
still significant at 23 weeks. The ability of the supernatant to suppress was prevented by 
addition of anti-IL- 10 antibody to cultures. 
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There is clear evidence that S. mansoni egg granuloma macrophages (GM) are 
alternatively activated, that they display modified function and that they play a key role 
immuno-modulating the disease. The GM arise from blood monocytes recruited to 
granulomata from the periphery (King et al., 2001). In: Mahmoud AAF, Editor. 
Schistosomiasis. London. Imperial College Press, 213-264). GM were unable to 
stimulate SEA Thl cell clones to proliferate in contrast to splenic APCs from infected 
mice and, in addition, culture of the Thl clones with SEA and GM made the Thl cells 
unresponsive to subsequent re-stimulation with splenic APCs (Stadecker et al., 1990; 
1999). The inhibitory effect of GM on proliferation of Thl clone cells in the presence 
of antigen and APC was inhibited by anti-IL-10 but not anti-TGF-0 (Flores Villanueva 
et al., 1994). GM even when stimulated by LPS and IFN--y expressed little if any B7- 1, 
B7-2 or MHC-11 but MHC-II and B7-2 expression could be upregulated by anti-EL-10 
treatment. The molecules B7-1 (Reiser et al., 1992) and B7-2 (Inaba et al., 1994) are 
critical costimulators for the activation of Th cells; as their absence can lead to T cell 
anergy (Harding et al., 1992; Wu et al., 1993; Zheng et al., 2004). On the other hand 
the cytokine IIL-10 (Moore et al., 1993) has variously shown to down-regulation of 
APC function, apparently through down-regulation of MHC class II (Kast et al., 1984) 
as well as B7 molecule expression (Ding et al., 1993). 
Furthermore, when tested in vivo by injecting eggs iv into infected mice GM led to a 
reduction of 26% in granuloma size and a marked reduction (-3 fold) in SEA induced 
proliferation of MLN cells and a striking loss of IL-2 production with an associated 
increased in IL-4 and IL-10 (Flores Villanueva et al., 1994). These GM were also able 
to inhibit expression of costimulatory molecules (B7-1) and MHC-11 on APC when 
injected in vivo into mice (Flores Villanueva et al., 1994). 
Recent studies have formally shown that GM conform to the characteristics of aaMo 
(Gordon, 2003). Arginase-1 (Arg-1) is highly abundant in the granuloma of WT mice 
but in IL-4/IL-10 KO mice which make a highly skewed Thl cytokine response Arg-1 
was undetectable (Hesse et al., 2001). Linehan et al. (2003) showed that GM expressed 
high levels of the prototype phenotypic marker of alternatively activated macrophages, 
the mannose receptor, and they confirmed the IL-4 dependence of this expression by 
showing a lack of MR expression in EL-4Ra/- mice. However, KCs and endothelial 
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cells were also MR positive in both WT and EL-4R-/- mice as there is constitutive 
expression (Linehan et al., 1999; Takahashi et al., 1998). This means that it is not 
possible to say from the study of Linehan et al. (2003) if the KCs were also 
"alternatively activated" although this was not revealed by the staining for arginase-I 
(Hesse et al., 2001). There is also evidence for aaMo in S. japonicum infections as these 
induce the synthesis of YM, a molecule expressed by aaMo (Nio et al., 2004). 
Thus the alternatively activated GM seems to have potent immuno-suppressive 
properties which are particularly effective against Thl cells leading to persistent 
immunological unresponsiveness. Although the schistosome granuloma is a 
predominant Th2 and to a lesser extent Thl response, the underlying Thl response 
clearly regulates the level of Th2 activity (section 1.1.11). Although this Th 1 response 
seems to regulate the level of Th2 mediated pathology (as seen in highly Th2 polarized 
IL- 12/IL- 10-/- mice). Hoffinann et al. (200 1) it clearly needs to be kept in tight control 
as Thl polarized (IL-4/EL-10 KO mice) show high and early death. Recent studies show 
that the GM exert a crucial anti-inflammatory role. Herbert et al. (2004) engineered 
mice in which only the macrophages (and also neutrophils) lacked the EL-4RU chain 
which is required for both IIL-4 and EL-13 signalling and so were unable to generate 
alternatively activated GM. These mice showed essentially normal granuloma size and 
cellular composition but suffered high mortality apparently due to uncontrolled 
inflammatory damage to the liver and gut i. e. the sites of granuloma formation. The 
evidence from these studies is that GM are aaMo and that they have profound 
inhibitory effects on the Thl component of the response to the egg antigens. 
An apparently different population of suppressor macrophages has been reported in S. 
mansoni infected mice. Injection of Lacto-N-fucopentose III (LNFP-IH) or Lacto-N- 
neontetraose (LNnt) coupled with dextran (LNFPIII-dex) induces the expansion of a 
GRI + /Dllb+/F4/80+/CDllc-/EL-10R- macrophage population in aT cell-independent 
manner, and expressing low levels of MHC class II, CD40 and CD86 molecules 
(Terrazas et al., 200 1; Atochina et al., 200 1). They spontaneously produce low levels of 
pro-inflammatory cytokines, (EL- 10, IL- 12, EL- 18, IFN--y), do not secrete NO or PGE2, 
but released IIL-10 and TGF-0. Interestingly, LNFP-III and LNnt primed macrophages 
suppress the proliferation of CD4+ T cells induced by CD3 and CD28 costimulation. 
Moreover, the inhibition of T-cell proliferation requires cell contact with suppressive 
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cells, and the process of inhibition was found to be NO- and IFN--y-dependent which is 
classically taken as a marker of the 'classically activated' suppressor population, in 
contrast, for example, to that of the typical B. malayi-elicited aaMo (Loke et al., 2000). 
It interesting to note that LNFP-HI also induces the release of EL-10 by PBMC from 
Schistosome-infected individuals and of EL- 10 and TGF-0 by B cells from Schistosoma- 
infected mice (Velupillai et al., 1994). Moreover, injection of structurally related 
glycoconjugate lacto-N-neotetraose-dextran (LNnT-dex) has also been shown to 
expand such suppressor cells and these were able to induce a Th. 2 phenotype on naYve 
CD4+ T cells, characterized by lower IFN--y, but increased IL-13 production (Terrazas 
et al., 2001). 
Overall there is a body of evidence that excreted/secreted oligosaccharides from 
helminth parasites in general and schistosomes in particular play an important role in 
inducing both Th2 responses (Okano et al., 1999) and suppressor macrophages. This 
results in the modulation of the host response and induction of anergy as the infection 
progresses (Atochina et al., 2001) effects which will profoundly affect the outcome of 
encounter with other infectious organisms. 
1.1.11.4 Modulation of the granulomatous response in chronic infections. 
In mice following the peak granuloma size which occurs at the acute phase 
approximately 8-10 wk post infection there is a decrease in mean granuloma size 
(Warren et al., 1967; Colley et al., 1975) and a characteristic decrease of the immune 
response to egg derived antigens (Colley, 1981; Nash et al., 1981; Grzych et al., 1991). 
This regulatory response has been named modulation (Boros et al., 1975) and coincides 
with the decrease of the symptoms observed during the acute phase of the infection. 
Studies in experimental models (Vella and Pearce, 1992; Wynn et al., 1993), have 
demonstrated that cytokines are important factors in the fonnation as well as the 
modulation of the granulomatous immune response to the egg. Various mechanisms 
have been suggested to explain the downregulation of granulomatous hypersensitivity. 
Henderson et al. (1992) studied the cytokine responses in the process of modulation as 
the schistosome infection progresses from the acute to the chronic phase, peak tissue 
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levels of both IL-4 and IFN--y mRNA were seen in acutely infected mice, and levels of 
both messages declined as infection became chronic. 
Numerous mechanisms have been postulated for this down-modulation, including a role 
for CD8+ T cells (Pedras-Vasconcelos and Pearce, 1996), anti-idiotypic Abs (Olds et 
al., 1989), B cells (Cheever et al., 1985), and IL-10 (Stadecker and Flores Villanueva, 
1994). To examine the role of endogenous IL-10 in the downmodulation of hepatic 
granuloma formation and lymphocyte responses that occurs in chronic schistosomiasis. 
Wynn et al. (1998) demonstrated that IL-10 gene knockout mice (IL-10T) displayed a 
significant increase in hepatic granuloma size at the acute stage of infection, which is 
associated with increased IFN--y, IL-2, IL- 10 and TNF-a mRNA expression in the liver 
and elevated Thl-type cytokine production by lymphoid cells. Sadler et al. (2003) also 
showed that the proliferative response to SEA and granuloma volume were 
downregulated in normal mice by 15 weeks (chronic infection) but not in IL-10-/- mice 
implicating IL- 10 in this important modulatory process in mice. 
In humans, evidence of the granuloma modulation was first reported by Neves and 
Raso, (1965) who demonstrated from granulomas derived from liver biopsies of acute 
patients and from hepatosplenic cases that all granulomas evaluated were significantly 
larger in the acute patients when compared to the individuals in the chronic phase. IL- 
10 has also been implicated in this down-modulation. Thus Malaquias et al. (1997) 
demonstrated that anti-IL-10 increased in vitro proliferative responses by PMBC from 
chronically infected humans in the presence of SEA and adult wonn antigen whereas 
this did not happen with cells from acute patients. 
1.1.11.4 The balance of Cytokine responses in humans in relation to disease 
1.1.11.4.1 Acute schistosomiasis in humans 
In humans schistosome infection causes a range of morbidities but there two main 
clinical syndromes are recognized, acute schistosomiasis (Katayama fever) and chronic 
schistosomiasis which takes different forms (chronic Intestinal form, 
Hepatosplenornegly syndrome), the development of which seems to be influenced to a 
large extent by the nature of the induced immune response and its effects on the 
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granuloma formation and associated pathogenesis in target organs (Dunne and Pearce, 
1999; Cheever et al., 2000). 
Acute schistosomiasis in humans is a debilitating febrile illness (Katayama fever) that 
can occur before the appearance of eggs in the stool and which is thought generally to 
peak between 6 and 8weeks after infection (Rabello, 1995). During acute illness, there 
is a measurable level of tumour-necrosis factor (TNF-u) in the plasma, and peripheral- 
blood mononuclear cells (PBMCs) produce large quantities of TNF-cý interleukin-10 
(IL-10) and IL-6 (de Jesus et al., 2002). Notably, cytokine production by PBMCs after 
stimulation with parasite antigen reflects a dominant T helper 1 (Thl), rather than Th2 
response (de Jesus et al., 2002). Field studies in endemic areas, combined with animal 
experiments, have led to the view that host genetics, infection intensity, in utero 
sensitization to schistosome antigen all influence the development of the immune 
response and so, disease severity. 
This acute febrile illness that is associated with the initial stages of schistosome 
infection seems to be uncommon in individuals who live in areas that are endemic for 
schistosomiasis. It occurs, instead, in individuals who have no previous history of 
exposure who become infected after travelling into endemic area. One explanation for 
this difference is that individuals can become sensitized to schistosome in utero as a 
result of maternal infection, which subsequently allows them to respond differently 
from 'nalve' individuals when themselves become infected. 
Data from analyses of cord-blood lymphocytes taken from the babies of infected and 
uninfected mothers support the view that in utero sensitization does occur and 
moreover, indicate that the fetal response is phenotypically similar to the response of 
the mother (King et al., 1998; Malhotra et al., 1997). The pre-existing Th2 response in 
such children might make them less likely to develop a pro-inflammatory response on 
first infection with schistosomes. An examination of disease in mice has shown that an 
inability to develop a Th2 response to regulate the initial pro-inflammatory response 
that is associated with acute schistosomiasis is lethal. This first became apparent when 
C57BL/6 IL-4-/- mice were infected with S. mansoni. Coincident with the onset of 
parasite egg production in these animals, a condition that was characterized by cachexia 
and significant mortality (Brunet et al., 1997; 1999; Fallon et al., 2000). These mice 
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developed normal hepatic granuloma (lacking the eosinophilic component) but 
pathological changes in the intestine were more evident in the absence of IL-4; non- 
haemorrhagic lesions on the mucosal surface (Brunet et al., 1997; 1999) were 
associated with the inefficient passage of eggs into the lumen (Fallon et al., 2000). This 
process was accompanied by detectable levels of lipopolysaccharide in the plasma, 
perhaps owing to the translocation of intestinal bacteria (Fallon et al., 2000). Analysis 
of the immune responses of infected IL-4-1- mice showed that there was a correlation 
between elevated levels of nitric oxide (NO) and disease severity (Brunet et al., 1997; 
1999). 
1.1.11.4.2 Chronic schistosomaisis in humans 
Chronic disease is graded according to severity. The most serious form is a life- 
threating hepatosplenic disease, which is usually accompanied by severe hepatic and 
periportal fibrosis, portal hypertension and portosystemic shunting of venous blood 
(Dunne and Pearce, 1999), and a lesser severe form chronic intestinal schistosomiasis. 
Although Th2 response seem to have a crucial role in modulating potentially life- 
threating disease during the initial stages of schistosomiasis, prolonged Th2 responses 
contribute to the development of hepatic fibrosis and chronic morbidity (Cheever et aL, 
2000). 
The main Th2 cytokine that is responsible for fibrosis is IL-13. So, schistosome- 
infected mice in which IL-13 is either absent (IL-13-l-) is ineffective (Fallon et al., 
2000), (IL-4Ra-chain KO) (Jankovic et al., 1999) or neutrilizing by treatment with 
soluble IL-13Ra2-Fc (Chiaramonte et al., 1999), fail to develop the severe hepatic 
fibrosis that normally occurs during infection, which leads to prolonged survival of 
these mice (Fallon et al., 2000). Mediators that are associated with Thl responses, such 
as IFN--y, IL-12, TNF-a and NO can prevent IL-13-mediated fibrosis (Hesse et al., 
2001). 
Infection intensity is one factor that can affect the severity of chronic schistosomatic 
disease, particularly in children (Mohamed-Ali et al., 1999). However, it seems to be 
more important whether infected individual is genetically predisposed to disease 
(Mohamed-All et al., 1999; Dessein et al., 1999). 
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Other anti-inflammatory cytokines are known to limit the degree of disease progression 
and seventy by modulating the schistosome granuloma. In a recent study, Correa- 
Oliveira et al. (1998) demonstrated that IL-10 is an important cytokine regulating the in 
vitro granulomatous reactivity of PBMC from intestinal (INT) patients. This was 
evidenced by blockage of this cytokine using anti-IL-10 mAb in vitro granuloma assay 
lead to a significant increase in granuloma size with cells from chronic intestinal 
schistosomiasis (INT) patients but not with individuals in the acute phase or with the 
hepatosplenic (HS) form of schistosomiasis. Furthermore, analysis of soluble IL-10 
levels present in the in vitro granuloma culture demonstrated that high levels of IL-10 
secretion occurred only in the cultures when PBMC from INT patients were tested. 
Moreover addition of recombinant IL-10 readily decreased the reactivity to SEA in 
PBMCs from patients with the three clinical syndromes (Acute, chronic intestinal 
schistosomiasis, and ambulatory hepatosplenic disease). Furthermore, the addition of 
anti-IL-4 rnAb to the in vitro granuloma cultures with PBMC from individuals with 
either acute or hepatosplenic schistosomiasis, lead to decrease in granuloma size, 
suggesting that IL-4 plays an important role in the granuloma formation and in 
maintenance of cellular response in the severe form of the disease. 
Serum IL-10 as well as in vitro cellular proliferation was found to be lower in HS 
patients followed by individuals of acute schistosomiasis further supporting the role of 
IL-10 on the regulation of the immune response to S. mansoni infection as well as on 
the control of the development of the severe form of schistosomiasis. These results 
demonstrate that lack of an effect of the blocking antibodies to IL-10 on the in vitro 
granuloma cultures is not due to the inability of these cells to respond to this cytokine, 
but again to lack of IL-10 secretion by PBMC from acute and hepatosplenic patients. 
Similar results were also obtained by other investigators demonstrating that in chronic 
asymptornatic schistosomiasis IL-10 plays a major role in regulating in vitro cellular 
proliferation (Araujo et al., 1996, Sadler et al., 2003). 
No IFN-'y production was observed in PBMC cultures from 45 patients living in 
endemic areas of schistosomiasis in Brazil, following in vitro stimulation with 
schistosomula and adult worm antigens and was independent on the intensity of 
infection (Araujo et al., 1994). This study was confirmed by another study on 22- 
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infected patients living in the same endemic area (Araujo et al., 1996), showing that the 
majority (86%) showed no lymphocyte proliferative responses and none of them 
showed IFN--y production, following in vitro stimulation of PBMCs with soluble adult 
worm antigen preparation (SWAP). This absence of IFN--y production was antigen 
specific since high levels of this cytokine were detected in same patients when their 
cells were stimulated with PPD or PHA (Araujo et al., 1994). In contrast, IL-4, IL-5 
and IL-10 were detected. Restoration of lymphoproliferative response and IFN-'Y 
production resulted from addition of anti-IL- 10 mAb to PBMC culture. 
There is also evidence of Th2 polarised responses and of IL-10 suppressed Thl 
responses in infected humans. Infected individuals generally show raised Th2-type 
responses, i. e. raised IgE and eosinophilia (Snyman et al., 1997; Souza-Atta et al., 
1999; Hagan, 1996). However, this is not always the case. On the basis of the amount 
of IFN--y or IL-5 (or other Th2 cytokines) that is produced by PBMCs in response to 
antigen, some individuals do seem to have a more Thl-like response. In one of the few 
studies that have attempted systemically to correlate the immune response with disease 
severity, patients with hepatosplenomegly owing to S. mansoni infection were found to 
have a Thl-like response and high plasma levels of TNF-receptor 1 (TNFRI) and 
TNFRII, whereas individuals who had less severe disease but similarly intense 
infections (as assessed by counting the number of eggs in faecal samples) had Th2 
responses and low plasma levels of soluble TNFR (Mwatha et al., 1998). 
In another study conducted of pedigrees in Sudan, in an area where S. mansoni is 
endemic, Dessein and collagues found that severe hepatic fibrosis (as identified by 
ultrasound) was more likely to occur in certain families (Dessein et al., 1999). A 
segregation analysis showed that a codominant major gene, known as SM2, is 
responsible for the familial distribution of hepatic fibrosis and portal hypertension. 
'Informative' families, which had multiple cases of severe fibrosis, were used to map 
SM2 to chromosome 6q22-q23, a region that contains the gene for IFN--y receptor I 
(IFN-y-Rl) (Dessein et al., 1999). One interpretation of these data is that mutations in 
the IFN7-Rl that led to loss of function of the receptor are associated with a lack of 
effectiveness of IFN--y in suppressing fibrogenesis. So in human studies, there is some 
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evidence that severe chronic disease is associated with Th I rather than Th2 responses in 
at least a proportion of the population. 
1.1.11.4.3 Role of T regulatory in immunity to infectious disease 
Recent studies have suggested that activation of DCs that secretes IL-10, but not IL-12, 
can direct naive T cell to a Trl subtype (tenned DCr) (McGuirk and Mills, 2002; Mills 
and McGuirk, 2004 ). 
Most recently, DCs can under certain conditions, differentiates into strong inducers of 
T reg cells (McGuirk and Mills, 2002). For example, if lipid fractions from S. mansoni 
are present during the maturation of human DCs, the DCs become conditioned to 
induce regulatory activity (such as IL-10 production) by naive T cell populations (van 
der Kleij et al., 2002). So regulatory accessory cells can develop under the influence of 
defined parasite molecules, and it seems that helminths might induce T reg cells 
through specific APC subsets. 
A further subtype of T cells with immuno-suppressive function and cytokine profiles 
distinct from either Thl or Th. 2 cells have been proposed and termed regulatory T 
(Treg) cells. Several subsets of regulatory T (Treg) cells with distinct phenotypes and 
distinct mechanisms of action have been described. These include typel Tr cells (TrI) 
(Groux et al., 1997; McGuirk and Mills, 2002; MacDonald and Pearce, 2002; Levings 
et al., 2001), which secretes high levels of IL-10, IL-5 and low to moderate levels of 
transforming growth factor (TGF-0), little or no IL-2, IL-4, or IFN--y production and 
proliferate poorly following polyclonal TCR-mediated activation (Groux et al., 1997). 
Functional studies on TrI cells have suggested that these cells have immuno- 
suppressive properties and have been shown to prevent the development of Thl- 
mediated autoimmune disease (Groux et al., 1997). The suppressive effect of Trl cells 
clones are reversed by neutralizing IL-10 suggesting that Trl cell suppression is a 
bystander effect mediated through the production of IL- 10. 
Type3 T (Th3) cells (Chen et al., 1994; Fukaura et al., 1996) are also CD4+ Treg cells, 
but primarily secrete TGF-0, which disrupts early IL-12 signalling events in T cells 
(Bright and Sriram, 1998; Gorham et al., 1998; Pardoux et al., 1999) and alters either 
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IL-12RI or R2 mRNA expression consequently suppressing IFN--y production, 
proliferation of T lymphocytes and thus suppressing Thl immune response. Similarly, 
TGF-O has multiple suppressive actions on T and B cells, macrophages, and other cell 
types (Letterio and Roberts, 1998; McCartney et aL, 1998). 
CD4+CD25+ T cells, is a population of CD4+ T cells that constitutively express the IL- 
2Ra (CD25) which is regarded as a robust marker of Tregs (Hori et al., 2002). 
CD4+CD25+ T cells comprise -5-10% of peripheral T-cell pool which exhibit potent 
immuno -suppressive properties both in vivo and in vitro (Shevach, 2000). They inhibit 
IL-2 production by a mechanism dependent on cell-cell contact (Shevach et al., 2000) 
and also expression of the inhibitory costimulatory molecule CTLA-4 (Thornton and 
Shevach, 2000; Read et al., 2000). Cell surface TGF-O might be involved in cell- 
contact suppression by CD4+CD25+ Tr cells (Nakamura et al., 2001). However, the 
presence of fully functional CD4+CD25+ Tr cells in both Smad3, TGF-O and TGF-O 
receptor-II defective mice have cast considerable doubt over the involvement of TGF-O 
in CD4+CD25+ Tr cells mediated suppression (Shevach, 2002). The suppression by 
CD4+CD25+ cells has been explained as being independent of membrane bound TGF-0, 
but these cells transferred suppressor activity to conventional CD4+ T cells, which 
functioned partially through soluble TGF-O (Jonuleit et aL, 2002). 
In addition to the various CD4+ Tr populations, recent studies have identified CD8+ Tr 
cells, which secretes either IL-10 or TGF-0 (Garba et aL, 2002; Gilliet and Liu, 2002). 
Tregs have been shown to suppress activation and proliferation of nayve T cells 
(Annacker et al., 2001), and suggested to suppress protective Thl responses against an 
infectious pathogen (McGuirk et al., 2002). However, certain TrI cells can also 
suppress inflammatory Th. 2 responses (Cottrez et al., 2000). The suppression of the 
protective immune response by anti-inflammatory cytokines or cells induced directly or 
indirectly by the pathogen might provide a plausible explanation for the chronic 
infections caused by certain parasites, bacteria, and viruses. 
There is strong recent evidence for the involvement of Treg in schistosomiasis. The 
demonstration that IL-10 is crucial for preventing schistosome eggs from inducing IL- 
12 dependent Thl responses (as happens in IL-10-1- mice [Hoffmann et al., 2000] led 
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McKee and Pearce, (2004) to investigate if Treg producing IL-10 were involved in 
schistosomiasis. They identified CD4+CD25+ and CD4-CD25+ cells in infected mice 
which produced IL-10 in response to SEA and which could inhibit IL-12 production by 
DC in response to CD40 ligation (with anti-CD40 antibody). Unlike the CD4+CD25+ 
population, the CD4-CD25+ also produced Th2 cytokines and were considered SEA 
specific Th2 cells. In the presence of SEA both populations from infected mice but not 
uninfected mice were able to inhibit IL-12 production by DCs. The CD4+CD25+ cells 
were found to express the the Treg transcription factor forkhead box P3 (Foxp3) which 
has been shown to program the development and function of Treg cells (Hori et al., 
2002). The CD4+CD25+ cells from infected mice were more effective than cells from 
uninfected mice in suppressing T cell proliferation (following anti-CD3 stimulation) 
and when transferred to IL- 10 -/- mice injected with eggs they inhibited the egg specific 
Thl response as judged by IFN--y production by 50% but had no effect on the Th2 
response. The CD4-CD25+ (Th2) population also inhibited the Thl response but also 
enhanced Th2 cytokines as expected. However, CD4+CD25+ cells from naive mice 
were equally effective as cells from infected mice and transfer of CD4+CD25+ cells 
from naYve mice into acutely infected IL- 10 -/- mice was also able to suppress Thl IFN-'y 
production. These authors conclude that the production of IL-10 by both antigen 
specific Treg and Th2 cells suppresses the development of Thl responses to 
schistosome egg antigens. 
1.2 The Th2 response stimulated by eggs influences the nature of immune responses to 
concomitant antigens/vaccines/infections 
The induction by schistosome infections of IL-4, EL-13 and IL-10 from Th2 cells and 
IL-10 from Treg cells has profound effects on the generation of Thl responses and 
macrophage function as is characteristic of these cytoldnes (O'Garra, 1998; Gordon, 
2003). Most people who live in areas that are endemic for schistosomiasis are also 
exposed to many other infectious diseases and there is growing interest in whether this 
influences an individual's immune response to other ongoing immune responses 
whether they be to vaccines, allergens, autoantigens or concurrent infections. Various 
of the studies on this and the modulation by other helminths has recently been reviewed 
by Cox, (2001) and some of these are reviewed below. 
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The realization that morbidity during schistosomiasis is dependent on a finely balanced 
Th2-Thl response to egg antigens also raises interesting questions about the potential 
for Thl polarizing responses induced by co-infecting organisms on the pathological 
response to the eggs. 
1.2.1 Antigens 
The principle that the Th2 response to S. mansoni could downregulate generation of a 
Thl response was first demonstrated when S. mansoni-infected mice immunized with 
sperm whale myoglobin (SwMb) which normally induces a Thl cytokine profile 
showed a down-regulation of antigen- specific splenocytes responses (IL-2 and IFN--Y 
production per CD4+ cell was reduced by 45% and 59% respectively) and elevation of 
Th2 responses (IL-4 per CD4+ cell was increased threefold) (Kullberg et al., 1992; 
1996). Addition of neutralising mAb specific for IL-10 to the spleen cell cultures, 
restored the suppressed IFN--y response seen in infected mice, demonstrating the role of 
IL- 10. 
In addition, altered autoimmune responses to self antigens induced by S. mansoni infection 
is indicated by reduced spontaneous incidence of insulin dependent diabetes mellitus, a 
Thl-mediated disease, in infected non-obese diabetic mice (Cooke et al., 1999). The 
absence of TUR-ce-chain rearrangements of a diabetogenic CD4+ T cell clone, BDC2.5 
transgenic mouse lead to development of diabetes (Haskins and McDuffie, 1990). Further 
studies have shown that IL-10 has been implicated in regulation of inflammation and 
autoimmunity (Asseman et al., 1999). A regulatory population of T cells which produces 
IL-10, involved in regulatory process that prevent diabetes BDC2.5/NOD mice has been 
identified in both humans and mice (Groux et al., 1997; Levings et al., 2001). Thl cells, 
dendritic cells and macrophages play a role in the development of diabetes (Parish et al., 
1995). IL- 10 is known to be able to inhibit both DC and macrophage function and IL- 10 is 
known to be an autocrine growth factor for DC, and neutralization of IL- 10, together with a 
DC maturation signal, has been shown to increase expression of CD80, CD86, and MHC, 
as well as production of IL-12 and TNF-a IL-10 inhibit the production of a range of 
inflammatory mediators (IL-10, IL-Icý and TNF-a) by macrophages, together with IFN-^ý 
have been shown to be particularly damaging to pancreatic 0 cells (Ablamunits et al., 
1994). Recently, Phillips et al. (2001) demonstrated that treatment with anti-IL-10R 
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facilitates the onset of diabetes in BDC2.5/TCR-a-transgenic NOD mice by increasing 
serum IL- 12 levels and permitting the expression of Th I immune response against islets 
Regarding responses to allergens von den Biggelaar et al. (2000) have reported a 
correlation between S. haematobium infection and reduced levels of immediate skin test 
responsiveness to house dust mite allergen. This reduced level of skin test responsiveness 
did not correlate with polyclonal IgE levels showing that this effect is not just due to 
swamping of IgE Fc receptors and infection did not affect the levels of mite specific IgE. 
Rather responsiveness correlated with levels of worn-i specific IL-10 produced in vitro. It 
was suggested that IL-10 may have local effects on mast cell function and these data 
support the notion that worms may play a role in the low levels of allergies which are 
reported to occur in developing countries. 
Regarding modulation of the response to the schistosome infection T cell unresponsiveness 
in vivo can be induced by various means; one of these involves the administration of 
specific antigen conjugated with B subunit of cholera toxin (CTB). This strategy has been 
successful in curtailing harmful immune response in models of autoinimunity (Kim et al., 
2001), allergy (Rask et al., 2000), and infectious disease (Xu et al., 1998). More 
specifically, significant inhibition of egg antigen- specific T cell responses and amelioration 
of experimental murine schistosomiasis was observed following intranasal (i. n. ) instillation 
of conjugates of CTB with GST28 and with the Sm-p40 antigen itself (Sun et al., 
2001). Hernandez et al. (2002) found that the intranasal treatment of infected CBA mice 
with a fusion of protein of cholera toxin B subunit (CTB) and the peptide 234-246 
(CTB:: peptide 234-246) resulted in significant down-modulation of hepatic granuloma 
inflammation and fibrosis. This was associated with upregulated production of 
transforming growth factor-0 by egg antigen stimulated hepatic granuloma cells as well as 
mesenteric LN CD4+ T cells. One possible approach to reduce the morbidity in 
schistosomiasis is the amelioration of the egg-induced immuno-pathology by means of 
downregulating the underlying pathogenic T cell responses. 
1.2.2 Decreased efficacy of Thl vaccines in schistosornal patients 
There have been a few studies conducted in schistosome endemic areas showing that 
schistosome induced Th2-response in infected individuals affected vaccine efficacy. IFN-y 
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production by PBMC to Tetanus-Toxoid (TT) following primary TT immunization was 
shown to be dramatically reduced in S. mansoni infected individuals and inversely related 
to infection intensity (Sabin et al., 1996). In contrast IL-4 levels did not show this dramatic 
difference. 
Similarly, Malhotra et al. (1997) demonstrated that infants become sensitised in utero to 
worm antigens from infected mothers and they subsequently showed (Malhotra et al., 1999) 
that children born of worm-infected (S. haematobium or Wuchereria bancrofti), mothers 
and vaccinated with BCG at birth make significantly lower IFN--y responses to PPD 
(purified protein derivative of Mycobacterium tuberculosis) at 10- 14 months after birth 
compared to offspring of uninfected mothers. The lower the helminth-driven Th1: Th2 
cytokine ratio (i. e. the more Th2-like) at birth the lower the PPD response. Similar results 
have been reported in individuals with other helminth infections (Cooper et al., 1999). In 
addition, Muniz-Junqueira et al. (1996) showed that S. mansoni patients particularly those 
with hepatointestinal disease, showed a decreased response after typhoid vaccine and they 
suggest that a diminished ability to mount an immune response towards typhoid antigens 
may interfere with the clearance of typhoid bacteria from the blood stream (chronic 
salmonellosis associated with schistosomiasis). 
However, Bassily et A (1997) showed that the immunogenicity of recombinant hepatitis B 
vaccine among infants of mothers with active schistosomiasis given the vaccine at 2,4 and 
6 months of age was not affected as judged by antibody levels to the recombinant Hepatitis 
B vaccine although cellular responses were not considered. 
1.2.3 Viral infections 
The influence on viral infections was first modelled in mice using Vaccinia virus. Virus 
specific IFN--y production and cytotoxic T cell responses (particularly CD8+ T cells) were 
markedly decreased and virus clearance was delayed in S. mansoni-infected mice exposed 
to recombinant Vaccinia virus. This was associated with a marked decline in IFN--y 
production and a slight increase in IL-4 and IL-5 to virus antigen. Inununohistochemical 
staining of liver sections fi7om vaccinia/S. mansoni co-infected mice with polyclonal anti- 
vaccinia antibodies revealed that viral epitopes are localized primarily within granulomas 
(Actor et al., 1994). These experiments suggest that egg granulomas, by providing a 
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micro environment for viral expression, in combination with the cytokine imbalance present 
during schistosome infection, can promote the expansion of Vaccinia virus and possibly 
other viral agents (Actor et al., 1993; 1994). 
HBV and HCV are both non-cytopathic hepatotropic viruses that can cause acute or chronic 
infections in humans which can result in severe hepatitis, cirrhosis and hepatocellular 
carcinoma. Both show overlap in their distribution with worm infections including S. 
mansoni. With HBV, approximately 10% of acutely infected adults and 90% of acutely 
infected neonates become chronically infected; and more than 80% of adults infected with 
HBV develop a chronic infection (Rehermann et al., 1996). There is increasing evidence to 
suggest that the outcome of infection is highly influenced by the early immune response, 
with strong, sustained virus-specific CD4+ and CD8+ T cell responses being associated 
with virus clearance (Rehermann and Chisari, 2000; Maini and Bertoletti, 2000; Sing et al., 
2001; Gruener et al., 2001). Control of virus replication is predominantly mediated by 
antiviral cytokines such as IFN--y and TNF-a (Guidotti and Chisari, 1996; Heise et al., 
1999; Guidotti and Chisari, 2001). However, the immune response also mediates much of 
the liver damage associated with HBV and HCV infections (Chisari and Ferrari, 1995; 
Koziel, 1999; Bertoletti and Maini, 2000). Both infections are found together with 
schistosomiasis specifically and worms in general in many several parts of the world. Co- 
infection of hepatitis B virus (HBV) and S. mansoni is a frequent event in humans but little 
is known about the interactions between two pathogens. The confluence of these viral and 
helminth infections in the liver, in which the dominant Th2 response during schistosomiasis 
might downmodulate the Th I -like anti-viral immunity, offers a possible explanation for the 
increased occurrence of chronic hepatitis-virus infection in schistosomiasis patients. 
Studies were later conducted in Brazil and in other regions, especially Egypt, where the 
prevalence of schistosomiasis and viral hepatitis is very high. The results were not uniform, 
some of them showing exacerbation of disease in co-infections between hepatitis B virus 
and schistosomiasis (Conceicao et al., 1998; Hammad et al., 1990; McClary et al., 2000a; 
Hamadto et al., 1989; Pereira et al., 1994; Andrade and Cheever, 1995), and a higher rate 
of chronicity of hepatitis (Serufo et al., 1998; Andrade and Cheever, 1995). Recent studies 
in HBV transgenic mice showed, surprisingly, that infection with S. mansoni inhibited virus 
replication, with concomitant increased NO and Thl-type cytokines (IFN--y, IFN-(x/0) and 
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in the absence of Th2-type cytokines at 5weeks p. i.. As judged by cytokine mRNA levels 
(by quantitative RNA protection assay) they noted upregulation of both Thl and Th2 
responses which both peaked at 8weeks and concluded that schistosome-induced IFN-'y 
overcomes a quantitative deficiency in HBV-induced IFN--y and mediates most of this 
antiviral activity (probably via NO). The S. mansoni-dependent antiviral effect was 
partially blocked by genetically deleting IFN--y, although it was unaffected by deletion of 
IFN-oýo. These results indicate that most of IFN--y produced by cytotoxic T cells 
(CTLs)(probably via NO) mediates most of antiviral activity and that IFN-u/O inhibits HBV 
viral replication via NO-independent pathways (McClary et al., 2000b; Guidotti et al., 
1996; 2000). Taken together, the data indicate that during S. mansoni infection the 
intrahepatic cytokine profile is initially of a Thl-type and this associated with the non- 
cytopathic inhibition of HBV replication. Surprisingly, Th2-type cytokines do not 
counteract the antiviral effect of IFN--y. Similar events may suppress HBV replication 
during human S. mansoni, irrespective of the presence of Th. 2 cytokines in the liver 
(McClary et al., 2000; Andrade et al., 2001). Therefore, it is possible that persistence of 
HBV may primarily result from quantitative deficiency of Thl -type responses rather than 
qualitative differences in the intrahepatic cytokine profile. Accordingly, it has been shown 
recently that the number of IFN--y-producing antigen T cells isolated from the peripheral 
blood of people chronically infected with HBV is much lower than that observed in the 
peripheral blood of people acutely infected with HBV (Jung and Pape, 2002). 
However, in contrast with the earlier study, Ghaffar et al. (199 1) demonstrated in his study 
that the increased HBsAg carrier rate was 25% at 12 months in those with schistosomiasis 
compared with 9% in those with on acute HBV infection, and patients with concomitant 
schistosomiasis had higher liver function test results compared to the AVH only. 
Concomitant schistosomiasis with the AVH increased the prevalence of splenomegly and 
prolonged HBsAg carrier state and frequently converts uncomplicated intestinal 
schistosomiasis to hepatosplenic schistosomiasis (Ghaffar et al., 1991). 
Moreover, it now seems clear that in Egypt at least, where HCV and schistosomiasis are 
two of the most important public-health problems and have geographically overlapping 
distributions, the coincidence of infection is a result of the unfortunate initial widespread 
transmission of HCV by mass parenteral antischistosomal therapy, which continued into 
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the 1980's (Frank et al., 2000). Several studies conducted in Egypt (Abdel Wahab et al., 
1994; Angelico et al., 1997; El-Zayadi et al., 1997; Hibbs et al., 1993; Koshy et al., 1993; 
1995; Waked et al., 1995; Kamal et al., 2000, Gad et al., 2001) and in Brazil (Yoshida et 
al., 1993; and 1993; Pereira et al., 1995) demonstrated a higher prevalence of HCV virus 
infection in schistosome patients and defined its importance in the decompensation of 
hepatic disease. 
Mabrouk, (1997) demonstrated that HCV and schistosomiasis play a major role in the 
development of hepatocellular carcinoma in Egypt. In addition, Kamal et al. (2001) showed 
that patients with acute HCV and schistosomiasis co-infection cannot clear viremia and 
show rapid progression to histological proven chronic active hepatitis and accelerated 
fibrosis. This rapid progression in the co-infected individuals is associated with a strong 
Th2 response in peripheral immune responses, suggesting that development of vigorous 
Thl responses facilitates clearance and delays disease progression. HCV-specific CD4+ 
proliferative response to HCV Ag was detected in 73% of patients infected with HCV alone 
which produced typel cytokines, compared with 8.6% of patients co-infected with HCV 
and S. mansoni which produced type2 cytokine production. In contrast, there was no 
difference in response to schistosomal antigens in patients infected S. mansoni alone, 
compared to those co-infected with HCV and S. mansoni. These findings suggest that the 
inability to generate an HCV-specific CD4+/Thl T cell response plays a role in the 
persistence and severity of HCV infection in patients with S. mansoni co-infection. In an 
earlier study, Kamal et al. (2000) demonstrated that patients with concomitant HCV and 
schistosomiasis infection were characterized by more advanced liver disease, higher HCV 
RNA titers, predominance of HCV genotype 4a, higher histological activity, higher 
incidence of cirrhosis and hepatocellular carcinoma as well as higher mortality rate. Indeed, 
there is evidence that schistosomiasis prevents the development of Thl response to HCV 
(Kamal et al., 2001a; 2001b). Similarly, Gad et al. (2001) demonstrated that concurrent 
HCV infection and schistosomal liver disease result in much more severe liver disease than 
that seen with either disease alone. However, the activity of HCV infection in terins 
[increased viral loads (viral titer) and/or replication] seems partially suppressed in patients 
with schistosomal liver disease. 
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Some other studies have not supported the exacerbation of disease in this co-infection. By 
multivariant analysis Angelico et al. (1997) showed that 55% of Anti-HCV positive sera 
had HCV-RNA of genotype 4a, which was associated with more severe liver disease but 
this occurred less frequently in patients with history of schistosomiasis. Similarly, Helal et 
al. (1998) reported a lack of enhancement of HCV pathology in schistosome patients and 
no significant difference between the schistosomal and non-schistosomal groups regarding 
the semi-quantitative histological score. However, Elrefaei et al. (2004) showed that 
Egyptian patients infected with HCV genotype 4a can mount HCV-specific CD4+ and 
CD8+ T cell responses despite the prevalence of concomitant schistosomiasis. 
On the other hand, there is some evidence that HBV and HCV infections are a factor in the 
development of hepatosplenic schistosomiasis (Dunne and Pearce, 1999). 
In a descriptive study of the prevalence of GB virus type C /Hepatitis G virus (GBV-C/ 
HGV) infection in a rural population of Northeastern Brazil, in which the prevalence of 
schistosomiasis is 80-90% Gallian et al. (1998) showed that despite the absence of 
parenteral risk exposure, the prevalence of GBV-C/HGV markers of infection (viremia, 
16.4%; specific antibody, 18.3%) were unusually increased. It was concluded that helminth 
infection influenced the immune response to GBV-C/HGV infection by shifting the balance 
of cytokine responses from Thl to Th2, resulting in a delayed viral clearance. 
The abundance of chronic helminth infections in sub-Saharan Africa has been proposed to 
influence the high susceptibility to HIV infection and apparent faster progression to AIDS 
observed in the region (Bentwich et al., 1995; Bentwich, 2000). It has shown that CD4+ T 
cells that produce type 2 cytokines (Th2 cells) provide a more conducive environment for 
the replication of certain strains of HIV-1 than do Thl cells (Maggi et al., 1994; Wang et 
al., 1998; Galli et al., 1998). For example, cells from persons who have active filariasis and 
associated Th2-like immune responses are more susceptible to HIV-1 infection than cells 
from the same individuals after antifilarial chemotherapy and diminution of the Th2-like 
phenotype (Gopinath et al., 2000). In addition, PBMC from HIV-1 positive schistosomiasis 
patients demonstrated decreased proliferation and decreased Th2-like cytokine production, 
less IL-4 and IL- 10 but similar (low) amounts of IFN--y than did HIV- 1 negative individuals 
with active schistosomiasis. Furthermore, in patients with HIV- 1, a decrease in CD4+ T 
cells was correlated with an increased Thl: Th2 cytoldne production ratio, which indicates 
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that there were a swing in the overall balance of the response from Th2 and Thl (Mwinzi et 
al., 2001). The reduced production of Th2 cytokines by PBMC from the schistosome-HIV 
co-infected patients is consistent with the hypothesis that HIV-1 has a predilection for 
antigen activated Th2 cells in an actual infection (Weissman et al., 1996), and that 
schistosome-antigen-responsive cells are then eliminated by the virus. Mechanistically, this 
could be occuring through IL-4-mediated up-regulation of CXCR4 and the switch to the 
syncytium-inducing phenotype of HIV- I that is associated with higher viral replication and 
an increased rate of CD4+ T cell decline (Wang et al., 1998; Galli et al., 1998; Suzuki et 
al., 1999; Nakayama et al., 2000). Although, treatment of schistosome infections in HIV-1 
positive patients does not lead an immediate drop in plasma HIV-1 loads (Lawn et al., 
2000), prompt diagnosis and treatment to prevent pathology in chronic schistosomiasis, 
which further lowers CD4+ T cells levels (Colley et al., 1983; Kalinkovich et al., 1998), 
may help HIV-1 infected persons with respect to overall immuno-competence. 
Mwanakasale et al. (2003) demonstrated that treatment with praziquantel is still very 
effective in control of S. haematobium even when there is co-infection with HIV. 
Interestingly, individuals with co-infection excreted fewer eggs and complained less of 
hernaturia than those without HIV infection, and the sensitivity and positive predictive 
value of reported hernaturia were lower in the group co-infected with HIV (Mwanakasale et 
al., 2003). Similarly, in a comparison of S. mansoni-infected HIV+ and HIV- patients, a 
correlation between diminished egg excretion and decreased CD4+T cell counts was 
apparent (Karanja et al., 1997). Similarly in animal models, the egg excretion is minimal in 
immuno-cornPromised miceý but can be increased by the transfer of sera or lymphocytes 
from infected animals (Doenhoff, 1997). 
Genital schistosomiasis has been proposed as a possible cofactor in the genesis of 
malignant disease that might contribute to its high incidence in regions where bilharziasis is 
endemic. Cervical cancer is the most common malignant tumour among women in 
Tanzania and other countries in Tropical Africa. Petry et al. (2003) demonstrated that 
infection with Schistosoma haematobium seems to favour persistent genital human 
papillomavirus (HPV) infection either by traumatizing the genital epithelium and/or by 
local immuno -suppression. As most cases show a history suggestive of bilharzias and/or 
active schistosomiasis there is evidence for a significantly increased risk of infection with 
high risk HPV types. 
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1.2.4 Bacterial infections 
A relationship between persistent or recurrent Salmonella species bloodstream infection 
(chronic salmonellosis) and schistosomiasis has been described in both adults and children 
(Gendrel et al., 1994; Omer, 1978; Mikhail et al., 198 1; Becquet et al., 1982, Hennequin et 
al., 1991; Lambertucci et al., 1987; 1998) and concurrent schistosomal infection has also 
been proposed to explain persistence of non-typhoid Salmonella (NTS) infection and poor 
response to antibiotic therapy. Both immunological and non-immunological reasons have 
been proposed to explain this. Murine studies of Salmonella typhi in concurrent infection 
with S. mansoni, revealed that S. typhi was more frequently cultured, bacterial growth rate 
was more rapid, and bacteria persisted much longer in mice infected with adult S. mansoni 
compared to the controls (Njunda and Oyerinde, 1996). Studies have shown that 
Salmonella bacterial pili adhere to a mannose receptor-like surface glycoprotein on the 
tegument of Schistosome mansoni, making it possible for the adult worm to provide a site 
of intravascular persistence leading to recurrent infection. Muniz-Junqueira et al. (1996) 
suggested that suppressed macrophage activity in schistosome-infected mice was involved 
as there was no increase in phagocytosis with increasing bacterial load. 
In the murine experimental model, acute and chronic S. mansoni infection can predispose to 
pyogenic liver abscess following concurrent infection with S. aureus (Lambertucci et aL, 
1998; Mahmoud and Awad, 2000; Teixeira et al., 2001). 
1.2.5 Protozoal infections 
Experimental studies in particular have shown that schistosome infections interact with a 
variety of protozoal species (Chieffi, 1992, Cox, 2001). 
In experimental malaria infection of C57BL/6 mice infected 8 weeks earlier with S. 
mansoni and superinfected with blood-stage Plasmodium chabaudi (which initially induces 
a Thl response) resulted in increased malaria parasitaemia (Susceptibility), attributed to a 
defect in TNF-a but not in IFN--y production in the co-infected mice. Reciprocally, spleen 
cell proliferative and Th2 responses to SEA were reduced for a month following the 
malaria infection but the S. mansoni pathology was not examined (Helmby et al., 1998). 
However, P. yoelii superinfection was actually shown to inhibit the development of 
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schistosome granulomas in experimentally infected mice by Abdel-Wahab et al. (1974). In 
contrast to C57/BL mice, A/J mice, which normally show high mortality associated with a 
Th2 response to P. chabaudi malaria, prior infection with S. mansoni surprisingly promotes 
a Thl response characterised by enhanced malaria specific IFN-T and mice are protected 
from death (Yoshida et al., 2000). Reciprocal interaction was reported in humans by 
Mutapi et al. (2000), who showed that malaria positive S. mansoni infected children 
produce significantly more anti-schisto some egg IgE and IgG3 than schistosome infected 
children who are negative to malaria. 
Toxoplasma gondii infection normally kills C57BL/6 mice due to intestinal inflammation 
associated with high IFN--y production. Marshall et al. (1999), reported that S. mansoni- 
infected mice super-infected with Toxoplasma gondii showed markedly reduced serum 
IFN--y and NO levels which were presumed to be due to inhibition of development of Thl 
responses by worm induced Th2 cytokines. However, T gondii cyst burdens were 
unaffected even though the animals showed accelerated mortality associated with 
hepatotoxicity. This was hypothesised to be due to high levels of systemic TNF-a since it 
was shown that S. mansoni can prime mice for TNF-a production after endotoxin challenge 
(Marshall et al., 1999) and suggested that T gondii may act like LPS in S. mansoni primed 
mice to produce high levels of TNF-a Araujo et al. (2001), showed that this TNF-a 
production was IL-12 dependent. Conversely, the T gondii superinfection induced a 
considerable reduction in schistosome granuloma size (Marshall et al., 1999). 
An early study of co-infection with T cruzi by (Kloetzel et al., 1971) showed a much 
higher and persistent T cruzi parasitaemia in co-infected animals but there was also slowed 
schistosome maturation, reduced worm burden and retarded ovideposition. 
There is some indication from epidemiological studies in Egypt that schistosome infection 
interferes with the acquisition of immunity to Entamoeba histolytica and/or E. dispar 
(Mansour et al., 1997). S. mansoni-infected mice are also reported to develop more intense 
infections with intestinal protozoa Entamoeba muris, Trichomonas muris and Spironucleus 
muris (Higgins-Opitz et al., 1990). 
A limited number of studies have investigated schistosome/ Leishmania spp co-infections. 
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Two studies have recently been carried out using the cutaneous infection L. major. Yoshida 
et al. (1999) reported that S. mansoni infection did not affect the outcome of L. major 
infection in either susceptible BALB/c and resistant C57BL/6 mice. Yoshida et al. (1999) 
demonstrated that Th2-dominant immune responses alter susceptibility of the host to other 
concomitant parasitic infections. Similarly, La flarnme et al. (2002), initially infected mice 
with 35-70 Sm. (peurto Rican strain) Sm cercaria and 2 weeks later infected with L. major). 
Also there was no major skewing of the immune response, popliteal lymph node cells of 
BALB/c mice expressed mRNA IL- 10 rather than IL-4 but C57BL/6 mice expressed IFN-y 
mRNA upon L. major antigen stimulation, even in S. mansoni-infected mice. In contrast 
La Flamme et al. (2002), demonstrated that infection with S. mansoni significantly delays 
the resolution of cutaneous lesions and parasitaemia following L. major infection given at 
+2 weeks after S. mansoni so that the time of generation of the resolving immune response 
to the L. major (4 weeks) coincided with the peak Th2 response in the S. mansoni infection. 
The co-infection with S. mansoni resulted in decreased Leishmania-antigen induced IFN--y, 
TNF-a and nitric oxide production, but increased levels of IL-4 by popliteal LN cells 4 
weeks after L. ma or infection. The L. major infection did not appear to alter the course of 
the S. mansoni infection. 
Coelho et al. (1980) assessed the susceptibility of mice infected with S. mansoni to the 
cutaneous infection L. mexicana. 12 days after inoculation with Leishmania lesions 
appeared in all of the seven mice with the double infection but in only one of the 10 control 
animals. The immuno-depressive effect of S. mansoni infection was implicated but not 
demonstrated. 
The only study on visceral leishmaniasis demonstrated that L. infantum infections are more 
severe in hamsters infected with S. mansoni (Mangoud et aL, 1998) whereas the L. 
infantum in hamsters delayed the S. mansoni ganuloma formation. 
1.2.6 Worm infections 
Infections with Schistosoma mansoni and other helminths are also widespread and 
overalapping so that co-infections are common. Recent schistosome co-infection studies 
showed that resistance to challenge with the intestinal nematode, Strongyloides 
venezuelensis is increased. The recovery of S. venezuelensis adult worms from the small 
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intestine was significantly decreased by S. mansoni co-infection, and the protection to S. 
venezuelensis appeared to act on migrating larvae, this a result of boosting of Th2 immune 
response due to both helminth parasites in S. japonicum-infected mice (Maruyama et al., 
2000) or S. mansoni-infected mice (Yoshida et al., 1999). This resistance (protection) to 
Strongyloides venezuelensis appeared to act on the migrating larvae and antibodies elicited 
by S. mansoni infection showed cross reactivity to third-stage larvae. Histology revealed 
that resistance was associated with eosinophilic infiltration in the lungs or mucosal 
mastocytosis depending on the route of challenge and that activation of eosinophils and 
intestinal mast cells was correlated with expression of mRNA for IL-13, IL-4, and IL-5 in 
S. japonicum infected mice (Maruyama et al., 2000). 
Trichuris muris superinfection profoundly altered the response to in a strain of mouse that 
normally made a non-protective Thl response to T muris and developed chronic infection 
(susceptible mice). Instead a protective Th2 response was made and the worms rejected 
(Curry et al., 1995). This was believed to be due to the Th2 cytokine environment at the 
time of development of the T muris response. In humans Keiser et al. (2002) did not find 
evidence of reciprocal protective effects in that a study among school children in Me 
d'lvore, demonstrated that increased intensity of S. mansoni was significantly correlated 
with an increased likehood of concomitant hookworm infections. 
1.2.7 Autoimmune diseases 
For many years it has been suggested that autoimmune disease may result in part from a 
deficit in regulatory T cells (Cooke et al., 1978). A variety of markers to define these 
regulatory T cells include CTLA-4 and CD25 (Takahashi et al., 2000). 
An ongoing schistosomiasis-induced Th2 responses might be host protective, and in 
preventing the onset of Thl-mediated autoirnmunity (for example, co-infection with 
schistosomiasis prevented diabetes mellitus in genetically predisposed non-obese 
diabetic mice) (Cooke et al., 1999). Also, Cooke et al. (2001), demonstrated that this 
observation was due to endogenous IL-10, as these BDC2.5/TCR-a transgenic NOD 
mice developed following anti-IL-IOR treatment, and similarly, Zaccone et al. (2003) 
demonstrated that S. mansoni antigens modulate the activity of the innate immune 
response and prevent the onset of typel diabetes and decreased incidence of allergy. 
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A most recent study confirming that pre-established infection with the parasitic 
helminth, Schistosoma mansoni, significantly reduced the incidence and delayed the 
onset of experimental autoimmune encephalomyelitis (EA-E) in C57BL/6 mice 
immunized with myelin oligodendrocyte glycoprotein (MOG)(35-55) peptide (La 
Flamme et aL, 2003). This altered disease progression was not solely due to the 
induction of a strong Th2 response, since intraperitoneal injection of schistosome eggs 
did not affect disease development. MOG-specific gamma interferon (IFN-gamma), 
nitric oxide, and turnour necrosis factor alpha production by splenocytes was 
significantly reduced in schistosome-infected mice compared to uninfected mice. 
However, similar levels of interleukin-10 (IL-10) were produced in an antigen- specific 
manner, suggesting that the induction of antigen- specific responses was not inhibited. 
Analysis of in vivo cytokine production by real-time PCR indicated that IL-12p4O, but 
not IFN-gamma, transcript levels were dramatically reduced in the spinal cords of 
schistosome-infected, MOG-immunized mice. Furthermore, analysis of the cellular 
composition of the spinal cords and brains revealed that a pre-established infection with 
S. mansoni decreased central nervous system (CNS) inflammation, particularly of 
macrophages and CD4 T cells, by downregulating the production of proinflammatory 
cytokines and altering CNS inflammation. 
Clear parallels exists between the immunology of allergy and of helminth infections in that 
both are associated with Th. 2-dominated immune response. Paradoxically, allergic disease 
seems to be less frequent in the developing countries that still have widespread helminth 
infection (Asher and Weiland, 1998), and evidence is accumulating that regulatory 
processes associated with helminth infection might be responsible (Yazdanbakhsh et al., 
2002; Wills-Karp et al., 1996). Recent studies in human populations with S. mansoni 
(Araujo et al., 2000) and S. haematobium (Van den Biggelaar et al., 2000) infections have 
shown inverse relationships between allergen responsiveness (skin prick test to house dust 
mite allergen) and schistosome infection. There was no correlation between this reduced 
level of skin test responsiveness and polyclonal IgE levels indicating that the effect was 
unlikely to be due to non-specific blockage of mast cell receptors by excess non-allergen 
IgE, which has been suggested as a mechanism of interference. However, there was an 
inverse correlation of skin test response with levels of IL-10 produced in vitro to 
schistosome antigen. It has been proposed that the regulatory mechanisms that are induced 
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as a component of the immune response to chronic helminth infection, such as the 
production of IL-10 and possibly TGF-0, can non-specifically suppress inflammatory 
consequences of allergic reactivity (Yazdanbakhsh et al., 2002). 
These findings have led to reappraisal of the "hygiene hypothesis", the basis of which was 
that the Th-2-cell mediated allergies would be counteracted by microorganisms that induce 
Thl cells. The association of Th-2-inducing helminths with inhibition of Th2-mediated 
inflammatory disease, has led to the proposal that mechanisms involving non-Thl cell 
populations, such as regulatory T (Treg) cells, are involved (Yazdanbakhsh et al., 2001; 
2002). 
1.3 Leishmania donovani Introduction, Life cycle and Disease 
All parasites of the genus Leishmania are obligate, intracellular parasites that infect cells of 
the mononuclear phagocyte lineage of their vertebrate hosts, in which they exists as 
amastigotes (reviewed by Alexander and Russell, 1992). There are two developmental 
forms of Leishmania: the extracellular motile promastigotes and non-motile intracellular 
amastigotes. The extracellular motile promastigotes are introduced into the mammalian 
host when an infected female sandfly of the genus Lutzomyia in the new world and of genus 
Phlebotomus in the old world takes a bloodmeal. Shortly after inoculation in the dermis by 
the bite of sandfly, the metacyclic promastigotes are thought to infect macrophages and/or 
dendritic cells of the skin (Langerhans cells)(Titus et al., 1994; Moll et al., 1995); and the 
salivary gland material from the sand fly Lutzomyia longipalpis has an inhibitory effect on 
macrophage function in vi . tro (Theodos and Titus, 1993). Where they transform into 
amastigotes (Moore et, gl., 1994). Visceral leishmaniasis (VL) occurs when members of 
Leishmania donovani complex (L. dQnovani, L. infantum, L. chagasi) are inoculated in the 
skin by the sandfly vector during a bloodmeal. However, cutaneous leishmaniasis is the 
most common form and can be caused by L. major in the old world and L. mexicana or L. 
amazonenesis in the new world (Bosque et al., 1995) 
In the case of visceral leishmaniasis (VL), due to L. donovani, L. infantum and L. chagasi, 
amastigotes spread via the blood stream to the bone marrow, spleen and lymph nodes but in 
advanced disease all organs may be involved (Ridley, 1980; Bittencourt and Barral, 1991). 
In humans and genetically susceptible mice, the liver, spleen and bone marrow become the 
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major sites of parasite growth and pathology (Rosbotham. et al., 1996; Smelt et al., 1997). 
Intracellular amastigotes grow rapidly in the liver for the first 28 days of infection and, 
depending on the mouse strain, are then cleared over the following month (Bradley et al., 
1977). Replication also occurs in the spleen and bone marrow and these become sites of 
chronic infection, with parasites surviving for the lifetime of the animal (Wilson et al., 
1996; Bradley and Kirkle, 1977). Dendritic cells (Moll et al., 1995) and especially 
fibroblasts (Bogdan et al., 2000) seem to be important sites of chronic infections suggesting 
that such cells are 'safe targets' possibly lacking the immune-potentiated killing 
mechanisms of macrophages. 
Regarding the various clinical forms of leishmaniasis, low numbers of viable organisms 
persist within lymphoid tissue and/or the site of former skin lesion after selfcure or 
successful chemotherapy (Ramirez and Guevara, 1997; Schubach et al., 1998). Such latent 
infection often quite frequently gives rise to severe reactivation of disease, including 
visceral leishmaniasis (VL) associated with, e. g. HIV co-infection (Alvar et al., 1997); the 
development of post-kala azar dermal leishmaniasis (PKDL) after cure of VL (el-Hassan et 
al., 1992); reactivation of fon-ner skin lesions, termed recidivans type (Momeni and 
Aminjavaheri, 1994); and the development of mucosal leishmaniasis months or years after 
healing of localized cutaneous ulcer (Saravia et al., 1985). 
Modification of splenic function seems to be an important aspect of L. donovani induced 
disease sequelae. In chronic VL, the spleen show many pathological features including 
germinal center involution and loss of follicular dendritic cells (Zijlstra and el-Hassan, 
2001; Smelt et al., 1997). Marginal zone macrophages (MZMs) are heavily infected soon 
after infection but then disappear (Smelt et al., 1997; Engwerda et al., 2002). Since MZMs 
are also specialized for the uptake of polysaccharide (Humphrey and Grennan, 1981), loss 
of this activity may allow increased systemic spread of encapsulated bacteria in humans 
infected with L. donovani. Indeed, secondary bacterial infections are responsible for 
significant mortality in such patients (Bryceson et al., 1995). Also, the disruption to 
lymphocyte migration is likely to contribute to the immuno-compromised status of patients 
with VL. The disease in humans is characterised. by fever (100%), splenomegly (96- 100%) 
hepatornegaly (50-100%), and enlarged lymph nodes (36-84%) (Siddig et al., 1990; Zijlstra 
et al., 1991; Hashim et al., 1994). Case fatality in VL ranges from 10-14% in those 
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diagnosed and treated, 100% in those who received no treatment (Hashim et al., 1994). 
Visceral leishmaniasis is an important problem in various parts of the world. Notably in 
recent years it has been the most important health problem in Sudan, particularly in the 
main endemic areas in the eastern and central regions and there have also been several 
major epidemics occurred in Western upper Nile province in southern Sudan claiming over 
100,000 lives in 1988 (Zijlstra. and el-Hassan, 2001; Khalil et al., 2002). PKDL was much 
more common than expected (56% of patients with VL developed PKDL) which served as 
a human reservoir of infection in the heavily populated and affected villages (Zijlstra and 
el-Hassan, 2001; Musa et al., 2002). 
1.3.1 Human immune response 
The majority of individuals remain subclinically infected (Badaro et al., 1986a) even 
though parasites may be detected in the visceral organs (Badaro et al., 1986b). Recent 
epidemiological studies of human visceral leishmaniasis suggest that up to 85% of infected 
individuals may also spontaneously control infection (Badaro et al., 1986b; Carvalho et al., 
1992; Evan et al., 1992; Holaday et al., 1993a). These individuals either remain 
asymptomatic or develop oligo symptomatic infection which eventually resolves without 
treatment (Badaro et al., 1986b; Carvalho et al. 1992; Evan et al., 1992; Holaday et al., 
1993a). However, subclinical infection can (even years later) progress to active disease if 
cellular immune function is suppressed, such as in the setting of human immunodeficiency 
virus infection (Alvar et al., 1997) indicating that there is a protective adaptive immune 
response controlling the disease. 
1.3.1.1 Subdinical form of VIL: 
There has been interest in the immunological characterization of the subclinical form of VL 
in relation to active disease in order to define whether and which immune components 
control the infection. Carvalho et al. (1992) observed high levels of IFN--y in cultures 
supernatant of 100% of oligosymptomatic individuals (subclinical cases) who evolved to 
spontaneous cure, supporting the fact that resistance is related to an efficient cellular 
immune response. IL-4 plays an important role in the progression to disease and is also 
involved in the downregulation of IFN--y, so the fact that it was not detected in the 
subclinical to spontaneous resolution cases maybe relevant (Carvalho et al., 1994; Uyemura 
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et al., 1993). A recent prospective cohort study, to identify the immunological markers for 
the subclinical form of VL compared to the acute form was conducted on 784 children aged 
0 to 5 years from Leishmania endemic area in Brazil (Gama et al., 2004). In the subclinical 
form of VL, variable levels of EL-2 were detected in 52.3% of children, IL-12 in 85.2%, 
IFN--y in 48.1 %, IL- 10 in 8 8.9%, and TNF-a in 100%, with the last two cytokines showing 
significantly lower levels than in the acute form. IL-4 was not detected in oligosymptomatic 
individuals. Multiple discriminant analysis used to determine the profile or combination of 
cytokines predominating in the subclinical form revealed both a Leishmania resistance 
(Thl) and susceptibility (Th2) cytokine profile (Gama et al., 2004). 
The subclinically infected individuals show evidence of parasite-specific T-cell reactivity 
(Carvalho et al., 1992), but active VL is associated with the absence of a parasite- specific 
cell mediated immune response (Carvalho et al., 1981; 1985). 
1.3.1.2 Clinical active VL: 
Only a small percentage of infected people develop active disease that is characterized by 
fever, wasting, hepatomegaly, blood cytopenia, and ultimately death. 
In infected humans, Ghalib et al. (1993) demonstrated both TH 1 (IFN--y and IL-2) and Th2 
(IL-10) cytokine mRNA in lymph nodes during acute disease and the ability of the 
infection to induce both Thl and Th2 responses was also shown by the demonstration of 
both Thl and Th2 CD4+ve clones in cured individuals (Kemp et al., 1993). However, 
Ghalib et al. (1995) reported that PBMC from patients with active disease did not produce 
Leishmania antigen specific IIL- 12 p40 or IFN-, y lymphokine which induces macrophages to 
express leishmanicidal activity (Murray, 1990; Murray et al., 1983). The deficient 
production of IFN--y is associated with an increase in CD4+ Th cells expressing a Th2 
cytokine profile (susceptibility), and with the production of IL-4, IL-10 and TNF-cj 
(Carvalho et al., 1994; Mattner et al., 1997; Bogdan and Rollinghoff, 1998). Also PBMCs 
produce IL-10 mRNA the level of which correlates with pathology (Ghalib et al., 1995). 
The lack of IFN--y production by PBMC during initial stages of infection predicts 
progression of disease, whereas individuals producing large amounts of IFN--y remain 
asymptomatic (Reiner and Locksley, 1995). The IL-10 appears to inhibit Thl cytokine 
production during active disease as treatment with anti-IL- 10 resulted in raised IFN-7 and 
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proliferation (Ghalib et al., 1993). Cure of VL is associated with a restoration of the ability 
to make IFN--y and IL- 1 2p4O (Bacellar et al., 2000) and of lymphoproliferation but this was 
blocked by addition of recombinant IL- 10 but not by IL-4 or TGF-O (Bacellar et al., 2000). 
So there is strong evidence that the presence of IL-10, a Th2 cell-associated cytokine 
(Mosmann and Coffman, 1989), is crucially involved in disease progression through its 
suppression of the secretion and/or host defence effects of activating cytokines, notably 
IFN--y (Howard and O'Garra, 1992; Lehn et al., 1989; Mosmann and Coffman, 1989; Silva 
et al., 1992). 
1.3.2 Murine model of visceral leishmaniasis 
Many of the clinical features of the spectrum of human VL occur in murine models in 
which parasites target resident macrophages in the liver, spleen, and bone marrow but 
multiply predominantly in the liver and spleen. Different mouse strains vary in their ability 
to control infection due to genetic differences in innate and adaptive immune responses. 
1.3.2.1 Infection in the liver 
L. donovani multiplies in Kdpffer cells, the resident macrophages of the liver and these 
provide the focus of small granulomas consisting predominantly of monocytes and T cells 
(Murray et al., 1987, McElrath et al., 1988). The parasite load and duration of infection 
vary markedly between different mouse strains but in the most commonly studied BALB/c 
mouse (regarded as a susceptible mouse) mature granulomas develop in the liver 21-28 
days. Liver parasitic burdens in naYve BALB/c mice progressively increase, peak at 4weeks 
as resistance is acquired, and then decline to low levels at 8-9 weeks (Murray et al., 1982; 
Murray et al., 1987; Wilson et al., 1996). This stage of disease is referred to as the chronic 
or recovery phase (Bradley, 1987). During this phase, parasites continue to proliferate in 
the spleen as described below (Smelt et al., 1997; Rousseau et al., 1997; Wilson et al., 
1996). 
Nude and SCID mice cannot control L. major infection unless they are reconstituted with 
CD4+ T cells (Mitchell, 1983; Holaday et aL, 1991) and Belkaid et al. (2001) demonstrated 
the importance of both CD4+ and CD8+ for resolution and clearance of parasites using 
anti-CD4 and CD8 mAb- CD4+ T cells predominate in the formation of mature granulomas 
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but CD8+ T cells are more abundant later and both are necessary for granuloma 
development (Stem et al., 1988). IFN--y and it's principal inducer, IL-12, are necessary to 
direct the assembly of T cells and blood monocytes into granulomas that encircle infected 
macrophages; granuloma assembly and maturation (Murray, 2001 a; Engwerda et al., 1998; 
Taylor and Murray, 1997; Murray et al., 2000; Satoskar et al., 2000; Murray, 2001b). 
1.3.2.2 Infection in the spleen 
Systemic L. donovani infection induces major changes to the architecture and the splenic 
cellular immune response. At 1 week post infection L. donovani parasites are primarily 
localized and phagocytosed by marginal and metallophillic macrophages surrounding the 
red pulp and the marginal zone (Gorak et al., 1998). There is an initial increase in the 
numbers of T cells and dendritic cells in the periarteriolar lymphoid sheath and marginal 
zone, but the red pulp where the abundant parasitized macrophages occur is not infiltrated 
by inflammatory cells until later in the course of infection. During this early phase, IL-10 
production has been shown within the marginal zone and TGF-0 production by 
macrophages in the red pulp (Melby et al., 2001). It has been suggested that these 
macrophage-inhibitory cytokines may suppress the development of protective, macrophage 
activating cytokine responses and allow the infection to establish. 
By day 28 of infection, when the visceral parasite burden starts to drop, the number of IL- 
I O-producing spleen cells returns to the baseline level, but IFN-'Y production was higher and 
the number of IL-12-producing cells was increased dramatically (Melby et al., 2001; 
Engwerda et al., 1998). It is believed that it is the interaction of T cells with the antigen 
presenting cells (dendritic cells) from the splenic PALS and marginal zone (Gorak et al., 
1998; de Smedt et al., 1996) rather than the abundant parasitized macrophages from the red 
pulp which initiates protective T cell response (Banchereau and Steinman, 1998). T cells 
and dendritic cells then move out of the lymphoid follicle and marginal zone into the red 
pulp where they can reduce the splenic parasite burden (Melby et al., 2001). Parasites 
proliferate in the spleen without inducing an inflammatory focus but splenomegly does 
occur with accumulation of fibrous tissue and mononuclear cell infiltrate (Saha et al., 
1991). Although some control is exerted over the spleen parasitaemia parasites do persist 
giving a chronic infection (Engwerda et al., 1998; Gorak et al., 1998; Smelt et al., 1997; 
Wilson et al., 1996). 
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Later on, breakdown of the white pulp structure, destruction of follicular dendritic cells and 
germinal centres (Zijlstra and el-Hassan, 2001; Smelt et al., 1997). Engwerda and Kaye, 
(2000) suggests multiple mechanisms may be involved in the failure to eliminate the 
infection from the spleen: lack of inflammatory foci in the spleen; failure in recruitment of 
lymphocytes to infected cells due to lack of chemoattractants, lack of cytokines (IL-12); 
increased production of TGF-0 leading to reduced capacity to generate (ROI, NO); and low 
levels of expression of MHC class II and competition between receptor-ligand pairs such as 
CTLA-4 for B7-1 and B7-2. 
1.3.2.3 The murine immune response to visceral leishmaniasis: 
1.3.2.3.1 Innate factors 
Inbred strains were found to segregate into two groups (Lshr or Lshs) depending on 
whether they are resistant (C3H/HeJ, C57BL/6) or susceptible (BALB/c, and BlOD2/n) to 
early replication of the parasite (Kaye et al., 1988; Davies et al., 1988; Lehmann et al., 
2000). 
Gene encoding Nramp 1 (natural resistant associated protein 1) which is present as two 
allelic forms, a dominant resistant phenotype and a recessive susceptible phenotype which 
control susceptibility to a variety of organisms including L. donovani (Blackwell et al., 
1996). Nramp 1 has recently been shown to be a transporter of bivalent cations (Goswami et 
al., 2001) which may have direct anti-microbial effects within the phagolysosome. MHC 
(H-2) genes also affect the outcome of infection by influencing the development of the 
adaptive immune response. H-2 d, f, q alleles confer late or non-curing phenotype, H-2 b an 
early curing and H-2 r, s rapid curing pheontypes (Blackwell et al., 1980). Disruption of 
MEC class II-genes renders otherwise resistant C57BL/6 mice susceptible (Erb et al., 1996; 
Chakkalath et al., 1995). It is known that an otherwise susceptible host can be rendered 
resistant to L. major infection by virtue of strong Thl induction through vaccination (Soong 
et al., 1995) or direct transfer of Thl cells (Reiner and Locksley, 1995). 
1.3.2.3.2 Adaptive response 
The key role of the adaptive immune response is shown by the fact that Nude (T cell 
deficient mice) and athymic mice (Miralles et al., 1994) are unable to control the spread of 
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the infection and ultimately die unless reconstituted with CD4+ T cells (Murray et al., 
1987). 
Inbred strains of mice show a range of patterns of infection kinetics and cytokine 
production. L. donovani infection in the liver induces mRNA expression of both Thl (IFN- 
-y, IL-2, IL- 12, TNF-q) and Th2 (IL-4 and IL- 10) cytokines in the liver over the first 2 8days 
of infection (Engwerda et al., 1996; Miralles et al., 1994). However, the balance of these 
cytokines varies markedly between different inbred strains of mice and it is the capacity to 
produce IFN--y which is correlated with resistance (Chatelain et al., 1992). C3H/HeN or 
C57BL/6 mice, for example, mount a Thl response with high levels of antigen specific 
IFN--y and are able to cure the infection within weeks and are then completely resistant to 
reinfection. IL-12, which stimulates T cells and NK cells to produce IEFN-, y (Trinchieri, 
1993), plays a key role in the control of infection in this model (Engwerda et al., 1998; 
Murray et al., 1997). In contrast susceptible mice e. g. BALB/c mice produce moderate 
amounts of both Thl (IFN--y) and Th2 (IL-4 and IL-10) cytokines and show a delay in 
recovery (Locksley and Scott, 1991). However, with time, visceral parasite burdens are 
reduced by >85%, and thereafter these chronically infected animals are resistant to 
rechallenge (Miralles et al., 1994). Although initially susceptible to infection, BALB/c 
mice proceed to develop aT cell-dependent immune response which results in control over 
visceral parasite replication (Murray et al., 1987; Miralles et al., 1994). 
In the liver parenchymal Kiipffer cells (KCs) become infected and as the immune response 
develops there is the formation of small lymphocyte and macrophage-rich granulomas 
around these amastigotes filled KCs. The Thl cytokines, notably IFN-, y activate 
inflammatory macrophages and infected KC secrete TNF-a throughout the infection 
(Engwerda et al., 1996). IFN--y induces ROI production by granuloma macrophages and 
IFN-, y and 'I'NF-a act together to induce expression of the type 2, inducible nitric oxide 
synthase (NOS2), expression of which can be demonstrated in L. donovani-infected tissues 
(Melby et al., 1998; Taylor and Murray, 1997; Engwerda et al., 1996). Use of gene knock 
out (KO) mice has shown that both ROI and RNI are necessary for the control of infection, 
ROI KOs showing delayed clearance but RNI KOs failing to control liver infection at all 
(Murray and Nathan, 1999). -[n vitro studies 
have also shown that Thl cytokines notably 
IFN--y can activate macrophages to kill ingested parasites via the production of reactive 
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oxygen intermediated (ROI), especially H202 (Murray, 1982; Murray et al., 1983) or 
reactive nitrogen intermediates (RNI) (Roach et al., 1993). TNF-a production also 
contributes to parasite killing by augmenting the production of reactive nitrogen 
intermediates by IFN--y-primed macrophages (Theodos et al., 1991). The essential role of 
TNF-a in the expression of macrophage anti-leishmanial activity is demonstrated by the 
fact that TNF-a deficient mice eventually die after L. donovani infection (Wilhelm et al., 
2001). Neutralisation of TNF-a also prevents control and resolution of infection although 
this does not affect the granuloma inflammation (Tumang et al., 1994). IFN-7 also leads to 
increase in MHC class I and II expression and contributes to efficient antigen presentation 
to lymphocytes. 
1.3.2.3.2 Modulation of the response by Th2 cytoldnes 
The association of protracted infections with Th2 responses characterized by low IFN--y and 
high IL-4, IL-5, IL-10 (Scott et al., 1988, Heinzel et al., 1989,1991; Mosser and Karp, 
1999) and TGF-0 production (Barral-Netto et al., 1992; Mosser and Karp, 1999) raises the 
question as to which are the key cytokines in this modulation. 
1.3.2.3.2.1 IL-4 
Confirming to the earlier data in human VL, neutralization of endogenous IL-4 in vivo by 
treatment with soluble murine IL-4 receptor did not result in significant decreases in the 
parasitic burdens in the spleen and liver but did cause a decrease in the serum IgE level of 
L. donovani-infected BALB/c mice (Miralles et al., 1994; Satoskar et al., 1995; Belkaid et 
al., 200 1). It was concluded that the capacity to produce IFN-, y rather than the presence of 
IL-4 determined the efficacy of the immune response in susceptible mice. This is in 
contrast to the role of IL-4 in L. major infections in which high levels of IL-4 induced by L. 
major is clearly a co-determinant of non-healing infections e. g. in BALB/c mice (Sadick et 
al., 1990). 
In agreement with its important role in human visceral leishmaniasis (Kaye et al., 1991; 
Karp et al., 1993, Ghalib et al., 1993, Holaday et al., 1993), IL-10 can also have a major 
influence on control of infection in mice. IL-10 is a immuno-modulatory cytokine, 
produced by a wide variety of cells, including activated Th2 cells, monocytes and 
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macrophages, B cells, thymocytes, and keratinocytes (De Waal Malefyt et al., 1991; 
Fiorentino et al., 1991; Go et al., 1990; Mizuno et al., 1994; Thompson-Snipes et al., 
1991). It plays a key role in deactivating macrophages by suppressing the afferent and/or 
efferent arms of the Thl cell activation mechanism (Moore et al., 2001; Groux et al., 1999). 
The effects on the afferent arm include its ability to downregulate MFIC class 11 molecules 
(Chang et al., 1994) and costimultory molecules such as B7.1, B7.2, and ICAM- I (Chang 
et al., 1994; Willems et al., 1994). Its effects on the efferent arm are also directed 
principally at inducing a state of macrophage deactivation (Bogdan et al., 1991) either by 
making the effector macrophages hyporesponsive to activating stimuli, including cytokines, 
notaby IFN--y, and/or by directly impairing the intracellular microbicidal effects (Bogdan et 
al., 1991). So IL-10 inhibits02-generation (Bogdan et al., 1991), TNF-cý NO generation in 
the parasitized macrophage (Bhattacharyya et al., 1998; 2001b). Since the Thl-associated 
proinflammatory cytokine TNF-a acts as a triggering signal for NO generation (Green et 
al., 1982) this further inhibits NO activity. Apart from its effects on macrophages it has 
recently been reported that repeated antigen-specific activation of both human and mouse 
CD4+ T cells in the presence of IL-10 results in the differentiation T regulatory cells (Trl) 
(Ruedl et al., 2000). 
1.3.2.3.2.2 IL-1 0 
IL-10 can effectively disable the afferent arm of the Thl cell-associated responses that are 
required for induction and expression of cell mediated immunity involved in the control of 
various intracellular pathogens such as Toxoplasma gondii and Trypanosoma cruzi (Neyer 
et al., 1997; Ghalib et al., 1993; Gasim et al., 1998; Hunter et al., 1997). It is now firmly 
established that IL-10 has an important role in various Leishmania species i. e. L. major 
(Vieth et al., 1994), L. amazonesis and L. mexicana (Padigel et al., 2003) and also L. 
donovani (Bhattacharyya et al., 2000c; Murray et al., 2002). 
Normal mice express IL- 10 mRNA as part of the initial response to L. donovani (Miralles 
et al., 1994) and recent studies of L. donovani-infected mice, firmly point to IL-10 as an 
important regulator of outcome. IL-10 KO mice showed enhanced anti-microbial action 
towards a variety of Leishmania species (e. g. L. donovani, L. major, and L. amazonensis 
(Moore et al., 2001; Murphy et al., 2001; Murray et al., 2002; Belkaid et al., 2001; Kane 
and Mosser, 2001; Padigel et al., 2003), and is typically accompanied by increased 
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expression of activating cytokines (e. g. IL-12, IFN--y, and/or TNF-U), induction of NOS, 
and generalized inflammation (Moore et al., 2001). The leishmanicidal activity against L. 
donovani in IL- 10 KO animals clearly requires both endogenous IIL- 12 and IFN-T, because 
treatment of KO mice with neutralizing anti-IL- 12 and anti-IFN--y monoclonal antibody did 
not fully restore parasite replication (Murphy et al., 2001; Murray et al., 2002). Similarly 
normal mice treated prophylactically with anti-IL-10R showed accelerated granuloma 
assembly and rapid parasite killing without untoward inflammation. There was increased 
IL-12 and IFN--y mRNA expression, inducible nitric oxide synthase reactivity (Murray et 
al., 2002). In a more recent publication, Murray et al. (2003) further demonstrated that IL- 
1OR blockade maintained IL-12 protein 40, markedly increased IFN--y serum levels, and 
enhanced tissue inducible nitric oxide synthase (NOS) expression and granuloma 
assembly. Treatment of in vitro L. donovani infected macrophages with anti-IL-10R niAb 
restored the PKC activity in the parasitized macrophages, and caused direct reduction of 
parasitic burden (Bhattacharyya et al., 2001a). Furthermore, preincubation of parasitized 
macrophages with neutralizing anti-IL-IOR mAb significantly blocked the inhibition of 
nitric oxide, RIO and murine TNF-a release by the infected macrophages (Bhattacharyya et 
al., 2001b). 
It has been suggested that IL- 1 OR blockade might be a potential immuno- and/or immuno- 
chemotherapeutic approach for this disease. Thus anti-IL-IOR treatment in conjunction 
with antimony, allowed a substantial reduction (-10-fold) in the dose of antimony required 
to kill the majority of liver amastigotes (Murray et al., 2000; 2001). In human leishmaniasis 
pentavalent antimony is administered daily over 28 days with significant toxic effects 
(Murray, 2001). Given its toxicity, reduction in either dose or duration of antimony therapy 
by co-administration of anti-IL- 1 OR, might improve treatment. 
Conversely, in IL- 10 transgenic mice L. donovan i parasite replication was unrestrained and 
the Thl associated cytokines, IL-12 and IFN--y were initially impaired and despite 
subsequent granuloma assembly, high levels of infection persisted (Murray et al., 2002). A 
high level of splenic IL-10 expression was observed in the murine model of visceral 
leishmaniasis, which in turn contributed to the suppression of splenic T-cell function and 
was associated with multiplication of the visceral parasites (Wilson et al., 1996). 
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In conclusion, production of IL- 10 during L. donovani infection reduces effective clearance 
of the parasite whereas a deficiency of IL-10 allows the Thl response to be highly effective 
in clearing the infection. 
1.3.2.3.3 Role of regulatory T cells 
There is growing evidence that regulatory T cells and, in particular, the endogenous 
CD4+CD25+ T cells (T reg cells) play fundamental role on control of Leishmania 
infections. Endogenous CD4+CD25+ T cells comprise 5-10% of peripheral CD4+ T cells in 
naYve mice and humans, and are believe to play in important role in suppressing potentially 
pathogenic responses in vivo, particularly T-cell responses directed against self-antigens 
(Shevach et al., 2002). T reg functions reflect a number of features of the immune response 
in Leishmania infections e. g. high levels of IL- 10 and transforming growth factor (TGF-0) 
and immuno -suppression (Thornton and Shevach, 1998; Papiernik et al., 1998). Apart from 
their proposed role in autoinimunity there is now a realization that CD4+CD25+ T cells 
operate in infectious disease suppressing excessive Th2 responses controlling protective 
Thl responses, allowing for parasite survival and perhaps as a consequence maintaining 
memory response in susceptible mouse strains. 
A recent study showed the involvement of Treg in L. major infection. (Belkaid et al., 
2002). During L. major infection CD4+CD25+ T cells accumulate in the dermis where they 
apparently suppress the ability of CD4+CD25- effector T cells to eliminate the parasite from 
the site due to both IL- 1 O-dependent and IL- 1 0-independent mechanisms. Despite this most 
parasites are eliminated but a few remain at the site and in the draining lymph nodes. 
Most recent study, Mendez et al. (2004) demonstrated that depletion of CD25(+) cells at 
the time of secondary challenge prevented disease reactivation at the site of persistent 
infection while strengthening the expression of immunity at the site of secondary challenge. 
Finally, transfer of T reg cells purified from infected mice into chronically infected mice 
was sufficient to trigger disease reactivation and prevent the expression of an effector 
memory response. 
However, large number of CD4+ve lymphocytes remain at the sldn site and 40-50% show 
Treg phenotype expressing CD25 and CTLA-4 and low for CD45RB (Sakaguchi et al., 
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1996; Thornton and Shevach, 1998; Piccirillo et aL, 2002). Such lesion-derived CD4+ 
CD25- T cells inhibited IFN--y production by antigen stimulated CD4+CD25+ T cells in the 
presence of L. ma or-infected macrophages but this was not reversed by the addition of 
anti-IL-10R although CD4+CD25+ T cells did release large amounts of IL-10. In vivo, 
transfer of CD4+CD25+ T cells plus CD4+CD25- T cells to RAG-'- mice (lacking T and B 
cells) was able to prevent the resolution of L. major infection which was induced by 
CD4+CD25- T cells transfer on its own. However, transfer of IL-10-1- CD4+CD25- T cells 
healed faster and completely showing that IL-10 production by the Treg is essential for 
maintaining the infection. It was particularly interesting that induction of resolution of 
infection by treatment with 1L-10R antibody during the chronic phase of infection were 
unable to resist reinfection showing that IL-10 induced maintenance of residual infection 
was necessary for maintenance of acquired immunity. 
In humans, the more severe and non-healing forms of leishmaniasis are associated with IL- 
10 (Karp et al., 1993; Gasim et al., 1998), might be due to an imbalance in the number and 
activity of parasite-driven regulatory T cells. Consequent to the chronic infection and the 
potential for disease reactivation, parasite persistence itself provides a major benefit to the 
host by maintaining life long immunity to reinfection. In addition, the regulatory T cells 
seem to produce the paradoxical effects of suppressing effector T-cells functions locally, 
while maintaining a recirculating pool of tissue-seeking memory cells that confer powerful 
immunity to reinfection. This equilibrium that is established between effector and 
regulatory T cells in sites of chronic infection reflects the co-evolution of the host and 
parasite survival strategies. 
1.3.2.3.4 Role of Th2 cytokines in polyamine production 
Recently a non-immunological consequence of Th. 2 cytokine action on proliferation of 
Leishmania parasites was described (Iniesta et al., 2001; 2002). This work was prompted 
by the knowledge that Leishmania infections induce both Th I and Th2 responses; that these 
two differing cytokine groups induce alternate macrophage activation leading to NOS or 
arginase 1 activation respectively; that arginase I leads to polyamine synthesis and that 
polyamines are required for the growth of all trypanosomatidae. It was shown that 
N(omega)-hydroxy-nor-L-arginine (nor-LOHA), a physiological inhibitor of arginase limits 
cellular infection in macrophages in vitro by L. major and L. infantum (Iniesta et al., 2001). 
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It was subsequently shown that proliferation of L. major arnastigotes in macrophage 
cultures could be triggered by IL-4, IL-10 and TGF-O and that this depends on arginase I 
induction which increased the pool of L-ornithine required for the production of 
polyarnines needed for parasite replication. 
Iniesta et al. (2001; 2002), demonstrated that arginase I induction in macrophages, 
triggered by Th2-type cytokines supports the growth of intracellular Leishmania 
amastigotes. This enzyme which synthesis L-ornithine which can be used by the parasite to 
generate polyamines and proliferate. This was done by treating L. major infected BALB/c 
macrophages with IL-4, IL-10 and TGF-0, which are all inducers of Arginase I in murine 
macrophages, led to increase in the number of intracellular amastigotes. Moreover, parasite 
proliferation and arginase activity levels in macrophages from the susceptible BALB/c 
mice were significantly higher than these from infected C57BL/6 cells when treated with 
identical doses of these cytokines, indicating that a strong correlation exist between the 
permissibility of the host cells to L. major infection and the induction of arginase I in 
macrophages. Therefore, arginase induction in the context of a Th2 predominant response 
might be a contributor to susceptibility in leishmaniasis (Iniesta et al., 2002). 
1.3.2.3.5 Latency is a direct result of imbalance of ThI/Th2 immune response 
An imbalance in the Thl- and Th2-type cytokine responses may allow certain pathogenic 
organisms to modify the host immune response to favour their own persistence and 
replicate within the host to cause disease (Mosmann and Sad, 1996; Reiner and Seder, 
1995; Trinchieri, 1997). Accordingly, live intracellular pathogens such as Leishmania 
(Weinheber et al., 1998; Kane and Mosser, 2001), Toxoplasma (Bliss et al., 2000), and 
Mycobacterium (Balcewicz-Sablinska et al., 1999) modulate macrophage phenotype as 
effective immune evasion strategies. Moreover, Ahuja et al. (1998) demonstrated that 
infection/pulsing of human CD34+ peripheral blood hemopoietic progenitor cell-derived 
dendritic cells (DCs) with L. donovani promastigotes, H. capsylatum, and M. kansasii 
impairs the constitutive production of IL-12 from these cells. 
The spleen and bone marrow can become sites of chronic infection, where parasites might 
survive for the life of the animal (Wilson et al., 1996; Bradley and Kirkley, 1977). 
Nonetheless, the observations that dendritic cells (Moll et al., 1995) and especially 
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fibroblasts (Bogdan et al., 2000), harbour low numbers of amastigotes during latency have 
provided strong support for the concept of 'safe targets'. Most recently, the ability of 
pathogens to establish latency involve Treg cells, Belkaid et al. (2002) showed that the 
persistence of L. major in the skin after healing in resistant C57BL/6 mice is controlled by 
an endogenous population of CD4+CD25+ regulatory T cells. During infection by L. major, 
CD4+CD25+ T cells accumulate in the dermis, where they suppress-by both IL-10- 
dependent and IL-10-independent mechanisms-the ability of CD4+ CD25- effector T cells 
to eliminate the parasite from the site. 
Self cure is associated with the killing of more than 99% of the parasites in the skin, and the 
animals develop long lasting immunity to secondary challenge. With respect to the various 
clinical forms of leishmaniasis, low number of viable organisms persist within the 
lymphoid tissue and/or the site of former skin lesion after selfcure or successful 
chemotherapy (Ramirez and Guevara, 1997; Schubach et al., 1998). 
Such latent infection often give rise to severe fonns of reactivation disease, including 
visceral leishmaniasis (VL) associated with, e. g. HIV co-infection (Alvar et al., 1997); the 
development of post-kala azar dermal leishmaniasis (PKDL) after cure of VL (el-Hassan et 
al., 1992); reactivation of former skin lesions, termed recidivans type (Momeni and 
Aminjavaheri, 1994); and the development of mucosal leishmaniasis months or years after 
healing of localized cutaneous ulcer (Saravia et al., 1985). 
An imbalance in the Thl-and Th2-cytokine responses may allow certain microbes to 
modify the host response to favor their persistence. Therapeutic strategies aimed at 
modulating a dysregulated Thl/Th2 response to infection, to secrete biologically active IL- 
12 and IFN--y. Based on these observations, there has been significant interest in restoring 
and/or modulating the imbalance in the Thl and Th2 responses by using 
cytokine/anticytokine therapies for recruiting pathogen-specific protective Th cell response 
(Badaro et al., 1990; DiPiro, 1997). 
A therapeutic strategy using genetically modified, microbial Ag-pulsed DCs, Ahuja et al. 
(1998) demonstrated in her study using retrovirus-mediated somatic gene transfer 
techniques to engineer human DCs to secrete biologically active IL-12 and IFN--y. DCs 
pulsed with microbial antigens (e. g. leishmania and histoplasma Ags) were capable of 
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inducing proliferative responses in autologous CD4+ lymphocytes. CD4+ lymphocytes 
cocultured with IL-12-transduced autologous DCs had enhanced Ag-specific proliferative 
responses compared to CD4+ lymphocytes cocultured with nontransduced or IFN--ý- 
transduced DCs. These results indicate that IL-12-transduced DCs may be specifically 
suited in inducing or down-modulating Ag-specific Thl or Th2 responses, and thus may be 
used as adjunctive therapy in those intracellular infections in which a dominant Thl 
response is critical for the resolution of infection. 
1.3.2.3.6 Leishmanial evasion of host immune response: 
Recent studies, demonstrated that the sandfly saliva which contain salivary peptide 
maxadilan suppresses macrophage leishmanicidal activity, which inhibits tumour necrosis 
factor-a (TNF-a), nitric oxide (NO) production (Hall and Titus, 1995) leading to 
acceleration of lesion development (Lima and Titus, 1996). It has been demonstrated that 
the epidermal Langerhans cells in vitro due to the absence of inducible nitric oxide synthase 
(NOS-2, NOS) in these cells neither allow the replication of intracellular parasites nor 
cause rapid parasite killing (Blank et al., 1996). 
The interaction between the parasite ligands and the host cell receptors can be both via 
direct binding or indirectly via parasite-associated host derived serum molecules (e. g. 
complement C3b/C3bi), fibronectin, C-reactive protein (Mosser and Rosenthal, 1993; 
Brittingham et al., 1995; Culley et al., 1996). These multiple receptor systems allow the 
parasite easy access into macrophages; these also facilitate access into Langerhans cells in 
the epidermis, where the parasites transform into amastigotes (Moll et al., 1993; 1996). 
Recently, Sutterwala et al. (1997) have showed that ligation of the Fc-YR by immune 
complexes not only inhibited the production of IL-12, but unlike complement receptor 
ligation, Fc-yR ligation also induced the synthesis and secretion of IL-10 only in cells 
containing a functional FcR-y-chain (Sutterwala et al., 1998). Additionally, the Leishmania 
amastigotes have host-derived IgG on their surface (Guy and Belosevic, 1993, Pearson and 
Roberts, 1990), which act as opsonin for enhanced parasite adhesion for the macrophages 
was proposed (Peters et al., 1995). Most recently, Kane and Mosser, (2001) demonstrated 
that host-derived surface IgG on Leishmania amastigotes allows them to ligate Fc-Y 
receptors on the inflammatory macrophages to preferentially induce the production of high 
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amounts of IL- 10, diminished their production of EL- 12, and TNF-cz and contributes to 
parasites growth in lesions (enhancement in parasite intracellular survival). 
1.3.2.3.7 Leishmanial co-infections: 
1.3.2.3.7.1 Viral infections 
The prevalence of human immunodeficiency virus type 1 (HIV-1) and visceral 
leishmaniasis (VL) coinfection ranges between 2 and 9% in patients living in 
Mediterranean countries (Alvar et al., 1997). Sicily in Italy has the highest number of 
cases of HIV and L. infantum coinfection in Europe after Spain, and with highest 
variety of zymodymes (Moreno-Camacho et al., 1998). In this area, 25 to 75% of 
visceral leishmaniasis cases occur in HIV-infected patients (Gradoni et al., 1996; 
Pintado et al. 2001; Alvar et al., 1992). 
Both subclinical and visceral leishmaniasis cases are frequent in HIV-1-seropositive 
individuals (Pineda et al., 1996), and is often a consequence of a reactivation of a latent 
infection, and the majority of studies have been carried out with symptomatic patients. 
Because subclinical cases of this disease the previous studies could underestimate the 
true extent of L. infantum and HIV- I coinfection in Europe. Pineda et al. (199 8) carried 
out bone marrow aspiration to 291 HIV-1 carriers in south Spain regardless of their 
symptoms and, results showed that 11% of patients showed visceral leishmaniasis and 
41% of patients had subclinical cases of infection. 
Amastigotes multiply slowly in cutaneous and LN macrophages and starts invading 
multiple visceral sites due to progressive T cell immuno-suppression (Alvar, 1994). 
Dissemination of the parasites that are commonly dermotropic has occasionally reported in 
severely immuno-suppressed HIV-1 infected patients (Pineda et al., 1998; Pratlong et al., 
1995). In contrast, Villanueva et al. (2000) and Kubar et al. (1998) demonstrated that many 
patients with L. infantum and HIV coinfection not receiving antiretroviral HAART therapy, 
do not develop VL despite severe and immuno -suppression. The clinical spectrum of VL, 
ranges from paucisymptomatic infections to disseminated forms with a typical locations of 
the parasite and frequent relapses despite appropriate treatment (Pineda et al., 1998; 
Villanueva et al., 1994; Rosenthal et al., 1995; Lozano et al., 1996). 
67 
The HIV coinfection can induce changes in clinical symptoms, response to treatment is 
lower in HIV-infected patients than immuno-competent patients (Piarroux et al., 1994; 
Pintado et al., 2001; Rosenthal et al., 2000), increased high rates of visceral leishmaniasis 
relapse (between 25 to 61%) and mortality. However, Sanchez et al. (1999) ruled out any 
major difference in clinical manifestations or laboratory data between the two groups. 
The incidence of concomitant opportunistic infections ranged from 42 to 68% of patients 
during any VL episode in the pre-HAART era (Rosenthal et al., 1995; Medrano et al., 
1992), but the percentage of overall concomitant opportunistic infections was only 34% in 
the present series and was 17% in patients who had received HAART. It has been recently 
pointed out that active VL is associated with increased viral replication and that the pre- 
treatment HIV viral load influences the response to antileishmanial therapy (Berhe et al., 
1999; Preiser et al., 1996), which impairs the patient's condition by further immuno- 
suppression (Cacopardo et al., 1996). This might be partly due to Th2 immune activation, 
as demonstrated by high plasma levels (Cacopardo et al., 1996) and from in vitro of 
PBMCs supernatant studies (Preiser et al., 1996; Nigro et al., 1999) demonstrated an 
increase in Th2 cytokines, IL-4, IL-6, and IL-10 in HIV-Leishmania co-infected patients 
than in HIV-alone infected individuals and the shift from Thl to Th2 cytokine response in 
the coinfected individuals is irreversible (Cacopardo et al., 1996). Multiple studies 
demonstrated the degree of the immuno-compromised state of L. donovanilHIV coinfection 
(Clerici and Shearer, 1993) that the shift from a Thl to a Th2 cytokine pattern has been 
previously hypothesized to parallel or even precede the progressive CD4+ impairment that 
accompanies the transition towards the final stage of acquired immunodeficiency syndrome 
(AIDS). 
The reason for this change in cytokine profile is due to impaired production of IL- 12 
(Chehemi et al., 1994; 1995). Moreover, levels of IFN-7 production from PHA-stimulated 
PBMCs was significantly higher in the HIV-positive group compared to that of the HIV- 
Leishmania coinfected subjects. Multiple studies stressed on the importance of IL-4 plays a 
more prominent role in HIV/Leishmania coinfection than IL-10 (Nigro et al., 1999; Kemp 
et al., 1993). However, many other investigators demonstrated the importance of IL-4 in 
both in vivo and in vitro studies in VL without HIV coinfection (Sundar et al., 1997; 
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Raziuddin et al., 1994). Furthermore, during the natural course of HIV infection, IL-4 also 
appears to play a primary role (Clerici et al., 1993; Navikas et al., 1994). 
It is also well known that highly active antiretroviral therapy (HAART) can modify the 
incidence of visceral leishmaniasis (Kaplan et al., 2000; Palella et al., 2003), clinical 
picture and response to specific drugs of some opportunistic infections. After long term 
HAART treatment causes improvement in monocyte-macrophage function and also in NK 
cells suggesting that their amelioration is needed to completely clear Leishmania spP. and 
prevent further relapses (Villaneuva et al., 2000; Mastroianni et al., 1999). 
The impact of antiretroviral therapy (HAART) the evolution of visceral leishmaniasis (VL) 
in HIV-1 infected patients was disputed (Villanueva et al., 2000), as the HAART neither 
prevents the incidence of VL relapse nor modifies the clinical picture described in the pre- 
HAART era despite the therapy decreased the viral load and decreased the incidence of 
opportunistic infections and dramatically increased the median of CD4+ T cell count/ýtl 
(Villanueva et al., 2000). However, in another prospective study for 180 days, Leishmania- 
HIV co-infected patients not treated with HAART, the relapse rate was 80% (Laguna et al., 
1999). 
1.3.2.3.7.2 Won-n infections 
Multiple studies demonstrated that leishmaniasis induces immuno- suppression and other 
superinfections is common. A study on human visceral leishmaniasis in area where L. 
chagasi is endemic (Zwingenberger et al., 1990) disclosed that over 50% of the population 
was also infected by different helminthiases. 
Rousseau et aL (1997) examined the influence of pre-infection with T spiralis 7 days 
earlier, on the course of visceral leishmaniasis due to L. infantum, presented an increase in 
IFN--y, IL-4, and IL-5 mRNA levels locally (in the liver and spleen) and systemically (in 
the blood). Eighteen days after Leishmania inoculation corresponding to the acute phase of 
leishmaniasis, the hepatic amastigotes burden in mice coinfection with L. infantum and T 
spiralis (LT) was significantly lower than that in mice infected with L. infantum only (L 
mice). On day 70, corresponding to the chronic phase, the splenic amastigotes load was 
significantly lower in LT mice than it in the L mice. IFN--y transcripts were over-expressed 
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in both L and LT mice. After Leishmania- specific in vitro stimulation, cytokine production 
was enhanced in both groups, but spleen cells from L mice produced significantly more 
IFN--y than did spleen cells from LT mice. Rousseau et aL (1997) concluded that there is: 
(i) a lack of a clear-cut correlation between the outcome of murine visceral leishmaniasis 
and the type of cytokine pattern; as L mice showed high spleen parasitic burden in spite of 
high IFN--y. (ii) demonstrate that in LT mice, leisbmaniasis takes a milder course than it 
does in L mice, providing information on the potential consequence of coinfection in a 
mammalian host. 
The previous study was in contrast to, experimentally induced Th2-associated response, in 
which BALB/c mice were presensitized with injections of heat-killed L. major 
promastigotes, which exacerbated visceral leishmaniasis (Murray et al., 1997). Also, 
Sadick et al. (199 1) found out that there was little effect on the course of L. major infection 
with coinfection with Nippostrongylus brasiliensis, despite the marked elevation of 
endogenous IL-4 levels. 
1.3.2.3.7.3 Protozoal infections 
However, in another model of coinfection (Oliveira et al., 2000), L. tropica-infected 
BALB/c mice reportedly had the ability to partially inhibit Toxoplasma gondii replication 
in vivo. Santiago et al. (1999) showed that susceptible BALB/c mice previously infected 
with T gondii 5days prior to challenge with L. major become protected against lesion 
development in the footpad. The basis of this T gondii-induced highly polarized Thl 
response independent of the host genetic background (e. g. BALB/c and C57BL/6 mice). 
The ability of T gondii to trigger a Thl response, the IL-12, IFN--y synthesis (initially by 
NK cells and later by T lymphocytes) (Hayashi et al., 1996), instead of Th2 response, in the 
BALB/c mice to control the Leishmanial infection. These results were similar to the ones 
observed in C57BL/6-resistant mice. 
Moreover, Santiago et al. (1999) showed that even at 16 weeks postinfection, the dually 
infected animals showed no major lesions in the footpads infected with L. major. In 
contrast, in chronic toxoplasmosis showed normal skin lesions development when 
superinfected with L. major. However, PCR-specific for L. major GP63 DNA showed a 
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small difference of tissue parasitism in footpads from mice infected only with L. major and 
mice chronically infected T gondii and coinfected with L. major. 
Focus of this thesis 
The above review describes the both S. mansoni and L. donovani induce Thl, Th. 2 and Treg 
responses which normally result in a finely balanced immune response which serves to 
contain/kill the parasite and minimize immuno-pathology. S. mansoni is characterized by a 
Thl>Th2 response and L. donovani by Thl>Th2 response and imbalances in both 
infections can cause severe disease. The liver is a focus of intense infection in both diseases 
with granulornatous responses around eggs or amastigote-infected Kupffer cells serving to 
contain/kill the parasites. 
The overlaping geographic distribution of S. mansoni and L. donovani e. g. Sudan means 
that both infections are found in the same areas (el-Hassan and Zijrich, 2001) and co- 
infections are known to occur El-Hassan (personal communication) and this may result in 
compromised immunological control and exacerbated disease. 
2.0 Aim of the study: 
To investigate in a murine model the consequences for infection, pathology, and immune 
responsiveness of concomitant infections with S. mansoni and L. donovani. Studies focused 
on superinfection by L. donovani on established S. mansoni infections and vice versa. 
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Chapter 2 
2.0 MATERIAL & METHODS 
2.1 Mice 
Outbred, CD-I strain, Swiss albino mice Charles River, UK were used to maintain the 
Puerto Rican strain of Schistosoma mansoni life cycle. Five to eight-week-old C57BL/6 
wild type mice were used in most of the experiments and either bred and maintained at 
the London School of Hygiene and Tropical Medicine (LSHTM). Biological Services 
Facilities according to the UK Home Office guidelines, or purchased from Charles 
River, UK. B-cell knock out mice on the same background (B6/[tMT) were bred and 
maintained in the Biological Services Facilities of LSHTM. The animals were housed 
under specific pathogen-free conditions in the Category 3 containment section at 
LSHTM, London, UK and had free access to food and water. All experiments were 
performed under the regulations of the Home Office Scientific Procedures Act (1986). 
2.2 Production of Cercariae and infection of mice 
The Puerto Rican strain of Schistosoma mansoni was maintained in laboratory-reared 
Biomphalaria glabrata snails. The snails were kept in clean tap water at 24-26'C. 
Cercariae were shed in a minimum volume of clean tap water at 28-30'C under direct 
illumination for 1-2 hours. S. mansoni cercariae were counted and used for infecting 
mice within two hours of collection. 
Mice were anaesthetized with sodium pentobarbitone (0.06 mg/g body weight Sagatal; 
May and Baker Ltd., Dagenham, England) arid then percutaneously infected on the 
shaved belly by the 'Ring Method' of Smithers and Terry, (1965) as adapted by 
Doenhoff et A (1978a). A suspension (0.2-0.5ml) of normal or irradiated S. mansoni 
cercariae was placed in a plastic ring retained on the skin of the belly region with the aid 
of transparent self-adhesive tape. This was left on the skin for about 20 minutes, at 
which time fluid and rings were removed and the animals allowed to recover under 
gentle warmth. 
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2.3. L. donovani infection 
An Egyptian strain of L. donovani (LV9) maintained in Syrian hamsters was used and 
amastigotes for infection were prepared as previously described (Smelt et al., 1997). 
Such parasites for infection were kindly prepared by Dr Chris Engwerda at LSHTM- 
For mouse infection 2xl 07 amastigotes were injected into the lateral tail vein in I OOAl of 
medium. 
2.4 Techniques used in sample recovery 
Because the organs were to be used for cell culture care was taken to carry out all 
procedures using aseptic techniques and sterile equipment. Mice were sacrificed with an 
intrapentoneal injection of 1001il pentobarbitone sodium solution (Sagatal) containing 
lOu/mI of sodium heparin [Sigma, UK]/mouse). At first, the animals were weighed and 
then the ventral body wall covering the abdomen and thorax removed. Blood was 
recovered from the heart using a 21g needle and syringe. The mouse was then 
suspended over a conical fannel leading into a 30ml Universal tube the hepatic portal 
vein cut and the portal system was perfused using sterile ice-cold perfusion buffer (1 Oml 
PBSxl, 25ýd Heparin sulphate(5u/ml), 50ýd 5mM Glucose, 10ýd 0.5 M EDTA) injected 
into the left ventricle of the heart. The liver and spleen were removed and weighed. 
Tissues specimens recovered and stored were as follows: 
I- Blood collected from the heart (for Liver transaminase tests). 
2- Perfusion fluid obtained through the cut portal vein for counting of adult S. mansoni 
worms. 
3- A portion of liver, spleen and small and large intestines was stored in 10% formal 
saline for histology. 
4- A portion of liver and spleen was stored in 100ýd RNA later (Ambion, Inc) at -20'C 
for RNase protection assays. 
5- A lobe of liver was stored at -20'C for determining the schistosome tissue egg count. 
6- A piece of liver was fixed with OCT fluid (Raymond Lamb, UK) into labelled cork 
blocks, covered with OCT and dropped into isopropanol in a glass bottle in contact with 
liquid nitrogen. These were subsequently stored at -70'C and used for cryosectioning 
for immuno-histocherrucal staining 
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7- A small slice of liver and spleen was used to make impression smears for determining 
the L. donovani LDU count. 
8- The remaining liver and spleen tissue was placed in complete culture medium on ice 
for use in in vitro cell culture. 
2.5. L. donovani impression smears 
The freshly cut specimens of liver and spleen were held in forceps and pressed lightly 
onto filter paper (Whatman number 1) a few times to remove excess blood and then 
pressed lightly onto a glass slide several times making several impression smears. 
Tissue imprints were fixed with 95% methanol alcohol for one minute and stained with 
Giemsa stain (BDH Laboratory supplies, England, UK). 
2.6 Parasitology assessments 
2.6.1 Schistosome adult worm counts: 
Perfusion fluid collected from each animal was allowed to settle and the supernatant 
removed, leaving around Iml fluid. A few drops of saponin solution (BDH) were added 
to lyse red blood cells and this fluid was poured intoa girded 6cm Petri dishes and 
screened for the presence of adult schistosome worms using a dissecting microscope. 
2.6.2 Liver egg counts 
Liver tissues were weighed and digested in 10ml of 4% Potassium hydroxide overnight 
in a water bath at 37C. After shaking 50ýtl samples were removed placed on a glass 
slide and the eggs were counted using the x40 objective of a compound microscope. 
Three separate counts were made for each specimen and then expressed as the number 
of eggs per whole liver. 
2.6.3 Leishman Donovani Units (LDU) 
The Geimsa stained liver and spleen imprints were examined microscopically using the 
x40 objective and the number of amastigotes counted relative to (1000) cell nuclei. 
Leishman Donovan units (LDU) for the organ were then calculated as the number of 
amastigotes per 1000 hepatic or spleen nuclei multiplied by the weight of the organ. 
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2.7 AntitFen DreDaration and reaLyents used 
2.7.1 Schistosome Antigens: 
Soluble egg antigen (SEA) was kindly supplied by Dr. M. Doenhoff (University of 
Bangor). The Iyophilised material was made up to 0.5mg/ml with PBS, centrifuged at 
15,000 g, filter sterilized (0.22Am membrane filter, Sartorius) and aliquoted in 50itl 
aliquots which were stored at -20'C 
SWAP was prepared from a frozen pellet of adult S. mansoni worms recovered from 
mice (provided by Dr Q. Bickle). This was homogenized in PBS using a glass tissue 
grinder and then centrifuged, filtered and aliquoted as described for the SEA. The 
schistosome antigen solutions were employed at concentrations of 20ýtg/ml for SEA and 
10ýtg/ml for SWAP based on previous experience in the laboratory. 
2.7.2 Formalinfixed Leishmanial amastigote antigen (FLAA): 
Purified amastigote preparations (109 parasites/ml) were diluted one to one (v/v) with 
4% neutral formalin and incubated for 30 min on ice, washed 3 times with PBS and 
resuspended in a small volume of PBS. After counting on a haemocytometer the 
concentration was adjusted to 2xI 08/ml , an equal volume of sterile glycerol added and 
the parasites stored at -20'C. Before using the parasites were washed 3 times (3000 rpm 
xlO min) in RPMI and recounted. The parasites were kindly supplied by Dr. C. 
Engwerda; ITD, LSHTM, London, UK). 
2.7.3 Mitogen: 
Concanavalin A (Con A) (SigmaDiagnostic INC, St Louis, Mo, USA) was used as a 
mitogen at a final concentration of 5ýtg/ml in cRPMI. 
2.8 In vitro cell cultures 
2.8.1 Spleen cell cultures 
Single spleen cell suspensions were prepared by gently pushing the spleen through a 
100ýtm cell strainer (Becton Dickinson-Falcon, UK) into a petri dish containing 
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complete medium (cRPMI: - RPMI-1640 medium [Gibco, UK] supplemented with 10% 
heat-inactivated foetal calf serum [FCS, Sigma, UK), ImM Sodium Pyruvate [Sigma, 
UK], 2mM L-glutamine [Sigma, UK], 50gM 2-Mercapto ethanol [Gibco, UK], lOOU/mI 
penicillin and 100[tg/ml streptomycin [Gibco, UK]). A 5ml syringe plunger to disrupt 
the tissue. The cell suspension was centrifuged at 1200 revolutions per minute (rpm), 
for 10 minutes at 40C, and the supernatant discarded. The cells were suspended in Iml 
of cRPMI and treated with 9 ml Gey's solution (Tris-buffered ammonium chloride 
solution) for lysis of splenic RBCs at room temperature for 7 minutes. The cells were 
then washed twice with cRPMI. Between the washes the cells were pelleted by 
centrifugation for 10 minutes at 1200 rpm. After counting the cells using 
haemocytometer, spleen cells were cultured at 37'C with 5%CO2 in flat-bottomed 96 
well microtiter plates (Nunc, Denmark) at 5xI 05 cells in a final volume of 200ýtl per 
well, in the presence of medium alone, Con A (5ýtg/ml), SEA (20ýtg/ml), SWAP 
(100ýtg/ml) and FLAA (1 07/ml) . 
All cultures are performed in triplicate. The cell culture 
supernatants were harvested at 24h for (IL-4) and 72h for (IFN-y, IL-10 and TNF-cc) 
(Rumbley et al., 1999). 
2.8.2 Liver lymphocyte preparation 
Owing to the low recovery of lymphocytes, five livers were pooled per group. The liver 
was aseptically chopped into small pieces using a scalpel and digested in a 0.1% 
collagenase D solution (Sigma, UK) in cRPMI for 60 minutes in a polypropylene tube. 
The tube was placed on an rotatory wheel and mixed end over end mixer in an incubator 
at 37C. Digested tissue were forced through a beaker covered over the top with sieve, 
to remove the large liver particles (mostly fibrose tissue). The cell suspension was 
centrifuged at 300rpm for 5minutes at RT to remove hepatocytes and undigested tissue. 
The retained supernatant was carefully collected, avoiding material from the pellet. The 
supernatant was pelleted and the cells washed three times in complete RPMI 1640 at 
1200rpm for 10min. The pelleted cells were resuspended in 5ml cR-PMI and carefully 
layered over 7ml histopaque-70 (Sigma, UK) supplemented with 5mM EDTA. This was 
spin at 1700 rpm for 15 minutes at RT with the brake off the centrifuge. The suspended 
cell layer which compromised as fussy ring layer above the heavy histopaque layer were 
carefully and completely collected with a pastette, diluted with cRPMI, washed three 
times in cRPMI and resuspended in Iml cRPMI. Cells were counted using a 
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haernocytometer, the concentration adjusted and the cells cultured as for spleen cells at 
5xI 05 /well in the presence of medium alone, Con A (5ýtg/ml), SEA (20ýtg/ml), SWAP 
(100ýtg/ml) and FLAA (1 07/ml). 
2.9 Measurement of cytokine levels 
Cytokine levels in culture supernatants were measured for IFN-y, IL-4, and IL-10 using 
anti-cytokine antibodies in commercially available enzyme linked immuno-sorbant 
assay (ELISA) kits (OptElATm cytokine detection kits [PharMingen, San Diego, CA]) 
according to the manufacturers recommended protocols. Briefly, 96-well Nunc 
Maxisorp plates were coated with 50/-tl/well of the primary antibodies diluted in freshly 
prepared coating buffer (0.1 M Carbonate, pH 9.5), covered, and incubated overnight at 
4'C. Plates were washed three times with PBS plus 0.05% Tween 20 (Fisher Scientific), 
blocked with assay diluent (PBS, with FCS, pH7.0) at 20OItL/well at room temperature 
for 2h and then washed again. Standard curves were generated using recombinant 
cytokines, serially diluted over a range of 3-2000 pg/ml, and samples were added at 
501il/well. Plates were covered and incubated for I hours at room temperature. The 
secondary antibodies were diluted in assay diluent, added at 501tl/well and incubated for 
I hour at room temperature. Following washing with PBS plus 0.05% Tween 20 
1001tl/well of substrate solution (Tetramethylbenzidine [TMEB] and Hydrogen peroxide 
[PharMingen, San Diego, CA]) was added to each well, and incubated for 30 minutes at 
room temperature in the dark. The reaction was stopped with 50/tl/well with IN 
sulphuric acid and the optical density read at an absorbance of 450 nm using an ELISA 
reader (NIRX microplate reader, Dynex Technologies, UK) within 30 minutes of 
stopping the reaction. The cytokine levels in the samples were calculated according to 
the standard curve obtained for each ELISA plate. 
2.10. Measurement of nitrite levels bv the Greiss assay (Nitric oxide estimation 
Griess reagent (1% sulphonamide, 0.1% napthylethylenediamine HCL, 2.5% 
orthophosphoric acid) was prepared in milli-Q water and dissolved for approximately 
Ihour at 37C. Sodium nitrite (Sigma) standards were prepared in cRPMI (starting at 
1 OAg1ml- 5 itg/ml-2.5 Itg/ml ... etc. ). 50ttl samples of test supernatants and of nitrite 
standards were added to wells of 96well plates (Nunc, Denmark) and 50 jil of Greiss 
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reagent added. After 5 minutes at room temperature the optical density was read at 
540mn, using a microplate reader (DYNEX) and the nitrite concentration detennined 
relative to the nitrite standard curve. 
2.11. Preparation of anti-IL-IOR monoclonal antibody (mAb). 
2.11.1 Culture of the IBI. 3A cell line 
The anti-IL-10R producing ATCC cell line (lBI. 3A) (Murray et al., 2002) was cultured 
at 3 7'C with 5 %C02 in cRPMI. Tissue culture supernatants were harvested in log 
phase growth, cells removed by centrifugation, and the supernatant collected. 0.01% 
sodium azide (NaN3)was added to the supernatants which were then stored in 4'C- 
Three litres of the culture fluid were accumulated. 
Supernatants are kept on ice in sterile flasks then Set the tubing into Persista pump 
sterilizing the tubing by running 70% ethenol into and outside the tubing. Attached to 
the (single path monitor LTV- 1 optical unit), 
2.11.2 Purification using Protein G affinity Chromatography: 
Cell culture supernatant was filtered using Whatman number I filter paper and then 
filter sterilized using 0.2/. tm filters (Nalgene). The supernatant was kept on ice. 
Protein G Sepharose Fast Flow gel (Pharmacia Biotech, UK) was packed in a plastic 
column (Sigma, UK) which was connected via a Persista pump through a LTV detection 
unit set at 280nm. The columns was equilibrated by running 5 column volumes of 
Running Buffer (0.02 M phosphate buffer, pH 7.0) through it. The supernatant was then 
slowly passed through the column at 4'C. The column was washed with Running buffer 
until the OD280 readings had returned to baseline. At this point Elution Buffer was run 
through the column (0.1 M glycine-HCI, pH 3.0-2.7) to dissociate specific IgG. The 
recovery was monitored and elute containing significant concentration of protein was 
collected. To preserve the activity of acid labile IgG 50itl of 1M Tris-HCI, pH 9.0 
(Neutralizing Buffer) was added to every lml of elute collected to bring the pH to 7.0. 
The antibody fractions were pooled and dialysed against 0.09% NaCl for 72 hours at 
4'C. The dialysis buffer was changed daily. The sample was then freeze-dried and 
resuspended in 1/10th the original volume with sterile distilled water. This was mixed 
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well and filter sterilized using 0.21im filter (Pall Gelman Lab., UK). The concentration 
of the antibody was calculated by diluting antibody in distilled water, measuring the 
optical density at 280nm using a spectrophotometer (UV-1201, spectrophotometer, 
Shimadzu, UK) and then using the following formula: 
Concentration of sample = Optical Density at 280nm xlO mg/ml x dilution factor. 
Extinction Coefficient at 280nm 
The antibody was kept at -20'C, until required. 
In this way 54mg of I. B. 13A was obtained for use in the in vivo depletion experiments. 
2.12. In vivo treatment with anti-IL-IOR antibody. 
To inhibit LL-10R function mice were injected intraperitoneally with lmg 1BI. 3A 
antibody/day on day +42 and 0.5mg on days +46, +49, + 52 and +55. The likely 
efficacy of this regimen was based on the protocol used by Phillips et aL, (2001). 
2.13. Plasma transminase assay 
Mouse serum samples had been stored at -200C. Sera from 5 mice per group were tested 
for liver function test at various time-points, +2, +4, +8wk post-infection with L. 
donovani. The presence of the liver-associated enzymes, aspartate aminotransaminase 
(AST) and Alanine Aminotransaminase (ALT) were deten-nined using commercial kit 
EC 2.6.1.2 UV-TEST (procedure NO. DG159-UV) for ALT, (procedure NO. DG158- 
UV) for AST (Sigma Diagnostic INC, St Louis, USA) as previously described 
(Winefield et aL, 1995). Briefly, 20ýtl of sera were added to 100ýtl of 0.2 M DL- 
aspartate and 1.8 mM (x-ketoglutaric acid in phosphate buffered saline (PH 7.5) (in 
measuring AST) and in measuring ALT (ALT reagent A) L-Alanine 1040 mmol/L, and 
70.4ptl (ALT Reagent B) 2-oxoglutarate. The solutions were mixed and incubated at 
37C for lh and then 100[tl of 2,4-diphenylhydrazine was added and the mixture was 
incubated for 20 min at room temperature. The reaction was stopped with Iml of 0.4 N 
NaOH and the optical density was measured at 340nrn using a Lambda 5 
spectrophotometer. 
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2.14. 
Specimens from liver, spleen and large intestines, fixed and stored in 10% fonnalin 
saline, were embedded in paraffin wax blocks, sectioned at 6ftm thickness and stained 
with hematoxylin and eosin. 
2.14.1 Schistosome granuloma observations 
For comparison of the S. mansoni egg granulomas between S. mansoni infected mice 
and mice with S. mansoni and L. donovani co-infections liver sections were prepared 
from mice with comparable egg burdens. The stained sections were systematically 
scanned field by adjacent field and each granuloma that met the criteria were measured. 
The granulomas selected were those which contained an egg with a morphologically 
distinguishable miracidia inside. These criteria meant that, on average, the granulomas 
would have been sectioned close to its centre and would not have been an old resolving 
granulomas in which the miracidia had been killed and the antigenic stimulus removed. 
Twenty one such schistosome granulomas per infected mouse were assessed. The 
longest diameter was measured using an ocular micrometer and the diameter at 90' to 
this was also recorded. The mean of these two measures was taken and used to calculate 
the granulomas volume assuming a spherical shape. The proportion of eosinophils, 
mononuclear cells and fibroblasts making up each granuloma were estimated and 
recorded. 
2.14.2 L. donovani granuloma observations 
L. donovani granulomas were characterised in haematoxylin. and eosin stained sections 
as described by Murray. (2001), Murray et al. (2002). As the amastigotes multiply 
within the KUpffer cell (KC) so the granuloma develops through identifiable stages 
which have been characterized as: 
Type of L. donovani Cellular reactions around the granuloma 
granulomas 
Infected Ktipffer cell: one or more than one adjacent infected cell with no 
associated inflammatory cells 
Fused KUpffer cell: Fusion of two or more infected KCs without adjacent 
inflarnmatory cells 
Immature granuloma: Infected KCs incompletely surrounded with more than 3 and 
less than 10 cells ad acent cells i 
Mature granuloma: Infected KCs completely surrounded with more than 10 cells 
Sterile granuloma: 
I 
Collection of inflammatory cells with no aniastigotes 
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Fields of sectioned tissue were examined and any foci containing amastigotes were 
recorded according to the above categorization of granulomas. The numbers of visible 
amastigotes present was also recorded. In this way data was collected from 30 
fields/mouse in the parenchyma and from similar numbers of fields inside the 
schistosome granuloma. In analysis of L. donovani granulomas an important population 
are those surrounded by inflammatory cells but in which the amastigotes have been 
killed i. e. "empty" granulomas. Unfortunately it was clear from sectioning of mice 
infected with only S. mansoni that morphologically similar inflammatory foci were also 
formed around Mipffer cells containing schistosome pigment. So in the Co-infected 
mice it was not possible to be certain what was an empty L. donovani granuloma or a 
"pigment reaction". 
2.15. Immuno-histochemical staining of amasti2otes with chromo2enic substrates 
Initial studies used chromogenic substrates to try to stain amastigotes to distinguish 
them from schistosome pigment which caused a problem in the slides initially stained 
with haernatoxylin and eosin.. Cryosections were cut from frozen liver specimens at 
61Lm using a cryostat and placed on polylysine slides (BDH) which were then frozen at - 
20'C until use. For staining sections were fixed with ice-cold acetone for 10 minutes 
and then hydrated for 5 minutes in PBS in a coplin jar on a shaker. Fix with 
parafon-naldehyde 2% for 10 minutes. They were then blocked with Ammonium 
chloride at 50ILM for 10 minutes. They were washed again with PBS for 5 minutes and 
dried. The sections were circled with a silicone pen to prevent liquid spreading from one 
section to another and the sections blocked with 50[d per section of 1.5% normal goat 
serum (Sigma, UK) in PBS for 20 minutes. The slides were dried and incubated with 
50itl per section of primary antibody (Hamster anti-LV9 serum or control normal 
hamster serum at 1: 100 dilution and obtained by Prof. P. Kaye, LSHTM, London, UK) 
for I hour at room temperature. The slides were then washed with PBS for 5 nuinutes, 
dried and the secondary antibody added. For the immuno-histochemistry this was a 
peroxidase labelled goat anti-hamster antibody (Kirkegaard and Perry Ltd, USA) at a 
dilution of 1: 500 for lhour at room temperature. After staining the slides were washed 
3x in PBS. To obtain a colour that could be distinguished from the schistosome pigment 
various substrates were tried. i. e. pink colour with Vector V. I. P. peroxidase substrate kit 
(Vector laboratories, Peterborough, UK), Red colour using peroxidase substrate kit AEC 
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SK-4200 (Vector laboratories, Peterborough, UK), and/or brown colour using 
peroxidase substrate kit DAB SK (Vector laboratories, Peterborough, UK). Although 
amastigotes which were free in the clear cytoplasm could be distinguished with these 
substrates the staining was either not strong enough or sufficiently different in colour 
from the haernatin pigment to be of use. 
2.16. Immuno-fluorescent stainin$! of amasti$! otes 
This was essentially similar to the method described above up to the incubation in 
primary antibody. After this the slides were washed with PBS for 5 minutes and the 
secondary antibody was added (Goat anti-hamster IgG; ALEXA-488-FITC; 1: 250 
dilution) (pharMingen, San Diego, CA) and incubated for I hour at room temperature in 
the dark in a humidified chamber. The slides were washed again in PBS for 5 minutes in 
the dark. The slides were dried and 10/d propodium iodide (Molecular Probes, Inc, 
USA) added per section and incubated in the dark for 20 minutes. After washing again 
with PBS for 5 minutes the slides were dried and 4AI per section of aqueous mounting 
medium with DAPI [Vectasheild mounting medium for fluorescence (Vector 
laboratories, Inc. Burlingame, CA 94010] added. A cover slide was placed over each the 
sections (avoiding air bubbles), the edges sealed with nail varnish and the slides left to 
dry in the dark after which they were further stored at 4'C. Sections were viewed using 
a Zeiss Axioplan immuno-fluorescence microscope at x400 magnification power in the 
dark. Images were recorded using a digital computerised camera (Optronics). 
Amastigotes were visualized as sharp green florescent spots and propidium iodide 
localized to the nuclei of surrounding inflammatory cells appeared red under UV light. 
This protocol was optimised using sections from mice with separate S. mansoni and L. 
donovani infections to avoid auto-fluorescence of haematin granules and to give clear 
distinction between amastigotes stained with immune hamster serum compared with 
control sera. The propidium. iodide staining allowed the type of L. donovani granuloma 
to be characterised, according to the number of surrounding cells and whether they were 
completely surrounding the amastigotes, as infected Kiipffer cells (KCs), fused KCs, 
immature granulomas, and mature granulomas (Murray, 2001; Murray et al., 2002). For 
quantitation thirty adjacent fields were examined for each mouse, and the percentage of 
reactions of each type were determined for each mouse. The number of 
amastigotes/focus in the different inflammatory foci was also recorded. 
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Chapter 3. 
Interaction between an established S. mansoni infection and a 
superimposed L. donovani infection - Parasitological and Immunological 
observations. 
Introduction 
Worm infections affect over a third of the world's population mainly in developing 
countries and infected individuals commonly harbour other infectious agents ranging 
from viruses to other species of worms. With an estimated 200 million (WHO, 1985; 
Doumenge and Mott, 1984; Bergquist. 2002) people infected with schistosomes a large 
number of people would be harbouring co-infections. Apart from the pathological burden 
imposed by multiple infections it is increasingly clear that wonn infections in particular 
can have deleterious effects on the pathogenesis and control of certain concurrent 
infections. In recent years emphasis has focussed on the modulatory effects schistosome 
infections have on the development of immunity to concurrent infections and other 
ongoing immune responses (Cox, 2001). The present study was concerned with the 
effects of Schistosoma mansoni and Leishmania donovani co-infections. These two 
infections are found together in certain area of the world e. g. southern eastern borders of 
Sudan (el-Hassan 'personal communication') and the likelihood of co-infections in 
humans is increased with the displacement and movement of people between areas 
endemic for these infections (Zijrich and el-Hassan, 2001). A further reason for interest is 
that both infections develop in the liver, L. donovani requiring formation of a Thl 
dependent granulomatous response around amastigote-infected macrophages and S. 
mansoni being characterised by Th2 dependent egg granulomas. In this chapter, two 
repeat co-infection studies in mice focused on the effect an established (8 week) S. 
mansoni infection has on a super-imposed L. donovani infection and specifically on the 
effects on parasite loads and on the immune responses stimulated. In susceptible strains 
of mice such as C57BL/6 used in these studies, control of the L. donovani infection and 
subsequent resistance to re-infection is mediated via a Thl-cell dependent, macrophage- 
activating mechanism involving IL-12 induction of IFN--y leading to the production of 
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parasite killing by reactive oxygen and nitrogen intermediates (Murray et al., 200 1; 
Engwerda et al., 1998; Satoskar et al., 2000; Wilson et al., 1996; Melby et al., 1998; 
Taylor and Murray, 1997; Murray and Nathan, 1999). In contrast, along with other worm 
infections, S. mansoni infection is characterised by induction of a Th2 biased response 
(Grzych et al., 199 1) which is associated with a number of immuno-modulatory 
processes which could influence the development of the protective Thl response to 
leishmaniasis in a variety of way. 
The key cells are the Th (T helper cells) lymphocytes. Such cells are initially 
uncommitted but they gradually differentiate into Thl and Th2 cells. Thl and Th2 
subsets of T helper cells were initially defined on the basis of differential cytokine 
production by Th cell clones, IL-2 and IFN--y for Thl clones and EL-4 and IL-5 for Th. 2 
clones (Mosmann et al., 1986; Mosmann and Coffinan, 1989; Swain et al., 1991). It is 
known that the different subsets develop from the same T cell precursor (Hseih et al., 
1993; Rocken et al., 1992; Paul and Seder, 1994) and the best understood influence on 
Thl commitment are cytokines present at the time of antigen presentation during APC/T 
precursor cell interaction i. e. IL-12 (from DC and macrophages) and IFN--y (from NK 
cells) (Hseih et al., 1993; Manetti et al., 1993; Macatonia et al., 1995). Thus, Thl 
responses are markedly reduced in IL-12-/- mice (Magram et al., 1996) and in mice 
depleted of STAT4 (signal transducer and activator of transcription 4) (Kaplan et al., 
1996) which is activated by IL-12 signalling (Jacobson et al., 1995). The influences on 
the development of Th2 responses are hotly debated but recent studies on S. mansoni 
demonstrate that egg antigen which is able to prime DCs for production of Th2 responses 
does not activate DCs to froduce known cytokines (MacDonald et al., 2001) and it has P 
recently been suggested that the Thl/Th2 commitment could be related to differential 
uptake of antigen into separate antigen processing compartments leading to differential 
antigen presentation of Thl and Th2 inducing antigens (Cervi et al., 2004). The 
committed Thl and Th2 populations themselves then preferentially produce IFN--y and 
IL-4 respectively and these cytokines are also able promote the further development and 
function of the same subset but inhibit the other subset. Thus, IFN--y promotes Thi 
development by up-regulating IL-12 production by macrophages (Trinchieri, 1995) and 
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maintaining functional IL-12 receptor expression on Thl cells (Szabo et al., 1997) but 
inhibits development of Th2 cells (Fitch et al., 1993; Maggi et al., 1992). Conversely IL- 
4 is a potent inducer of differentiation of Th precursor cells to Th2 effectors (Maggi et 
al., 1992) which act as growth factors to expand the Th. 2 response and can down-regulate 
IL- 12RO2 expression on Th2 cells making them unresponsive to IL- 12 (Rogge et al., 
1997; Szabo et al., 1997). Also IL-10 which is associated with Th. 2 responses and worm 
infections inhibits Thl development and activation (Sher et al., 1992, Moore et al., 1993; 
2001). Both IL-10 and IL-4 can inhibit dendritic cell function by inhibiting IL-12 
production in immature DCs (Kalinski et al., 1998) and also their development so 
reducing their stimulatory potential and inducing a tolerogenic type of DC (Steinbrink et 
al., 1997). 
The onset of patency in Schistosoma manson i- infected mice at 5-6 weeks post infection 
induces a down-regulation in parasite antigen- and mitogen- induced Thl cytokine 
secretion (IL-2 and IFN--y) with a simultaneous increase in the production of Th2 
cytokines (IL-4, IL-5) and also IL-10 (Grzych et al., 1991). That this was due to the eggs 
themselves was shown by injection of eggs in the lung of recipient mice leading 
development of "synchronous pulmonary granuloma" model (Wynn et al., 1993; 1997). 
Th2 responses are also common in infected humans (Snyman et al., 1997; Souza-Atta et 
al., 1999; Hagan, 1996), although the level of Th2 responsiveness is influenced by other 
factors such as host genetics. For example the Sm2 gene, which is responsible for familial 
hepatic fibrosis and portal hypertension, is located in 6q22-q23, a region that contains the 
gene that encodes IFN--y receptor 1 (IFN--y RI) (Dessein et al., 1999). Although the Th. 2 
cytokines, IL-4 and IL- 13, result in collagen synthesis around the parasite eggs lodged in 
the tissues (Fallon et al., 2000), which underlies the pathogenesis of the disease, the Th. 2 
response is regarded as protective as its absence e. g. in IL-4-/- IL-4/IL-10-1- or IL-4/IL-13- 
/_ mice (Brunet et al., 1999, La Flamme et al., 2001; Hoffinann et al., 2000; Fallon et al., 
2000) results in a switch to Thl inflammatory responses to the persistent egg antigen 
stimulation during acute infection inducing damaging inflammatory disease characterised 
by high levels of IFN--y, TNF-a and nitric oxide (Cheever et al., 2000; Fallon, 2000). 
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Similarly, severe hepatosplenic schistosomiasis in humans is associated with highly 
elevated IFN--y, NO and TNF-a (Dunne and Pearce, 1999). So the generation of a Th2 
bias to the egg is preferable to pro-inflammatory Thl responsiveness although Thl 
responses to egg antigens persist in a balanced state and exert a regulatory effect on the 
Th2 response as shown by the increase in granuloma size, severe fibrosis and marked 
mortality in mice treated with anti-IFN-, y (Luckacs and Boros, 1993). 
Whether the concentrations of IL-4 and IL-10 would be sufficient to influence DC 
activation at the time of presentation of antigen from a co-infecting organism would be 
influenced by various factors such at the level of infection and the specific location of the 
IL-4 production in schistosome infection in relation to the prime site(s) of antigen 
presentation in induction of Thl responses to co-infecting organisms. In the case of S. 
mansoni, egg granulomas are formed predominantly in the liver and the gut but also in 
the spleen and lungs. It is clear that Th2 cells able to produce Th2 cytokines in response 
to specific antigen re-stimulation are found in the spleen (Grzych et al., 1991) but also 
within the egg granulomas themselves as has been shown from studies on cells isolated 
from granulomas (Kaplan et al., 1998; Hayashi et al., 1999; King et al., 2001). Apart 
from the Th2 cells recruited to embolised eggs, the high percentage of eosinophils present 
in the granulomas are a source of IL-4 and Rumbley et al. (1999) reported that activated 
eosinophils comprise the majority of cytokine producing cells in the granuloma and are 
the dominant source of IL-4. Thus in the liver there would be high concentrations of Th. 2 
cytokines associated with the granulomas and this could also have direct effects on the 
generation/function of the granulomas which develop around macrophages infected with 
L. donovani. It is conceivable also that IL-4 production by schistosome granulomas 
formed in the spleen could affect Thl cell priming to antigens presented predominantly in 
the spleen inducing a Thl to Th2 bias in the response. 
S. mansoni infections themselves are subject to immune modulation. Thus after the eighth 
week of infection in mice there is a down-modulation of the granulomatous response 
around newly produced eggs (Andrade and Warren, 1964; Chensue and Boros, 1979) 
such that in chronic infections (variously defined as 15 to 20 weeks post infection) Th2 
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responses are down-regulated (Grzych et al., 1991; Henderson et al., 1992: Chensue et 
al., 1992). Numerous mechanisms have been proposed for this immuno-modulation but 
the reciprocal inhibitory effects of the dual but Th2 dominated (Th2>Thl) response 
mediated by IL-4 and IFN-, y together with inhibition of both responses by IL- 10 (Sadler 
et al., 2003) are believed to be important in mediating a generally anergic state with 
down-regulation of both Th2 and Thl responses (Chensue et al., 1994; Jankovic and 
Sher, 1996; Wynn et al., 1997; Boros and Whitfield, 1998). Apoptosis of sensitized 
lymphocytes in the granuloma has also been reported and suggested to account for 
modulation (Lundy et al., 200 1; Rumbley et al., 200 1) and IL-4 and IL- 10 induction of 
Fas ligand expressing B- Ia lymphocytes have been reported to mediate CD4 apoptosis 
(Lundy and Boros, 2002). Whatever the mechanism of this down-modulation of immune 
responsiveness to the schistosome egg antigen, there could be bystander consequences for 
L. donovani infections especially in the liver. A key function of IL-10 is the down- 
regulation of macrophage function e. g. reducing antigen presentation, inhibiting 
expression of co-stimulatory molecules and also reducing microbicidal functions 
(Marshall et al., 2001; MacDonald et al., 2001; Bogdan and Nathan, 1991; Moore and 
O'Garra, 2001). 
Macrophages with suppressive properties rather than stimulatory properties have recently 
been described and appear to be of two distinct types 'classically activated' macrophages 
which are IFN--y dependent and generally described in relation to cancers and viral 
infections (Young et al., 1996) and those activated by IL-4 and IL-13 to produce arginase 
and so are diverted from the production of NO (Murata et al., 2002; Rodriguez-sosa 2002). 
Such cells have been demonstrated in mice in response to implanting the filarial worm 
Brugia malayii in the peritoneal cavity (Allen et al., 1996; MacDonald et al., 1998) These 
develop profound Th2 responses with recruitment of high numbers of eosinophils and 
macrophages to the site of parasite infection (Falcone et et al., 2001), parallelled with 
suppression in the proliferative response (Loke et al., 2000). 
Both types of suppressor macrophages have been implicated in schistosome infections 
(Classically activated - Atochina et al., [2001] and aaMo - Linehan et al., 2003). Herbert 
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et al. (2004) showed that the anti-inflammatory phenotype of aaMo is crucial to modulating 
severe inflammatory disease in the liver. The role these cells may have in the course of S. 
mansonilL. donovani co-infections is considered more extensively in Chapter 4 but from 
the aspect of immuno-modulation they are likely to suppress generation of protective 
responses by suppressing cellular proliferation (Loke et al., 2000) and by showing 
reduced ability to present antigen and to express co-stimulatory molecules (Jankovic et 
al., 2004; MacDonald et al., 200 1). 
The operation of CD8+ suppressor T cells has been suggested as a mechanism of 
endogenous desensitization in schistosomiasis (Chensue and Boros, 1979) but recently 
attention in the area of suppressor T cells has been focused on naturally occurring 
regulatory CD4+ cells. These cells, originally defined as CD4+CD25+ have since been 
defined by the additional markers (GITR, CTLA-4 and FoxP3 [Gavin and Rudensky, 
2003]). Although their importance in regulating auto-immunity has been emphasized they 
have also been shown to influence the development of immunity to infection as in L. 
major infection. Almost half of the CD4+ T cells in L. major lesions were CD4+CD25+ 
Tr cells some of which were L. major antigen specific (presumed to be cross reacting 
with host tissue epitopes against which these Tr cells are targeted). The cells are believed 
to derive from the natural pre-immune population pool of CD4+CD25+ Tr cells and to be 
able to reduce tissue damage but promote parasite persistence due to IL-10 dependent 
cellular suppression (Belkaid et al., 2002). In doing so, they may suppress sterilizing 
immunity but help to maintain long term T-cell memory and functional immunity. In 
studies of auto-immunity suppression of immune activation has been shown to be 
mediated by IL-10 and TGF-O (Gavin and Rudensky, 2003). Such cells have not been 
described in egg-induced schistosome granuloma described as expressing CD4+CD25+ T 
cells and demonstrates the major source of IIL-10 production and exhibited potent 
suppressive activity in vitro (Hesse et al., 2004)' but they could make a significant 
contribution, possibly along with Th2 cells to the EL-10 seen in the infection and if they 
were similarly recruited to sites of granulomatous responses could also mediate the 
contact-dependent suppression which they have also been shown to mediate at least in 
vitro (Wood and Sakaguchi, 2003). 
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In addition to systemic immuno-modulatory effects of schistosome infection, the sites of 
infection provide an altered cellular environment for co-infecting organisms which may 
be particularly relevant for intracellular organisms. In the case of S. mansoni infection 
this is particularly relevant for organisms co-infecting the liver which is the prime site for 
the egg granulomas which result in the recruitment/generation of large numbers of T 
cells, eosinophils, fibroblasts and macrophages into the organ. For example, the 
granuloma comprises around 30% macrophages (Oswald et al., 1993; Andrade and 
Cheever, 1995) providing alternative sites for the invasion of organisms which live inside 
macrophages e. g. Leishmania species. 
The immuno -modulatory effect of S. mansoni infection was first investigated using a 
single antigen. Acutely S. mansoni infected mice were injected with sperm whale 
myoglobin (SwMb), an antigen which typically induces strong Thl responses in nonnal 
uninfected mice (Kullberg et al., 1992; 1996). It was found that splenocytes from 
schistosome-infected SwMb-immunized animals produced significantly lower Thl 
cytokines (IL-2 and IFN--y) and three fold higher IL-4 per CD4+ cell compared with 
immunized uninfected mice. Although this could be due simply to EL-4 produced by the 
schistosome infection suppressing the development of Thl cells and promoting Th2 cells 
it was found that addition to the cultures of neutralizing mAb to EL- 10 partly restored the 
suppressed IFN--y response to SwMb seen in infected mice, suggesting a role for EL- 10 in 
the observed down-regulation and this could come from Treg cells. An essentially similar 
pattern of skewed response was seen in Tetanus-Toxoid (TT) immunization i. e. following 
primary TT immunization specific IFN--y production was shown to be reduced in S. 
mansoni-infected individuals and inversely related to infection intensity (Sabin et al., 
1996). In contrast EL-4 levels did not show this inhibition. 
Altered responses have also been observed to viruses, bacteria, protozoa and other worms 
and the results attributed principally to the counter-regulatory effects of Th2 cytokines 
(notably IL-4) on the induction of the usual Thl responses. Thus, S. mansoni-infected 
mice showed delayed clearance in S. mansoni-infected mice exposed to recombinant 
Vaccinia virus. They showed decreased virus-specific IFN-y production and cytotoxic T 
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cell responses (particularly CD8+ T cells) and a slight increase in EL-4 and IIL-5 to virus 
antigen. It was suggested that egg granulomas, by providing a micro-environment for 
viral expression, in combination with the cytokine imbalance present during schistosome 
infection, can promote the expansion of vaccinia virus and possibly other viral agents 
(Actor et al., 1993; 1994). 
An important example of modulation is the interaction between schistosome infection 
and Hepatitis C in Egypt, which is considered to be the most important public-health 
problem due to the geographically overlapping distributions. Several studies conducted in 
Egypt (Abdel Wahab et al., 1994; Angelico et al., 1997; El-Zayadi et al., 1997; Hibbs et 
al., 1993; Koshy et al., 1993; Waked et al., 1995; Kamal et al., 2000; Gad et al., 2001) 
and in Brazil (Yoshida et al., 1993; Pereira et al., 1995) demonstrated a higher prevalence 
of HCV virus infection in schistosome patients and defined its importance as seen by 
higher HCV RNA titers, decompensation of hepatic disease (higher histological activity, 
higher incidence of cirrhosis and hepatocellular carcinoma), poor response to 
combination anti-viral-therapy, as well as higher mortality rate. Multiple mechanisms 
have been postulated: (i) Chronic helminth infections, such as schistosomiasis, tip the 
Th 1 -like/Th2 -like balance towards a Th2-like immune response (Sher et al., 1992), 
evidenced by a strong Th2 response in peripheral immune responses (Kamal et al., 2001) 
and are accompanied by a decreased ability to mount specific antiviral immune responses 
(ii) Due to the fact that chronic schistosomiasis causes T-cell hypo-responsiveness 
(Roberts et al., 1993; Grogan et al., 1996; Yazdanbankhsh, 1999) and decreases the total 
T cell count (Colley et al., 1983; Kalinkovich et al., 1998), there will be decreased 
cytotoxic effector T cells for elimination of HCV virus (iii) Endogenous EL-10 produced 
by Treg cells in response to schistosome infection may cause deactivation of 
macrophages and, together with alternative activation of macrophage functions, result in 
decreased microbicidal functions e. g. NO synthesis. EL-10 was proposed to account for 
the low percentage of HCV-specific CD4+ proliferative responses to HCV antigen 
(8.6%) in patients co-infected with HCV and S. mansoni (who tended to produce type2 
cytokine production) compared to 73% of patients infected with HCV alone (who 
produced typel cytokines) (Kamal et al., 2001). These findings suggest that the inability 
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to generate an HCV-specific CD4+/Thl T cell response plays a role in the persistence 
and severity of HCV infection in patients with S. mansoni. 
A relationship between persistent or recurrent bloodstream infections with Salmonella 
spp. (chronic salmonellosis) and schistosomiasis has been described in both adults and 
children (Gendrel et al., 1994; 1984; Hennequin et al., 1991; Lambertucci et al., 1998). 
Moreover, Hennequin et al. (1991) suggested that schistosomes behave as reservoirs of S. 
typhi bacteria and Salmonella bacterial pili adhere to a mannose receptor-like surface 
glycoprotein on the tegument of Schistosome mansoni (Mei et al., 1996) providing a site 
of intravascular persistence and causing periodic bacterial discharges. 
In mice infected with S. mansoni increased susceptibility has been shown to the parasites 
Entamoeba histolytica (Knight and Warren, 1973), Trypanosoma cruzi (Kloetzel et al., 
1973), and Leishmania major (La Flamme et al., 2002). Minimal increases in 
parasitaemia were seen with Plasmodium chabudii spp (Helmby et al., 1998) although 
not P. yoelli or P. berghei (Lwin et al., 1982). However, a strain of mouse which is 
normally susceptible to persistent infection with Trichuris muris becomes resistant (Curry 
et al., 1995). There is evidence that schistosome infections can alter the host's response 
to concurrent infection with Toxoplasma gondii (Marshall et al., 1999). Superinfection of 
S. mansoni infected mice with T gondii resulted in reduced T gondii-Thl induced gut 
pathology associated with markedly reduced serum EFN--y and NO levels presumably due 
to inhibition of development of Thl responses by schistosome induced Th2 cytokines 
(Marshall et al. 1999). 
Like Hepatitis C, Leishmania donovani also infects the liver although it also has serious 
effects on the spleen, also. L. donovani and schistosomes are found in similar areas in 
certain countries e. g. Sudan and are likely to occur in the same patients but to date 
nothing is known about the possible interaction between these infections. However, 
Zijlstra et al. (1991a) and Zijlstra and el-Hassan, (2001), demonstrated a high incidence 
of Kala Azar in displaced people from southern Sudan along the river Nile areas, 
decribing the poor immunological (suppressed or absent IFN--y production from PBMCs 
91 
Zijlstra et al. (1991a) and Zijlstra and el-Hassan, (2001), demonstrated a high incidence 
of Kala Azar in displaced people from southern Sudan along the river Nile areas, 
decribing the poor immunological (suppressed or absent IFN-7 production from PBMCs 
of infected Kala Azar patients) and poor therapeutic response. Such latent infections 
often give rise to severe forms of reactivation disease, including visceral leishmaniasis 
(VL) associated with, e. g. HIV co-infection (Alvar et al., 1997) and the development of 
post-Kala Azar dermal leishmaniasis (PKDL) after cure of VL (el-Hassan et al., 1992). 
The possible involvement of worm infections in general and schistosomiasis in particular 
to this apparently exacerbated disease remains to be determined. In view of this it is of 
interest to determine if there is exacerbation of disease in experimental infections with 
these two parasites. This is of particular interest since they both induce granulomatous 
responses in the liver, in the case of S. mansoni, strong Th2 dominated reactions to the 
egg and in contrast with L. donovani, Thl dominated responses. 
Aim of research 
To study the reciprocal effects of an established patent S. mansoni infection and a super- 
imposed L. donovani infection in terms of parasitology and immunology. 
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3.3. Results 
Two essentially similar experiments are described and referred to as Experiment I and 
Experiment 2. 
3.3.1 Experimental design - Experiment 1 
Sixty six female C57BL/6 mice were divided into 4 groups. Initially thirty mice were each 
infected with 25 Schistosoma mansoni cercariae via the percutaneous route. This relatively 
low dose of cercariae was chosen in order to produce an infection that was not lethal during 
the acute phase but which meant that most mice would have a bi-sexual, egg-producing 
infection. Eight weeks after the schistosome infection 15 of the mice were co-infected, via 
the lateral tail vein, with 2x 107 amastigotes of Leishmania donovani strain LV9. The 
remaining 15 were left with the schistosome infection only. A further group of 15 mice 
received the Leishmania infection alone. Finally a group of 21 mice were untreated 
(CONTROLS). 
Groups of mice were sacrificed at three time-points: 10,12, and 16 weeks post S. mansoni 
infection (+2, +4, and +8 wks post infection with LV9). Throughout the thesis these time 
points are cited with reference to the duration of the superimposed infection i. e. +2, +4 and 
+8 wk rather than with reference to the duration of the schistosome infection. Five mice 
were sacrificed from the infected animal groups and seven mice from the control group. 
The use of more mice in the control group was to try to get sufficient lymphocytes from the 
livers of the control group. In contrast the livers of the infected mice were expected to have 
abundant cells. Throughout the thesis the groups of mice infected with L. donovani alone 
are referred to as LEISH, the S. mansoni alone as SCHISTO and the co-infected mice as 
CO-INFECT. 
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3.3.1.1 Animal and organ weights - Experiment 1 
The weights of the mice sacrificed at each of the time points is shown in Figure 3.3.1. Over 
the time of the experiment the SCHISTO and CO-INFECT mice showed a loss of condition 
with signs of wasting but as can be seen in Figure 3.3.1 there was no significant difference 
in the weights of mice from the different groups at any of the time points. 
Figure 3.3.1- Mean weights of mice [Experiment I]. 
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Figure 3.3.1. 
_Mean weights 
of mice (±S. E. ) at time of sacrifice based on 4 or 5 
mice/time point. SCHISTO and CO-fNFECT mice received 25 S. mansoni 
cercariae percutaneously and 8 weeks later the CO-INFECT mice received 2xlO 
7 
amastigotes of L. donovani intravenously along with the LEISH group (i. e. at week 
0 post L. donovani infection). Control mice were uninfected naYve mice. 
The weights of the livers and spleens were also recorded and the data is shown in Figure 
3.3.2. At +2 weeks the liver and spleen weights were increased significantly compared to 
CONTROLS for the SCHISTO and CO-INFECT groups (p=0.013, <0.0001 for the liver 
and 0.0002,0.0003 for the spleen) but not the LEISH group. The livers and spleens of the 
SCHISTO and CO-INFECT groups were also significantly heavier than the LEISH group 
(p=0.0086, <0.0001 for the liver and p=0.0002,0.0003 for the spleen). By +4 and +8 weeks 
all infected groups showed significant hepatomegaly and splenomegaly compared with the 
CONTROLS (Liver: at +4 weeks, p<0.0001 for all groups; at week +8, p< 0.0001,0.0019 
and 0.0007 for SCHISTO, CO-INFECT and LEISH respectively; spleen: at +4 weeks, 
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p=0.0003,0,0004,0.0002 for SCHISTO, CO-INFECT and LEISH respectively and at +8 
weeks, <0.0001 for all groups). 
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Figure 3.3.2: Mean weights of livers and spleens 
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Figure 3.3.2: Mean weights of livers and spleens of mice (±S. E. ) at time of 
sacrifice based on 4 or 5 mice/time point. For description of the groups see 
legend to Figure 3.3.1. 
The CO-fNFECT group showed increased liver and spleen weights compared to the 
SCHISTO and LEISH groups at +4 weeks but this was only statistically significant relative 
to the LEISH group (p=0.004) in the liver and the SCHISTO group in the spleen (p=0.04). 
At +8 weeks the CO-fNFECT group showed significantly elevated liver weight compared 
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to the LEISH group (p=0.017) but not the SCHISTO group. Spleen weights were 
significantly higher in the CO-INFECT group than either the LEISH (p=0.024) or the 
SCHISTO (p<0.0001) groups but significantly higher in the LEISH than the SCHISTO 
(p=0.0006). 
The percentage differences in liver and spleen weight are of interest as organ size could 
contribute to parasite proliferation notably of L. donovani. The CO-INFECT liver weights 
at +2, +4 and +8 weeks were 75,44 and 74% higher in CO-INFECT compared to LEISH 
mice and the spleen weights, 173,20,54% higher. So early during the L. donovani 
infection, the livers and spleens of the CO-INFECT mice represent potentially more liver 
and spleen tissue for L. donovani infection. Thereafter, at +4 and +8 weeks both single 
infections were associated with hepatosplenomegaly, the S. mansoni infection contributing 
relatively more to the hepatomegaly and the L. donovani more to the splemomegaly as 
shown by the persistently greater liver weight in the SCHISTO compared with the LEISH 
groups and vice versa for the spleen. 
3.3.1.2 Parasitological results - Experiment 1 
3.3.1.2.1 Effect of L. donovani superinfection on the established S. mansoni worm 
burden and egg production - (Experiment 1) 
Worm and egg burdens from the Schisto and Co-infect groups are shown in Table 3.3.1. 
Not all mice which had been exposed to schistosome cercariae were found to have bisexual 
adult worm infections. At +2 and +4 weeks, 4 out of the 5 mice in the SCHISTO and CO- 
fNFECT groups had bisexual infections and at +8 weeks 5 out of 5 SCHISTO mice and 4 
out of 5 CO-INFECT mice had bisexual infections. There were no significant differences 
between the mean worm recoveries from the two groups at any of the time points although 
worrn pair numbers were marginally higher in the CO-INFECT groups at each of the time 
points. 
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Table 3.3.1: Mean adult worm and geometric mean liver egg burdens (±SD) 
SCHISTO and CO-INFECT groups at +2, +4 and +8wk after L. donovani 
soer-infection. 
Group 
Time 
Mean worm count Geometric Geometric mean 
eggs/ 
(wk) Total 
(±SD) 
Pairs 
(±SD) 
mean egg count 
(±SD)o worm pair* (±SD) 
SCHISTO +2 8.0 (±4.1) 2.8 (±1.5) 15127 (±9116) 5402(±8447) 
+4 8.4 (±2.9) 2.8 (±1.1) 18782(±8629) 6708(±3274) 
+8 8.2 (±1.8) 2.6 (±0.9) 22141(±6922) 8516(±3914) 
CO- 
INFECT +2 8.3 (±1.5) 3.5 (±0.6) 15132(±6858) 4323(±2064) 
+4 7.4 (±3.3) 3.2 (±1.6) 15092(±4747) 4716(±1747) 
+8 9.3 (±2.4) 3.8 (±1.3) 16273(±3658) 4282(±1197) 
Table 3.3.1: C5713L/6 mice were infected with 25 S. mansoni cercariae and super-infected 
with L. donovani 8 weeks later. #Egg count expressed as total for the whole liver. 
*Estimated using the number of mature female and male worms recovered in each animal. 
n=4 or5 mice. 
The mice with bisexual worm infections were seen at autopsy to have granulornatous livers 
demonstrating the presence of patent infections. The geometric mean egg counts (GMECs), 
which were carried out on a weighed section of liver, were adjusted, based on the weight of 
the liver, to represent the number of eggs per liver. There were no significant differences 
between the GMECs of the SCHISTO and CO-INFECT groups at any of the time points. 
The GMEC/worm pair were lower at each of the time points in the CO-INFECT group 
compared with the SCHISTO alone group although none of these values were significantly 
different. 
It is clear from the above that the superimposed L. donovani infection had no significant 
effect on the established worm burden or the numbers of eggs in the liver, which would be 
influenced by the rate of egg deposition and the rate of resolution of the egg granulomas. 
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3.3.1.2.2 Effect of prior S. mansoni infection on the superimposed L. donovani 
infection (ExperimenLI). 
Mice were sacrificed at +2, +4, and +8 weeks post-infection with L. donovani infection, 
and liver and spleen imprints were prepared and stained with Giemsa. The slides were 
examined under x40 magnification and the number of amastigotes counted relative to 1000 
cell nuclei. The intensity of infection in the whole organ (liver or spleen) was expressed as 
Leishman Donovan units (LDU) i. e. the number of amastigotes per 1000 hepatic or spleen 
nuclei multiplied by the weight of the organ in grams. 
The results are shown in Figure 3.3.3. Overall, the LEISH animals showed an initial 
infection in both liver and spleen but were able to control the disease, showing a 
progressive reduction in the LDU in the liver from +2 to +8 wk and an initial increase 
followed by a decline between +4 wk and +8 wk in the spleen. In contrast the CO-INFECT 
mice showed steadily increasing LDU in both liver and spleen. The failure to resolve the 
parasite burden in the CO-INFECT mice compared to the LEISH alone mice became 
particularly apparent between +4 and +8 wk post infection with L. donovani. 
At +2 weeks the mean LDU value for the liver was actually 40% lower in the CO-INFECT 
group than in the LEISH group (p=0.02). However, in the spleen, where the overall LDU 
values were very much lower than in the liver throughout, LDU values were twice as high 
in the CO-INFECT than in the LEISH animals (p=0.02). 
At +4 weeks there were no significant differences between either the liver or the spleen 
LDU values in the LEISH and CO-INFECT groups. The levels of infection were 
comparable to the +2 week values in the liver but increased compared to the +2 week 
values in the spleen. 
By +8 week the mean liver LDU values had dropped markedly (13.4 fold) in the LEISH 
group (p<0.0098) but had increased in the CO-INFECT group (1.7 fold) although not 
statistically significantly, such that the mean LDU values for LEISH and CO-fNFECT 
groups were significantly different (27-fold, P=0.0035). 
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Figure 3.3.3.: Comparison of Leishman Donovan Units (LDU) from Liver and 
Spleen imprints at +2, +4 and +8 weeks post L. donovani 
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Figure 3.3.3.: Graphs show the mean (±SE) LDU for five mice from the CO-INFECT and 
LEISH groups. *** Significantly different from LEISH (p=0.0035). ** Significantly different 
from LEISH (p=0.02). Description of the groups see legend to Figure 3.3.1. 
In the spleen LDU counts increased between +2 and +4 weeks in both LEISH and CO- 
INFECT mice but then declined sharply (4.2 fold) between +4 and +8 weeks in the LEISH 
but increased in the CO-INFECT (3.3 fold) such that there was an 11.3 fold higher LDU 
count in the CO-INFECT compared with the LEISH alone (p=0.02). 
Overall therefore, the LEISH and CO-INFECT mice showed a similar response to the L. 
donovani infection at +2 and +4 wk in both the liver and spleen but between +4 and +8 wk 
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there was a marked divergence in both organs, the schistosome infected mice failing to 
control the L. donovani infection. 
3.3.2. Experimental design - Experiment 2 
This is essentially a repeat of Experiment I with the same experimental design except that 
group sizes were increased because a few of the animals in the first experiment had lost 
condition towards the end of the experiment and consideration had to be given to culling 
them. Numbers were also increased to try to obtain adequate cell numbers for the liver 
lymphocyte cytokine deten-ninations. However, one CO-INFECT mouse had to be killed 
because of illness on day 61, and a SCHISTO mouse on day 65. Several CO-INFECT mice 
were observed to be sick on day 100 with symptoms similar to middle ear disease e. g. 
tilting of head, ataxic gait and two had to be culled on day 103. 
3.3.2.1 Animal and organ weights - Experiment 2 
Mouse weights at sacrifice are shown in Figure 3.3.4. 
Figure 3.3.4. Mean weights of mice. 
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Figure 3.3.4.: Mean weights of mice (±S. E. ) at time of sacrifice based on 4 
or 5 mice/time point. For description of the groups see legend to Figure 
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There were some statistically significant differences between the group weights at 
particular time points (e. g. at +2 weeks the mean SCHISTO group weight was statistically 
significantly higher than that of the CONTROL [0.0032] and LEISH [0.0021] groups) but 
such differences were not consistent between different time points and so may have 
represented random variations. There were no significant differences between the groups at 
+8 weeks. The weights of the livers and spleens are shown in Figure 3.3.5 
Figure 3.3.5: Mean weights of livers and spleens 
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Figure 3.3.5: Mean weights of livers and spleens of mice (±S. E. ) at time of sacrifice 
based on 5 mice/time point. For description of the groups see legend to Figure 3.3.1. 
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The data is essentially similar to that in the first experiment (Figure 3.3.2. ) and so only the 
key features will be emphasized. The CO-INFECT groups showed the highest weights for 
both liver and spleen at each time point, significantly higher than the LEISH group at +2, 
+4 and +8 weeks (respectively p<0.0001, <0.0001 and 0.0046 for the liver and <0.0001, 
0.023 and 0.0164 for the spleen). The percentage greater mean weights between CO- 
INFECT and LEISH groups were 76,48,52 % at +2, +4 and +8 weeks respectively for the 
livers and 123,58 and 76% for the spleens. 
3.3.2.2. Parasitological results - Experiment 2 
3.3.2.2.1 Effect of L. donovani superinfection on the established S. mansoni worm 
burden and egg production - (ExperimenLQ 
Worm and egg burdens from the SCHISTO and CO-INFECT groups are shown in Table 
3.3.2. 
Table 3.3.2.: Mean adult worm and geometric mean IiVer egg burdens (±SD) in Schisto 
and Co-infect groups at +2, +4 and +8weeks after L. donovani super- 
infection. 
Group 
Mean worm count Geometric 
Geometric mean 
Time eggs/ count mean e (wk) Total Pairs gg (:: LSD)4 worm pair* 
(±SD) (±SD) (±SD) 
SCHISTO +2 7.5 (±3.1) 2.0 (±1.2) 20706(±10679) 10353(±7214) 
+4 7.5 (±4.0) 3.2 (±1.6) 12946(±4470) 4046(±2039) 
+8 6.4 (±3.9) 2.2 (±1.3) 12102(±5603) 5501(±3977) 
CO- 
+2 
11.3 **4.8 13323 (±4811) 2776(±902) 
INFECT (±1.7) (±0.5) 
+4 5.4 ± (2.9) 2.0 (±1.2) 10231(±5828) 5116(±3484) 
+8 6.7 (±1.8) 2.6 (±0.9) 1 
12815(±2329) 4929 (±2797) 
C57BL/6 mice were infected with 25 S. mansoni cercariae and super-infected with L. 
donovani 8 weeks later. # Egg count expressed as total for the whole liver. *Estimated from 
the number of mature female and male worms recovered in each animal. ** Significantly 
different worin pair burden from SCHISTO (p=0.005). n=5 mice/ group. 
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There were no significant differences between the mean worm recoveries from the two 
groups at any of the time points although worm pair numbers were higher in the Co-infect 
group perfused at +2 wk. The GECs were similar in the CO-INFECT and SCHISTO groups 
at +4 and +8wk but were lower at +2wk but this difference was not statistically significant. 
Similarly the GEC/worm pair values were similar for both groups at +4 wk and +8 wk but 
higher in the SCHISTO group at the +2 wk time point (10353±7214 cf 2776±902) although 
this difference was not statistically significant (p=0.053). 
3.3.2.2.2 Effect of prior S. mansoni infection on the superimposed L. donovani 
infection (Experiment 21. 
The LDU counts are shown in Figure 3.3.6. The patterns of infection in the LEISH and CO- 
INFECT groups were similar to Experiment 1 in that the infection resolved in the LEISH 
group but not in the CO-INFECT group. 
At +2 wk after L. donovani infection both groups had similar LDU counts from the liver. In 
the spleen the counts were again much lower in both groups compared with the liver but 
were already 5 fold higher in the CO-INFECT group than the LEISH group (p=0.01 1). 
Between +2 and +4 wk there was a significant decline in liver LDU in the LEISH group 
(p=0.0002). LDU in the CO-INFECT mice also showed a significant drop in LDU in the 
liver between +2 and +4 wks (p=0.02) but this was 2.5 fold higher than in the LEISH group 
(p=0.005). In the spleen the LDU levels increased but remained low in the LEISH group 
but in the CO-INFECT group the LDU increased sharply (p=0.0009) to be 13 fold higher 
than in the LEISH group (p=0.0002). 
Between +4 and +8 wk there was a further significant decline in liver LDUs in the LEISH 
group (3.1 fold, p=0.01 respectively) but the CO-INFECT group showed a 1.5 fold increase 
in liver LDU which was 11.5 fold higher than in the LEISH group at +8 weeks (p=0.002). 
In the spleen the mean LDU value again increased, 4 fold, between +4 and +8 weeks in the 
LEISH group (p=0.002). There was also a4 fold increase in the spleen LDU for the CO- 
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INFECT group (p=0.002) but the mean LDU value was 12.5 fold higher for the CO- 
INFECT group than for the LEISH group (p=0.0006). 
Figure 3.3.6.: Comparison of Leishman Donovan Units (LDU) from Liver and Spleen imprints 
at +2, +4 and +8 weeks post L. donovani sqper-infection. 
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Figure 3.3.6.: Graphs show the mean (±S. E. ) LDU for five mice from the CO-INFECT and 
LEISH groups. ** Significantly different from LEISH group (p=0.005 and 0.002 at +4 and +8 
weeks respectively). *** Significantly different from LEISH group (p=0.01,0.0002, and 0.0006 at 
+25 +4 and +8 weeks respectively). For description of the groups see legend to Figure 3.3.1. 
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3.3.1.3 Immunology results - Experiment I 
Cytokine production (IFN-, y and IL-4 as markers of Thl and Th2 responsiveness 
respectively) and the immunoregulatory cytokine IL-10, was assessed in supernatants 
obtained from spleen cells from three individual mice per group and from pooled liver- 
derived lymphocytes. Cells were cultured in vitro at a concentration of 5xI 06/Ml with 
medium alone, mitogen (ConA), schistosome antigens (soluble worm antigen preparation 
[SWAP] and soluble egg antigen [SEA]), and leishmanial antigen (formalin-fixed 
amastigote antigen [FLAA]). 
3.3.1.3.1 Detection of IL-4 production from spleen IMphocytes by ELISA 
The cytokine data is plotted with the ConA data (Figure 3.3.7. ) and also without it (Figure 
3.3.8. ) so as to emphasize the antigen- specific responses but the description of the data 
refers to both graphs together. 
At +2weeks post LV9 splenocytes from both the SCHISTO and CO-INFECT groups 
produced raised levels of IL-4 in the presence of ConA compared with CONTROLS in 
which no IL-4 was detected. Splenocytes from the LEISH group produced low levels of IL- 
4 to ConA, significantly lower than the SCHISTO group (p=0.037) but not significantly 
different from the CO-INFECT group owing to the high value in one of the mice. With the 
specific schistosome antigens, SEA and SWAP (see Figure 3.3.7. ), IL-4 was raised in both 
SCHISTO and CO-INFECT groups but undetectable in the CONTROLS. Although the 
levels of IL-4 were higher for both SEA and SWAP in the CO-INFECT group the 
differences were not statistically significant. The LEISH group did not show responses to 
SWAP or SEA and none of the groups showed a response to FLAA. 
At +4 weeks post LV9 both the SCHISTO and CO-INFECT groups showed significant IL 
4 production to ConA relative to control mice (p=0.007,0.004 respectively). 
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Figure 3.3.7. Comparison of the levels of IL-4 in supematants of spleen cell 
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Figure 3.3.7. Graphs showing the means and standard errors from IL-4 detected by ELISA 
based on three mice from each group sacrificed at +2, +4 or +8 weeks after the L. donovani 
infection. Cultures of 5xlO 6 spleen cells/ml were stimulated with medium alone, ConA at 
5ttg/ml, schistosomal antigens (SWAP and SEA at 101tg/ml) or fixed leishmanial 
amastigote antigen (FLAA, at 10 7 amastigotes/ml). For description of the groups see legend 
to Figure 3-3.1. 
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Figure 3.3.8. Comparison of the levels of IL-4 in su-pematants of spleen cell cultures 
without ConA data. 
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Figure 3.3.8. Data from Figure 3.3.7 redrawn without showing ConA results. See legend to 
Figure 3.3.1. 
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The highest ConA-induced IL-4 production was from the SCHISTO group and this was 
elevated compared with the response in the SCHISTO group at +2 weeks and significantly 
higher than in both the CO-INFECT and CONTROL groups (p=0.007,0.028 respectively). 
In the presence of SEA, IL-4 production by SCHISTO and CO-INFECT mice was 
comparable and again significantly raised compared with controls (p=0.02 and 0.03 
respectively). SWAP specific responses were also elevated in both groups but the 
difference was not statistically significant owing to some response in one of the control 
mice. 
At +8 weeks there was evidence of elevated spontaneous IL-4 production (i. e. in the 
presence of medium alone) in all of the infected groups. For the SCHISTO and CO- 
INFECT groups the difference was significant relative to CONTROLS (p=0.001 and 0.005 
respectively). In the presence of ConA only the CO-INFECT mice showed significantly 
elevated IL-4 production (p=0.02). This group also showed significantly elevated 
production in the presence of SWAP, SEA, and FLAA (p=0.02,0.008, and 0.01 
respectively) although only the values for SWAP and SEA were significantly higher than 
for medium alone (p=0.05,0.04 respectively) and none of the values were significantly 
higher than the corresponding values for the SCHISTO group. Lower but significantly 
raised IL-4 levels compared with CONTROLS were seen with cells from the SCHISTO 
group with SWAP, SEA, and FLAA (p=0.02,0.009 and 0.002 respectively), however only 
the SWAP values were significantly higher than the medium alone (p=0.04). Cells from 
LEISH mice showed somewhat elevated mean IL-4 production compared with controls but 
these were not significant and not antigen specific. 
3.3.1.3.2. Detection of IFN-j production from spleen IMphoc3les by ELISA 
As shown in Figure 3.3.9. CONTROL cells produced significant and comparable levels of 
IFN-7 at each of the time points in the presence of ConA but in the presence of medium 
alone or the specific antigens there were minimal responses. 
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Figure 3.3.9. Comparison of the levels of IFN-j in supematants of spleen cell cultures 
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Figure 3.3.9. Graphs showing the means and standard errors for IFN--y detected by ELISA 
based on three mice from each group sacrificed at +2, +4 or +8 weeks after the L. donovani 
infection. Cultures of 5xI 06 spleen cells/ml were stimulated with medium alone, ConA at 
51tg/ml, schistosomal antigens (SWAP and SEA at 101tg/ml) or fixed leishmanial 
amastigote antigen (FLAA, at 107 amastigotes/ml). For description of the groups see legend 
to Figure 3-3.1. 
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Schisto alone Co-infect Leish alone control 
At +2 weeks post LV9 each of the infected groups, SCHISTO, LEISH and CO-INFECT 
showed raised IFN-7 production compared to the controls in the presence of medium alone 
and the various parasite antigens. The SCHISTO group showed responses to ConA 
comparable with the controls but showed raised responses relative to controls with medium 
alone, SWAP, SEA and FLAA. The schistosome antigens, SEA and SWAP did not 
stimulate significantly higher responses compared with medium alone indicating a 
spontaneous production of IFN--y but no evidence of a specific recall response. The LEISH 
and CO-INFECT groups showed similar responses to medium, ConA and SEA but there 
was a surprisingly high response to SWAP in the LEISH group, significantly higher even 
than was observed in the SCHISTO and CO-INFECT groups (p=0.008,0.0001 
respectively) and perhaps suggesting some cross reactivity but since a comparable response 
was not seen at later time points the significance of this apparent SWAP response is 
unclear. In the presence of FLAA the highest response was from the LEISH group, 
significantly higher than from the CONTROL and SCHISTO groups (p=0.0007,0.007 
respectively). Of particular interest was the fact that cells from the CO-INFECT mice made 
a significantly lower IFN--y response (p=0.01) to FLAA than the LEISH alone group. 
The IFN--y levels observed at +4 weeks showed some similarities to the +2 week data in 
that cells from the SCHISTO and CO-INFECT mice showed raised, apparently 
spontaneous production in the presence of medium alone and this was not significantly 
altered by addition of SWAP. The IFN-7 levels in response to Con A and SEA were 
somewhat higher than in medium alone but the differences compared with the medium 
alone were not significant. The raised level of response to SWAP seen at +2 weeks in the 
LEISH group was not seen at +4weeks. The most noticeable difference compared with the 
+2 week time point was the reversal in the pattern of IFN--y production in the LEISH and 
CO-INFECT groups. The CO-INFECT animals produced noticeably higher IFN--y in 
response to FLAA compared to LEISH animals, however, due to the high standard error, 
the CO-INFECT value was not statistically significantly higher with FLAA than the 
medium alone value (P=0.064) and also not significantly higher than the LEISH response 
to FLAA. 
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At +8 weeks levels of IFN--y in response to all antigens were markedly lower than at the 
earlier time points. There was no longer IFN--y production in the presence of medium alone 
by cells from SCHISTO, LEISH or CO-INFECT MICE. Neither the SCHISTO and CO- 
INFECT group showed noticeable IFN--y specific recall responses in the presence of 
schistosome antigens (SWAP, SEA). The LEISH and CONTROL groups showed 
comparable and significant ConA-induced IFN--y production in the presence of ConA 
compared with medium alone (p<0.0001 and 0.008 respectively) and the SCI-11STO 
response to ConA was also significant (p=0.002). However, the Con A induced response in 
the CO-INFECT mice was significantly lower than that in the CONTROL, LEISH or 
SCHISTO groups (p=0.02,0.0005 and 0.048 respectively). Both the CO-INFECT and 
LEISH groups showed elevated IFN--y responses to FLAA but this was only significantly 
higher than the CONTROLS for the LEISH group (p=0.007). Notably, IFN--Y production 
stimulated by FLAA was lower in the CO-INFECT group compared with the LEISH group 
although this was not statistically significant (p=0.09). 
3.3.1.3.3. Detection of IL- 10 production from s-plenocyles by ELISA 
At +2 weeks, as shown in Figure 3.3.10., Con A stimulated splenocytes from the CO- 
INFECT and the SCHISTO animals produced the highest levels of EL-10, although the 
differences compared to CONTROLS and to medium alone were not statistically 
significant. 
Similarly the SCHISTO and CO-INFECT groups produced similar, elevated, levels of IL- 
10 in response to both schistosome antigens but especially to SEA. The differences relative 
to CONTROL mice were statistically significant for both SWAP (p=0.004,0.05 
respectively) and SEA (p<0.0001,0.01 respectively). Both the LEISH and CO-INFECT 
groups showed production of IL-10 to FLAA but this was only significant higher than 
CONTROL values for the LEISH group (P=0.001) and this was not significantly higher 
than the CO-INFECT EL-10 value (p=0.08). 
At +4 weeks Con A induced IL-10 levels were again high in the SCHISTO and CO- 
INFECT groups although owing to some variability these values were not significantly 
different from the CONTROL values (p= 0.08 and 0.07 respectively). The SCHISTO and 
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Figure 3.3.10. Comparison of the levels of IL-10 in supematants of spleen cell cultures 
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Figure 3.3.10. Graphs showing the means and standard errors for IL-10 detected by ELISA 
based on three mice from each group sacrificed at +2, +4 or +8 weeks after the L. donovani 
infection. Cultures of 5xlO 6 spleen cells/ml were stimulated with medium alone, ConA at 
51tg/ml, schistosomal antigens (SWAP and SEA at 10[tg/ml) or fixed leishmanial amastigote 
antigen (FLAA, at 10 7 amastigotes/ml). For description of the groups see legend to Figure 
3.3.1. 
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CO-INFECT groups also produced similarly raised levels of IL- 10 in response to SEA and 
SWAP, although this was only statistically significant relative to the controls in the 
SCHISTO group (p=0.05,0.02 for SWAP and SEA respectively). Interestingly, a high level 
of FLAA induced IL-10 production was seen from the CO-INFECT group (values of 5993, 
1760 and 2338pg/ml for the three mice) and only minimal levels from the LEISH group 
(38,67, and 299pg/ml) and CONTROL mice (86,0 and 74pg/ml) but owing to the 
individual variation the values were not statistically different. 
At +8 weeks the mean IL-10 levels in response to ConA, SEA and SWAP were markedly 
lower than those observed at the +2 and +4 week time points. Although the levels of IL- 10 
were low the values were significantly elevated in some groups. The CO-INFECT group 
followed by the SCHISTO group produced highest levels of IL-10 production in response 
to Con A, however this was only statistically significant in the SCHISTO group compared 
to the controls (p=0.03). The CO-INFECT group produced significantly more IL-10 in 
response to SWAP compared to both the CONTROL and the SCHISTO groups (p=0.002 
and 0.01 respectively). However, both the SCHISTO and CO-INFECT groups produced 
similar but not statistically significant levels of IL- 10 in response to SEA. Additionally, the 
CO-INFECT group produced the highest levels of IL-10 to FLAA (P<0.001 compared to 
the CONTROL) but this was also significant for the LEISH group (p=0.004). 
It is interesting to note that the IL- 10 response to FLAA largely mirrored the pattern of the 
IFN--y response notably with regard to the FLAA response and also to the general reduction 
in response seen at +8 weeks. 
3.3.1.3.4. Detection of Nitrite production in splenocyte cultures 
As a measure of nitric oxide production and so of classical macrophage activation nitrite 
levels were measured in the supernatants from in vitro spleen cell cultures. Overall low 
levels of nitrite were detected (Figure 3.3.11. ). 
At +2weeks, there were no sign of nitrite production in response to ConA, SEA, FLAA 
antigens in any of the infected or control mice. 
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Figure 3.3.11.: Levels of Nitfite produced in splenocyie ý: tdturcs 
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Figure 3.3.11.: Graphs showing the means and standard errors for nitrite detected 
using the Greiss reaction, based on three mice from each group sacrificed at +2, +4 
or +8 weeks after the L. donovani infection. Cultures of 5xl 06 spleen cells/ml were 
stimulated with medium alone, ConA at 5Ag/ml, schistosomal antigens (SWAP and 
SEA at 10ttg/ml) or fixed leishmanial amastigote antigen (FLAA, at 107 
amastigotes/ml). For description of the groups see legend to Figure 3.3.1. 
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At +4weeks post L. donovani infection the only responses higher than the CONTROL 
levels were in the CO-INFECT group where the highest mean level of nitrite was in 
response to ConA followed by FLAA and in the LEISH group which FLAA stimulated an 
elevated response. None of these values were significantly elevated relative to control 
values. 
At +8weeks, the CO-INFECT animals produced the highest level of nitric oxide in 
response to ConA and this was statistically significant relative to the controls (p=0.04). The 
SCHISTO animals showed significant levels of nitric oxide production in response to SEA 
compared to both LEISH and CONTROL animals (p=0.03,0.03 respectively). The CO- 
INFECT animals produced significant levels of nitric oxide in response to FLAA compared 
to LEISH, SCHISTO and CONTROL groups (0.03,0.01, and 0.02 respectively). 
In conclusion, although the levels were low it may be relevant that the LEISH animals 
produced the highest nitric oxide in response to FLAA at +4 weeks but by +8 weeks after 
infection when the infection had increased markedly in the CO-INFECT mice nitric oxide 
production in response to FLAA was highest in that group. 
3.3.1.3.5. Detection of IL-4 and IFN-Iproduced by liver-derived IMphocyies 
Two methods were used in these studies to produce liver lymphocytes, one involving 
collagenase D digestion (Dr Chris Engwerda, 'personal communication') and the other simple 
mechanical disruption using a glass homogenizer. Both subsequently involved spinning on a 
histopaque cushion. The digestion method was used in this first experiment although the 
disruption method was later found to provide a higher yield of cells and was used in a second 
experiment. However, even with this method insufficient lymphocytes could be produced 
from the liver cells especially from the CONTROL animals to be tested individually and so 
cells were processed and tested as pools. Wells were set up in triplicate and the results shown 
represent the mean of these. Overall it proved difficult to get pure populations of cells and 
there were variable levels of contamination by liver parenchymal and other cell types. It was 
the control cells that proved most difficult to obtain in sufficient numbers and clear of 
contaminating parenchymal cells. The data showed some anomalies especially for EFN--y but 
some of the data was consistent with expectation and so the results are reported. 
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At +2 wk post L. donovani super-infection (see Figure 3.3.12a) IL-4 was only detected in the 
ConA stimulated cultures from the SCHISTO and CO-INFECT groups and in the SEA 
stimulated culture from the SCHISTO group. The IFN--y data was difficult to interpret as the 
medium alone cultures showed quite a high response in the SCHISTO and LEISH groups 
whereas with FLAA the highest response was with the FLAA and CO-INFECT groups. With 
SEA there was also a response seen in the CONTROL group. This was comparable in the 
LEISH group but higher in the CO-INFECT and SCHISTO groups. The IFN--y production 
with Con A group showed a pattern more similar to what might be expected as there was a 
high production in the LEISH group and somewhat lower in the SCHISTO group and no 
production in the CONTROL cells but the CO-INFECT group also showed a response 
similar to the SCHISTO group. 
At +4 weeks (see Figure 3.3.12b), the EL-4 data was again consistent and as expected 
showing a similar trend to the +2 week time point. There was evidence of spontaneous IL-4 
production in the SCHISTO and CO-INFECT groups in the presence of medium but the 
significance of this is uncertain because with FLAA there was a comparable level in the 
CONTROL group. With Con A and SEA the responses were higher and only seen in the 
SCHISTO and CO-INFECT groups. The EFN--y data was again puzzling as the CONTROL 
cells gave high values with both medium alone and the other stimulants. In the Con A and 
SEA cultures this was particularly high (note the difference in scale on the ConA graph in 
Figure 3.3.12b). 
At +8 weeks (see Figure 3.3.12c), the SCHISTO group again showed comparable EL-4 
production in the presence of Con A although no CO-INFECT response was seen in contrast 
to the +4 time-point. Interestingly the SEA stimulated IL-4 responses in both SCHISTO and 
CO-INFECT were markedly lower than those recorded at +4 weeks. Similarly, the IFN--y 
levels tended to be substantially lower than at the earlier time points, although this time the 
control levels were lower and closer to what would be expected. With medium alone all of 
the groups showed low and similar levels. 
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Figure 3.3.12a: Comparison of IL-4 and IFN-Iproduced by cultures of liver-derived 
Im-phocytes. 
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Figure 3.3.12a: Lymphocytes were recovered from livers pooled from 5-7 mice/group at 2 
weeks post L. donovani infection. Cultures of 5xIO 
6 cells/ml were stimulated with medium 
alone, ConA at 5Ag/'ml, schistosomal antigens (SWAP and SEA at 10ttg/ml) or fixed 
leishmanial amastigote antigen (FLAA, at 107 amastigotes/ml). Supernatants were recovered at 
24hr (for IL-4) or 72hr (for IFN--y) and assayed by cytokine ELISA. Data represent the mean of 
three replicate ELISA wells. For description of the groups see legend to Figure 3.3.1. 
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Figure 3.3.12b: Comparison of IL-4 and IFN-j produced by cultures of liver-derived 
lyLnphocvtes. 
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Figure 3.3.12b: Lymphocytes were recovered from livers pooled from 5-7 mice/group at +4 
weeks post L. donovani infection. Cultures of 5xlO 
6 cells/ml were stimulated with medium alone, 
ConA at 5Ag/ml, schistosomal antigens (SWAP and SEA at IOAg/ml) or fixed leishmanial 
amastigote antigen (FLAA, at 10 
7 amastigotes/ml). Supernatants were recovered at 24hr (for IL-4) 
or 72hr (for IFN--y) and assayed by cytokine ELISA. Data represent the means of three replicate 
ELISA wells. For description of the groups see legend to Figure 3.3.1. 
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Figure 3.3.12c: Comparison of IL-4 and IFN-j produced by cultures of liver-derived lvm-phocvtes. 
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Figure 3.3.12c: Lymphocytes were recovered from livers pooled from 5-7 mice/group at +8 
weeks post L. donovani infection. Cultures of 5x 10 
6 cells/ml were stimulated with medium alone, 
ConA at 51tg/ml, schistosomal antigens (SWAP and SEA at 10ttg/ml) or fixed leishmanial 
amastigote antigen (FLAA, at 10 
7 amastigotes/ml). Supernatants were recovered at 24hr (for IL- 
4) or 72hr (for IFN--y) and assayed by cytokine ELISA. Data represent the means of three 
replicate ELISA wells. For description of the groups see legend to Figure 3.3.1. 
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With FLAA the LEISH group showed the highest IFN--y production and the CO-INFECT 
group substantially less. With ConA the LEISH cells also produced the highest amount of 
IFN--y but the control cells produced a similar level whereas both SCHISTO and CO- 
INFECT groups produced lower levels. This pattern of response to FLAA and Con A was 
very similar to that seen with the spleen cells at +8 weeks (Figure 3.3.9. ). 
3.3.2.3. Immunology results - Experiment 2 
3.3.2.3.1 Detection of IL-4 production from spleen IMphoc)jes by ELISA 
As above, the data is plotted with the ConA results (Figure 3.3.13. ) and also without them 
(Figure 3.3.14. ). The EL-4 data in general is similar to the first experiment (Figure 3.3.7. and 
3.3.8. respectively). 
The highest levels of IL-4 production following stimulation with ConA were in the 
SCHISTO group at the +2 and +4 week time points (after the L. donovani infections) 
although, because of the large standard error, at neither time point was this statistically 
significantly different from the CONTROL despite the fact that no EL-4 could be detected 
in the CONTROL at week +2 whereas the values from the SCHISTO mice were 137,145 
and 466 pg/ml. Lower Con. A-induced IL-4 was seen in the CO-INFECT group at both time 
points although the differences were not statistically significant. Because of the low 
standard error the ConA-induced IL-4 response from the CO-INFECT group was 
significantly higher than from the CONTROL or LEISH groups at +4wks (p=0.002, 
p=0.0002). Results for the SCHISTO cultures at +8weeks showed a lower mean ConA 
induced IL-4 value than at earlier times but at this tine the differences were statistically 
significant compared to both LEISH and CONTROL (p=0.003,0.004 respectively) and this 
was comparable to that in the CO-INFECT group. 
Regarding antigen-specific responses (Figure 3.3.13. ), significantly raised IL-4 to SWAP 
was detected at week +2 in the SCHISTO group (p=0.04) but not in the CO-INFECT group 
and there was only a slight and not significant elevation in both groups to 
SEA. At +4 
120 
weeks SEA and SWAP both induced raised levels of IL-4 compared with CONTROLS in 
both the SCHISTO and CO-INFECT groups but the only significant value was for SEA in 
the CO-INFECT group (p=0.04). There was an anomalous response with one of the mice in 
the CONTROL group responding to SWAP and FLA-A. At +8 weeks raised antigen 
specific IL-4 production was also seen in the SCHISTO and CO-INFECT groups with both 
SEA and SWAP but the values were only significantly different (p=0.04) from the LEISH 
and CONTROL groups for the SCHISTO group. There was a slightly elevated but not 
significant IL-4 response by cells from the LEISH and CO-INFECT groups to FLAA. 
121 
Figure 3.3.13. Comparison of the levels of IL-4 in supematants of spleen cell cultures 
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Figure 3.3.13. Graphs showing the means and standard errors for IL-4 detected by ELISA, 
based on three mice from each group sacrificed at +2, +4 or +8 weeks after the L. donovani 
infection. Cultures of 5x 106 spleen cells/ml were stimulated with medium alone, mitogen 
(ConA at 5jtg/ml), schistosomal antigens (SWAP and SEA at 10ttg/ml) or fixed leishmanial 
amastigote antigen (FLAA, at 10 7 amastigotes/ml). For description of the groups see legend to 
Figure 3.3.1. 
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Figure 3.3.14. 
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Figure 3.3.14.: Data from Figure 8 redrawn without showing ConA results. See legend 
to Figure 3.3.1. 
control 
control 
123 
3.3.2.3.2 Detection of IFN-]ý production from spleen IMphocy! es by ELISA 
As shown in Figure 3.3.15., CONTROL cells produced significant and comparable levels 
of EFN--y at each of the time points in the presence of ConA but medium alone or the 
specific antigens produced minimal responses apart from SWAP which tended to produce 
non-specific (or possibly naturally cross-reacting) responses even with the CONTROL 
cells. 
At +2 weeks ConA induced comparable mean EFN--y responses from the CONTROL and 
LEISH groups. A significantly lower mean value was seen for the CO-INFECT group 
relative to the CONTROLS (p=0.03). The SCHISTO mean value was also lower than 
CONTROLS but higher than the CO-INFECT although these differences were not 
statistically significant. With SWAP and SEA there was no significantly increased EFN--y in 
any of the groups relative to the controls. Of particular interest was the FLAA response 
which was significantly higher than for control mice (p<0.0001). Importantly, although 
there was some IFN--y production by the CO-INFECT animals the level was not 
significantly increased relative to the CONTROLS and significantly lower than the LEISH 
group value (p=0.0003). 
At +4 wk all of the infected groups showed lower IFN production relative to the controls 
and this was significantly lower for the CO-INFECT and LEISH mice (p=0.004,0.02 
respectively). As at +2 weeks the CO-INFECT group again showed the lowest response 
and this was significantly lower than the SCHISTO response (P=0.03). There was no 
evidence of schistosome antigen specific IFN--y production as the highest levels (to SWAP) 
were in the CONTROL group at (+4 weeks). In the presence of FLAA responses were 
again only seen in the LEISH and CO-INFECT groups, but only the CO-INFECT value 
was significantly elevated compared to the CONTROL (p=0.002). Of interest is the fact 
that the IFN--y levels to FLAA in the SCHISTO and CO-INFECT groups were almost 
identical unlike the +2 and +8 week times. 
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Figure 3.3.15. Comparison of the levels of IFN-j in supematants of spleen cell cultures 
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Figure 3.3.15. Graphs showing the means and standard errors for IFN-7 detected by 
ELISA based on three mice from each group sacrificed at +2, +4 or +8 weeks after 
the L. donovani infection. Cultures of 5xI 06 spleen cells/mI were stimulated with 
medium alone, ConA at 5ttg/ml, schistosomal antigens (SWAP and SEA at 
10itg/ml) or fixed leishmanial amastigote antigen (FLAA, at 10 
7 amastigotes/ml). 
For description of the groups see legend to Figure 3.3.1. 
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At +8weeks the pattern of ConA-induced IFN--y production was very similar to the + 12 week 
time points i. e. highest from the CONTROLS, lowest in the CO-INFECT mice and at 
intermediate levels in the other two groups. As at the +4 week time point the CO-INFECT 
level of IFN--y was significantly lower than the SCHISTO one (P=0.03). As at earlier time- 
points there was little evidence of schistosome antigen driven IFN--Y production even in the 
SCHISTO group although the highest mean value was for this group with SWAP. As at 
earlier time-points, only the Leishmania-infected groups showed IFN--y production to FLAA 
although the difference was not statistically significant compared to the CONTROLS. The 
CO-INFECT group also produced significant levels of IFN--y compared to the CONTROLS 
in response to FLAA (p=0.008) although the mean value was 3-fold lower than the LEISH 
alone value. 
3.3.2.3.3 Detection of IL- 10 production from s-plenoc3qes by ELISA 
At +2 weeks post LV9, as shown in Figure 3.3.16., splenocytes from the SCHISTO group 
produced the highest levels of IL-10 to ConA, SEA and SWAP (p=0.001,0.02 and 0.001 
respectively compared to CONTROLS). IL-10 levels were somewhat lower in the CO- 
INFECT group compared with the SCHISTO group but were elevated compared with 
CONTROLS (statistically significant for the ConA response, p=0.04). The ConA, SWAP 
and SEA induced IL- 10 responses were all higher than in the LEISH group but this did not 
reach significance. Both the LEISH and CO-INFECT groups produced similar elevated 
levels of IL-10 in response to FLAA but this was only statistically significant compared to 
CONTROLS for the LEISH group (p=0.02). 
At +4 weeks EL-10 levels in response to ConA, SEA and SWAP were lower than at the +2 
week time point for the SCHISTO group. The highest Con A-induced EL-10 production 
was from the SCHISTO group and this was significantly higher than from both the CO- 
INFECT and LEISH groups (p=0.03,0.02 respectively). SEA-induced EL-10 responses 
were again highest in the SCHISTO group, significantly higher than in the CONTROL 
(p=0.04). The SCHISTO group also produced EL-10 to SWAP. 
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Figure 3.3.16 Comparison of the levels of IL-10 in supematants of spleen cell cultures 
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Figure 3.3.16. Graphs showing the means and standard errors for IL- 10 detected by 
ELISA based on three mice from each group sacrificed at +2, +4 or +8 weeks after 
the L. donovani infection. Cultures of 5xlO 6 spleen cells/nil were stimulated with 
medium alone, ConA at 51tg/ml, schistosomal antigens (SWAP and SEA at 
1OAg/ml) or fixed leishmanial amastigote antigen (FLAA, at 10 7 amastigotes/ml). 
For description of the groups see legend to Figure 3.3.1. 
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The CO-INFECT animals produced significant IL-10 in response to SWAP compared to 
the CONTROLS (p=0.001). Although the LEISH group also produced some EL-10 to 
SWAP presumably due to cross-reacting or non-specific responses, the CO-INFECT IL-10 
response was significantly higher (p=0.39). However, the lack of ConA or SEA induced 
responses in the CO-INFECT was an anomaly, inconsistent with the results of the first 
experiment (Figure 3.3.10) and with the other data for Experiment 2. No explanation for 
this is clear and it may have represented a technical error e. g. a failure to add the stimulant. 
Both the LEISH and CO-INFECT groups produced comparable and significant levels of 
IL-10 to FLAA stimulation (p=0.003 and 0.02 respectively compared to CONTROLS). 
At + 8weeks the pattern of IL-10 response in the SCHISTO group was similar to previous 
times albeit again a little lower than the previous time point and only SWAP induced a 
significant level of response compared with the CONTROLS (p=0.003). In contrast the 
CO-INFECT group produced the highest levels of EL-10 ConA to all of the antigens and 
higher levels than at earlier time points although, because of large individual variations, the 
differences were not significantly different for ConA, SEA and SWAP from the other 
groups apart from the CONTROL group (p=0.01,0.02 respectively for SWAP and SEA). 
Only the CO-INFECT and LEISH groups produced EL-10 to FLAA and this higher in the 
CO-INFECT group albeit not significantly. 
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3.3.2.3.4. Detection of Nitrite -production in splenoc3le cultures-Experiment 2 
The data (Figure 3.3.17. ) were similar to the first experiment (Figure 3.3.11. ). 
At +2 weeks post-L. donovani, there was no significant production of nitric oxide in 
response to ConA, SEA, FLAA antigens in any of the groups. 
At +4 weeks there was no elevated production of nitric oxide in response to mitogen 
(ConA) in any of the infected groups. Meanwhile, in response to the schistosome antigen 
(SEA) the CO-INFECT animals produced elevated nitric oxide levels compared to the 
SCHISTO (p=0.04), LEISH (p=0.02) and CONTROL animals (not statistically significant). 
Significantly elevated levels were seen compared with CONTROL mice with FLAA in 
both the CO-INFECT and LEISH groups (p=0.02 and 0.01 respectively) and strikingly, the 
level of nitrite was significantly higher in the LEISH group compared with the CO- 
INFECT group (p=0.02). 
At +8 weeks, elevated responses were seen with ConA in all infected groups but this was 
only statistically significant relative to CONTROL for the SCHISTO group (p=0.003). 
Interestingly, the SCHISTO mice produced significant levels of nitric oxide production in 
response to SEA compared to the CO-INFECT, LEISH and CONTROL animals (p=0.03, 
0.03, and 0.007 respectively) perhaps indicating more of a Thl role in the chronic 
granulomatous response. The CO-INFECT animals produced the highest levels of nitric 
oxide in response to FLAA but this was not statistically significantly higher than the 
LEISH values and CONTROL. 
In conclusion, these results showed a similar pattern to the results obtained from the earlier 
experiment (Figure 3.3.11. ), showing that the LEISH group produced notably higher levels 
of nitric oxide in response to FLAA compared with the CO-INFECT group at +4weeks but 
that by +8 weeks this pattern is reversed, the nitrite levels being lower than at +4 weeks in 
the LEISH and higher in the CO-INFECT (Fig. 3.3.17. ). 
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Figure 3.3.17.: Levels of Nitrite produced in splenocyte culaires 
2 weeks 
20 
18 
16 
-14 
E 12 
10 
8 
6 
z4 
2 
0 
Schisto alone Co-infect 
0 Medium 
4 weeks 
20 
18 
16 
14 
-12 
E 
-6)10 
8 
6 
z4 
2 
0 
+8 weeks 
20 
18 
16 
14 
-12 
10 
8 
6 
4 
2 
0 
Schisto alone 
Co-infect 
Co-infect 
0 ConA 
o SEA 
m FLAA 
Leish alone 
Leish alone 
Leish alone 
control 
control 
control 
Figure 3.3.17.: Graphs showing the means and standard errors for nitrite detected using the 
Greiss reaction, based on three mice from each group sacrificed at +2, +4 or +8 weeks after 
the L. donovani infection. Cultures of 5xl 06 spleen cells/mI were stimulated with medium 
alone, ConA at 5[tg/ml, schistosomal antigens (SWAP and SEA at 10[tg/ml) or fixed 
leishmanial amastigote antigen (FLAA, at 10 7 amastigotes/ml). For description of the groups 
see legend to Figure 3.3.1. 
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3.3.2.3.5. Detection of IL-4 and IFN--y -produced by liver-derived lvmlDhocvtes bv ELISA 
As mentioned in section 3.3.1.3.5. the simple mechanichal method of recovery of liver 
lymphocytes was used throughout this second experiment because it had been found to yield 
more cells. However, when the cytokine data was obtained the results were odd and were 
generally not consistent with the first experiment. It is considered that the data is generally 
unreliable but it is presented here for completeness. 
As seen in Figure 3.3-18a the IL-4 data for the +2 week time point was consistent with 
expectation and with the pattern of data from the first experiment (Figure 3.3.12a) i. e. high 
levels IL-4 in both the SCHISTO and CO-INFECT groups with ConA and SEA but little 
from any of the other groups. The lower level of SEA response with the CO-INFECT cells 
compared with the SCHISTO was also consistent with the liver responses in the first 
experiment. The IFN--y results are also reasonable in that the highest response with FLAA 
was seen with the LEISH group reflecting the spleen cell response at this time and elevated 
responses were also seen with both the CO-INFECT and LEISH groups with Con A. 
The IL-4 data for +4 weeks (Figure 3.3.12b) appears to be unreliable in that with ConA the 
highest responses were seen with CONTROL cells and none with the SCHISTO mice. Also 
the SEA response was low with all groups. This data is inconsistent with the +2 week data, 
with the liver cell data from Experiment I (3.3.12a) and with the spleen cell data (Figure 
3.3.7. ). However, the IFN--y results were more plausible in that the highest FLAA response 
was seen in the LEISH mice followed by the CO-U*; FECT mice and there was little response 
in the CONTROL cells, in medium alone or in SEA. 
Unfortunately the +8 week liver cytokine results were all considered unreliable because of 
very high values for the CONTROL cells and for medium alone (Data not shown). 
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Figure 3.3.18a: Comparison of IL-4 and IFTN-j produced by cultures of liver-derived 
lyMphoc3qes. 
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Figure 3.3.18a: Lymphocytes were recovered from livers pooled from 5-7 mice/group at +2 
weeks post L. donovani infection. Cultures of 5 X106 cells/ml were stimulated with medium alone, 
ConA at 5ttg/ml, schistosomal antigens (SWAP and SEA at IO)ug/ml) or fixed leishmanial 
amastiQote antigen (FLAA, at 107 amastigotes/ml). Supernatants were recovered at 24hr (for IL-4) 
or 72hr (for IFN--y) and assayed by cytokine ELISA. Data represent the means of three replicate 
ELISA wells. For description of the groups see legend to Figure 3.3.1. 
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Figure 3.3.18b: Comparison of IL-4 and IFN-j produced by cultures of liver-derived 
Irnphocytes. 
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Figure 3.3.18b: Lymphocytes were recovered from livers pooled from 5-7 mice/group at +4 
weeks post L. donovani infection. Cultures of 5X106 cells/ml were stimulated with medium alone, 
ConA at 51tg/ml, schistosomal 
7 
antigens (SWAP and SEA at 10ttg/ml) or fixed leishmanial 
amastigote antigen (FLAA, at 10 amastigotes/ml). Supernatants were recovered at 24hr (for IL-4) 
or 72hr (for IFN--y) and assayed by cytokine ELISA. Data represent the means of three replicate 
ELISA wells. For description of the groups see legend to Figure 3.3.1. 
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Overall the liver lymphocyte data for this experiment was disappointing and less reliable 
than the first experiment. It is concluded that although the yield of cells regarded as 
lymphocytes based on their small size and spherical shape in the haemocytometer was 
higher using the homogenization method than the collagenase D digestion method used in 
the first experiment, the former cell preparations produced odd and unreliable results. With 
such cells the data was inconsistent, the results fitting with expectation at times but 
inconceivable results being found at other times. It would have been valuable to have 
carried out some cellular characterization of the populations obtained. 
3.4. Discussion 
These studies set out to look at the interaction of the Th2 inducing S. mansoni 
infection and a super-imposed Th I inducing L. donovani infection. The results, based on two 
essentially similar experiments, showed marked interactions. There was significant 
enhancement of hepatosplenomegaly and morbidity of the mice. Taking the two experiments 
together there was no evidence that the super-imposed L. donovani infection affected the 
establishment or egg production of the pre-existing S. mansoni infection. However, the L. 
donovani infection started off replication similarly in CO-INFCT and LEISH mice but there 
was a subsequent failure to control the infection in the CO-INFECT mice. Much of this 
discussion and the further chapters in this thesis are concerned with trying to explain how 
this happens. 
The experimental protocol used was chosen to give as light an S. mansoni infection 
as possible (i) to be as close to the human level of infection as possible (even a single worm 
pair in a mouse is equivalent on a body size ratio to an excessively high infection in a 
human) and (2) so that any synergy in morbidity would be as low as possible to allow the 
interaction to be studied for as long as possible. In fact the use of 25 cercariae gave mean 
worm pair burdens of 2-3 worm pairs and a relatively low proportion of mice which did not 
have a bisexual ego, producing infection. Nevertheless the CO-INFECT mice did suffer 
increased morbidity and some died or had to be euthanized. Overall, though, the 25 S. 
mansoni cercariae and 2x 10 L. donovani amastigotes seemed to represent a balanced level 
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of infection for the duration of the experiments set up. Regarding the reasons for the 
increased morbidity/mortality in the CO-INFECT mice the overall weight of the mice in all 
of the infection and control groups differed little at each time point but both the L. 
donovani and the S. mansoni infections caused hepatosplenomegaly and the CO-INFECT 
mice showed an additive effect having the highest mean spleen and liver weights. 
Hepatosplenornegaly per se would not necessarily cause morbidity but would increase the 
stress on the animals, apart from causing portal hypertension and the sequelae of 
complications ranging from increased incidence of bleeding (GIT hemorrhage) to minor 
complications such as congestive gastropathy causing anorexia and weight loss and 
eventually death. Further consideration of the causes of morbidity are dealt with below and 
in Chapter 5. 
S. mansoni worm burdens and importantly worm pair burdens were consistent in the 
SCHISTO and CO-INFECT groups and at the different time points in both experiments 
demonstrating that the L. donovani infection had no effect on survival of the worms. With 
regard to possible effects of the LEISH infection on egg production/egg persistence in the 
liver, the GMEC per worm pair were indeed a little higher in the SCHISTO animals than 
the CO-INFECT at each of the time points in Experiment 1 but the differences were not 
significant. In Experiment 2 the GMEC/worm pair was higher in the SCHISTO group 
compared with the CO-INFECT group at +2 weeks but essentially similar at +4 and +8 
weeks. This high GMEC/worrn pair at +2 weeks for the SCHISTO group was inconsistent 
with the data from the first experiment, data from later time points for Experiment 2 and 
data from other Experiments (data not shown) so this result is considered unreliable. It 
could have arisen from a failure to recover all of the worms from some of the mice in this 
group. Overall the data show that the super-imposed LEISH infection has minimal if any 
effect on the established schistosomes or their egg production and survival. Since the 
schistosome egg is the principle inducer of the Th2 response in schistosomiasis (Warren, 
1978; Pearce et al., 1991; Grzych et al., 1991) the consistency in liver egg burden between 
CO-INFECT and SCHISTO mice means that direct assessment can be made of any 
immuno-modulatory effects the L. donovani infection might have had on anti-egg immune 
responses. 
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The patterns of infection in the LEISH animals are as reported previously in mice i. e. 
control of the parasites in the liver between weeks +4 and +8 eventually resulting in 
elimination and gradual increase in the spleen LDU leading to persistent infection (Murphy 
et al, 2001). 
It is clear that the major effect observed in the CO-INFECT mice was that they 
failed to develop this control such that higher L. donovani LDU were seen compared with 
the LEISH alone particularly at +8 weeks. However, it is important to stress that early 
during the co-infection there were not marked differences. Thus, in the livers of CO- 
INFECT compared with LEISH animals LDU at +2 weeks post super-infection were 1.7 
fold lower in Experiment 1 and comparable in Experiment 2. This means that L. donovani 
shows comparable rates of replication in naYve mice and mice harboring S. mansoni 
infections of 8-10 weeks duration. By +4 weeks LDU were comparable in Experiment I 
and 2.5 fold higher in Experiment 2 indicating that by this time there were signs of a loss of 
control of the L. donovani infection. This was much more marked at +8 weeks when LDU 
were 27 fold higher in Experiment 1 and 12.5 fold higher in Experiment 2. A similar result 
was seen in the spleen with LDU at +8 weeks being 11.3 fold highe in the CO-INFECT 
compared with the LEISH in Experiment I and 12.4 fold highe in Experiment 2. 
It would obviously have been interesting to know how the L. donovani LDUs would 
have progressed beyond the +8 week time point i. e. would the L. donovani infection have 
been resolved or continued uncontrolled. However, as judged by the morbidity seen in the 
second experiment in particular it seems unlikely that it will be easy to study this co- 
infection at later time points using the same combination of mic e/schisto some strain and L. 
donovani strain and levels of parasite infection. Twenty five cercariae were used in these 
experiments and the resulting mean worm burdens were pretty low (mean of 3.1 worm 
pairs in Experiment 1 and 2.8 in Experiment 2) but by reducing the exposure it would be 
possible to obtain a lower mean worm burden. Reducing the infection in this way would 
mean that a higher proportion of mice did not have a mixed egg producing infection and so 
larger group sizes would be needed. Also the effects on the L. donovani LDU might have 
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been dependent on the level of schistosome infection and so it might have taken longer 
anyway for the effect on the L. donovani to develop. 
Various possible explanations have been considered to explain the failure of the 
CO-INFECT mice to control the infection and much of the rest of this thesis is aimed at 
investigating the most likely of these possibilities. The hypotheses, which have developed 
during the work, are laid out next. 
(1) S. mansoni induced hepatosplenomegaly provides additional tissue sites for L. donovani 
proliferation (i. e. there is simply more tissue in general for L. donovani to infect); 
(2) this added tissue in the liver would comprise active S. mansoni egg granulomas rich in 
recruited macrophages and in the spleen, would comprise blood as a result of hypertension 
but also increased numbers of immune cells including recruited macrophages from the 
spleen (King et al., 2001), responding the antigenic challenge of the eggs (i. e. there are 
more suitable host cells [macrophages] to infect); furthermore the local immunological 
changes in the liver organ particularly in Kiipffer cells show a Th2-deviated immune 
response which may lead to further susceptibility towards L. donovani infection (Hayashi et 
al., 1999). (3) there is a failure to induce a sufficiently strong protective systemic Thl 
response to L. donovani antigens by the spleen i. e. there was a lower EFN--y response to 
FLAA due to: 
(i) the Th2-skewed response to S. mansoni resulting in direct action of IIL-4 on Thl 
development (O'Garra, 1998) or (ii) to indirect effects of schistosome or Leishmania 
induced IL- 10 (which is produced by Th2 cells but also several other cell types [e. g. Treg 
cells] and not strictly a Th2 cytokine) on antigen presenting cell functions such as 
downregulation of co-stimulatory molecules and EL-12 production (Bogdan et al., 1991; 
Moore et al., 2001). (iii) action of other regulatory cytokines e. g. TGF-O (Barrel et al., 
1995). 
(4) lower IFN--y levels may result in reduced development/reduced rate of maturation of L. 
donovani granulomas (comprising antigen-specific Thl cells and recruited macrophage and 
which are most clearly seen in the liver) i. e. there would be a reduced frequency of 
development of mature L. donovani granulomas; 
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(5) L. donovani granulomas may physically fail to form correctly within the context of the 
inflammatory cells of the S. mansoni granulomas and so there may be a lack of control in 
infected macrophages within the egg granuloma; (6) even if morphologically normal 
mature granulomas form the macrophages have a reduced capacity to become activated and 
so produce leishmanicidal factors [nitric oxide, ROI and TNF-U]. This could be due to 
lower IFN--y [as in (3) above] or: (7) high levels of IL-10 induced by the S. mansoni 
infection serve to down-regulate macrophage activation to develop leishmanicidal activity 
(Moore et al., 2001; Groux et al., 1999). 
(8) inability of the macrophages to become leishmanicidal could be due to the fact that 
macrophages in schistosome infected mice are alternatively activated [by IL-4 and IL-13 
(Linehan et al., 2003)] and so are poor at directing L. donovani granuloma formation and/or 
show poor leishmanicidal activity superoxide and NO production (Gazzinelli et al., 1992); 
(9) such effects on impaired macrophage function may be more pronounced within the S. 
mansoni egg granulomas in which the aaMo predominate (Linehan et al., 2003) so that 
there is preferential L. donovani replication within infected macrophages within the egg 
granulomas; 
(10) reduced leishmanicidal. activity due to down-regulated IFN--y production or down- 
regulated macrophage activation could result in a failure to kill amastigotes resulting in 
accumulation of amastigotes within L. donovani infected macrophages i. e. there would be a 
higher mean numbers of amastigotes in CO-INFECT mice compared with LEISH mice 
and/or in the infected macrophages within the S. mansoni granulomas compared with the 
parenchyma of CO-INFECT mice. 
With regard to (1) and (2), i. e. greater organ size and availability of macrophage host cells 
for infection in the S. mansoni infected mice, comparison of the organ weights shows that the 
percentage differences between organ weights in the LEISH and CO-INFECT groups were 
small and not sufficient to explain the many fold greater LDUs in the CO-INFECT mice at 
+8 weeks. The egg granuloma comprises around 30% macrophages (Oswald et al., 1993; 
Andrade and Cheever, 1995) and this may offer an increased density of potential 
macrophage host cells although of course the granuloma does displace the normal liver tissue 
that is rich in Kiipffer cells. Although this idea cannot be discounted, there is no evidence 
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that the spread of the L. donovani is limited by available macrophages. The super-infection 
was given +8 weeks after the S. mansoni infection and since egg deposition would have 
started at 5-6 weeks there was a significant granulomatous response and schistosome induced 
organ enlargement in the liver at the time. However, the LDU counts were comparable 
(Experiment 2) or even lower (Experiment 1) in the CO-INFECT mice at +2 weeks post 
super-infection showing no evidence of enhanced replication in the CO-R,; FFECT mice over 
the first two weeks of infection. S. mansoni egg granulomas were not commonly seen in the 
spleen in histological sections (data not shown) and so the increased infection in the spleen in 
the CO-INFECT mice could not be due to increased availability of granuloma macrophages. 
The next hypothesis to be considered (3 above) is that there is a failure to induce a 
sufficiently strong protective systemic Thl response to L. donovani antigens by the spleen 
due the Th2-skewed response to S. mansoni (i. e. there was a lower IFN--y response to 
FLAA). The effects of IL-4 in inducing Th2 development are dominant over Th I polarizing 
cytokines (Hsieh et al., 1993, Seder and Paul, 1994, ) i. e. if IL-4 reaches a certain threshold 
during initiation of an immune response Th. 2 cells will predominate and then by producing 
increasing levels of EL-4 this will accelerate Th. 2 development. The above data clearly show 
that in the SCHISTO alone and the CO-INFECT mice there is elevated EL-4 and IL-10 
which in the case of the CO-INFECT were produced in recall responses to both 
schistosome antigen and FLAA. 
It is clear that Thl responses are required for control of L. donovani infections in mice. 
Processes leading to the induction of the protective Thl response to L. donovani begin soon 
after infection i. e. Th I chemokine m. RNA expression is seen at 2hr post infection and peaks 
at 5hr (Cottrell et al., 1998; 2000) and splenic DCs show IL-12 production within 5 hours 
of infection (Gorak et al., 1998). Development of a pro-inflammatory response involving 
IL-23 IL- 12 and IFN--y develop and are crucial to the control and resolution of the infection 
(Kaye et al., 1991; Engwerda et al., 1996; 1998). For example, depletion of IL-12 or IFN--y 
with monoclonal antibody (mAb) during the initial infection of mice results in markedly 
increased LDU in the liver at day 14 (Murphy et al., 2001). IFN--y -/_ mice show 
uncontrolled parasite proliferation for 8 weeks post infection although LDU eventually 
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decline between 8 and 12 weeks which appeared to be controlled by TNF-a as anti-TNF-a 
treatment reversed the control (Taylor and Murray, 1997). 
Regarding the possible modulatory role of EL-4 on progression of L. donovani infections 
there has been considerable interest in the role of endogenous IL-4 induced by the L. 
donovani infection in both mice and humans. In mice IL-4 mRNA expression is seen in the 
tissues of infected mice soon after infection but this does not seem to progress and is 
believed to be rapidly overcome by a protective Thl response (Miralles et al., 1994). 
Studies using anti-IL-4 antibody treatment (Miralles et al., 1994; Murray, 1994) showed no 
effect on the kinetics of visceral infection. Furthermore, EL-4 -- mice did not show 
enhanced protection (Satoskar and Alexander, 1995) compared with the wild-type mice. So 
this data suggested that endogenous induction of IL-4 responses play little or no role in 
controlling experimental L. donovani infection. 
In fact IL-4 has more recently been shown to have a subtle influence on Thl/Th2 
commitment. Studies of L. major infection in BALB/c mice which are susceptible to 
infection and normally make a strongly polarized Th2 response (Reiner and Locksley, 
1995; Biedennann et al., 2001) demonstrated that if IL-4 is present (by injection) during 
the initial activation of DCs (within the first 8hr of infection) the mice are made resistant 
and DCs in the draining lymph node made large amounts of EL-12 at 16 hrs post infection. 
At 8 weeks of infection these mice made higher levels of EFN--y and markedly lower levels 
of EL-4 mRNA in the lymph node when compared with untreated mice. However, if the 
injection of IT_-4 is extended to 16 and 24 hr, when the DC/CD4 T cell priming is occurring 
the resistant phenotype is reversed and the cytokine production in the lymph nodes reverts 
to that of the untreated mice i. e. high EL-4 and low IFN-T. So the influence of EL-4 on 
responses to co-administered antigen or infectious organism is crucially dependent on the 
timing and persistence of the elevated EL-4. 
Of direct relevance to hypothesis (3) are studies aimed at experimentally increasing IL-4 
levels during L. donovani infection. Murray et al. (1997) showed that EL-4 transgenic mice 
which over-expressed EL-4 produced a strong Th2 response as judged by IgE production 
but showed almost exactly the same pattern of liver LDU as WT mice, effectively resolving 
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the infection at 8 weeks post infection. However, these mice were on a 129/Sv background 
which are generally innately resistant to Leishmania infection (Bradley et aL, 1979) and it 
was suggested that the failure to show exacerbated disease against L. donovani was because 
the enhanced IL-4 secretion alone was not sufficient to overcome the innate resistance of 
the 129/Sv strain. No studies seem to have been reported on IL-4 transgenics on a C57BL/6 
background as used in the current studies. 
However, in BALB/c mice, Murray et al. (1997) showed that treatment with exogenous IL- 
4 complexed with anti-IL-4 on day-1 of L. donovani infection led to a transient increase in 
liver LDU at week 2 post infection and repeated treatment, twice weekly over four weeks, 
led to a protracted effect (3 fold increase at 4 weeks, and 6 fold increase at 8 weeks). Once 
the IL-4 treatment stopped the infection was controlled as shown by the parasite loads 
dropping between 4 and 8 weeks in a similar way to the untreated mice. This data indicated 
that IL-4 itself could interfere with the development of the protective Th 1 response. 
To return to the possibility that S. mansoni induced Th2 responses may have a modulating 
effect on co-infecting L. donovani, previous studies have shown elevated IL-4 to both 
ConA and schistosome antigens following S. mansoni infection of mice (Grzych et al., 
1991, Wynn et al., 1993; 1997). In the present studies, the Th2 bias induced by the S. 
mansoni infection relative to L. donovani infection and to naive cells was clearly seen by 
both ConA and schistosome antigen specific stimulation of splenocytes which induced 
elevated levels of IL-4 only in the schistosome infections in both experiments. The liver- 
derived lymphocytes from the SCHISTO and CO-INFECT mice also showed high ConA 
and antigen specific IL-4 production. The ConA induced IL-4 responses tended to be lower 
in the CO-INFECT than the SCHISTO mice at +2 and +4 weeks in both experiments. 
However, there was essentially no difference between the schistosome specific (SEA and 
SWAP) IL-4 responses in the SCHISTO and CO-INFECT mice indicating that the 
proliferation of L. donovani in liver and spleen had no significant effect on the nature and 
level of the schistosome specific cytokine responses. 
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In the SCHISTO mice the spontaneous, antigen- specific and/or ConA production of EL-4, 
EFN--y and IL-10 by splenocytes were generally reduced or markedly reduced at +8 weeks 
compared with the +4 and/or +2 week time points. SEA induced EL-4 responses in the liver 
lymphocytes were also lower at +8 weeks (16 weeks post S. mansoni) than earlier. 
Significantly and markedly lowered EL-4, EFN-7, and EL-10 production and cellular 
proliferation by MLN or spleen cells to SEA stimulation were also reported in chronic 
(+ 15/16 weeks) compared with acute (+8 week) infections (Grzych et al., 199 1, Henderson 
et al., 1992, Chensue et al., 1992, Sadler et al., 2003) and this has been related to the 
"endogenous desensitization" seen in granulomatous responses in chronically infected mice 
(Domingo and Warren, 1968). Recently, EL- 10 has been implicated in this as in EL- 10 -/- KO 
mice both SEA specific IFN--y and IL-4 production were significantly increased in the acute 
phase (approx 12 and 6 fold respectively) but, in contrast to normal mice, remained high at 
the chronic phase. In addition cellular proliferation of spleen and MIN cells were equally 
high at +15 weeks as at +8 weeks and importantly there was no reduction in granuloma 
diameter in the chronic infection. These results in IL-10 KO mice suggested that IL-10 
functions to depress both Thl and Th2 cytokines in schistosome infections and that this can 
be manifest at a time when EL-10 itself is also downregulated (Sadler et al., 2003). 
In the CO-INFECT group in the present studies, the drop in IL-4 levels at +8 weeks was 
not seen in Experiment I and in fact the ConA, SEA and SWAP induced EL-4 levels were 
higher at +8 weeks than at +4 weeks and higher than in the SCHISTO group suggesting 
that the down regulation in chronic infection associated with long term S. mansoni infection 
may be modulated by the L. donovani infection. In Experiment 2 this pattern was less clear 
but there was still a greater reduction in the EL-4 responses in the SCHISTO compared with 
the CO-INFECT mice. 
Individuals co-infected with schistosomiasis and HIV showed decreased PBMC 
proliferation and also decreased Th2-like cytokine production, compared with those from 
HIV-1 negative patients with active schistosomiasis. Those co-infected individuals 
responded to egg antigen by making dramatically reduced levels of IL-4 and EL-10 but 
similar (low) amounts of IFN-7 than did HIV-1 negative individuals which indicates that 
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there was a swing in the overall balance of the response from Th2 and Th 1 (Mwinzi et al., 
2001). An explanation for the reduced production of Th2 cytokines in PBMC of the 
schistosome-HIV co-infected patients is that the antigen-activated Th2 cells are more easily 
infected by HIV-1 (Weissman et al., 1996) and so it is possible that schistosome-antigen- 
responsive cells were being infected and eliminated by the virus. 
In general, minimal or no schistosome antigen specific IFN--y responses were seen in the 
splenocyte response from either the SCHISTO or CO-INFECT groups relative to the 
CONTROL mice and the ConA induced IFN--y responses were generally also lower than 
for CONTROL mice. This pattern was also seen with the liver lymphocytes. Interestingly, 
as with the EL-4 response the CO-INFECT mice produced lower IFN--y following ConA 
stimulation than both the SCHISTO and LEISH mice at most of the time points. A 
possible explanation for this would be that the cells recovered from the CO-INFECT mice 
would represent a balance between those specific for each infection and so likely to be 
biased to Th2 (for SCHISTO) and Thl (for LEISH) but the possibility of inhibitory 
mechanisms developing in the CO-INFECT animals cannot be excluded. It would be 
possible to further investigate the frequency and dynamics of antigen specific Th2/Thl 
cells in the spleen and liver by antigen specific ELISPOT analysis of IFN-, y or EL-4/5 
(Murphy et al., 1997) or by FACS analysis, for example looking at the T1/ST2 marker of 
Th2 cells and intracellular cytokine staining for IFN--y for Thl cells (Kropf et al., 2002). 
With regard to the cytokine response to L. donovani, neither splenocytes or liver 
lymphocytes from LEISH mice made FLAA-specific EL-4 responses at any time from +2 to 
+8 weeks. This is consistent with the demonstration that early IL-4 mRNA expression 
following L. donovani infection is rapidly overcome by a protective Thl response (Miralles 
et al., 1994). In contrast FLAA specific IFN-T production by splenocytes was significantly 
elevated at +2 weeks in the LEISH mice relative to the CONTROL mice or to cultures with 
medium alone. By +4 weeks antigen specific IFN--y levels were lower and in Experiment I 
were lower again at +8 weeks. The spleen data is consistent with Murphy et al. (2001) who 
showed a significant drop in leishmanial antigen specific IFN--y production between +2 and 
+4 weeks of infection in C57BL/6 mice. 
143 
Compared with the LEISH mice, the FLAA-specific IFN--y levels were lower in the CO- 
INFECT mice at +2 and +8 weeks in Experiment I although at +4 weeks the CO-INFECT 
showed higher FLAA specific IFN--y production compared with the LEISH. In Experiment 
2 the same pattern held with the CO-INFECT mice showing lower IFN--y at +2 and +8 
weeks but minimal difference at +4 weeks. It is particularly clear from both experiments 
that the early +2 week response is reduced in the CO-INFECT mice. But there was 
evidence of a recovery of the response at +4 weeks followed later by a down-regulation of 
the IFN--y response in the CO-INFECT mice at +8 weeks. 
This pattern of Leishm an ia- specific IFN--y production does not correlate directly with the 
observed ability to control the L. donovani infection as judged by the LDU values in the 
liver or the spleen. Notably, despite the markedly lower IFN--y production in the CO- 
INFECT mice at +2 weeks (22,000 cf 62000 in Experimentl, 1000 cf 22000 in Experiment 
2) the LDU were comparable or higher in the CO-INFECT compared with the LEISH. 
There could of course be a delay between the presence of FLAA specific IFN-, y producing 
T cells in the spleen and the competence to mediate leishmanicidal activity. This could be 
due to delay in the trafficking of the cells to the appropriate location for example. The data 
from the liver lymphocytes shows that in Experiment 1 there was no sign of FLAA-specific 
EFN--y production by the liver lymphocytes at +2 or +4 weeks whereas in Experiment 2 
such IFN--y production was seen at +2 and +4 weeks and as in the spleen was markedly 
higher in the LEISH compared with the CO-INFECT mice. It could be argued that 
induction of a protective response was more rapid in Experiment 2 than in Experiment 1 
and indeed the LDU in the LEISH mice were lower than in the CO-INFECT even at +2 
weeks in Experiment 2 whereas the reverse was true in Experiment I and there was a 
marked decline in LDU between +2 and +4 weeks in the LEISH mice in Experiment 2 and 
a somewhat lower reduction in Experiment 1. With regard to the differences between the 
two experiments it is worth noting that the mean LDU values at +2 weeks were markedly 
higher in Experiment 2 than in Experiment 1 which could have influenced the kinetics of 
development of the immune response. Differences in parasite loads following different 
inoculation have been reported (Melby et al., 2001) and indeed marked differences in L. 
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donovani establislunent can occur between different experimental groups of mice 
inoculated with the same number of parasites (see Chapter 6) 
At +8 weeks, when the LDU in both liver and spleen were markedly higher in the CO- 
INFECT in both experiments, the levels of FLAA-specific IFN--Y produced by the 
splenocytes were 2-3 fold higher in the LEISH compared with the CO-INFECT. Also the 
liver lymphocyte response in Experiment 1 showed three fold higher IFN--y production in 
the LEISH. So there is a correlation at this time point between elevated FLAA-specific 
IFN--y production and reduced LDUs. 
So the data shows that the CO-INFECT mice did make schistosome specific M-4 and did 
show reduced levels of Leishmania-specific EFN--y at certain times during the time course 
of the experiment. Before considering the temporal relationship of these responses the 
involvement of IL-10 will be considered. 
With regard to hypothesis (8), there is evidence from human and murine studies that IL-10 
is associated with suppression and/or modulation of responsiveness during L. donovani 
infections and it is clearly established that IL-10 is produced during schistosome infections 
(Grzych et al., 199 1; Pearce et al., 199 1; Sadler et al., 2003). 
Several studies show that in human visceral leishmaniasis caused by L. donovani and L. 
chagasi patients show a marked depression of T cell responses, characterized by the 
absence of EL-2 and IFN--y production by lymphocytes on in vitro stimulation with 
Leishmania Ag. Furthermore, clinically apparent or progressive disease is associated with a 
Th2 response (Zwingenberger et al., 1990; Carvalho et al., 1992; Cenini et al., 1993; 
Carvalho et al., 1994; Sundar et al., 1997). For example, Carvalho et al. (1994) studying L. 
chagasi showed that although EFN--y and EL-4 levels in the supernatants of PBMC 
lymphocyte cultures were minimal, mRNA for these cytokines and for EL-10 were present 
and restoration of T cell proliferative responses and IFN-7 production was achieved by 
addition of a neutralizing mAb against EL-10 but not against EL-4 although mAb against 
both had a synergistic effect. A more significant role for EL-4 in this modulation in L. 
donovani was suggested by the studies of Sundar et al. (1997) who found IFN--y, IL-4 and 
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EL-10 activity in 53%, 84%, and 56% of patient samples compared with 90%, 10%, and 
20% in healthy co-endemic people. The patients had comparable levels of IFN--y to the 
normal but three-and 13-fold increases in IL-10 and EL-4, respectively and the lack of IFN- 
-y response was associated with the presence of EL-4 alone or in combination with IL-10 but 
not with EL-10 alone. However, other studies report that IL-4 is also not consistently 
expressed in human kala-azar (Babaloo et al., 2001; Ghalib et al., 1993) EL-10 production 
correlates with pathology (Karp et al., 1993). 
Other human studies have shown elevation of IFN--y during active disease (Karp et al., 
1993; Kenney et al., 1998) along with elevation of IIL-4 and IL-10. The elevated EL-10 was 
markedly diminished following treatment. This correlation of active disease with elevated 
IL-10 in the face of elevated IFN-, y supports suggestions that the cellular immune 
depression that is associated with active disease in humans may be due mainly to the direct 
inhibitory effects of EL- 10 rather than to a lack of IFN--y (Holaday et al., 1993; de Medeiros 
et al., 1998). 
Studies in mice have concerned both depletion and over-expression of EL-10. Studies on 
depletion of IL-10 are described in more detail in Chapter 4 but in brief here it is known 
that treatment with anti-EL-10R antibody (Murray et al., 2002; Murray et al., 2003) or 
infection of IIL-10-/- mice (Murphy et al., 2001) results in a reduction or resolution of the 
infection indicating that endogenous EL-10 is responsible for down-modulating the 
protective response in nonnal mice. Of more direct relevance to the present co-infection 
study, studies showed that EL-10 transgenic mice which over-express EL-10 had increased 
LDU compared with controls at 3 weeks (50% increased) and 7 fold increased at 8 weeks 
(Murray et al., 2002). Also there was an approximately 6 fold reduction in IFN--y mRNA 
production in the livers of the transgenic mice and a significant (-5 fold) reduction in the 
production of parasite-free (resolved) granulomas at 4 and 8 weeks and a 50% and 25% 
reduction in mature granulomas at 4 and 8 weeks respectively. In addition NOS expression 
in liver granulomas at 2 weeks was virtually absent in the transgenics. It was concluded that 
the effects of the EL- 10 over-expression was initially attributable to the general suppression 
of Thl responsiveness but eventually granulomas did form and then it is suggested that the 
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IL-10-directed macrophage inhibitory effects (Bogdan et al., 1991; Moore and O'Garra, 
2001) were prominent resulting in heavily parasitized macrophages within structurally 
normal mature granulomas. So the CO-INFECT mice showed a similar trend to the IL-10 
transgenics although the transgenics showed a greater effect in terms of an earlier effect on 
LDU and a greater fold increase in IFN--y response although in the present studies 
Leishmania-specific EFN--y release by splenocytes was measured rather than the non- 
specific liver mRNA level in the liver. In fact the CO-INFECT animals only showed 
lowered IFN-, y levels at +2 weeks (2.7 and 9 fold lower in experiments 1 and 2 
respectively) and at +8 weeks (2.1 and 2.9 fold lower responses) whereas at +4 weeks there 
was a 2.5 fold greater response in Experiment 1 and a comparable response in Experiment 
2. The difference may reflect the fact that although IIL-10 may play a major role in the CO- 
INFECT mice there are many additional interacting immune responses involved compared 
with the transgenics. To return to the production of EL-10 during the course of the current 
co-infections, the SCHISTO and CO-INFECT mouse cell cultures produced significant 
levels of IL- 10 following SEA andJor SWAP stimulation in both experiments at +2 and +4 
weeks post super-infection. FLAA specific LL-10 was also produced in the LEISH and CO- 
INFECT mice and in Experiment I at +2 weeks this was somewhat higher in the LEISH 
than in the CO-INFECT mice. But by +4 weeks in experiment 1 FLAA specific IL-10 was 
only produced in the CO-INFECT mouse cultures in which it was produced at a high level. 
Production of IL- 10 mRNA and of EL- 10 producing cells has been reported during the first 
two weeks of infection, declining to baseline by +4 weeks (Melby et al., 1998; 2001). At 
+8 weeks the patterns of production of EL- 10 to both schistosome antigens and FLAA were 
similar in both experiments, highest in the CO-INFECT group with respect to both 
schistosome antigens and FLAA. Although it is clear from the in vitro data that the CO- 
INFECT mice would generally be producing more M-10 than the LEISH mice throughout 
the time course there was, as with IFN-7, no direct correlation between the in vitro IL-10 
levels and the LDUs e. g. at +2 weeks post infection the LDU were similar for both LEISH 
and CO-INFECT mice and notably in Experiment 1 significantly higher levels of EL-10 to 
both the schistosome antigens and FLAA were produced by the CO-INFECT mice in vitro 
but there were comparable LDU levels. It was not until 8 weeks that higher EL-10 
147 
production to both schistosome and leishmanial antigens correlated with higher LDU in 
both experiments. 
In summary, it is clear that he CO-INFECT mice did manifest schistosome induced Th2 
cytokine responses characterized by IL-4 production in both liver and spleen throughout the 
time course of these experiments. FLAA specific IFN--y production by both splenocytes and 
liver lymphocytes was found in both LEISH and CO-INFECT mice but was markedly and 
significantly lower in the CO-INFECT than the LEISH mice at +2 weeks post super- 
infection. It was also lower at +8 weeks. However, despite this down-regulation of the 
Leishmania-specific Thl response in the CO-INFECT mice there was no corresponding 
elevated FLAA specific IL-4 production. These results are consistent with the idea that the 
presence of schistosome specific IL-4 could influence the development of Leishmania 
specific IFN--y production and that this at least in part explains the loss of control of the L. 
donovani infection. However, there was not a direct temporal correlation between the 
FLAA specific IFN-, y production and control of the infection e. g. biggest differences 
between CO-INFECT and LEISH were seen at +2 weeks when the LDUs were either 
higher in the CO-INFECT or only a little lower. Schistosome specific IL-10 was also 
produced to the schistosome antigens throughout the time course. In addition, there was 
FLAA specific IL-10 production which was enhanced in the CO-24FECT mice. EL-10 is 
involved in IFN--y production in L. donovani infection as is shown by the marked elevation 
of IFN--y in infected IL-10 -/- mice (Murphy et aL, 2001). However, it is worth noting that 
treatment of the KO mice with mAb to IFN--y only partially increased the parasite loads but 
anti-IL- 12 treatment had a greater effect in restoring parasite loads. This indicates that only 
part of the inhibitory effects of EL- 10 may be mediated via its effects on reducing IFN--y in 
LEISH mice. Altematively/in addition, the schistosome-induced IIL-10 could be acting 
directly to inhibit macrophage activation (Moore et A, 2001). The above data is not able to 
distinguish between these two possible alternative effects of IL-10 although the levels of 
IL- 10 to FLAA fitted somewhat better with the LDU values than the IFN--y levels in that 
the biggest differences between the CO-INFECT and LEISH animals (more EL-10 in the 
CO-INFECT) occurred later in the infection when the LDUs also showed the biggest 
differences (higher in CO-INFECT). 
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In addition to IL-10, other immuno-regulatory cytokines are known. TGF-O can inhibit 
generation of IFN--y by differentiating Thl cells in vitro and has an even greater effect on 
Th2 development (Heath et al., 2000). Like IL-10, TGF-O is produced at high levels in 
schistosome infection (Grzych et al., 1991, Pearce et al., 1991). IL-21, another immuno- 
regulatory cytokine which has been described more recently, is preferentially produced by 
Th2 cells and acts on Th I cells to specifically inhibit IFN--Y production by inhibiting IL- 12 
responsiveness of developing Thl cells (Wurster et al., 2002). Since neither of these 
cytokines were measured in these co-infection studies, their possible involvement is only 
speculation but it would be interesting to know how the patterns of expression of these 
cytokines related to the course of the L. donovani infection. Distinct regulatory CD4+ T 
cell subsets, known as Tregs or Th3 cells have also been described which can inhibit both 
inflammatory responses such as those that lead to auto-immunity and also Th2 cell 
mediated pathologies by processes that involve TGF-3 (Powrie and Mason, 1990; Groux et 
al., 1997; Bridoux et al., 1997; Lafaille et al., 1997). The involvement of these cells in 
schistosome infections has not yet been established but it is possible that they could also 
play a role in the immuno -regulation seen. 
A couple of other studies are particularly relevant to this co-infection study. Murray et al. 
(1997) set out to look at the effects of biasing the Leishmania-specific immune response 
towards Th2. For this they immunized the mice with four weekly subcutaneous injections 
with heat-killed L. major promastigotes (HKLP) a strategy which had earlier been shown to 
prevent induction of protective immunity against L. major leading to fatal disease (Liew et 
al., 1985). This resulted in a cross-reacting Th2 response to L. donovani as shown by 
elevated IgE levels before L. donovani challenge and even more elevated responses 4 
weeks following infection. This protocol resulted in significant increases (2-fold) in LDU 
by 2 weeks post infection and this higher level was maintained in the vaccinated mice 
although it had declined to a very low level by 8 weeks. Treatment of these vaccinated 
mice with either anti-EL-4 or anti-EL-10 resulted in normal levels of control of the infection 
showing that in this model neither cytokine acting alone could undermine the immune 
control and suggesting that both EL-4 and EL-10 mediated processed were operating. La 
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showing that in this model neither cytokine acting alone could undennine the immune 
control and suggesting that both IL-4 and EL-10 mediated processed were operating. La 
Flamme et al. (2002) recently studied the effect of concurrent S. mansoni infection on the 
course of L. major which also requires a strong IFN--y mediated response to control the 
infection (Reiner et al., 1995). In this study the L. major infection was given after 2 weeks 
of the S. mansoni infection so that the peak Thl response to the L. major (at +4 weeks) 
corresponded with the peak Th2 response to S. mansoni (at 6-7 weeks post infection). They 
found a complex dynamic relationship in which parasite burdens were comparable at +4 
weeks but at +8 weeks remained constant in the CO-INFECT but dropped by 50% in the 
LEISH. Thereafter parasite burden declined in both to resolve by +16 weeks. At +4 weeks 
EL-4 response to L. major antigen was seen in popliteal lymph node cells in the CO- 
INFECT but not the LEISH mice and there was lower antigen specific IFN--y, TNF-cz and 
NO production. At +8-+16 weeks the Leishmania-specific IFN--y showed little change in 
the LEISH but increased progressively in the CO-INFECT to overshoot the LEISH levels. 
So the lower IFN-, y at +4 weeks did not correspond to higher parasite loads in the CO- 
INFECT at that time but led to a subsequent delay in parasite clearance which was seen at 
+8 weeks at which time the IFN--y levels were in fact higher than in the LEISH animals. 
This lag between the apparent inhibition of Leishmania-specific EFN--y production and lack 
of control of the Leishmania-infection is similar to the results obtained in the present study. 
It was further shown that, in the presence of EFN--y, peritoneal macrophages from 
schistosome infected mice were less able to kill L. major in vitro than normal macrophages 
and this response was greatest in the presence of the non-adherent PEC population of cells 
which include T, B and granulocytes. Preliminary data was referred to indicating that IL-10 
from such cells was responsible for the impaired responses. It was suggested that the Th_2 
response to S. mansoni modulates the development of the protective Thl response to L. 
major with the result that there is a delay in lesion development and to control of the 
parasite load. As this increases however, so the Thl response eventually develops and 
overshoots in the face of increasing parasite load and eventually controls the infection. As 
in the present studies with L. donovani, the extent to which the delay in control is due to 
impaired IFN-7 production or to enhanced EL-10 production is unclear. 
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In conclusion, the work in this chapter has shown that a superimposed L. donovani 
infection has no significant effect on a pre-existing S. mansoni worm burden or egg 
production but the there is a progressive failure to control the L. donovani infection. 
Various hypothesis have been put forward to explain this. Of these it is possible that IL-4 
and/or EL-10 production which is induced by the schistosome infection in the CO-INFECT 
mice could be responsive for down-regulation of Leishmanial specific IFN--y which is 
required for protection although there is not a direct temporal association. Between the 
levels of these cytokines and loss of control of the Ld infection. The immuno- 
regulatory/immuno- suppressive properties of both IL-4 and IL-10 on Thl responses are 
clearly established (Powrie et al., 1993). The present studies were not able to distinguish 
which was the most important in the co-infection model. Studies in the next chapter set out 
to try to investigate more directly the role of EL-10. Studies in Chapter 5 relate to other 
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Chapter 4 
Investigation of the role of IL-10 on the progression of L. donovani in co- 
infected mice using B-cell deficient (IMT) mice or C57BL/6 mice treated 
with anti-IL-IOR mAb. 
Introduction 
The most significant observation from the studies in Chapter 3 was the failure of S. 
mansoni-infected C57BL/6 mice to control progression of a superimposed L. donovani 
infection with the result that at +8 weeks post infection there were high levels of LDUs in 
the livers and spleens of the co-infected mice (CO-INFECT) and minimal levels in mice 
only infected with the L. donovani infection (LEISH). The cytokine analysis showed that 
the S. mansoni infection had, as expected (Grzych et al., 1991; Pearce et al., 1991; Kaplan 
et al., 1998) induced a Th2-biased response as judged by IL-4 production by spleen cells to 
Con A, SEA and SWAP but little IFN--y to the same stimuli. The Th2-biased response was 
also generally demonstrated in the response of liver-derived lymphocytes (Hayashi et al., 
1999; King et al., 2001). Also as expected (Solbach and Laskay, 2000) the LEISH infection 
induced strong IFN--y production but no IL-4 to leishmanial antigen (FLAA) i. e. a Thl- 
biased response. The CO-INFECT animals showed similar Th2 responses to the SCHISTO 
mice but the anti-FLAA IFN--y response was reduced especially at +2 weeks and then again 
at +8 weeks compared to the LEISH mice. The early difference in IFN-7 levels suggests 
that the Th. 2 environment due to the schistosome infection may have interfered with the 
development of the IFN--y response to L. donovani through the inhibitory action of IL-4 on 
the expansion of Thl cells (Lehn et al., 1989; Miralles et al., 1994; Carvalho et al., 1994). 
However, at +4 weeks the IFN--y response in the CO-INFECT mice was comparable or 
greater than in the LEISH alone group suggesting that the development of the Thl response 
was not prevented but apparently delayed. Nevertheless at +8 weeks post L. donovani 
super-infection the FLAA-specific IFN--y response was again lower in the CO-INFECT 
mice. 
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The other cytokine response demonstrated during the S. mansoni infection which has also 
been previously demonstrated in S. mansoni infected mice (Flores Villanueva et al., 1994a; 
Wynn et al., 1998; Sadler et al., 2003) and humans (King et al., 1996) was the induction of 
IL-10 responses as seen following ConA and schistosome antigen stimulation of spleen 
cells in vitro. In addition there was evidence that in the CO-INFECT mice there was an 
enhanced IL-10 response to L. donovani antigen, FLAA. IL-10 has been shown to be 
produced during L. donovani infection in mice and to be a critical cytokine in: - inhibiting 
Thl cell responses predominantly through effects on APC function (Murray et al., 2002; 
Moore et al., 2001; Groux et al., 1999); inhibiting the intracellular killing of L. donovani 
(Bhattacharya et al., 2001a; Murray et al., 2002); and controlling susceptibility to L. 
donovani (Heinzel et al., 1991, Melby et al., 1998) as further shown by rapid control of 
infection in IL-10 KO mice (Murphy et al., 2001; Murray et al., 2002; Kane and Mosser, 
2001), loss of control of infection in IL-10 transgenic mice which over-express IL-10 
(Murray et al., 2002; Groux et al., 1999) or following neutralization of IL- 10 (Ishida et al., 
1992; Ghalib et al., 1993; Romani et al., 1994; Chatelain et al., 1992; 1998; Bhattacharyya 
et al., 2001; Castro et al., 2000; Murray, 2000; 2001; Murray et al., 2002; 2003). 
Moreover, IL-10 is responsible for progression of other intracellular and extracellular 
organisms by effectively disabling the afferent arm of the Thl cell-associated responses 
that are required for induction and expression of cell-mediated immunity leading to disease 
persistence and reactivation e. g. Mycobacterium tuberculosis, HIV, Toxoplasma gondii, 
malaria, Leishmania species, and Trypanosoma cruzi (Gerosa et al., 1999; Ostrowski et al., 
200 1; Plebanski et al., 1999; Neyer et al., 1997; Ghalib et al., 1993; Gasim et al., 1998). 
So experiments were planned to try to further implicate IL-10 in mediating the enhanced 
effects on L. donovani infections. Consideration was given to using IL-10 gene targeted 
mice (IL-10 KO), but various experiments had shown that such mice are essentially 
resistant to L. donovani infection (Murphy et al., 2001; Murray et al., 2002; Kane and 
Mosser, 2001) which itself shows the importance of this cytokine in controlling Thl 
responses. Therefore other approaches were considered to investigate the role of IL-10. 
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Although originally considered a Th2 cytokine, IL-10 is now thought of as a generally 
regulatory cytokine and is known to have a variety of cell sources e. g. activated Th. 2 cells, 
Treg cells, B cells, basophils, monocytes, macrophages, thymocytes, keratinocytes and to 
be produced during both Th2 and Thl responses (Belkaid et al., 2001; 2002; Shevach et al., 
2001; De Waal et al., 1991; Mizuno et al., 1994; Thompson-Snipes et al., 1991). Work by 
Ham and colleagues has implicated B cells as a likely major source of IL-10 during S. 
mansoni infection (Ham et al., 1989). Thus during S. mansoni infection, Velupillai and 
Ham (1994) found that spleen cells from infected BALB/c mice 8 weeks post infection 
proliferated in response to the schistosome egg oligosaccharide, Lacto-N-fucopentaose III 
which contains the Lewis' trisaccharide which is a highly antigenic component of the egg 
antigen. The responding population was found to be B220+, CD4- CD8- i. e. B-cells and 
purified B cells from the infected mice produced high levels of IL-10 in response to the 
oligosaccharide. The B cells also produced PGE2 which also has a negative effect on 
development of Thl cells (Betz and Fox, 1991). Palanivel et al. (1996) have also shown 
ligand-specific activation of IL-10-producing B cells in leishmaniasis and lymphatic 
filariasis models in which Th2 activation occurs. In these experiments peritoneal exudate B 
cells were shown to secrete large amounts of IL-10 in vitro in response to stimulation with 
soluble leishmanial extract in L. ma or infections and soluble microfilarial extract. The 
conclusion from these studies was that there was a correlation and perhaps causal 
relationship between expansion of ligand-specific IL-10-producing B and B-1 cells with 
dominance of Th2-type T cells. 
In view of this demonstration of a key role for B cells in production of IL- 10 in S. mansoni 
infected mice an experiment was planned to carry out the co-infection in B-cell deficient 
mice i. e. AMT strain mice (Smelt et al., 1997; Jankovic et al., 1998), in comparison with 
Wild Type (WT), C57BL/6 mice as above. If the greater L. donovani infection observed in 
the S. mansoni infected mice was due to the effects of B cell-dependent IL-10 production 
then it would be expected that the percentage increase in LDU would be less in the jtMT 
mice. 
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The other approach taken was to administer anti-IL- I OR mAb to CO-INFECT mice starting 
at week 6 after super-infection to see if it was possible, by inhibiting the action of IL- 10, to 
reverse the loss of control of the L. donovani infection which was seen most dramatically at 
8 weeks after superinfection. At the time of setting up this experiment it was known that 
IL-lOK0 mice showed greatly enhanced resistance to infection as discussed above 
(Murphy et al., 2001; Murray et al., 2002) but the later papers on IL-10 receptor 
administration to L. donovani infected mice (see below) were not published. However, it 
had been shown that established L. major infections could be controlled by anti-IL-IOR 
treatment. In these experiments there was little or no increase in IFN--y expression or 
secretion or additional inflammation suggesting that it was macrophage responsiveness to 
the existing Thl cell response which was enhanced by removal of the modulating effects of 
IL- 10 by the anti-IL- 1 OR treatment (Belkaid et al., 200 1). It was anticipated that similar IL- 
1OR treatment in L. donovani infection was likely to lead to enhanced control and, 
subsequent to carrying out this experiment, it was indeed shown by Murray et al. (2002) 
that administration of anti-IL-10R mAb to BALB/c L. donovani infected mice on day +1 
post infection and again at weekly intervals led to a suppression of the infection which was 
virtually resolved by week 3 when the liver LDU in control mice was still near the peak 
level. In a later study anti-IL-IOR mAb was administered to an established L. donovani 
infection at day 14 post infection and this also had a significant effect in reducing liver 
parasite burden on day 21 in both BALB/c (reduced 68%) and C57BL/6 mice (reduced 
57%) (Murray et al., 2003a). The treatment resulted in a 2.5 fold increase in serum IL-12 
but a dramatic 55-fold increase in IFN-7 i. e it had a marked effect on the afferent arm of the 
immune response. 
In spite of the anticipated and subsequently demonstrated enhanced control of L. donovani 
infection in LEISH alone mice the use of anti-IL- 1 OR treatment at the time when the loss of 
control in the CO-INFECT mice was increasing was envisaged as testing the anti-IL-IOR 
treatment as a therapy for the uncontrolled infection in CO-INFECT mice which it was 
postulated was due to S. mansoni induced IL-10. 
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4.2. Results 
4.2.1. Co-infection of jtMT and C57BL16 mice. 
Experimental design 
The experimental design was similar to the first two experiments with SCHISTO, CO- 
INFECT, LEISH and CONTROL groups. Appropriate groups of mice of each strain (10 
mice/group) were infected percutaneously with 25 cercariae of S. mansoni and/or with 
2xlO 7 amastigotes of LV9 strain by tail-vein injection. The L. donovani infection/co- 
infection was given 8 weeks post S. mansoni infection. It had been intended that groups of 
mice would be sacrificed at +8wks p. i. with L. donovani superinfection but after 5 weeks of 
the L. donovani infection a viral infection was discovered in a different section of the 
animal unit and this meant that the unit had to be closed and the animals under 
experimentation had to be culled. So this experiment had to be terminated at just 5 weeks 
after co-infection. 
4.2.1.2. Co-infection of gMT and C57BL/6 mice - effect of prior S. mansoni 
infection on L. donovani LDU. 
At +5wks p. i. with L. donovani, the LDU obtained from both liver and spleen imprints of 
infected C57BL/6 mice showed similar results to the 8 week time points in the previous 
experiments (Figure 4.1). Thus the CO-INFECT animals showed increased parasitic burden 
in both liver (3.25 fold higher than the LEISH group, p= 0.0052) and spleen (2.8 fold higher, 
but not significant, p=0.091). 
The L. donovani-infected B-cell deficient mice showed much lower LDUs in both liver and 
spleen compared to infected C57BL/6 mice. In the liver the CO-INFECT JtMT mice showed 
6.8 fold lower LDU than the CO-INFECT C57BL/6 (p=0.003) and in the corresponding 
LEISH groups LDU were 3.4 fold lower in the ItMT (0.003). The same pattern was observed 
in the spleens of jtMT mice, with 4.4 fold lower LDU in the CO-INFECT group (but not 
significant, p=0.055) and 5 fold lower in the LEISH group (p= 0.038). 
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Figure 4.1. Comparison of Leishman Donovan Units (LDU) from liver and spleen imprints 
following infection or co-infection of B-cell deficient (AMT) and C57BL/6 mice 
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Figure 4.1: Graphs showing the mean (±S. E. ) LDU from the livers and spleens of mice from 
the CO-INFECT and LEISH groups of infected C57BL/6 and jtMT mice (7-10 mice/group). 
For description of the groups see legend to Figure 3.3.1. 
The markedly lower LDUs in jtMT mice was an expected complication (Smeldt et al., 
2000) which prevents statistical comparisons between the two strains but with regard to the 
comparison of the L. donovani infection in naYve and S. mansoni 
infected mice of both 
strains, there was a greater fold increase in the LDUs in the 
livers of the CO-INFECT 
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C57BL/6 AMT 
C5713L/6 mice (2.25 fold, P= 0.0052) than the jtMT mice (0.63 fold, NS, p=0.36). In the 
spleens however, in which there were very low counts, the fold increases were more 
similar, 2.8 for the C57BL/6 mice and 3.25 for the ItMT mice but neither were significant 
(0.054 and 0.055 respectively). 
In conclusion, it was observed that the percentage increase in liver LDU in the CO- 
INFECT compared with the LEISH mice was less in the jtMT compared with the C57BL/6 
mice supporting the notion that S. mansoni induced B cell derived IL- 10 may play a role in 
inhibiting anti-L. donovani immunity. 
4.2.1.3. Co-infection of uMT and C57BL/6 mice - Cvtokine resDonses 
Spleen cell cultures were set up as described in Chapter 3 section 3.3.7. except that the 
concentration of antigen was doubled in this experiment following experience of other 
experiments in the laboratory (Quentin Bickle, 'personal communication'). Liver cell 
preparations were made using the homogenisation method. 
IL-10 production: (i) ftom splenocy! es 
In the C57BL16 (wild type) mice: 
As shown in Figure 4.2., ConA levels in the infected groups were comparable to or lower 
than in the CONTROLS. There was an elevated and comparable level of IL- 10 to SWAP in 
the CONTROL, LEISH and CO-INFECT groups but the most notable response was seen 
in the SCHISTO mice which showed the highest IL-10 production in response to SWAP 
significantly higher than in the LEISH and CONTROL groups (p=0.02,0.03 respectively). 
Moreover, the schistosome infected animals also showed markedly elevated IL-10 in 
response to SEA, significantly higher than in CO-INFECT, LEISH and CONTROL groups 
(p=0.006,0.0002, and <0.0001 respectively). However, there was little sign of enhanced 
IL-10 responsiveness in the CO-INFECT group. The mean level of IL-10 production to 
SEA in this group was higher than the CONTROL and LEISH groups but this was not 
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statistically significant. There was a low level of IL-10 production in response to FLAA in 
the LEISH group but little in the CO-INFECT group. 
Figure 4.2. Comparison of the levels of IL- 10 in supematants of spleen cell cultures 
from C57BI/6 mice and B-cell deficient 
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Figure 4.2 : Graphs showing the means and standard errors for IL- 10 detected by ELISA 
based on three mice from each group sacrificed at +5 weeks after the L. donovani infection. 
Cultures of 5xlO 6 spleen cells/ml were stimulated with medium alone, mitogen (ConA at 
5/. ig/ml), schistosomal antigens (SWAP and SEA at 20ttg/ml) or fixed leishmanial amastigote 
antigen (FLAA, at 107 amastigotes/ml). For description of the groups see legend to Figure 
3.3.1. 
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In the B-cell deficient mice: 
In the B-cell deficient mice IL-10 production was notably lower (5-7 fold) in all groups 
supporting the notion that B cells may be a general source of IL-10 responses. With ConA, 
the SCHISTO mice showed the highest production of IL- 10 compared to the CO-INFECT, 
LEISH and CONTROL (p=0.02,0.009, and 0.03 respectively). The SCHISTO animals also 
produced the highest IL- 10 production in response to schistosome antigens (SWAP, SEA) 
compared to the naive controls, however, this was not statistically significant. The 
SCHISTO SEA response was significantly higher than that of the CO-INFECT and LEISH 
mice (p==0.03). 
IL-10 production: (ii) from liver-derived Iymphocyte 
In the C57BL16 (wild type, WT) mice: 
As shown in Figure 4.3, the mean levels of in vitro production of IL- 10 by the pooled liver- 
derived lymphocytes from the C57BL/6 mice were higher in the SCHISTO and CO- 
INFECT groups than the CONTROLS and LEISH mice. In these cultures the levels of IL- 
10 were 3-3.5 fold higher than the levels recorded from the spleen cell cultures. The 
SCHISTO mice produced the highest levels of IL-10 to the ConA, SEA and SWAP but 
these were also raised in the CO-INFECT group. It was of particular interest that the CO- 
INECT mice also produced elevated IL-10 to FLAA relative to all other groups notably to 
the LEISH group. 
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Figure 4.3. Companson of the levels of IL- 10 in supematants of pooled liver-derived 
lymphoe3les from C57BI/6 mice and B-cell deficient mice, 
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Figure 4.3 : Graphs showing the IL- 10 detected by ELISA in 72hr cultures of liver-derived 
lymphocytes mice from mice sacrificed at +5 weeks after the L. donovani infection. 
Cultures of 5xl 06 liver-derived lymphocytes/ml pooled from 5-7 mice were stimulated with 
medium alone, mitogen (ConA at 5ttg/ml), schistosomal antigens (SWAP and SEA at 
20ttg/ml) or fixed leishmanial amastigote antigen (FLAA, at 107 amastigotes/ml). For 
description of the groups see legend to Figure 3.3.1. 
In the B-cell deficient mice: 
The pattern of response by the liver-derived lymphocytes from the B-cell deficient mice 
was similar to the wild-type (WT) mice in that elevated responses were only seen in the 
SCHISTO and CO-INFECT groups. As in the spleen the levels of IL-10 were generally 
lower than in the VVT mice but less so than with the spleen cell cultures. The SCHISTO 
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animals produced the highest levels of IL-10 in response to ConA, SWAP, and SEA. The 
CO-INFECT mice showed some production of IL- 10 in response to ConA and SEA relative 
to the CONTROLS but this was notably lower than in the SCHISTO mice. Interestingly 
compared to the WT mice, the /. tMT mice did not make IL-10 responses to SWAP. In view 
of the elevated IL-10 production to FLAA by the liver lymphocytes from the WT CO- 
INFECT group it was of particular note that the AMT CO-INFECT mice did not make any 
IL-10 to FLAA. So this data is consistent with the notion that the enhanced IL-10 
production from B cells induced both by S. mansoni and L. donovani specific responses 
could compromise the development of protective anti-leishmanial immunity especially in 
the liver. 
The highest responses by the liver lymphocytes were to ConA rather than the specific 
antigens in contrast to the spleen cells which responded most strongly to the specific 
antigens perhaps suggesting that different IL-10-producing cells (i. e. ConA responsive) 
may be present in and contributing to IL- 10 production in the liver. Also a relatively higher 
IL-10 response to SEA by the liver lymphocytes than the splenocytes in the ttMT mice may 
suggest that B cells are a more important source of IL- 10 in the spleen than in the liver. 
IFN--y production from splenocVtes 
In the C57BLI6 (wild type) mice: 
In response to ConA all groups showed elevated IFN--y levels (Figure 4.4) which were 
highest in the CONTROL cells as was previously observed (Figures 3.3.9 and 3.3.15, 
Chapter 3). The IFN--y production by the SCHISTO mice was significantly lower than the 
CONTROLS (p=0.009). The SCHISTO group produced the highest IFN--y in response to 
SWAP but this was not significantly higher than that in the CONTROLS although it was 
significantly higher than the LEISH group (p<0.0001). Minimal responses were seen with 
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Figure 4.4. Comparison of the levels of IFN-j in supematants of spleen cell cultures 
from C57BL/6 and ttMT mice 
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Figure 4.4 : Graphs showing the means and standard errors for IFN--y detected by ELISA 
based on three mice from each group sacrificed at +5 weeks after the L. donovani infection. 
Cultures of 5xIO 6 spleen cells/ml were stimulated with medium alone, mitogen (ConA at 
51tg/ml), schistosomal antigens (SWAP and SEA at 20Ag/ml) or fixed leishmanial 
amastigote antigen (FLAA, at 10 7 amastigotes/ml). For description of the groups see legend 
to Figure 3.3.1. 
SEA and only in the CO-INFECT and LEISH groups although this was significant for the 
LEISH group relative to the CONTROLS (p=0.002) possibly due to cross reactivity at this 
higher level of SEA re-stimulation (20itg/ml). 
Most importantly, only the CO-INFECT and LEISH groups produced elevated levels of 
IFN-, y in response to FLAA compared to both the SCHISTO and CONTROL mice (p=0.05, 
0.05 respectively relative to the former and p=0.02,0.02 respectively to the latter). Notably 
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there was no difference in the levels of IFN--y between the CO-INFECT and LEISH groups 
in spite of the marked differences in L. donovani parasite burdens 
In the B-cell deficient mice: 
Splenocyte cultures from the B-cell deficient mice showed a similar pattern and similar 
levels of ConA-induced IFN--y production to the C57BL/6 mice, with the CONTROL mice 
producing the highest IFN--y response. Also as with the C57BL/6 mice, the SCHISTO 
animals produced the highest levels of IFN--y in response to SWAP although this was not 
significantly elevated. Again similar to the C57BL/6 response, the LEISH and CO-INFECT 
groups of 1tMT mice were the only ones to show elevated levels of IFN--y in response to 
FLAA although these were not statistically significantly different from the CONTROL 
values. Although elevated relative to the CONTROLS, the levels of IFN-T to FLAA were 
notably lower than with the LEISH and CO-INFECT C57BL/6 mice, and this difference 
between the mouse strains was statistically significant for the LEISH groups (p<0.05) but 
just failed to reach significance for the CO-INFECT groups. When considered in relation 
to the ConA-induced IFN--y levels, which were comparable in the two mouse strains, the 
lower IFN--y response to FLAA in the ItMT mice was clearly seen and could indicate some 
specific involvement of B cells in the generation of the FLAA IFN-, Y response in addition to 
the IL-10 response. 
IL-4 production from splenocytes 
In the C57BL16 (wild type, WT) mice: 
The data including the ConA results are shown in Figure 4.5 and redrawn without the 
ConA data in Figure 4.6. 
There was a similar pattern of low IL-4 responsiveness as seen in earlier experiments (see 
Figures 3.3-7,3.3-8,3.3.13,3.3.14 in Chapter 3). With ConA stimulation the SCHISTO 
animals produced the highest IL-4 response but only the CO-INFECT animals showed 
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significantly different levels compared to the LEISH group (p=0.03). Once again, the 
SCHISTO animals produced the highest levels of IL-4 in response to (SWAP, SEA) 
although this was not significantly elevated compared to other groups. There was no IL-4 
production in response to FLAA in any of the groups. 
In the B-cell deficient mice: 
A similar pattern of IL-4 production to that of the C57BL/6 mice was obtained in the 
different groups of [tMT mice. Thus, the SCHISTO and CO-INFECT animals produced the 
highest IL-4 in response to ConA. The responses in the LEISH and CONTROL groups 
were significantly lower (p=0.001,0.0006 respectively to the former, p=0.05,0.03 
respectively to the latter). Once again, the SCHISTO animals produced the highest 
production of IL-4 in response to SEA and this was higher than in the CO-INFECT mice 
although it was not statistically significantly higher than in any of the other groups. There 
were minimal responses to FLAA in any of the groups. 
Intriguingly the SCHISTO and CO-INFECT groups of /. tMT mice produced noticeably 
higher IL-4 levels in response to ConA compared to the same groups in the C57BL/6 mice 
and the difference was statistically significant for the SCHISTO groups (p=0.01). However, 
this difference was not seen in relation to the antigen specific responses. 
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Figure 4.5. Companson of the levels of IL-4 in supernatants of spleen cell cultures 
from C57BL/6 and gMT mice 
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Figure 4.5 : Graphs showing the means and standard errors for IL-4 detected by ELISA 
based on three mice from each group sacrificed at +5 weeks after the L. donovani 
infection. Cultures of 5xl 06 spleen cells/ml were stimulated with medium alone, 
mitogen (ConA at 5[tg/ml), schistosomal antigens (SWAP and SEA at 20[ig/ml) or fixed 
leishmanial amastigote antigen (FLAA, at 107 amastigotes/ml). For description of the 
groups see legend to Figure 3.3.1. 
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Figure 4.6. Comparison of the levels of IL-4 in supema ants of spleen cell cultures 
from C57BL/6 and 4MT mice - as in Figure 4.5 but without ConA data 
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Figure 4.6: For legend see Figure 4.5. 
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4.2.2 Effect of IL-10 neutralization using IL-10R mAb on S. mansonilL. donovani co- 
infection. 
Because of the intrinsic resistance of the AMT mice to L. donovani, the above experiment 
was not conclusive in establishing if S. mansoni induced IL-10 was responsible for 
inhibiting L. donovani immunity. So an alternative approach was considered, to inhibit IL- 
10 during the course of the infection with an anti-IL- I OR mAb. 
4.2.2.1. Experimental desi 
Since the experiment was set up to focus on the prophylactic value of treatment of the CO- 
INFECT mice with IL-10R mAb only CO-INFECT, LEISH and CONTROL groups were 
set up above. Briefly 16 mice were infected with 25 cercariae and then super-infected with 
2x 10 7 LV9 i. v. (CO-INFECT) along with a group of 16 previously uninfected mice 
(LEISH). A further group of CONTROL mice was also set up. Half of the mice were 
injected i. p. with the anti-IL-10 rnAb and the other half with the control rat Ig at the rate of 
lmg i. p. / on day +42 and 0.5mg on days +46, +49, + 52 and +55. Mice were sacrificed on 
day 56. 
Unfortunately the anti-IL- 1 OR mAb caused death of some mice in the CO-INFECT group. 
Two mice died following the first injection, one following the second and two following 
the fourth. One mouse died from the CONTROL rat IgG group. However, there was no 
apparent toxicity of the IL-10R mAb itself as no mice died in either the LEISH or 
CONTROL groups. Although this only left 3 mice in the CO-INFECT/anti-IL-10R group 
the data proved of interest and is presented below. 
4.2.2.2. LDU values following in vivo treatment with IL- I OR mAb 
One mouse in the CO-INFECT group treated with control rat IgG showed extremely high 
LDU values (12-65 for the liver and 1.585 for the spleen) relative to the others in the group. 
This was so much higher than the rest of the group that the values for this mouse were 
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removed from the data plotted in Figure 4.7 But it is included in the data plotted in Figure 
4.8. 
Figure 4.7. Comparison of Leishman Donovan Units (LDU) from liver and splee 
iMprints following infection or co-infection of C57BL/6 mice treated 
with anti-IL- I OR mAb - 
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Figure 4.7: Graphs showing the mean (±SE) LDU for the CO-INFECT and LEISH 
groups treated i. p. with rat monoclonal anti-mouse IL-1 OR antibody (Img on day +42, 
0.5mg on days +46,49,52 and 55). They were sacrificed on day +56. These graphs 
exclude one mouse from the CO-INFECT group which had very high LDU counts. Data 
is based on 6 mice for the CO-INFECT plus rat IgG, 3 mice for the CO-INFECT with 
anti-IL-1OR and 5 for each of the LEISH groups. For descriptions of the groups see 
legend to Figure 3.3.1. 
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Figure 4.8 Comparison of Leishman Donovan Units (LDU) from liver and spleen 
iMprints following infection or co-infection of C57BL/6 mice treated 
with anti-IL- I OR mAb- Data as in Figure 4.7 but including one outlier 
mouse result from the CO-INFECT which was not included in figure 4.7. 
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Figure 4.8: Graphs showing the mean (±SE) LDU for the CO-INFECT and LEISH 
groups treated i. p. with rat monoclonal anti-mouse IL-10R antibody (Img on day +42, 
0.5mg on days +46,49,52 and 55). They were sacrificed on day +56. These graphs 
include one mouse from the CO-INFECT group which had very high LDU counts. Data is 
based on 7 mice for the CO-INFECT plus rat IgG, 3 mice for the CO-INFECT with anti- 
IL-IOR and 5 for each of the LEISH groups. For descriptions of the groups see legend to 
Figure 3.3.1. 
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As seen in Figure 4.7. and 4.8., as in the previous co-infection experiments, the CO-INFECT 
mice showed a loss of control of the L. donovani infection compared with the LEISH mice. 
Thus in the groups receiving the control rat IgG the CO-INFECT mice had a 6.3 fold 
increase in liver LDU compared with the LEISH (p=0.0338) and 20 fold increase if the 
mouse with the high value is included although because of the high values this difference 
was not statistically significant. For the spleen LDUs the reductions were 13 fold (p=0.02) or 
27 fold, with the high value included. 
Moreover, the Leishmania infected mice treated with Rat IgG showed significantly lower 
liver and spleen LDUs compared to CO-INFECT animals (p=0.03,0.02 respectively). 
Generally, the CO-INFECT mice treated with IL-10R mAb showed a reduction of LDUs 
compared to those treated with rat IgG. With the high LDU mouse excluded the CO-INFECT 
mice treated with IL-10R mAb showed a 1.9 fold reduction in liver LDUs and with the 
mouse included a6 fold reduction. The LDUs in the spleen were 3.1 fold less with the mouse 
excluded and 6.3 fold lower with this mouse included. But given the low numbers surviving 
and the large variations none of these differences were statistically significant. 
So in spite of the mouse deaths in the CO-INFECT group there was evidence that the anti-IL- 
10 treatment was able to reduce the high L. donovani LDU in the CO-INECT mice but it was 
not possible to conclude that this was due to inhibition of S. mansoni mediated IL-10 
responses as the LEISH infected mice treated with IL- 1 OR mAb also showed a reduction in 
the spleen LDUs (2.2 fold lower) and a marked reduction in liver LDUs (4.5 fold lower) 
compared to the LEISH group treated with Rat IgG, and this difference was statistically 
significant for the liver LDUs (p=0.012). 
4.2.2.3 Detection of cytokine production 
Note: Both IL- 10 and IFN--y production by cells from the CONTROL/anti-IL- I OR treated 
mice showed very high levels of IL-10 and IFN--y with all treatments including medium 
alone. All of the other groups showed variable responses with the different treatments and it 
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is concluded that the data for this gToup was unreliable and this was not included in the 
analysis (shown as N. S. [not shown] in Figures 4.9 and 4.10). 
Levels ofIL-1 Ofrom spleen cells in vivo treated with anti-IL-I OR or rat-IgG 
The pattern of IL-10 production (see Figure 4.9. ) shared some similarities was the data for 
the 8 week time points in the two experiments in Chapter 3 (Figure 3.3.10 and 3.3.16). As 
with both of these earlier sets of data there was IL-10 production to FLAA in both the LEISH 
and CO-INFECT groups and as in the earlier data this was higher in the CO-INFECT 
although the difference was not significant. There was however, no specific IL- 10 production 
to the SEA above that seen in the cultures in medium alone at this time. This is consistent 
with the down-regulated IL-10 production seen Figure 3.3.10 but Figure 3.3.16 showed 
higher levels especially in the CO-fNFECT. The reason for this difference is not apparent. 
Figure 4.9. Comparison of the levels of IL-10 in supematants of pooled splenoc3qes from 
mice treated with anti-IL- I OR antibpdy 
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Figure 4.9 Comparison of the mean levels (±SE) of IL-10 in supernatants of splenocytes 
from CO-INFECT, LEISH and CONTROL groups treated i. p. with rat monoclonal anti- 
mouse IL-10R antibody (Img on day +42,0.5mg on days +46,49,52 and 55). They were 
sacrificed on day +56. For descriptions of the groups see legend to Figure 3.3.1. 
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Regarding the effects of the anti-IL- 1 OR treatment this had no significant effect on the levels 
of IL- 10 production in either the CO-INFECT or LEISH mice. 
Levels ofIFN-, y from spleen cells in vivo treated with anti-IL- I OR or rat-IgG 
Figure 4.10 shows IFN--y production from spleen cells from mice treated in vivo with anti-IL- 
IOR or rat-IgG. The pattern of IFN--y responses notably to ConA and FLAA in the CO- 
fNFECT and LEISH groups treated with the control IgG were consistent with the +8 week 
time points in the earlier experiments (Figures 3.3.9 and 3.3.15, Chapter 3) i. e. the level of 
IFN-7 production was higher in the LEISH than in the CO-INFECT mice and this was 
significant for the ConA data (p=0.02). There were no significant responses to SEA above 
the medium alone values. 
Figure4.10. Comparison of the levels of IFN-jin supematants of pooled splenocý4es 
from mice treated with anti-IL- 1 OR antibod 
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Figure 4.10 Comparison of the mean levels (±SE) of IFN--y in supernatants of splenocytes 
from CO-INFECT, LEISH and CONTROL groups treated i. p. with rat monoclonal anti- 
mouse IL-10R antibody (1mg on day +42,0.5mg on days +46,49,52 and 55). They were 
sacrificed on day +56. For descriptions of the groups see legend to Figure 3.3.1. 
The in vivo treatment with anti-IL- 1 OR antibody enhanced the level of IFN--y production by 
splenocytes from the LEISH mice in response to ConA and FLAA as compared with the 
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response by cells from the LEISH/control rat IgG antibody group. The difference was 
statistically significant for the FLAA response (p=0.02). There was little evidence of 
enhanced IFN--y production in the CO-INFECT following the anti-IL-10 treatment as 
compared with the control IgG treatment. The ConA response was increased somewhat but 
not significantly and the FLAA response not noticeably different. 
4.3 Discussion 
These studies were concerned with trying to obtain supportive evidence for the immuno- 
regulatory role of S. mansoni induced IL-10 on the failure to control L. donovani infection 
in CO-INFECT mice which was postulated in Chapter 3. Consideration of using IL- 10 gene 
targeted mice (IL-10 KO) was ruled out as various experiments had shown that such mice 
are essentially resistant to L. donovani infection (Murphy et al., 2001; Murray et al., 2002; 
Kane and Mosser, 2001). Furthermore, IL-10KO mice show greater susceptibility to S. 
mansoni infection as judged by increased morbidity with the development of large 
schistosomal granulomas (Hoffmann et al., 2000; Metwali et al., 1996; Wynn et al., 1997), 
and increased mortality during the chronic stages of infection (Hoffmann et al., 1999; 
2000). In view of the morbidity seen in CO-INFECT mice in Chapter 3 it was considered 
probable that IL-10KO mice would not have survived the duration of the planned 
experiments. So the two approaches followed here were to look at CO-INFECTION in (i) B 
cell KO mice which in view of the proposed B cell source of IL- 10 in S. mansoni infection 
in mice (Ham et al., 1989; Williams et al., 2001) would be expected to produce less IL-10 
than WT controls and (ii) mice treated late during CO-INFECTION with anti-IL-IOR 
antibody. These protocols were not without their problems but the data is not inconsistent 
with the proposed immuno-regulatory role for S. mansoni-induced IL- 10. 
In the studies using jtMT mice, the parasitological data from the WT (C57BL/6) control 
mice was consistent with the results from Chapter 3 in that even though the experiment had 
to be terminated at +5 weeks post L. donovani infection there was a comparable lack of 
control of the L. donovani infection in the CO-INFECT mice as at the +8 week time point 
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in Chapter 3, with parasite loads in the liver and spleen the CO-INFECT mice 3-fold higher 
than in the LEISH alone group. 
However, the jiMT mice showed generally lower susceptibility to the L. donovani 
infection, the LEISH alone mice showing 3-fold lower LDUs compared with the WT mice. 
Such lowered susceptibility had previously been shown by Smelt et al. (1997) who reported 
significantly lower LDU in jtMT mice as early as 15 days post infection. Unexpectedly 
they found enhanced neutrophil infiltration into the L. donovani granulomas in the liver 
early after infection which they suggested maybe due to a lack of B cell derived IL-10 
which is known to regulate neutrophil production/activation. It was suggested that ROI 
produced by TNF-u activated neutrophils may be the basis of the enhanced control in ýtMT 
mice as ROI have been shown to play an important role especially early after infection 
(Murray and Nathan, 1999). Unfortunately this differential susceptibility in the LEISH WT 
and /. tMT animals in the present experiments meant that it was not possible to directly 
compare the LDU values in the jtMT and WT CO-INFECT mice. However, in the livers, 
the relative increase in LDUs in 1AMT mice in the CO-INFECT mice over the LEISH mice 
was lower in the AMT than the C57BL/6 mice (increased only 0.63 fold in the CO-INFECT 
compared with the LEISH mice [N. S. ] in AMT and increased 2.25 fold in the CO-INFECT 
compared with the LEISH in the C57BL/6 mice [P= 0.0052]). In other words in the absence 
of B cells there was relatively little effect of the S. mansoni infection on the control of the 
L. donovani infection. So could this be due to a lack B cell produced IL-10 in the S. 
mansoni infected mice? 
As in the experiments in Chapter 3, in in vitro splenocyte cell culture, the SCHISTO WT 
type (C57BL/6) mice showed markedly elevated EL-10 in response to SEA, significantly 
higher than in CO-INFECT, LEISH and CONTROL groups (p=0.006,0.0002, and <0.0001 
respectively). However, in the CO-INFECT mice there was little evidence of raised IL-10 
responses relative to the LEISH mice or the CONTROLS except for the SEA response but 
this was not statistically significant. This was somewhat different from the experiments in 
Chapter 3 both of which showed elevated IL- 10 responses in the CO-INFECT mice to both 
schistosome and leishmanial antigens. The reasons for this difference are not clear. 
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However, the liver lymphocytes in CO-INFECT WT mice did show elevated IL-10 
production to both schistosome and leishmanial antigens compared with the LEISH and 
CONTROL mice. Such higher levels of antigen specific cytokine production by granuloma 
macrophages compared with splenocytes has been reported previously for both IL- 10 (King 
et al., 2001) and IL-4 (Hayashi et al., 1999). So, the liver EL-10 data at least demonstrates 
elevated levels of IL-10 to both schistosome and leishmanial antigen in the CO-INFECT 
WT mice. 
In the AMT mice in vitro cell culture from both the livers and spleens of the SCHISTO 
AMT mice showed markedly lowered IL-10 compared to the WT mice. Given that the 
levels of schistosome infections in the ItMT and C57BL/6 mice were comparable, this 
difference in IL-10 response supports the notion (Ham et al., 1989; O'Garra et al., 1992) 
that B cells are an important source of IL-10 in S. mansoni infection and that this can be 
induced in response to the schistosome products. The IL-10 levels were also lower in the 
spleen and notably the liver responses of the jiMT compared with the WT CO-INFECT 
mice. So the IL-10 cytokine data is consistent with the idea that B cells lead to enhanced 
IL- 10 production in S. mansoni infected mice and that during L. donovani co-infection this 
could serve to compromise the development/action of anti-leishmanial immunity. 
Whereas the higher IL- 10 levels in the liver of CO-INFECT compared to LEISH WT mice 
correlated with the higher LDU in the CO-INFECT mice, the levels of splenocyte IFN--y 
were comparable between the groups suggesting that IFN--y does not mediate this difference 
in parasite control. However, in both of the two earlier experiments (in Chapter 3) there 
was evidence of lowered FLAA specific IFN-, y production in the CO-INFECT mice 
compared with thee LEISH at +2 and +8 weeks but either similar or higher production in 
the CO-INFECT at +4 weeks. So it is possible that the higher LDU in this experiment 
(terminated at +5 weeks post super-infection) reflects earlier deficiency in IFN--y 
production in the CO-INFECT mice. 
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Given the immuno-regulatory role of IL-10 it might have been expected that the proposed 
absence of B cell-derived IL- 10 would have led to an increase in IFN--y levels in the AMT 
compared with the WT mice. However, the jtMT mice in vitro cell cultures from both the 
livers and spleens of the SCHISTO and CO-INFECT ItMT mice showed lowered IFN-'y 
responses to schistosome antigen than the WT mice, giving no indication that the lack of B 
cells and the IL-10 they may produce had skewed the immune response away from a Th2 
response to a Thl response. In fact very low IFN--y levels to FLAA were seen in the /. tMT 
mice. IFN-7 levels were not reported by Smelt et al. (2000) but the lack of IFN--y may be 
explained simply by the low parasite burdens which develop in these animals as a result of 
the proposed neutrophil mediated attrition resulting in low antigen stimulation. 
Alternative to the effects on IFN--y production, the elevated EL-10 production in the liver of 
the CO-INFECT mice could mediate immuno -modulatory effects via modulation of 
macrophage activation (Moore et al., 1999) making them refractory to activation by IFN-y 
for intracellular killing (Moore et al., 1993; Kane and Mosser, 2001; Gazzinellini et al., 
1992). 
Unexpectedly the SCHISTO and CO-INFECT groups of tiMT mice produced noticeably 
higher IL-4 levels in response to ConA compared to the same groups in the C57BL/6 mice 
and the difference was statistically significant for the SCHISTO groups (p=0.01). The 
reasons for this are unknown. In the papers showing that S. mansoni infection induced B 
cell outgrowth and production of IL-10 from B cells stimulated with egg carbohydrates it 
was suggested that this route of IL-10 production might promote the Th2 responses seen 
during acute schistosomiasis in mice (Fitch et al., 1993). So it would have been expected to 
have seen lower Th2 responses in mice lacking B cells and so lacking the ability to produce 
IL-10 via this route. However, this difference was not seen in relation to the antigen 
specific responses and why it was restricted to the Con A response is not clear. 
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To conclude this experiment it could be argued that the relatively lower fold increase in 
LDU in the liver of the AMT mice (CO-INFECT vs. LEISH) compared with the WT mice 
(CO-INFECT vs. LEISH) could be due to lack of B-cell derived IL-10 inhibiting 
macrophage-mediated killing of L. donovani in the ItMT mice. However, it should be 
emphasized that the ýtMT mice are much less susceptible to infection with L. donovani than 
the C57BL/6 mice and that this is believed to be due to the rapid cytotoxic effects of 
recruited neutrophils (Smelt et al., 1997) and it is unclear how the schistosome infection 
would affect this potent neutrophil mediated killing. 
The complications which arose from the relative resistance of B cell deficient mice meant 
that this was not a profitable approach to addressing the role of IL-10 and so this 
experiment was not repeated. Instead an attempt was made to see if treatment of the 
established co-infection with anti-IL- I OR mAb would serve to prevent or reverse the trend 
of increasing L. donovani LDU in the CO-INFECT mice. 
Unfortunately, the anti-IL- I OR mAb caused death of some mice in the CO-INFECT group 
but there was no apparent toxicity of the IL-1 OR mAb itself, as no mice died in either the 
LEISH or CONTROL groups. A SCHISTO alone group was not included in this study as 
the intention was only to look at the effects on the loss of L. donovani control. In retrospect 
it would have been a useful control. 
Regarding the reasons for the mortality seen, Sadler et al., (2003) reported a higher 
mortality in S. mansoni infected IL-10-/_ mice over a 15 week period, but showed that 
the knockout (KO) mice had larger, less well defined schistosome granulomas but no 
appreciable difference in cellular composition. Extensive areas of hepatocellular 
necrosis were seen around the granulomas, significantly greater at both 8 and 15 weeks 
post S. mansoni infection. They ruled out differences in antibody which were similar in 
the two strains levels but reported markedly higher SEA-induced IFN--y levels in MLN 
and spleen cell cultures and suggested that excessive production of inflammatory 
mediators such as nitric oxide caused the liver damage. There is evidence that the 
proposed role for "alternatively activated" granuloma macrophages in inhibiting 
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cellular proliferation and the pro-inflammatory component of the anti-egg response 
involves IL-10 (Flores Villanueva et al., 1994a) and mice which are unable to generate 
AAMO suffer inflammatory disease and death (Herbert et al., 2004). This is consistent 
with the pathology and high mortality seen in Thl polarized (IL-4/EL-10 KO) mice 
(Hoffmann et al., 2000). In the present study, therefore, it is likely that the 
administration of anti-IL- 10 antibody during the chronic phase would have similarly led 
to unregulated pro-inflammatory responses and to tissue damaging NO production 
perhaps notably around the schistosome granulomas. 
Apart from the effects that blockage of IL-10 function may have on the schistosome 
granulomatous response the CO-INFECT mice in this study would also have had high L. 
donovani counts at the time of neutralization. So the sudden neutralization of IL-10 
function is likely to have resulted in rapid and marked increases in production of NO in the 
liver due to pro-inflammatory anti-L. donovani responses. This is in agreement with 
Murray et al., (2003a) who showed that anti- IL-10R mAb treatment of early 14 day L. 
donovani infections resulted in a dramatic 55-fold increase in IFN--y leading to rapid control 
of the L. donovani infection via the activation of NO and reactive oxygen species. Although 
this early 14 day infection was controlled without mouse morbidity, in the present studies 
the inflammatory response in the liver is likely to have been much greater due to the 
development of the Th I response and the high parasite loads. It is concluded that blockage 
of IL-10 function is likely to have led to sudden increases in the pro-inflammatory 
responses to both L. donovani and S. mansoni granulomas in the liver leading to 
inflammatory damage and death. 
Despite the death of several of the animals three were left to allow an assessment to be made 
of the effect of blocking IL- 10 function on reversing the schistosome-induced inhibition of L. 
donovani immunity. As in the previous co-infection experiments, the CO-INFECT mice 
treated with the control antibody showed a loss of control of the L. donovani infection 
compared with the LEISH mice. In the current experiment, the LEISH mice treated with 
control rat IgG showed significantly lower liver (6.3 fold) and spleen (13 fold) LDUs 
compared to CO-INFECT animals treated with same antibody (p=0.03,0.02 respectively). 
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The CO-INFECT mice treated with IL-IOR mAb showed lower liver LDUs (1.9 fold 
reduction) and spleen LDUs (3.1 fold reduction) compared to the CO-INFECT mice treated 
with control rat IgG. One of the CO-INFECT mice developed exaggerated and progressive 
parasitic burden in both liver (16 fold higher values than mean liver LDU in other mice of the 
same group) and spleen (8-4 fold higher values) and if this mouse was included the 
difference would have been greater. Thus the anti-EL- I OR treatment did serve to reduce the 
uncontrolled L. donovani proliferation in CO-INFECT mice suggesting that IL-10 was 
exerting a negative influence on killing of L donovani and that this could be relatively rapidly 
reversed. As a therapy therefore the anti-IL-IOR treatment was effective. However, although 
they had lower LDU than in the CO-INFECT mice the LEISH alone mice also showed lower 
liver LDUs (4.4 fold reduction) and spleen LDUs (2.3 fold reduction) when treated with the 
anti-IL-10R rnAb compared to the LEISH mice treated with control rat IgG. Similarly 
reduced LDU following anti-IL-10R mAb treatment in L. donovani infected BALB/c mice 
were recently reported by Murray et al., (2003a). 
How the inhibition of IL-10 function led to apparently greater control in both the LEISH 
and CO-INFECT groups in the current experiment is uncertain. IFN--y production to FLAA 
was increased in LEISH mice treated with anti-IL-IOR mAb compared to the control rat 
IgG (p=0.02). So the data showing reduced L. donovani parasite loads in the anti-IL-10R 
treated LEISH mice fits with the idea that the treatment enhances IFN--y production. This 
also came in agreement with other studies showing that anti-IL-10R mAb treatment 
enhances Thl responses (Castro et al., 2000). However, the level of increased IFN--y 
production was only 2.3 fold compared with the control IgG treated mice. By contrast, 
Murray et al. (2003) reported a 55 fold increase in IFN--y in mice following treatment with 
the same mAb but there were differences compared with this experiment. Murray et al. 
(2003) measured serum levels, they used BALB/c mice and the treatment started at day 14 
post infection rather than the 42 days post infection in the experiment described here. 
It was particularly interesting that although the anti-IL- I OR treatment led to lower LDU in 
the livers and spleens of the CO-INFECT mice this treatment did not induce elevated 
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Leishmania specific IFN--y production. This suggests that in the CO-INFECT mice the 
lowered FLAA specific IFN-, y response which was seen at +8 weeks in the various co- 
infection experiments in this thesis is not principally due to IL- 10 mediated suppression. So 
in both the LEISH and CO-INFCT mice other EL-10 mediated effects may be more 
important in the lack of L. donovani control than effects on IFN-7 levels i. e. (i) induced 
blockade of IL-10R signalling (Miralles et al., 1994), via restoring the PKC activity in the 
parasitized macrophages (Bhattacharyya et al., 2001b); (ii) blocked inhibition of nitric 
oxide, ROI and murine TNF-a release by the infected macrophages (Bhattacharyya et al. 
2000; Murray et al., 2003), affecting granuloma assembly (Murray et al., 2002). (iii) 
APC/Th I cell interactions via costimulatory molecules (iv) Thl cell proliferation (Ghalib et 
al., 1993). 
In chronic cutaneous L. major infection, anti-IL-10R injections eliminated persisting 
parasites apparently by increasing macrophage responsiveness to existing level of Thl cell 
reactivity. Neither increased levels IFN--y expression and/or local cellular responses were 
up-regulated in treated C57BL/6 mice (Belkaid et al., 2001). 
In conclusion, in spite of the increased mouse deaths in the CO-INFECT group there was 
evidence that the anti-IL-10 treatment was able to reduce the high L. donovani LDU in the 
CO-INECT mice but it was not possible to conclude with certainty that this was due to 
inhibition of S. mansoni mediated IL-10 responses as the LEISH infected mice treated with 
anti-IL-10 mAb also showed a reduction. The fact that the anti-IL-IOR treatment did not 
result in increased IFN-, y production suggests that the prime effect of the IL- 10 is to inhibit 
macrophage function reducing granuloma formation and leishmanicidal killing within the 
granulomas. 
181 
Chapter 5 
Biochemical and histopathological responses in the liver to S. mansonA. donovani Co- 
infection 
Introduction 
The work in Chapters 3 and 4 had shown: (i) that L. donovani parasites were able to 
proliferate more effectively in mice with a pre-existing S. mansoni infection than in naive 
mice (ii) that the co-infected mice showed elevated IL-4 and IL-10 responses to 
schistosome antigens and IL-10 to leishmanial, infections (iii) that the co-infected mice 
showed lower leishmanial specific IFN-, y responses. In section 3.4. of Chapter 3 various 
hypotheses were outlined to explain the lack of control in the CO-INFECT mice. Prominent 
amongst these was the idea that the S. mansoni induced cytokines notably IL-4 and IL-10 
could suppress the afferent and efferent arm of the protective Thl response against L. 
donovani i. e. the generation around Ld infected KCs in the liver of IFN--y mediated 
granulomas comprising activated macrophages secreting TNF-a and the leishmanidical 
ROI and NO. The data from Chapter 4 although not conclusive were consistent with the 
idea that IL-10 could be involved in the failure to control L. donovani in the co-infected 
mice. 
Among the hypotheses were the following: (Hypothesis 2) that S. mansoni hepatic egg 
granulomas are rich in recruited macrophages and so there may be a higher density of foci 
of L. donovani infection within -the egg granulomas coMpared with 
the parenchyma; 
(Hypothesis 4) that lower IFN--y levels may result in reduced development/reduced rate of 
maturation of L. donovani granulomas (comprising antigen-specific Thl cells and recruited 
macrophage and which are most clearly seen in the liver) i. e. there would be a reduced 
frequency of development of mature L. donovani granulomas; (Hypothesis 5) that L. 
donovani may physically fail to form correctly within the context of the 
inflammatory cells of the S. mansoni granulomas and so there may be a lack of control in 
infected macrophages within the egg granuloma; (Hypothesis 6) that even if 
morphologically normal mature granulomas form, the constituent macrophages have a 
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reduced capacity to become activated and so to produce leishmanicidal factors which may 
result in higher mean numbers of amastigotes in L. donovani foci in CO-INFECT mice 
coMpared with LEISH mice; (Hypothesis 7) Alternatively activated macrophages which 
predominate in the schistosorne egg granulomas may be poor at directing L. donovani 
granuloma formation and/or show poor leishmanicidal activity. In this case amastigotes 
may accumulate within L. donovani infected macrophages in the egg granuloma resulting 
in higher mean numbers of amastigotes in the infected macrophages within the S. mansoni 
granulomas compared with the iDarenchvma of CO-INFECT mice and/or LEISH mice. 
The studies in this chapter were concerned principally with the functional consequences of 
the proposed immune modulation by the S. mansoni infection on the resolution of the L. 
donovani infection. For this purpose attention was focused on the generation of L. donovani 
granulomas or other foci of Ld infection in the liver because in singly (LEISH) infected 
mice the evolution of mature granulomas and the resultant leishmanicidal activities within 
these are believed to be necessary for control of the infection. So attention was focused on 
histological or immuno -histological analysis of the L. donovani and the S. mansoni 
granulomas in the CO-INFECT and LEISH mice. In addition, the data in Chapter 3 also 
showed that although the superimposed Ld infection did not induce a significant 
modulation of the S. mansoni immune response from Th2 to Thl, the CO-INFECT mice 
did produce IFN--y to leishmanial antigens and it was considered possible that this could 
have influenced the Th2 response to the S. mansoni. So histological observations on the S. 
mansoni egg granulomas were also made. 
Immune granulomas, both the S. mansoni and the L. donovani induced ones are localised 
inflammatory reactions containing T cells and represent a form of delayed-hypersensitivity. 
They share a number of common features including prolonged antigenic stimulation that is 
not easily cleared by phagocytic cells. In the case of the schistosome eggs this is due to the 
prolonged release of soluble egg antigens through microspores in the egg shell and the large 
size of the schistosome granuloma formed as host protective immune reaction. In the case 
of Leishmania the parasite chooses to live inside phagocytic cells and is able to persist 
there. Granulomas are often associated with the fusion of macrophages to form flattened 
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epithelioid and multinucleated giant cells. The recruited T cells contribute to the attraction 
of myeloid inflammatory effector cells which can vary between granulomas of different 
A origin (Chensue and Boros, 1979; Kunkel et al., 1998). 
During acute infection of mice, the S. mansoni egg granuloma is a Th. 2 cytokine dominated 
response, with the granuloma cells producing IgG1, IgE, and large quantities of Th2 
cytokines IL-4, IL-5 (Metwali et al., 2002) and IL-13 (Fallon et al., 2000). IL-13 is 
responsible in mice for fibrosis and consequently for schistosome pathology (Fallon et al., 
2000). However, egg antigen specific Thl cytokines are also produced in S. mansoni 
infected mice and studies in double knock out mice (IL-4/IL-10-/-, Thl biased; IL-12/IL-10- 
/-, IFN--y/IL- 10-/-, Th2 biased) suggest that the granulomatous response is finely balanced in 
normal mice. However, if this is skewed in the Thl direction it results in severe 
inflammatory disease and animal death, whereas if the granulomatous response is skewed 
towards a Th2 gives rise to increased fibrosis and increased mortality (Hoffmann et al., 
2000). This is because mediators associated with Thl responses, e. g. IFN--y, IL-12, TNF-u 
and NO can prevent IL-13 mediated fibrosis (Hesse et al., 2002). Both Th2 and Thl 
cytokines are produced in humans to egg antigens and are also likely to counter regulate 
each other to minimize damage to the host. For example, there is evidence that fibrosis in 
human schistosomiasis may be linked to polymorphisms in the IFN--y receptor 1 gene 
associated with lack of effectiveness of IFN--y in suppressing fibrosis (Dessein et al., 1999). 
However, the role of IL-13 has yet to be firmly established in human disease (Pearce and 
MacDonald, 2002). There is evidence of an association of hepatosplenic disease with 
elevated Thl responses and plasma levels of soluble TNF-a receptor I and 11 (Mwatha et 
al., 1998), although'the link between hepatosplenic disease and fibrosis in humans is still 
uncertain (Dessein et al., 1999). Nevertheless it is clear from mice that increased IFN--y can 
downregulate the Th2 mediated granulornatous response. The administration of IL- 12 
together with egg antigen, promotes a more Thl response and results in reduced Th. 2 
responses, liver fibrosis and granuloma size (Cheever and Yap, 1997; Wynn et al., 1994). 
In these present studies the induction of elevated IFN--y response to the superimposed L. 
donovani infection in the liver could modulate the S. mansoni Th2 response leading to 
reduced Th2 responses and granuloma size. 
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The liver apart from providing an altered cytokine environment for L. donovani 
development, in a S. mansoni infected mouse also presents a markedly altered cellular 
envirom-nent i. e. the schistosome egg granulomas contain predominantly eosinophils, 
lymphocytes, fibroblasts and macrophages (Weinstock and Boros, 1983). The granuloma 
macrophages derived from blood monocytes are recruited to the granuloma from the 
periphery (King et al., 2001); Initiation and regulation of disease in schistosomiasis: 
Mahmoud AAF, editor. Schistosomiasis. London: Imperial College Press, 213-264. ) and 
may offer additional sites for L. donovani infection. In addition it is clear that the 
schistosome granuloma macrophages are of the "alternatively activated macrophage 
(aaMo)" phenotype which are characteristically immuno-suppressive and anti- 
inflammatory. AAMos were first defined as such by Stein et al. (1992) who showed that 
EL-4 treatment of murine macrophages deactivated the macrophages and upregulated 
mannose receptor (MR) expression. Recently by staining for MR, Linehan et al. (2003) 
showed that GM were MR positive whereas GM in IL-4Rd/- mice were not. The term 
aaMo was originally applied to describe macrophages activated by IL-4 or IL-13 (Stein et 
al., 1992) and to distinguish such cells from those deactivated by IL- 10 but the concept of 
alternatively activated macrophages is now used more broadly and considered in terms of 
their function (Noel et al., 2004). 
"Classical activation" of macrophages is mediated by Thl cytolcines which promotes the 
secretion of proinflammatory cytokines, the up-regulation of NO and02_ production and 
enhances the capacity of macrophages to activate T cells i. e. the processes typically involved 
in the generation of resistance to L. donovani infection. In contrast the Th2 cytokines, IL-4 
and IL- 13, have been shown to promote aaMo from bone marrow derived macrophages in 
vitro (Goerdt et al., 1999) and these cells secrete anti-inflammatory cytokines, they do not 
produce significant levels of NO and superoxide and have non-specific anti-proliferative 
properties (Gordon, 2003). A key feature of aaMo's is that IL-4 and IL-13 induce the 
expression of arginase (Hesse et al., 2001), which converts L-arginine to L-ornithine which 
can lead to collagen production and fibrosis. Arginase-1 is heavily expressed in S. mansoni 
egg granulomas but is not induced in Th2 deficient mice (Hesse et al., 2001). Importantly 
L-arginine is also the substrate for NOS which is activated by IFN--y ligation and which 
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leads to production of NO and citrulline. An intermediate in this pathway is L- 
hydroxyarginine which inhibits arginase activity and so yet another way in which the Th2 
granulomatous response leading to fibrosis, is modulated by the concurrent Thl response 
(Hesse et al., 2001). However, the activation of arginase-1 by Th. 2 cytokines reduces the 
availability of L-arginine for NO production and this seems to be critical in preventing Th I 
mediated nitrosative damage such as occurs in S. mansoni infected Th2 deficient mice, e. g. 
IL-4-/- mice (Brunet et al., 1997). The critical role of Th2 activated aaMo's in S. mansoni 
infection was elegantly shown recently in mice with a selective deletion of IL-4Ra in 
macrophages and so which cannot develop aaMo show rapid wasting and death with 
elevated iNOS production in both the liver and gut. It is concluded that the alternatively 
activated granuloma macrophages are unable to produce tissue damaging NO or 
superoxide, counter-balancing the destructive potential of S. mansoni egg-induced Thl 
inflammation (Herbert et al., 2004). 
In fact Stadecker et al. (1990) were the first to show the presence of immuno-modulatory 
macrophages in schistosomiasis. They found that isolated granuloma macrophages (GM) 
strongly inhibited the ability of splenic APC to stimulate SEA-specific CD4+ve Thl cell 
clones in vitro and exposure to GM plus SEA renders the Thl cells anergic to 
restimulation. This effect was dependent on IL- 10, and not TGF-O both of which inhibitory 
factors can be produced by macrophages (de Waal Malefyt et al., 1991; Assoian et al., 
1987). The GM showed downregulated expression of costimulatory molecules, B7-1 and 
B7-2 which could be restored by inhibition of the endogenous IL-10 production (Flores 
Villanueva et al., 1994b). Furthermore transfer of purified GMs in vivo down-regulated egg 
granuloma formation and was associated with a marked decrease in IL-12 production 
(Flores Villanueva et al., 1994a). This earlier work supports the conclusions that the GM 
have profoundly immune- suppressive and anti-inflammatory properties which serve to 
prevent damaging inflammatory responses in schistosomiasis but which are likely to have 
profound effects on the leishmanicidal response to L. donovani infection of GM or of 
adjacent macrophages. 
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The development, structure and function of Leishmania donovani granulomas have been 
thoroughly reviewed by Murray, (2001). The parasite targets tissue macrophages and 
resistance depends on T cells, Thl type cytokines and activated mononuclear phagocytes 
recruited to the developing granulomas. In the liver the resident macrophages (Kapffer cells 
[KCs]) are initially infected and then a central core of fused parasitized KCs becomes 
surrounded by cytokine secreting I specific T cells (IFN--y producing) and infiltrating blood 
monocytes. Within the mature granuloma, macrophages are activated by IFN--y and TNF-U 
leading to the production of leishmanicidal components (NO and ROI) killing the 
intracellular amastigotes (Murray and Cartelli, 1983, Murray, 1982; Melby et al., 1998; 
Taylor and Murray, 1997; Engwerda et al., 1996). Although this is the classical response 
leading to parasite attrition in animals which have developed specific T cell responses, the 
presence of structurally intact mature granulomas does not necessarily lead to parasite 
killing. For example, ineffective granulomas form in TNF-a KO mice, (Murray and Nathan, 
1999). Since IL- 10 has been shown to inhibit macrophage secretion of mediators such as IL- 
10, IL-6 and TNF-a (Fiorentino et al., 1991a; Chensue et al., 1989; Bogdan et al., 1991; 
Ralph et al., 1992), it is possible that the elevated levels of IIL-10 in CO-INFECT mice could 
inhibit leishmanicidal activity within formed L. donovani granulomas without necessarily 
affecting the development of mature granulomas as judged by histological appearance. Anti- 
leishmanial effects can also occur in the absence of tissue reactions (invisible granulomas) 
and enlarged granulomas (hypertrophied granulomas) can lead to enhanced killing. 
Furthermore, typical L. donovani granulomas do not form in the spleen. 
In order to gain some insight into which of these potential mechanisms may be most 
important in causing the higher parasite loads in CO-INFECT mice, the work in this Chapter 
was principally aimed at examining the histopathological response in the liver with a 
particular focus on the nature of the L. donovani granulomas i. e. their 
development/maturation, tissue distribution and level of amastigote loads. Some data is also 
presented on histological analysis of the possible effects of the L. donovani infection on the 
formation of S. mansoni egg granulomas and before considering the histopathology, data is 
presented on another aspect of the pathological response; the evidence for liver damage 
based on biochemical analysis of liver enzyme release into the serum of infected mice. 
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5.2. Results 
5.2.1. Liver enzyme concentrations 
5.2.1. I. Blood concentration of liver enzyMes (ALT/ASD 
EUeriment 1 
In the co-infection experiments in Chapters 3 and 4 some of the CO-INFECT mice showed 
greater morbidity than the SCHISTO mice whereas none of the LEISH mice showed 
marked signs of illness. Because S. mansoni and L. donovani both infect the liver it was 
anticipated that there would be enhanced damage to the liver in the CO-INFECT mice and 
so serum was taken in order to test for liver enzymes in the experiments in Chapter 3 and 4. 
Data is presented for the first two experiments in Chapter 3. As seen in Figure 5.1. each of 
the infected groups showed higher enzyme levels at most of the time points compared with 
the control levels. 
At +2wk (post LV9) the highest level of liver damage (ALT/AST) was among the CO- 
INFECT followed by the LEISH and then by the SCHISTO animals but the results were 
only statistically significant different from the CONTROL for the SCHISTO mice (p=0.002 
and 0.03 respectively for ALT and AST) but these were not significantly different from the 
other groups of infected mice. The enzyme levels for the SCHISTO group remained at a 
relatively constant level at the subsequent +4 and +8 week time points. 
At +4 weeks the SCHISTO values were significantly higher than in the CONTROLS 
(p=0.02,0.005 respectively for ALT and AST). Between +2 and +4 weeks both the ALT 
and AST generally increased in both the LEISH and CO-INFECT groups to reach peak 
values and for both infected groups these were approximately 8 and 4 fold higher than 
CONTROLS the differences being statistically significant (p=0.001,0.02 respectively for 
LEISH and p=0.0005, and 0.02 respectively for the CO-INFECT). For the LEISH group the 
increase between +4 and +8 weeks was significant for both ALT and AST (0.01 and 0.01 
respectively). 
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Figure 5.1. Comparisons of the degree of liver damage in different infected groups as 
judged by serum liver enzvmes, ALPAST - Experiment 1 
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Figure 5.1. Graphs showing showing the Mean ± SE levels of Liver transaminases 
[Aspartate aminotransaminase (AST), Alanine Aminotransaminase (ALT)] in Units/L in 
the blood of infected animals at +2, +4 and +8wks p. i. with LV9 for Experiment 1. For 
description of groups see legend to Figure 3.3.1. The data is from 5 mice/group 
At +8weeks the CO-INFECT animals had the highest ALVAST values followed by the 
LEISH group but these were not significantly different and not significantly higher than the 
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CONTROL values. Meanwhile, the SCHISTO group because of the low variation, still 
showed significantly raised ALT values compared with CONTROLS (p=0.03). 
5.2.1.2. 
_Blood concentration of 
liver enzyMes (ALTAST) : Experiment 2 
As seen in Figure 5.2 the results are remarkably similar to those in Figure 5.1 
Figure 5.2. CoMparisons of the degree of liver damage in different infected groups as 
judged by serum liver enzymes, ALTAST - Experiment 2 
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Figure 5.2. Graphs showing showing the Mean ± SE levels of Liver transaminases 
(ALVAST) in Units/L in the blood of infected animals at +2, +4 and +8wks p. i. with 
LV9 for Experiment 2. For description of groups see legend to Figure 3.3.1. The data is 
from 5 mice/group 
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At each of the time points the ranking of levels of serum enzymes was similar to the 
previous experiment. 
At +2wk the highest level of liver damage (ALVAST) was again among the CO-INFECT 
animals compared to the controls (p=0.0005,0.001 respectively) followed by the LEISH 
animals (p<0.0001, p=0.003 respectively) and the SCHISTO group (p=0.002 and 0.02 
respectively). As before the enzyme levels for both the SCHISTO group and CONTROLS 
remained at a relatively constant level at the subsequent +4 and +8 week time points but the 
CO-INFECT and LEISH groups increased noticeably between +2 and +4 weeks. 
At +4weeks the LEISH group showed the highest liver damage (p=0.0003,0.002 
respectively relative to CONTROLS) but the CO-INFECT values were very similar and 
also significantly higher than the CONTROLS (p=0.004, and 0.0003). 
Moreover, the SCHISTO group developed significant liver damage for ALT and AST 
relative to the controls (p=0.001,0.03 respectively) but this was significantly lower 
compared to levels in the CO-INFECT animals (p=0.04,0.009 respectively), or LEISH 
animals (p=0.004,0.01 respectively). 
At +8wk generally the levels of ALVAST remained similar in the SCHISTO animals 
gradually declined. The LEISH values showed a drop in level of both enzymes compared 
with the +4 week time point but these were still significantly raised compared with controls 
(p=0.02,0.04 respectively). The CO-INFECT values were the highest (p=0.02,0.03 
respectively compared to the CONTROL) remaining at the same level as at +4 weeks for 
AST and showing some decline in ALT levels but less than for the LEISH ALT levels. 
5.2.2. Effect of Leishmania superinfection on the schistosome granuloma 
To assess whether the superimposed and ultimately uncontrolled L donovani infection 
affected the immuno -pathological response in the liver to schistosome eggs 
histopathological analysis was carried out into the size and cellular composition of 
individual granulomas in SCHISTO compared with CO-INFECT mice. Animals with 
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comparable numbers of recovered adult worms and geometeric mean egg counts were 
selected and analysis carried out on tissue from 3 mice of each. Observations were made at 
+4 and +8 week time points, +4 weeks being the time of the peak Thl response in L. 
donovani infections (Murray, 2001a) and +8 weeks being the time of peak L. donovani 
parasite loads. To ensure that the different granuloma sections were comparable only 
reactions with a central egg present were assessed. In addition because the granulomas in a 
particular liver could be of a range of ages depending on when the inducing egg was 
produced and so either newly formed, maximal in size or resolving, only granulomas with 
an egg containing a miracidium were assessed as shown in Figure 5.3. 
Figure 5.3. Section of liver tissue showing the cellular composition of a lypical S. 
mansoni eiza aranuloma. 
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Figure 5.3. Section of liver tissue from a SCHISTO mouse at +8 weeks post L. 
donovani superinfection (+16 weeks post schistosome infection) stained with 
haernatoxylin and eosin (H&E) showing an S. mansoni granuloma containing a 
central egg containing a miracidium. (Mir) and surrounding granulornatous tissue 
containing fibroblasts (F), eosinophils (E) and mononuclear cells (M). 
Magnification x 400 
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The longest granuloma diameter was recorded together with the diameter at 90' to this. 
From the mean of these two values the liver volume was calculated and the comparison of 
the SCHISTO and CO-INFECT data is shown in Figure 5.4. It is clear from both 
experiments that at +4 weeks the mean egg granuloma volumes in the CO-INFECT. mice 
were higher than in the SCHISTO alone mice, however the difference was not statistically 
significant. At +8 weeks there was an increase in granuloma size in the SCHISTO mice but 
this was not statistically significant. As a consequence there was no difference between egg 
granuloma sizes at +8 weeks in the SCHISTO and CO-INFECT mice. 
Figure 5.4. S. mansoni egg granuloma size in SCHISTO and CO-INFECT mice 
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Figure 5.4. Mean and SE of the volume of granulomas from livers of SCHISTO and 
CO-INFECT animals at +4 and +8 weeks post L. donovani superinfection in 
experiments 1 and 2 (see Chapter 3). Histological sections were stained with (H&E) and 
transverse and longitudinal diameters were measured from 21 mature granulomas/mouse 
from 3 mice using standardized micrometry. The volumes of granulomas were 
calculated from the mean radius (i. e. 4/37rR 
3) 
. The mean ±SE are 
based on 63 
observations. 
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To determine if the effect of the L. donovani infection on the schistosome egg granulomas 
could be related to changes in the cellular composition of the egg granulomas, semi- 
quantitative estimates were made of the major identifiable cell types represented in the 
granuloma i. e. mononuclear cells, eosinophils, and fibroblasts. As demonstrated in (Figure 
5.5. A and B) it is clear that the percentage of these three cell types was very constant with 
no obvious or significantly significant differences between +4 and +8weeks in either 
groups nor between the SCHISTO and CO-INFECT groups. 
Figure 5.5. A CoMparison of cellular coMposition of S. mansoni egg Uanuloma in 
SCHISTO and CO-INFECT mice at +4, and +8weeks - Experiment 1. 
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Figure 5.5. A. Experiment 1. Graphs showing the mean (±SE) percentage 
frequency of eosinophils, mononuclear cells and fibroblasts in the S. mansoni egg 
granulomas analysed in Figure 5.4. (see legend) i. e. from 
SCHISTO and CO- 
INFECT mice at +4 and +8weeks post superinfection. 
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Figure 5.5. B. Comparison of cellular composition of S. mansoni egg granuloma in 
SCHISTO and CO-INFECT mice at +4, and +8weeks - Experiment 2. 
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Figure 5.5. B. Experiment 2. Graphs showing the mean (: ESE) percentage 
frequency of eosinophils, mononuclear cells and fibroblasts in the S. mansoni egg 
granulomas analysed in Figure 5.4 (see legend) i. e. from SCHISTO and CO- 
INFECT mice at +4 and +8weeks post superinfection. 
5.2.3. Effect of S. mansoni infection on L. donovani granulomas- IFAT/propidium 
iodide staining. 
Immune killing of L. donovani amastigotes in mice is due to the development of small 
inflammatory granulomas formed of cellular reactions around amastigote infected Kiipffer 
cells of comprising CD4+ve T cells lymphocytes and macrophages (Wilson et al., 1996; 
Bradley and Kirkley, 1977). As the amastigotes multiply within the Kiipffer cell (KC) so 
the granuloma develops through identifiable stages which have been characterized as: 
Infected Kilpffer cell: one or more than one adjacent infected cell with no associated 
inflammatory cells; Fused Kiipffer cell: Fusion of two or more infected KCs without 
adjacent inflammatory cells; Immature granuloma: Infected KCs incompletely surrounded 
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with more than 3 and less than 10 cells adjacent cells; Mature granuloma: Infected KCs 
completely surrounded with more than 10 cells; Sterile granuloma:, Collection of 
inflammatory cells with no amastigotes, in which the amastigotes may have been destroyed 
by immune components. A couple of typical L donovani mature granulomas are shown in 
Figure 5.6. 
Figure 5.6 Typical mature L. donovani granulomas in LEISH mice 
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Figure 5.6 Photomicrographs of liver sections from a LEISH mouse at +8 weeks post- 
infection stained with H&E showing a mature granuloma containing many amastigotes 
(A) (TOP) and one in which most of the amastigotes have been killed (BOTTOM). 
Sections were cut at 5 gM. G=L. donovani granuloma cells. P= liver parenchymal cells 
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The production of TNF-a (Engwerda et al., 1998) and NO (Roach et al., 1993) within the 
granulomas has been shown to increase as the granuloma matures and is believed to be 
responsible for parasite destruction. The failure of S. mansoni infected mice to control the 
L. donovani infection at 8 weeks post infection suggests that there may be a failure in 
development of the L. donovani granulomas. In order to investigate this, studies were 
planned to compare the cellular composition, tissue distribution and amastigote content of 
granulomas in liver tissue. 
5.2.3.1. CoMplications caused by haematin pigment. 
Histopathology using paraffin sections stained with haemotoxylin and eosin was tried first. 
In the first series of sections prepared from Experiment I (Chapter 3) it was considered that 
this histological approach would have limitations, in particular for looking at numbers of 
amastigotes, because it was clear from the CO-INFECT histology that many of the KCs in 
the S. mansoni infected mice contained S. mansoni pigment (haematin) including the KC in 
L. donovani granulomas (see Figure 5.7. Top). This meant that it was difficult to 
distinguish the amastigotes from the pigment. It was subsequently realized that the staining 
of these initial sections was not optimal for identification of L. donovani amastigotes and 
that this could be improved by increasing the blueing step for the haemotoxylin staining 
(see for example Figure 5.7. bottom) and this was used in later studies (section 5.2.4). 
Another complication for the CO-INFECT mice was that in the S. mansoni infected mice, 
in addition to the circumoval granulomas, inflammatory foci also formed around KCs 
containing schistosome pigment in the parenchyma and these reactions resembled L. 
donovani granuloma (see Figure 5.8. Top). So in CO-INFECT mice if such reactions were 
seen to contain amastigotes they could be defined as L. donovani granulomas but if 
amastigotes could not be seen it was not certain if the reactions were just pigment reactions, 
sterile (resolved) L. donovani granulomas (as in Figure 5.8. bottom) or mature granulomas 
in which it was not possible to distinguish amastigotes from pigment. 
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Figure 5.7. Mature L. donovani granulomas in a CO-INFECT mouse 
stained with different protocols of haematoxyolin and eosin. 
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Figure 5.7. Photomicrographs of sections of liver tissue from a CO-INFECT 
mouse at +8 weeks post infection showing (Top) the initial H&E staining in which 
distinguishing amastigotes and schistosome pigment was difficult and (Bottom) 
modification of the staining (increasing blueing step with haemotoxylin) to 
improve detection of L. donovani amastigotes (A). 
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Figure 5.8. Comparison of an inflammatoEy focus containing haematin pigment in 
a SCHISTO mouse and a sterile granuloma in a LEISH mouse. 
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Figure 5.8.. Photornicrograph of sections of liver tissue from (TOP) a SCHISTO 
mouse at +8 weeks post infection showing an inflammatory focus around KCs 
containing S. mansoni pigment and resembling a L. donovani granuloma. (BOTTOM) 
a sterile (resolved) granuloma from a LEISH mouse at +8 weeks. KC= haernatin filled 
Kupffer cells; E= eosinophils; M- mononuclear cells. 
4b 
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To try to overcome these problems caused by the haematin pigment studies were carried 
out to try to immuno-label the amastigotes inside granulomas using hamster anti-L. 
donovani (anti-Ld) immune serum followed by a range of labeled anti-hamster antibodies. 
5.2.3.2. ImmunohistochemistU with chromogenic substrates 
Initially attempts were made to use immuno-histochemical methods using enzyme linked 
antibodies and a range of different colour chromogenic substrates [e. g. Vector V-I-P. 
peroxidase substrate kit (gives pink color), peroxidase substrate kit AEC SK-4200 (gives 
red color), peroxidase substrate kit DAB SK (gives brown color). However, even with blue 
substrates it was not possible to get a clear distinction between labeled parasites and 
pigment (data not shown). 
5.2.3.3. Immunofluorescent staining of amastigotes 
A further attempt was made using indirect immuno-fluorescence. In order to visualize 
amastigotes and surrounding inflammatory cells at the same time propodium iodide which 
stains nuclei of inflammatory foci red under UV light was tried (see Figure 5.9 A). Using 
this system it proved possible to identify the amastigotes as sharp florescent green objects 
and the nuclei of surrounding inflammatory cells were stained red (Figure 5.9 [Q. The 
staining was specific for L. donovani and there was no staining in the livers of SCHISTO 
alone mice (Figure 5.9 [D]). By focusing up and down with the microscope it was possible 
to distinguish individual amastigotes pretty well and this seemed to give a fairly accurate 
estimate of amastigote numbers (Figure 5.9 [Q. 
So this method (referred to as IFAT/PI) was used to assess the development of L. donovani 
granulomas. Figure 5.10 shows how the propodium iodide staining was used to characterize 
granulomas. The white rectangle delineates a mature granuloma (>10 cells and completely 
surrounding the amastigotes) and the yellow rectangle an immature one (<10 cells and/or 
not surrounding the amastigotes) in the parenchyma adjacent to a schistosome egg 
granuloma. Foci of amastigote infection also occurred within the egg granulomas but owing 
to the presence of propodium iodide staining egg granuloma cell nuclei it was not possible 
to determine accurately whether discrete L. donovani granulomas formed around these foci 
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(see blue rectangle). Consequently in this analysis scoring of the maturation status of the L. 
donovani granulomas was only made for reactions in the parenchyma of both the CO- 
INFECT and LEISH animals. However, amastigote counts were made from all reactions 
including those within the egg granulomas. 
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Figure 5.9. MAT staining of L. donovani amastigotes and propidium iodide 
staining of cell nuclei in L. donovani granulomas. 
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Figure 5.9. Photomicrographs from the liver of a CO-fNFECT mouse at +8 weeks. [A] - 
paraffin embedded liver section using light microscope at power x40 showing a schistosome 
granuloma with multiple eccentric macrophages containing haernatin pigment (in white 
rectangle); [B]-cryosection of tissue from the same mouse showing a similar granuloma stained 
with hamster Anti-LV9 serum (1: 100 dilution) followed by FITC labeled Goat anti-hamster 
antibody (1: 250 dilution) and counter stained with propodium iodide- Viewed under tungsten 
light; [C]- as in [B] but viewed under U. V. light (green staining amastigotes and red staining 
host cell nuclei can be seen); [D]- cryosection of a granuloma from the liver of a SCHISTO 
mouse stained as in [B] (there is no green fluorescence). 
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Figure 5.10. IFAT staining of L. donovani granulomas in the region 
of S. mansoni granulomas. 
Figure 5.10. Photomicrograph of L. donovani granulomas on the periphery of an S. 
mansoni egg granuloma for a CO-INFECT mouse at +4 weeks showing L. donovani 
granulomas in the liver parenchyma adjacent to a schistosome egg granuloma: 
Yellow rectangle-immature granuloma; white rectangle- mature granuloma 
containing green fluorescing L. donovani arnastigotes. The blue rectangle shows a 
focus of L. d arnastigotes at the edge of the egg granuloma and it is not possible to 
differentiate inflammatory cells which may be associated with this focus from the 
inflammatory cells in the egg granuloma 
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5.2.3.4 L. donovani granulomatous response and associated amastigote number. - 
Experiment I 
Attention was focused on the +4 and +8 weeks time points which correspond to the times 
when the CO-INFECT mice showed a loss of control of the L. donovani infection. Using 
the above method, stained sections from 4-5 mice at each time period were assessed using 
the criteria for categorizing L. donovani granulomas described above (section 5.2.3. ) i. e. 
infected kýqDffer cell(s), Immature ZTanuloma, Mature granuloma. 
Because of the problem of distinguishing Sterile granulomas of L. donovani from the S. 
mansoni pigment reactions this category of granuloma was left out. For each mouse the 
sections scanned and 30 strictly adjacent microscope fields were carefully examined and 
the category of granuloma recorded along with the number of amastigotes seen. This 
approach yielded results on the percentage of each granuloma type and the mean number of 
amastigotes per reaction. 
5.5.3.4.1 L. donovani Granulomatous responses -Experiment I 
The percentage of reactions of each type were calculated for each mouse and the mean 
values for the mice are shown in Figure 5.11. 
At +4 weeks there was no significant difference between the percentage of each of the 
different types of reactions between the CO-INFECT and LEISH animals although the CO- 
INFECT mice did show a higher percentage of Infected KCs than the LEISH animals. 
Between +4 and +8weeks the LESIH animals showed a marked increase in the proportion 
of Mature granulomas (from 40 to 73%, p=0.004). However, the CO-INFECT mice did not 
show a significant increase (40-48%) of Mature granulomas, the LEISH group showed a 
significantly higher percentage than the CO-INFECT at +8weeks (73 cf 48%, p=0.025). In 
parallel with the higher percentage of Mature granulomas there was conversely more 
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Immature granulomas and significantly more IKCs in the CO-INFECT than the LEISH 
mice (3 2 cf 15 %, p=O. 0 15). 
Figure 5.11. The percentage of different types of L. donovani inflammatoKy foci charactenzed 
using IFAT/Pl at +4 and +8weeks after super-infection. -EUeriment I. 
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Figure 5.11. Graphs showing the mean (±SE) percentage of Infected Kiipffer cells, 
Immature granulomas, or Mature granulomas in the livers of mice from the CO- 
INFECT and LEISH groups at +4 and +8 weeks post-infection. Note: Sterile 
granulomas are not included in this analysis because in the CO-INFECT sections it 
was not possible to distinguish these from the reactions around S. mansoni . pigment. 
Reactions in 30 adjacent microscope fields were counted and the data represents the 
mean values from 5 mice in each group. 
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5.2.3.4.2. L. donovani amastigote numbers - Experiment I 
The mean numbers of amastigotes recorded in each of the different categories of L. 
donovani reactions is shown in Figure 5.12. 
Figure 5.12. Mean number of amastigotes in the different types of L. donovani 
wanulomas at +4 and +8 weeks - Experiment I 
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Figure 5.12. Graphs showing the mean (± S. E. ) number of amastigotes/Mature 
gra 111oma, Immature granuloma or Infected Kilpffer cell in 
5 mice from the CO- 
INFECT and LEISH groups at +4 and +8 weeks. Reactions in 30 adjacent 
microscope fields were counted and the data represents the mean values 
from 5 mice 
in each group. 
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There were low but comparable numbers of amastigotes in the IKCs of both LEISH and 
CO-INFECT mice at both +4 and +8 weeks. 
Similarly, both the LEISH and the CO-INFECT animals showed comparable numbers of 
amastigotes per Immature granuloma at both +4 and +8weeks. 
With the Mature Rranulomas, the mean number of amastigotes were comparable in both 
groups at +4 weeks. Between +4 and +8 weeks, there was a marked reduction in the mean 
number of amastigotes per Mature granuloma in the LEISH group (p=0.05). The reduction 
in the CO-INFECT group was less. This meant that at +8 weeks the amastigote counts in 
the CO-INFECT group was significantly higher than in the LEISH group (p=0.048). 
5.2.3.5. Use of anti-Ld MAT and propidium iodide staining to characterize the 
donovani granulomatous response and associated amastigote number. - 
Experiment Il 
5.2.3.5.1 L. donovani Granulomatous responses -Experiment 11 
The results of the repeat experiment are shown in Figure 5.13. Similar results were obtained 
to the earlier experiment. There was little difference in the frequency of the different types 
of L. donovani granulomas at +4 weeks. As before there was a significant increase (from 
50.7 to 77.6%, p=0.001) in the percentage of Mature granulomas in the LEISH animals 
between weeks +4 and +8. In contrast there was no significant change in the frequency of 
Mature granulomas in the CO-INFECT group (54.3 cf 51.5% at +4 and +8 weeks). This 
meant that the percentage of Mature gTanulomas in the LEISH mice was significantly 
higher than in the CO-INFECT mice at +8 weeks (p=0.001). 
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Figure 5.13. The percentage of different types of L. donovani inflammato1y foci 
characterized usinR IFAT/Pl at +4 and +8weeks after su-per- 
infection. - 
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Figure 5.13. Graphs showing the mean (±SE) percentage of Infected K4ffer cells, 
Immature Rranulomas, or Mature granulomas in the livers of mice from the CO- 
INFECT and LEISH groups at +4 and +8 weeks post-infection. Note: Sterile 
granulomas are not included in this analysis because in the CO-INFECT sections it 
was not possible to distinguish these from the reactions around S. mansoni pigment. 
Reactions in 30 adjacent microscope fields were counted and the data represents the 
mean values from 5 mice in each group. 
The data was similar to the previous experiment in several aspects (Figure 5.14). Again 
there was no evidence of significantly greater numbers of amastigotes in the IKCs or 
immature granulomas of CO-INFECT compared with LEISH mice at either +4 or +8 
weeks. The results are different from Experiment I because the amastigote counts were not 
reduced at +8 weeks compared to +4 weeks but were comparable in the LEISH animals 
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Figure 5.14. Mean number of amastigotes in the different lypes of L. donovani 
RTanulomas at +4 and +8 weeks - E2Meriment II 
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Figure 5.14.: Graphs showing the mean (± S. E. ) no. of amastigotes/Mature 
granulomas, Immature granulomas or Infected Kqpffer cell(s) in 5 mice from the 
CO-INFECT and LEISH groups at +4 and +8 weeks. Reactions in 30 adjacent 
microscope fields were counted and the data represents the mean values from 5 mice 
in each group. 
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and significantly increased in the CO-INFECT group (p=0.04). However, like Experiment I 
the amastigote count at +8 weeks was significantly higher in the CO-INFECT group than 
the LEISH group (p=0.002). 
This IFAT/PI method proved to be valuable in allowing investigation of the numbers of 
amastigotes and the frequency of the different types of granulomas. It was introduced as the 
original haematoxylin and eosin staining of sections from experiments I and 11 had been too 
red and did not allow the discrimination of L. donovani amastigotes from S. mansoni 
pigment both of which were found inside kupffer cells of CO-INFECT mice. However, 
during the sectioning of a different experiment the sections produced by the LSHTM 
histology unit were much bluer and the morphology of the granulomas was much clearer as 
shown in Figure 5.7. It was realized that the H&E method was superior to the IFAT/PI 
method for morphological characterization of the L. donovani granulomas and also for the 
accurate quantitation of the amastigote numbers and so was used to confirm and extend the 
observations made using IFAT/Pl. The analysis was extended to include the +2 week time 
points. 
5.2.4. Effect of S. mansoni infection on the L. donovani granulomas - Haemotoxylin 
and eosin staining. 
So essentially this was a repeat of the above method but using H and E staining which 
allowed greater detail of the granulomatous response to be analyzed. As for the IFAT/Pl 
staining, 30 adjacent fields were counted and, unlike in the IFAT/PI analysis, the 
distribution of the L. donovani granulomas in the liver parenchyma and within different 
regions of the S. mansoni granulomas themselves was recorded. It was hoped that the data 
would allow (i) a detailed characterization of the morphology of the foci in CO-INFECT 
compared to LEISH mice and quantification of (ii) the differences in density of the L. 
donovani foci between LEISH and CO-INFECT mice and (iii) the differences in density 
between the parenchyma and S. mansoni egg granulomas of the CO-INFCT mice, (iv) the 
progression of these to maturity (perhaps a measure of the degree of Ld specific immune 
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responsiveness, (v) the amastigote numbers per focus (perhaps a measure of the degree of 
immunological control). 
5.2.4.1. (i) Qualitative observations on the mo! phology of L. donovani foci 
Histological sections were cut from mice at the different time points for all co-infection 
experiments in Chapters 3 and 6. For the qualitative analysis described below attention was 
focused on the +8 week post L. donovani infection time point when the major differences 
between the LEISH and CO-INFECT LDUs were seen. 
As shown in Figure 5.15 reactions were seen in both the liver parenchyma and within the S. 
mansoni egg granulomas. L. donovani granulomas in the parenchyma can be clearly 
distinguished from the surrounding parenchyma. In contrast, for the majority of reactions, 
L. donovani infected cells present within the egg granulomas (arrowed below) were not 
surrounded with discrete inflammatory foci which could be distinguished from 
inflammatory cells of the egg granuloma itself. 
Figure 5.15. Low power images of liver tissue from CO-INFECT 
mice at +8 weeks post infection. 
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Figure 5.15. Photomicrograph of low power image showing L. donovani granulomas in the 
liver parenchyma and a S. mansoni egg granuloma containing numerous L. donovani infected 
cells. This was from a CO-INFECT mouse +8 weeks after co-infection with L. donovani. 
LdPG - L. donovani parenchymal granuloma, LdSG - 
foci of L donovani amastigotes 
within the S. mansoni egg granuloma. SG - S. mansoni egg granuloma. E-S. mansoni egg. 
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The nature of the L donovani reactions within the egg granulomas are considered below but 
first the reactions in the parenchyma are described. 
5.2.4.1.1. L. donovani granulomas in the parenchyma. 
The various categories of L. donovani granulomas defined in section 5.2.3 of this Chapter 
were seen in both LEISH and CO-INFECT sections. Obvious differences were the presence 
of schistosome pigment and of a proportion of eosinophils in the CO-INFECT L. donovani 
granulomas. In Figure 5.16 schistosome pigment is shown in an infected single Mipffer cell 
(IKC) containing many amastigotes but lacking any surrounding cellular infiltration. 
Figure 5.16: Infected KUpffer cell in a CO-fNFECT mouse showing amastigotes 
to2ether with schistosome pip-ment. 
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Figure 5.16. Photornicrographs showing infected Kiipffer cells containing L. 
donovani and schistosome pigment in a CO-INFECT mouse at +8 weeks post L. 
donovani superinfection. For description of the different groups see legend to 
Figure 5.2.3. 
In Figure 5.17. a comparison is shown of mature L. donovani granulomas in a LEISH and a 
CO-I`NFECT mouse. Superficially the granulomas appear similar; consisting of a 
mononuclear cell infiltration. Amastigotes contained in separate cells within the granuloma 
are indicated along with schistosome pigment and eosinophils 
in the CO-INFECT mouse. 
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In the CO-INFECT section groups of more isolated amastigotes outside of the mature 
granuloma are also arrowed. Such isolated groups outside the main focus were designated 
as separate foci. 
Figure 5.17. Mature granulomas in the parenchyma of LEISH and CO-fNFECT mice. 
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Figure 5.17. Photomicrographs showing mature granulomas from a LEISH 
and a CO-INFECT mouse at +8 weeks post L. donovani superinfection. For 
description of the different groups see legend to Figure 5.2.3. P= schistosome 
pigment. E= eosinophils. A= amastigotes, A* = groups of amastigotes outside 
the main focus. 
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Some L. donovani granulomas in CO-INFECT mice showed a large percentage of 
eosinophils and heavy schistosome pigment as shown in Figure 5.18. The eosinophils in 
such reactions could be a reaction to the schistosome pigment present as they were seen in 
the pigment reactions around macrophages containing schistosome pigment in the 
SCHISTO mice infected with S. mansoni alone (Figure 5.8). Such reactions posed some 
difficulty for interpretation as they appeared to be completely surrounded by cells but the 
cells concerned were mainly eosinophils rather than mononuclear cells. 
Figure 5.18: Mature L. donovani granulomas in a CO-INFECT mouse showing a large 
percentage of eosinophils and schistosome pigment. 
Figure 5.18: Photomicrographs showing mature granulomas from a CO-fNFECT mouse at 
+8 weeks post L. donovani superinfection. E= eosinophils. A= amastigotes. 
5.2.4.1.2. L. donovani reactions inside the S. mansoni granulomas 
Foci of L. donovani infected cells were commonly seen inside the S. mansoni granulomas 
and could be found throughout the egg granulomas. Figure 5.19. shows a relatively low 
power image comparing the appearance of leishmanial granulomas 
in the parenchyma. 
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Figure 5.19: Comparison of L. donovani reactions in the parenchyl]2a and within the 
scbistosome egg Uanulomas of CO-INECT mice at +8 weeks post L. 
dononvani superinfection 
On 
Figure 5.19: Photornicrograph showing mature L. donovani granulomas in the liver 
parenchyma compared with L. donovani-infected cells within the cells comprising a S. 
mansoni egg granuloma of a CO-INFECT mouse +8 weeks after co-infection with L. 
donovani. LdPG - L. donovani parenchymal granuloma, LdSG - foci of L. donovani 
amastigotes within the S. mansoni egg granuloma. 
The cellular organization making up mature granulomas in the parenchyma can be clearly 
seen. In contrast, within the egg granulomas focal cellular organisation around the L. 
donovani-infected cells could not be distinguished from the other inflammatory cells 
comprising the egg granuloma which in this instance were around 50% eosinophils. As a 
consequence it was particularly difficult to characterize a region comprising several distinct 
amastigote-containing cells as representing one focus or several. This was a particular 
problem regarding counting the number of amastigotes per focus (see below). Although 
somewhat subjective it did appear that within the egg granulomas the areas of L. donovani 
infection commonly comprised foci from just one or two to numerous amastigotes. This 
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can be seen in the lower power image in Figure 5.19 in which 6 apparently discrete foci of 
L. donovani infection are indicated (LdSG arrowed) containing from 3 to >15 amastigotes. 
The absence of discernible surrounding cellular infiltration gave the impression that the 
focus of L. donovani infection was spreading. 
Other common features of foci of L. donovani infection within schistosome egg granulomas 
are demonstrated in several other sections shown in Figures 5.15,5.19,5.20,5.21 [top & 
bottom], 5.22,5.23 (top) which show L donovani foci in association with different 
regions/cell types within the egg granulomas. 
L. donovani infected cells were commonly seen in the periphery of the granulomas. Figure 
5.20. shows the boundary between the egg granuloma and the parenchyma. 
Figure 5.20 L. donovani infected cells are common in the peripheKy of the S. mansoni egg 
Rranulomas. 
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Figure 5.20: Photomicrograph showing several adjacent L. donovani infected cells in the 
periphery of an S. mansoni egg granuloma from a CO-INFECT mouse at +8 weeks after 
superinfection. EOS = eosinophils. LdSG = L. donovani foci within the S. mansoni egg 
granuloma. 
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Numerous eosinophils can again be seen. Although there seems to be some indication of 
organization of cells around the area of infected cells in this section this cannot be clearly 
distinguished as a L. donovani granuloma. Foci of L. donovani infection were also found 
deeper within the egg granuloma. Figure 5.21 an shows infected macroPhage at the 
fibroblast/eosinophil boundary. 
Figure 5.21. Focus of infection in a fibroblast/eosinophils reizion of a schistosome eizia granuloma. 
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Figure 5.21. Photornicrographs at low (x40) and higher (xIOO) magnification from a CO- 
INFECT mouse at +8 weeks after superinfection showing an area of L. donovani infection 
within a schistosome egg granuloma. Egg= S. mansoni egg, EOS =eosinophil rich area, F= 
area of fibroblasts and collagen deposition. Isolated groups of single or a few amastigotes 
which may be free or in cells are indicated by arrows with dotted lines. Solid arrows show 
more heavily infected cells. 
217 
Again it is clear (i) that there is no discrete cellular organization around the infected cells 
and (ii) that the region contains several infected cells some with many and other with just a 
few amastigotes. 
Figure 5.22 shows an area rich in lymphocytes and macrophages including some which are 
heavily infected with amastigotes and containing lots of schistosome pigment. Again it is 
not possible to distinguish any discrete organization of cells around the numerous L. 
donovani-infected cells. 
Figure 5.22 : Multiple foci of infection and lack of organisation of L. donovani 
granulomas in mononuclear-rich areas within the S. mansoni egg granuloma. 
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Figure 5.22 : Photornicrograph from a CO-INFECT mouse at +8 weeks of infection from within 
an S. mansoni egg granuloma. Macrophages containing amastigotes are indicated by arrows with 
solid lines. An isolated small group of amastigotes apparently free and not contained within a cell 
is indicated by the arrow with dotted lines. 
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For the purpose of trying to quantify the number of amastigotes within infected 
macrophages in order to compare amastigote attrition between the parenchymal and egg 
granuloma regions of CO-INFECT mice or between LEISH and CO-INFECT mice, the 
inability to discern discrete L. donovani granulomas within the egg granulomas posed a 
problem. This is exemplified in the comparison shown in Figure 5.23 [top and bottom] of a 
region of infection within the egg granuloma and in the parenchyma of the same mouse. In 
the top section from within the egg granuloma no discrete L. donovani granuloma(s) can be 
seen and there are several groups of amastigotes ranging from 3 to 10 per group. The 
difficulty is in deciding whether all of the amastigotes in this section should be taken as one 
L. donovani focus or each focus counted separately in this section the small groups of 
amastigotes outside the main area were regarded as separate foci of infection and so their 
amastigote content is recorded separately. 
This point is emphasized because as is shown later the mean amastigote count for the focus 
shown in Figure 5.23 (top) was lower than if it had been counted as one focus of infection. 
In contrast in the L. donovani focus in the parenchyma (Figure 5.23 bottom) the 
amastigotes are also spread out but clearly occur within the confines of a discrete mature L. 
donovani granuloma. In this instance all of the amastigotes would be counted as from one 
focus. 
These examples of the L. donovani foci reactions within S. mansoni egg granulomas show 
(i) that it is not possible to distinguish cellular recruitment specifically to the L donovani 
infected cells within the S. mansoni granulomas and so not possible to be certain that any L. 
donovani granulomas forrn within the S. mansoni granuloma and if so their state of 
maturation (ii) that the lack of the delineating L. donovani granulomas makes it difficult to 
determine the limits of individual foci and so the mean amastigote count. 
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Figure 5.23 Comparison of amastigote distribution in foci of L. donovani infection 
within an egg granuloma (top) and in the parenchyma (bottom) 
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Figure 5.23. Photomicrographs from a CO-fNFECT mouse +8 weeks after L. 
donovani superinfection showing a region of L. donovani infection inside an S. 
mansoni egg granuloma (Top section) and a discrete mature granuloma in the 
parenchyma (bottom section). The arrows indicate separate infected macrophages 
that are regarded as part of the same inflammatory focus. Apparent spread of the 
infection to satellite areas (SAT) outside this focus are also arrowed. Granulomas 
apparently leads to dissemination of amastigotes is indicated by arrows. 
220 
5.2.4.1.3. L. donovani infection inside the S. mansoni egg shells. 
L. donovani infected macrophages were seen throughout S. mansoni egg granulomas. In a 
proportion of the empty egg shells, at the centre of older granulomas, large numbers of 
amastigotes could be seen infecting large giant cells (multinucleate macrophages). 
Examples of this are shown in Figure 5.24. The detailed morphology of these reactions is 
difficult to relate to the in vivo organisation. There appears to be a space around the egg 
shell which is surrounded by fibrin-like material. Whether this is truly an area lacking cells 
in vivo or the apparent space is an artifact of preservation and sectioning is unclear. In 
Figure 5.24. [top] it appears that the macrophages are outside the egg shell whereas in 
Figure 5.24. [bottom] it appears that a giant cell is inside the shell as well as cells outside 
which are making contact with the surrounding fibrin-like tissue. Even allowing for some 
artifact of fixation and sectioning it does not appear that there was intimate contact between 
the infected cells and inflammatory cells. Again numerous eosinophils can be seen in the 
surrounding cellular response. 
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Figure 5.24. L. dononvani infection of macronhages associated with the S. mansoni eu shell at 
the centre of ejzjz jzranulomas. 
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Mad Figure 5.24. Photomicrographs from CO-INFECT mice +8 weeks after L. donovani 
superinfection showing sections of the egg shells at the centre of S. mansoni egg 
granulomas with associated L. donovani infected macrophages. A= amastigotes, S= S. 
mansoni egg shell, IGC = infected giant cell, E= eosinophils. 
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5.2.5.2. Quantitative observations. 
The LDU data from Chapter 3 had shown substantially higher numbers of total 
amastigotes in the livers and spleens of CO-INFECT mice compared with LEISH mice 
at +8 weeks. In the final section of this Chapter analysis of the histological material was 
carried out to address the following hypotheses which might explain this finding: (i) that 
the S. mansoni egg granuloma macrophages provide an additional and possibly higher 
density of alternative sites for L. donovani infection than the liver parenchyma 
macrophages [hypothesis 2 in Chapter 3 discussion](ii) that reduced leishmanicidal 
activity results from reduced progression of L. donovani granulomas to the mature state 
in CO-INFECT mice [hypothesis 4 in Chapter 3 discussion] (iii) that L. donovani 
granulomas may physically fail to form correctly within the context of the inflammatory 
cells of the S. mansoni granulomas [hypothesis 5]. This was reported in section 
5.2.4.1.2. and the extensive characterization of foci of L. donovani infection during this 
although no quatification is recorded (iv) that reduced leishmanicidal activity around 
foci of L. donovani infection in CO-INFECT mice results in increased mean numbers of 
amastigotes per focus [hypothesis 6] (v) that infection of alternatively activated 
macrophages within the schistosome egg granulomas would result in reduced 
amastigote killing compared with infected Kupffer cells in the parenchyma of CO- 
INFECT mice resulting in higher mean amastigote counts in the foci of L. donovani 
infection in the egg granulomas [hypothesis 7]. These alternatives (i) -(v) are referred 
to in the sections below. 
Histological sections were cut and stained with haematoxylin and eosin. Microscopic 
analysis was carried out on 30 adjacent fields in the parenchyma of LEISH and CO- 
INFECT mice and similar number of fields inside the schistosome granuloma of the CO- 
INFECT mice. This analysis was carried out for 3 mice per group. For the CO-INFECT 
group mice were chosen which had comparable schistosome parasitic burdens in tenns of 
adult worm pairs and geometric egg counts. 
5.2.5.2. l. Comparison of the density of sites of L. donovani amastigote infection in the 
parenchyma of LEISH animals, in the parenchyma of CO-INFECT mice 
and inside the S. mansoni egg granulomas of CO-INFECT mice [(0]. 
This analysis yielded data on the density of reactions which is shown in Figure 5.25 for 
both Experiments I and II. The overall trend is clear and similar in both experiments i. e. 
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there is a progressive decline in the density of foci detected in the LEISH mice from +2, 
+45 +8 weeks (p=0.05,0.003 respectively expt 1) (p-0.02,0.003 respectively expt 2) 
whilst in the CO-INFECT mice the density in the CO-INFECT mice increases. 
Figure 5.25. Com-parison of the density of foci of L. donovani infection 
in the parenchyma or egg granulomas of LEISH and CO-INFECT 
mice. 
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Figure 5.25.: Comparison of mean density of total inflammatory reactions in LEISH 
animals compared with those in the parenchyma or within the S. mansoni egg granulomas 
of CO-INFECT mice (CO-INFECT-PA and CO-INFECT-GN, respectively). The values 
represent the mean (± SE) from 5 mice for each of which the number of L. donovani foci 
of infection were counted in 30 adjacent fields from microscopic examination of 
histological sections at +2, +4 and +8 weeks post L. donovani superinfection. 
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However at +2weeks in experiment I, the LEISH infected animals actually showed a 
significantly higher mean density of infected foci in the parenchyma compared with the 
CO-INFECT (p=0.007). Similarly in experiment 11, the LEISH infected animals actually 
showed a significantly higher mean density of infected foci in both the CO-INTECT 
parenchyma and inside the schistosome granuloma (p=0.002,0.04 respectively). 
The other prominent observation was that CO-INFECT animals showed a higher density 
of reactions inside the schistosome granuloma compared with within the parenchyma at 
all time points in both repeat experiments although this was only statistically significant 
at +2wks (p=0.002, <0.0001 respectively). Overall there were around 1.5 fold more foci 
in the same area of granulomatous tissue compared with the parenchyma at all times. So 
this does show some support for the idea that there is preferential development of L. 
donovani within the egg granulomas (hypothesis 2). 
5.2.5.2.2. Analysis of the maturation state of L. donovani granulomas [(ii)] 
The mean frequency of the following types of L. donovani foci of infection were 
determined in 30 fields from CO-INFECT and LEISH mice: infected Kiipffer cells (in 
the parenchyma) and macrophages (Infect Kpf), fused Ktipffer cell (Fused Kpf), 
immature granulomas (Immature Grn) and mature granulomas (Mature Grn). Because it 
was not possible to distinguish L. donovani granulomas associated with foci of infection 
within the schistosome egg granulomas this analysis was only done on reactions in the 
parenchyma. The data from Experiments I and 2 are shown in Figures 5.26. and 5.27. 
respectively. 
It is clear from both experiments that the LEISH infected animals showed a progressive 
increase in the frequency of mature granulomas as the infection was controlled. But this 
progression was much less pronounced in the CO-INFECT mice. 
At +2 weeks, there was little difference between the groups apart from a higher 
frequency of FKCs in the LEISH (p=0.03,0.04) with a corresponding higher frequency 
of immature granulomas in the CO-INFECT (NS in Experiment 1, P=0.03 'in 
Experiment 2). 
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Figure 5.26 Frequency of different types of L. donovani granulomas in the parenchym 
of CO-INFECT and LEISH mice - Experiment 1. 
2 weeks 
100 
80 
cu ou 
E CD 
E 
C) 40 CY) 
20 
0 
4 weeks 
100 
C. ) 
12 80 
60 
F)40 
20 
0 
8 weeks 
100 
0 
80 
E 60 E 
cf) 40 
20 
0 
r-I t-% J'N IKI r- r- fý -r 
Infect Kpf fused Kpf hmmt Grn Wture Grn 
Infect Kpf fused Kpf InTnat Grn Nbture Grn 
Figure 5.26. Graphs showing the mean (± SE) percentage of the different types of 
foci of L. donovani infection containing arnastigotes: Infect Kpf - infected 
KUpffer cell, fused KUpffer cell, h-nmat Gm - immature granuloma, Mature Gm - 
mature granuloma (p=0.03). For definition of these reactions see section 5.2.3. 
Data is based on the foci counted in 30 fields from each mouse and 3mice/group. 
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Figure 5.27 Frequency of different types of L. donovani ),,. ranulomas in the liver 
parenchyma of CO-INFECT and LEISH mice - Experiment 2 
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Figure 5.27. Graphs showing the mean (± SE) percentage of the different types of 
foci of L. donovani infection containing amastigotes: Infect Kpf - infected KUpffer 
cell, fused KUpffer cell, Immat Gm - immature granuloma, Mature Gm - mature 
granuloma (p=0.03). For definition of these reactions see section 5.2.3. Data is based 
on the foci counted in 30 fields from each mouse and 3mice/group. 
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At +4weeks,, the LEISH animals showed an increased frequency of mature granulomas 
compared to CO-INFECT animals (NS in Experiment 1, P=0.01 in Experiment 2). 
Reciprocally, the CO-INFECT animals showed higher frequencies of immature 
granulomas compared to the LEISH animals (p=0.03 in Experiment 1, p=0.002 in 
Experiment 2). 
At +8weeks, the LEISH animals showed a higher frequency of mature granulomas 
compared to the CO-E%4FECT (NS in Experiment 1, p= 0.009 in Experiment 2) and 
reciprocally less formation of newly IKCs, FKCs and inunature granulomas. 
5.2.5.2.3. Comparison of the mean numbers of L. donovani amastigotes per focus 
of infection in the LEISH and CO-INFECT mice [(iv) and (v)]. 
This data is shown in Figure 5.28. The mean number of amastigotes at +2 weeks post 
infection were rather similar in both groups (between 8-13 amastigotes) and also 
between the parenchyma and granulomatous tissue of the CO-INFECT mice but in both 
experiments the LEISH animals had the highest numbers. In Experiment I this was 
significantly higher than in the parenchyma of CO-E*,; FECT (p=0.04) and in Experiment 
2 was significant compared to both the CO-INFECT parenchyma and schistosome 
granuloma foci (p=0.01,0.03 respectively). Subsequently, amastigote counts 
progressively decreased in the LEISH animals between +2 and +8wks (p=0.007 in 
experiment 1 and p=0.002 in experiment 2). The amastigote count in the CO-INFECT 
animals in the parenchyma remained fairly constant between +2 and +4 weeks but also 
showed a decline between +4 and +8 weeks in both experiments (p=0.05 experiment 1, 
p=0.02 in experiment 2), however, there were NS in amastigote count in CO-INFECT 
animals inside the schistosome granuloma between both time points +4 and +8 weeks). 
Overall, it is clear from this analysis of mean amastigote levels that there was little 
indication that L. donovani granulomas in CO-INFECT mice showed enhanced 
accumulation of amastigotes compared with LEISH alone animals even for foci of 
infection within the egg granulomas. 
228 
Figure 5.28. Comparison of the mean number of L. donovani amastigotes in all foci 
of infection in the -parenchMa and/ within the S. mansoni granulomas of LEISH and 
CO-INFECT mice. 
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Figure 5.28. Mean ± SE of the number of amastigotes in all foci of infection: leish - 
data from foci in the LEISH parenchyma, Co-total (P+G) - data from foci in the 
parenchyma and the granulomas of CO-INFECT mice. Co-Parench - data just from the 
parenchyma of CO-INFECT mice, Co-S. Gran - data from foci within the schistosome 
egg granulomas of CO-H*ýFECT rnice. Data is based on the foci counted in 30 fields 
from each mouse and 3 mice/group. 
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It was considered possible that the mean amastigote levels from all reactions might hide 
selective differences between the leishmanicidal. activities of different types of L. 
donovani ganulomas in CO-E',,; FECT compared with LEISH animals. So the data was 
analyzed to look at amastigote count by type of focus. Because of the failure to 
distinguish Ld granulomas within the Schistosome egg granulomas this analysis is only 
done on the parenchymal data. The data is shown in Figure 5.29. 
Figure 5.29. CoInparison of the mean numbers of amastigotes in the different ! Ypes o 
foci of L. donovani infection in CO-WFECT and LEISH mice. 
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Figure 5.29. Comparison of the mean (± SE) amastigote counts in the different L. donovani 
foci of infection: IKC - Infected Kiipffer cell, FKC - Fused Kdpffer cell, hum gm - 
Immature granuloma, Mat grn - mature granuloma. LSH - LEISH mice, CO-I - CO-INFECT 
mice. Data is based on the analysis of reactions in 30 fields from 3 mice as above. 
230 
IKC IKC FKC FKC Imm gm Imm gm Mat gm Mat gm 
LSH Co-[ LSH Co-I LSH Co-I LSH Co-I 
IKC IKC FKC FKC Imm gm Imm grn Mat gm Mat gm 
LSH Co-I LSH Co-I LSH Co-I LSH Co-I 
The data on the mean number of amastigotes in IKC or FKCs is not particularly 
consistent between the two experiments. On balance there was no consistent difference 
in the mean numbers of amastigotes in the IKCs or FKCs of the LEISH or CO-INFECT 
mice at any of the time points. It was of particular interest to know if the L. donovani 
granulomas which formed in the CO-INFECT mice were characterized by a failure to 
control the infection and accumulation of amastigotes. The mean number of amastigotes 
in the inu-nature and mature L. donovani granulomas were higher at +2 and +4 weeks in 
both experiments in the CO-INFECT than LEISH , in the immature granuloma at +2wks 
and +4wks (P=0.02, and NS in experiment 1) and (p=0.001 and 0.02 respectively in 
experiment 2). Similarly, the mean count of amastigote count in the mature granulomas 
were higher in both experiments at +2 and +4 weeks in the CO-INFECT than LEISH 
(p=0.006,0.003 respectively in experiment 2), however it was NS at both timepoints in 
experiment 1. In the first experiment a higher mean amastigote count in the immature 
and mature granulomas of CO-MECT compared with LEISH mice was also seen at 
the +8 week time point but the opposite trend was seen in the second experiment 
(p=0.002 in immature granuloma, and NS in the mature granuloma). So overall there 
was evidence of higher mean amastigote numbers in the immature and mature 
granulomas at +2 and +4 weeks in both experiments and in the first experiment also at 
+8 weeks. However, the differences were generally not statistically significant. 
The amastigote counts in Figure 5.28 did show that there was a higher mean amastigote 
count in the foci of infection within the schistosome egg granulomas particularly at 
week +8. The histopathology showed that the foci of infection were difficult to define 
and it appeared that a proportion of the reactions appeared to be diffuse (see section 
5.2.4.1.2. and figure 5.19,5.20,5.22). A number of these "satellite" reactions would be 
recorded as containing relatively few amastigotes (figure 5.23). So it was reasoned that 
there may be L. donovani infected macrophages, particularly alternatively activated 
macrophages in the S. mansoni granulomas which may have been unable to control the 
L. donovani proliferation resulting in accumulation of high number of amastigotes but 
the inclusion of the low amastigote counts from the newly infected macrophages would 
bring the mean value down. To check to see if there was evidence of a proportion of 
highly infected macrophages in the CO-INFECT mice the frequency distribution of the 
amastigote counts was plotted. 
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5.2.5.2.4. Frequency distribution of the amastigote counts in CO-MECT and 
LEISH mice. 
The data is shown in Figures 5.30 and 5.3 1. It can be seen that there is a wide standard 
error for the values but two relevant points can be made. Firstly in both experiments the 
majority of reactions contained 5-10 amastigotes at all of the time points in both CO- 
INFECT and LEISH mice. Secondly there was no evidence for a population of more 
highly infected cells in the CO-INFECT compared with the LEISH mice and there was 
also no evidence for a higher frequency of heavily infected reactions in the CO-INFECT 
mice than the LEISH mice. Furthermore, there was no indication for an increased 
frequency of such heavily infected cells in the S. mansoni egg granulomas than in the 
parenchyma of CO-INFECT mice. 
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Figure 5.30. Frequency (percentage) of the different numbers of amastigotes in L. 
donovani foci in CO-INFECT and LEISH mice -Experiment I- 
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Figure 5.30. Percentage of the total L. donovani foci with particular numbers 
of contained amastigotes. Co-par - reactions in the parenchyma of CO- 
INFECT mice, Co-S. grn - reactions within the S. mansoni granulomas of 
CO-INFECT mice, Leish - reactions in the parenchyma of LEISH mice. 
Data is based on 30 fields and represents the mean ± SE from 3 mice. 
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Figure 5.31. Frequency (percentage) of the different numbers of amastigotes 
in L. donovani foci in CO-INFECT and LEISH mice -Experiment 2. 
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Figure 5.31. Percentage of the total L. donovani foci with particular numbers 
of contained amastigotes. Co-par - reactions in the parenchyma of CO- 
INFECT mice, Co-S. grn - reactions within the S. mansoni granulomas of CO- 
INFECT mice, Leish - reactions in the parenchyma of LEISH mice. Data is 
based 30 fields and represents the mean ± SE from 3mice. 
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5.3. Discussion 
This chapter was concerned with three aspects of the co-infection: the possible 
synergistic effect of both infections on damage to the liver function; effects on the size 
and cellular composition of the S. mansoni egg granulomas; and effects on the 
distribution, maturation and amastigote content of L. donovani granulomas. 
Aspartate aminotransaminase (AST), and Alanine Aminotransaminase (ALT) showed 
similar patterns to each other and in both experiments. Both the S. mansoni and L. 
donovani infections alone induced some elevation of liver enzyme levels, rather more 
with S. mansoni which was also characterized by a rise in enzyme levels between +2 
and +4 weeks (+10 and +12 weeks post schisto) and a decline between +4 and +8 
weeks. This decline would be consistent with the reported decline in egg granuloma 
sensitivity as the infection becomes chronic (Colley, 1975; Hernandez et al., 1997) but 
in this study as described below such a decline in granuloma volume was not seen 
between +4 and +8 weeks. The CO-INFECT mice showed a similar level of response to 
the SCHISTO mice rather than an additive one except for the final time point when the 
levels were higher in the CO-INFECT than the SCHISTO which corresponds to the 
time when the L. donovani LDU levels were rising. It is possible that this evidence of 
increased liver damage at +8 weeks contributed to the observed morbidity and mortality 
in some of the CO-MECT mice, compared to the SCHISTO alone mice which showed 
a stable and consistent rise of liver enzymes (ALVAST) (Pyrrho et al., 2004; 
Chiaramonte et al., 2001). 
The analysis of the size and cellular composition of the S. mansoni egg granulomas was 
undertaken because it is clear that this response is tightly controlled by interacting Thl 
and Th2 cytokines and the action of Th2 cytokine-induced alternatively activated 
granuloma macrophages (Pearce and MacDonald, 2002). Marked skewing of the 
response towards a Thl response as occurs in IL-4/IL-10-/- mice results 
in high mortality 
and elevated inflammatory mediators (Hoffmann et al., 2000) 
but less extreme 
diversion, by immunization with rIL-12 plus schistosome eggs results in lowered Th2 
cytokine responses, smaller granulomas and reduced fibrosis 
(Wynn et al., 1995). So it 
was conceivable that a superimposed L. donovani infection 
by inducing Thl responses 
in the liver would serve to lower the egg granuloma volume. 
However, the data showed 
235 
a larger volume in the CO-R; FECT than the SCHISTO alone at both +4, +8 weeks in 
both experiments, however there were no significant differences in both timepoints in 
the two repeat experiments. Clearly in both experiments there was a dramatic reduction 
volume of the granuloma at +8wks. This schistosome granuloma modulation is in 
agreement with other studies in human (Falcao et al., 1998) and murine studies showing 
peak granuloma size which occurs at the acute phase approximately 8-10 wk post 
infection there is a decrease in mean granuloma size (Warren et al., 1967; Colley et al., 
1975). 
There was no clear indication from the splenocytes, anti-egg cytokine responses how 
this down-modulation could have occurred as schistosome antigen-specific IL-4, IL-10 
and IFN--y levels were essentially similar at +4 weeks between the CO-INFECT and 
SCHISTO mice. There was no effect on the schistosome granuloma volume in other co- 
infection studies as reported in S. mansoni-infected mice exposed to recombinant 
Vaccinia virus (Actor et al., 1993; 1994). However there was a marked reduction in 
schistosome granuloma volume as reported by Marshall et al. (1999) who showed that 
infection with pre-existing Toxoplasmosis gondii, and superinfection with Schistosome 
mansoni skewed the Th 1 -like/Th2 -like balance towards a Th2-like immune response. 
This was accompanied by a marked decline in IFN-7, NO production and a slight 
increase in IL-4 and IL-5 to virus (Actor et al., 1993; 1994) and Toxoplasmosis antigens 
(Marshall et al., 1999). The other point to note was that in the SCHISTO alone nuice 
there was an apparent increase in egg granulomas size between +4 and +8 weeks (+12 
and +16 weeks post S. mansoni infection) in contrast to the reduction in granuloma 
volume ("endogenous desensitization") which has been reported to occur between the 
acute and chronic state of the infection and which is attributed to a variety of different 
immuno -regulatory responses (reviewed in King, 
C. L. (2001) Initiation and regulation 
of disease in schistosomiasis. In Mahmoud, A. A. F. (Ed). Schistosomiasis. Imperial 
College Press, London p213-264). However, this modulation can already occur by +12 
weeks (Diab et al., 1989) and in a recent study in C57BL/6 mice used here there was 
only around 23% reduction between the vigorous acute, 8 week granuloma and those at 
15 weeks (Sadler et al., 2003). There was essentially no difference in the cellular 
composition of the egg granulomas between the different groups or the different time 
points. It would be interesting to extend this analysis to the +2 week time point and to 
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confinn the result, but attention was not focused on this here because the apparent effect 
on granuloma volume in the CO-INFECT mice was transient and there was a greater 
interest in the potential significance of the increased L. donovani response. 
As discussed in the results section the initial haematoxylin and eosin staining of liver 
histology did not give good differentiation of L. donovani amastigotes from schistosome 
pigrnent. Following attempts at immuno-staining of cryosections for amastigotes using 
L. donovani infected hamster serum a method was developed using IFAT. This method 
yielded some useful data but the eventual refinement of the haematoxylin staining to 
clearly show the amastigotes was the best method for morphological and quantitative 
analysis. 
To investigate the possibility that the macrophages of the S. mansoni egg granulomas 
offer a favorable site for L. donovani infection, data on the density of foci containing L. 
donovani amastigotes in the parenchyma and egg granulomatous tissue was collected 
from the haernatoxylin and eosin stained tissue as the demarcation of the schistosome 
granuloma from the parenchymal tissue was more clearly defined than by the IFAT 
method. The term "focus of L. donovani infection" is used to refer to the infection sites 
within the S. mansoni granulomas because characteristic L. donovani granulomas did 
not form in this location (see later). In the LEISH mice there was a progressive decline 
in the density of foci from +2 to +4 to +8 weeks. However this decline was much less 
sharp in percentage terms than the LDU values. In contrast there was a progressive 
increase in the density of foci in the CO-INFECT mice. At +8 weeks the percentage 
differences in the density of foci of CO-INFECT compared with LEISH mice were 1.9 
and 3.4 fold in the parenchyma and 4.25 and 5.05 fold higher in the granulomatous 
tissue for Experiments I and II respectively. These compare with the corresponding fold 
increases in LDU values of 27 fold (Experiment I) and 12.5 fold (Experiment II). The 
LDU values reflect both the density of foci and the arnastigote content and also allows 
for the organ weights and at +8 weeks these were approximately 1.75 fold higher for the 
livers of CO-INFECT compared with LEISH mice. If the liver weight component is 
removed from the LDU values the amastigote "density" as judged by the impression 
smears would become 15.4 and 7.1 higher in CO-INFECT than LEISH. This is still 
higher than the density of L. donovani reactions recorded in the histological analysis of 
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the sections and this could reflect a higher mean number of arnastigotes per reaction in 
the foci which are present in the CO-INFECT tissue. 
In relation to hypothesis 2, that S. mansoni hepatic egg granulomas are rich in recruited 
macrophages and so there may be a higher density of foci of L. donovani infection 
within the egg granulomas compared with the parenchyma it was interesting to note that 
there was indeed a somewhat higher density of reactions containing L. donovani 
amastigotes in the schistosome granulomatous tissue than in the parenchymal tissue (1 .5 
fold higher density). This appears to give support to the idea that there is preferential 
development of L. donovani within the egg granulomas in the CO-INFECT mice 
(hypothesis 2). However, this apparent bias to infection of the egg granuloma 
macrophages compared with the parenchymal Kiipffer cells was seen at a similar level 
at +2, +4 and +8 weeks. Since the density of foci in the parenchyma of LEISH animals 
was actually higher at +2 weeks than in either the parenchyma or egg granulomas of the 
CO-INFECT mice, this indicates that although there may be some preference for 
infection of the granuloma macrophages even early in infection this does not lead to an 
overall higher density of infection in the CO-INFECT mice. This suggests that there is 
not a limitation in the availability of suitable cells for invasion in the normal liver that 
can be overcome by the presence of increased egg granulomas. Furthermore, as is seen 
by the comparable or higher LDU values in the LEISH compared with the CO-INFECT 
mice at +2 weeks, this early infection of egg granuloma macrophages does not result in 
more rapid proliferation of L. donovani. 
This is interesting because the infected cells in the schistosome granulomas may well be 
AAMo (Stein et al., 1992; Goerdt and Orfanos, 1999) which have immuno-suppressive 
properties; with decreased EL-12R; NO; EL-lfl, EL-6 and TNF-0ý paralleled with 
suppression in the proliferative response (Loke et al., 2000). These AAMo show 
increased Th2 cytokines and chemokines and produce high levels of anti-inflammatory 
EL-10 and TGF-0 and reduced co-stimulatory molecules CD80, CD86, and MHC class 
11 expression in comparison to expression induced by bacterial stimulants (MacDonald 
et al., 2001). So it does not seem that during the first two weeks of Ld infection of the 
liver (S. mansoni granulomas would have been there from the start) L. d can proliferate 
any more effectively in the AAMos than in the classically activated macrophages of 
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normal LEISH mice. It may well be that the levels of anti-Ld IFN-T were insufficient to 
activate the infected KCs for leishmanicidal activity during this first two weeks. 
Analysis of the frequency of the different stages of L. donovani granuloma maturation 
showed that the schistosome infection did not interfere with the development/maturation 
of L. donovani granulomas in the parenchyma during the first two weeks of infection at 
which time the percentage of mature granulomas was comparable between CO-INFECT 
and LEISH. Subsequently, in the LEISH animals the control of the infection between +2 
and +8 weeks was accompanied by an increase in the frequency of mature granulomas 
and a decrease in the frequency of IKC and FKC (Murray, 2001a; Taylor and Murray, 
1997; Murray et al., 2000; Satoskar et al., 2000; Murray, 2001b). In contrast in the CO- 
INFECT mice it is clear from both experiments and from both the IFAT and the 
histology that the distribution of the different types of L. donovani granulomas did not 
change much with time so that there were ultimately significantly lower percentages of 
mature granulomas in the CO-INFECT mice than the LEISH mice at +8 weeks. This 
seems to support hypothesis 4, that lower IFN-T levels may result in an 
impaired/reduced rate of maturation of L. donovani granulomas but another explanation 
is that any mechanism leading to higher amastigote replication in the CO-INFECT mice 
would mean that there were more amastigotes surviving to infect new KCs and so there 
would be a higher proportion of IKC and FKCs. Certainly the LDU counts (Chapter 3) 
showed that there was a sharp decline in amastigote counts in the LEISH animals 
between weeks +4 and +8 (3.1 - 13.4 fold drop) but an increase in the CO-INFECT 
mice. As the number of amastigotes available to establish new foci of infection dropped 
in the LEISH animals so the proportion of mature (older) reactions would increase and 
the converse would be true in the CO-INFECT mice. In conclusion these studies based 
purely on the morphology of the L. donovani granulomas are not able to demonstrate if 
there is impairment in the rate of development of individual L. donovani granulomas 
which would account for impaired leishmanicidal activity. 
Regarding Hypothesis 5, that L. donovani granulomas may physically fail to form 
correctly within the context of the inflammatory cells of the S. mansoni granulomas and 
so there may be a lack of control in infected macrophages within the egg granuloma, it 
was clearly not possible to distinguish any cellular accumulation associated with the L. 
donovani-infected macrophages from the cells comprising the S. mansoni egg 
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granulomatous tissue. Such foci of infection were most abundant in the periphery of the 
granulomas but L. donovani reactions and arnastigotes were also found throughout the 
S. mansoni granuloma and surrounded by the various cell types found in the different 
regions of the egg granuloma e. g. eosinophils, fibroblasts, mononuclear cells. Although 
it was clear that the lymphocyte/macrophage rich granulomas typical of L. donovani 
infection in the parenchyma of LE1SH animals did not form within the egg granulomas 
it was not possible to be certain if any of the surrounding cells were leishmanial antigen 
specific or recruited by leishmanial specific responses and thus possibly able to produce 
pro-inflammatory cytokines, IFN--y and TNF-a The L. donovani infected giant cells 
inside the empty egg shells at the centre of S. mansoni appeared to be isolated from 
close cellular attention. It was suggested that egg granulomas, by providing a 
microenvironment Vaccinia, preferentially infected the granuloma macrophages, in 
combination with the cytokine imbalance present during schistosome infection, can 
promote the expansion of vaceinia virus and possibly other viral agents (Actor et al. 
1993; 1994). 
It would have been useful to have been able to immunostain the L. donovani 
granulomas for TNF-a and other immuno-modulatory cytokines e. g. TGF-O to look at 
the activation state of the constituent macrophages but use of the same reagents as used 
by Gorak et al. (1998) was unsuccessful owing to the masking caused by the presence 
of the haernatin pigment in many of the CO-INFECT L. donovani granulomas and even 
use of different coloured substrates as described in section 5.2.3.2. was unsuccessful. 
In LEISH infected mice there would be amastigote replication within macrophages in 
parallel with the recruitment of anti-leishmanicidal cells as the immune response 
developed. In LEISH mice the action of antigen specific Thl cells would eventually 
lead to macrophage activation and so to intracellular killing of the amastigotes. If this 
intracellular killing was compromised in CO-INFECT mice it might be predicted that 
there would be uncontrolled replication in the infected cells leading to high peak 
numbers with eventual cell destruction and amastigote release (Hypothesis 7). Analysis 
of the mean number of amastigotes per focus of infection showed an interesting pattern 
declining from a mean of 12-14 at +8 weeks to 4-6 at +8 weeks in the LEISH animals. 
Given that there was progression to a higher percentage of mature granulomas relative 
to JKC or FKCs +8 weeks, this lowered mean value presumably reflects increasing 
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leishmanicidal activity of the mature granulomas resulting in intracellular killing of 
amastigotes. However, the CO-INFECT animals also showed a decline in mean 
amastigote counts between +4 and +8 weeks despite the increasing numbers of LDU. 
This does not necessarily mean that the -peak amastigote counts were comparable in 
LEISH and CO-INFECT mice because, as discussed above, the uncontrolled 
proliferation would lead to establishment of new infections of KCs or macrophages; a 
proportion of which would contain low numbers of parasites which would reduce the 
mean count. 
Restricting analysis of the amastigote numbers to the immature or mature L. donovani 
granulomas, which reflects the ability of the Leishmania specific immune response to 
develop leishmanicidal activity showed a more interesting trend. Overall there was 
evidence of higher mean amastigote numbers at +2 and +4 weeks in both experiments 
and in the first experiment also at +8 weeks. In conclusion this analysis of parenchymal 
foci gives support the idea that although morphologically comparable L. donovani 
granulomas can form in the CO-INFECT mice these granulomas have a reduced ability 
to kill the contained amastigotes. IIL-10, causes deactivating macrophages by 
suppressing the afferent and/or efferent arms of the Thl cell-associated mechanism 
(Moore et al., 2001; Groux et al., 1999). IL-10 also suppresses antigen-presenting cells 
(Mitra et al., 1995), T cell co-stimulatory mechanisms, T cell activation, specific T cell 
proliferation and inhibits type I cytokine synthesis and production, in particular IFN-y, 
TNF-cý IL-10, IL-6, EL-12 by Thl clones (Mosmann and Moore, 1991; Fiorentino et al., 
1991). 
Hypothesis 7 was infected alternatively activated macrophages within the schistosome 
egg granulomas may show particularly poor leishmanicidal activity and that this might 
lead to amastigote accumulation resulting in higher mean numbers of amastigotes in the 
infected macrophages within the S. mansoni granulomas compared with the parenchyma 
of CO-INFECT mice and/or LEISH mice. There was slightly higher mean amastigote 
counts in the foci of infection within the schistosome egg granulomas particularly at 
week +8 although this was not significantly different from that in the LEISH mice. It 
was reasoned that heavily infected cells might occur but that if there was rapid 
proliferation there would also be many newly infected cells with few amastigotes. 
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However, analysis of the frequency distribution of amastigote counts gave no evidence 
for the presence of a population of more highly infected cells in the CO-INFECT 
compared with the LEISH rnice. 
A possible explanation for the failure to see increased amastigote numbers in the CO- 
INFECT mice is that arnastigotes may fail to be killed within macrophages in the CO- 
INFECT mice but, owing to a limit in the numbers which can be contained within the 
macrophages, they may simply break out to invade additional cells rather than be killed 
with the result that differences in mean amastigote counts would not be seen. Some of 
the reactions especially within the egg granulomas gave the appearance of a "spreading 
focus of infection" with a range of levels of infection in macrophages in adjacent areas. 
One place where high numbers of L. donovani arnastigotes were seen was inside the 
giant cells which had invaded the egg shells at the centre of the S. mansoni granulomas. 
It could be argued that the existence of such heavily infected cells argues against the 
idea that macrophages will only support a relatively finite number of arnastigotes but 
clearly these infected cells represent a special case. They were not in close contact with 
any other cells and there was no evidence of any form of a L. donovani granulomatous 
response. These L. donovani infected egg shells were not seen very frequently but they 
grapbically suggest that the infected macrophages at the centre of the Th2 dominated S. 
mansoni egg granuloma are not likely to have effective leishmanicidal activities. 
It is concluded that (i) although the schistosome egg granuloma provides a source for 
infection for L. donovani the mere presence of this additional source of macrophages 
does not account for the proliferation of Ld in CO-INFECT (hypothesis 2) (ii) in the 
hepatic parenchyma there was an increased frequency of mature L. donovani 
granulomas in the LEISH as the infection resolved but not in the CO-INFECT but it is 
likely that this reflects the lack of parasites for establishment of the immature 
granuloma stages in the LEISH rather than a failure in progression to the mature stage 
in the CO-INFECT (hypothesis 4) (iii) there were higher mean amastigote numbers in 
the immature and mature granulomas in the CO-INFECT mice suggesting a failure of 
leishmanicidal. activity within the granulomas (hypothesis 6) (iv) typical hepatic L. 
donovani granulomas do not fon-n around foci of infection within the schistosome egg 
granulomas and reduced killing of amastigotes due to the lack of granuloma formation 
(hypothesis 5) or to the presence of immuno-suppressive alternatively activated 
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macrophages (hypothesis 7) leads to the slightly increased L. donovani amastigote 
numbers (v). However, there was no evidence of heavy accumulation of amastigote 
numbers within foci of infection in either the parenchyma or granulomatous tissue of 
CO-INFECT mice and it is concluded that a variety of mechanisms could account for a 
reduced killing of amastigotes within infected macrophages in CO-INFECT mice in 
particular within the egg granuloma but that this does not result in accumulation of 
amastigotes within the cell compared with LEISH mice but rather results in cell 
breakdown and subsequent infection of new cells rather than amastigote killing. 
The various ways in which the strongly polarised Th2 response could inhibit anti-L. 
donovani immunity have been described earlier (5.1). Apart from influencing the 
development of Thl cells themselves, IL-4, IL- 10 and the other Th2 cytokine IL- 13 are 
also able to inhibit the microbicidal activities of macrophages exposed to Thl cytokines, 
by inducing arginase-I production which competes with inducible NO synthase for L- 
arginine, the common substrate for both enzymes (Modolell et al., 1995). IL- 10 strongly 
synergizes with IL-4 and IL-13 by strongly upregulating IL-4RU- (Lang et al., 2002). 
IL-10 also inhibits macrophage migration inhibition factor (MIF) which like IFN can 
also induce NO production from human monocytes (Wu et al., 1993). IL-10 has 
recently been shown to inhibit the expression of a large proportion of the genes 
activated by the Thl stimulus LPS including numerous pro-inflammatory genes e. g. IL- 
125 IL-6 and TNF-a (Lang et al., 2002). 
As also shown in the present studies spleen cells from infected mice are able to produce 
IL-10 in response to SEA stimulation and this was shown to inhibit APC function 
resulting in the suppression of SEA mediated proliferation of SEA specific Thl cell 
clones (Flores Villanueva et al., 1993). This activity started at 5 weeks post S. mansoni 
and peaked at +8 weeks thereafter declining a little to +14 weeks but still being 
significant at +23 weeks. La Flamme et al. (2002) have shown that peritoneal 
macrophages from 6-8 week S. mansoni infected mice activated with IFN--y were 
markedly less able to kill L. major in vitro as judged by increased rates of infected 
macrophages and this corresponded to impaired production of NO. The fact that this 
effect was seen with peritoneal macrophages shows the systemic nature of the inhibition 
of leishmanicidal activity. Such inactivation could result from the effects of IL-10 or 
TGF-O both of which are produced in high amounts in schistosome infection (Grzych et 
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al., 1991; Pearce et al., 1991) and which have been shown to inhibit IFN--Y mediated 
killing of L. major by macrophages (Barral-Netto et al., 1992; Vouldoukis et al., 1997). 
IL-10 has also been shown to inhibit such killing of L. infantum (Vouldoukis et al., 
1997). L. donovani amastigotes infecting human monocytes in vitro can be killed by 
treatment with Nff but this is also prevented by prior exposure of human monocytes to 
IL-10 (Wu et al., 1993). As an extension of this work it would be valuable to assess the 
in vitro leishmanicidal activity of activated peritoneal macrophages from S. mansoni 
infected mice for L. donovani as carried out for L. major (La Flamme et al., 2002) and 
to use macrophages from the different time points in the infection studied here (+2 - +8 
weeks). It would also be interesting to compare this activity with that of egg granuloma 
macrophages. Finally it would also be valuable to compare the "alternatively activated" 
status of L. donovani infected macrophages within the liver parenchyma, egg 
granulomas and the spleen of CO-INFECT mice as judged by double staining for 
macrophage mannose receptor using the specific monoclonal antibody (Linehan et al., 
2003) and for amastigotes using the immune hamster serum as used above. 
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Chapter 6 
Interaction between an established L. donovani infection and a 
superimposed S. mansoni infection 
Introduction 
The experiments in this chapter were designed to give insight into the effects of prior 
exposure to L. donovani on a subsequent S. mansoni infection. In contrast to the studies in 
the previous chapters in which a S. mansoni infection was established first and a Th2>Thl 
environment created, the design in this Chapter meant that the ThI>Th2 response induced 
by prior L. donovani was established first. 
A number of possible effects were considered possible as outlined below: 
As described in earlier sections and demonstrated in the mouse experiments in Chapter 3 L. 
donovani results in a Thl>Th2 response (Engwerda et al., 1996, Miralles et al., 1994) in 
which the key endogenous cytokines leading to control of the disease are IL-12, IL-2, IFN- 
-y, TNF-cý and GM-CSF (Murray et al., 1993; 1995; 2000; Tumang et al., 1994; Murray. 
1997; Engwerda et al., 1998; Satoskar et al., 2000; Murray and Delph-Etienne, 2000). In 
C57BL/6 mice this Thl response increases to a peak at around 4 weeks of infection when 
parasite numbers plateau and start to decline (Murray, 2001a). Superinfection of L. 
donovani infected mice with S. mansoni, once this Thl response had developed, would 
result in the schistosome larvae migrating through the lungs when this Thl response was 
ongoing. The lung stage of schistosome migration is particularly susceptible to immune 
mediated trapping including by Thl (IFN--y) mediated inflammation in immune mice 
exposed to irradiated cercariae (Coulson, 1997; Wilson and coulson, 1999). A significant 
proportion of lung stage schistosomula appeared to be trapped in the lungs of normal 
animals (Mangold and Dean. 1992) and it was considered possible that enhanced levels of 
systemic Thl response might be present as a result of the L. donovani infection and lead to 
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bystander enhancement of the innate trapping response leading to reduced survival of 
larvae due to the promotion of innate trapping of schistosomula. 
The acute response to the schistosome egg results in rapid induction of a Th-biased 
response in which Th2 cytokines, IL-4, IL-5 and IL-13 predominate and the resulting egg 
granuloma comprises a large proportion of eosinophils and fibroblasts, components of the 
immune response associated with IL-5 and IL-13 respectively (Hesse et al., 2001; 
Chiaramonte et al., 1999; Kaplan et al., 1998). Despite the Th2 dominated response, 
immuno-modulating Thl responses are present as seen by the increase in granuloma size 
following IFN--y neutralisation (Luckacs and Boros, 1993). If the Th I response to the egg 
antigens is promoted by prior immunization with eggs plus rIL- 12, the granuloma size and 
fibrosis is reduced resulting in enhanced survival (Wynn et al., 1994). However, if the 
response to the egg is strongly skewed to Thl, as in infected IL-4 KO (Brunet et al., 1997) 
or IL-4/IL-10 double KO (Hoffmann et al., 2000) there is high production of pro- 
inflammatory cytokines and higher mortality. So in the present studies it was considered 
possible that the nature or size of the schistosome granuloma and morbidity might be 
altered by the Thl biased response induced by a pre-existing Leishmania donovani 
infection. Depending on the level of putative skewing towards a Thl response to the egg 
antigens this could either reduce the egg granuloma size and reduce disease or lead to 
damaging pro-inflammatory responses. 
However, although the acute phase of L. donovani infection in mice results in strong Thl 
responses which control the infection it is known that L. donovani causes T cell immuno- 
suppression (Alvar, 1994; Zwingenberger et al. 1990; Bogdan et al., 1996) and that the 
morbidity and mortality associated with infection is often due to secondary infections 
(Kadivar et al., 2000; Desjeux, 1992). Immuno -deficiency may occur during the chronic 
stage of the disease in both humans and mice (Ho et al., 1983; Gomes et al., 1998; 
Dasgupta et al., 1999) and T cell anergy to multiple antigens and PHA has been described 
in visceral leishmamasis patients (Aikat et al., 1979; Ho et al., 1983). 
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Leishmania parasites have been shown to induce a variety of immune evasion mechanisms 
which results in their persistence (Bogdan and Rollinghoff, 1998; Zambrano-Villa et al., 
2002). Although L. donovani infection in the liver induces mRNA expression of Thl (IFN- 
y, IL-2, IL-12, TNF-a), immuno-regulatory cytokines associated with Th. 2 responses (IL-4, 
and IL-10) are also expressed in the liver over the first 28 days of infection (Engwerda et 
al., 1996, Miralles et al., 1994), more so in certain strains of mice than others. Th2 
associated cytokines (IL-4, PGE2, TGF-0 and IL-10) appear important in regard to 
pathogenicity since they can suppress specific T cell proliferation and inhibit type 1 
cytokine synthesis and production and/or host defense effects of activating cytoldnes, 
including IFN-, y and IL-2 (Howard, 1986; Mosmann and Coffman, 1989; Silva et al., 1992). 
Endogenous IIL- 10 might inhibit cellular inimune responses not just to Leishmania antigens 
but also to bystander antigens resulting in T cell anergy to multiple antigens and PHA as 
observed in some VL patients (Aikat et al., 1979; Ho et al., 1983). With respect to the 
current study on superimposed S. mansoni, IL-10 has been implicated in inhibiting the size 
of acute stage granulomas and in bringing about the down-regulation of granuloma size in 
chronic infection (Sadler et al., 2003). Leishmanial infection also suppresses: antigen 
presenting activity of macrophages by reduced expression of MHC-II molecules through 
inhibition of PKC activity (Bhattacharyya et al., 2001a; 2001b); co-stimulatory molecule 
expression such as B7.1, B7.2, and ICAM-1 (Saha et al., 1995); production of oxygen 
intermediates (ROI), especially H202 (Murray, 1982; Murray et al., 1983) and reactive 
nitrogen intermediates (RNI) (Roach et al., 1993) leading to reduced macrophage 
leishmanicidal activity. Recently Engwerda et al. (1998) have shown splenic marginal zone 
macrophages disappear at 28 days post infection of mice with Leishmania donovani. This 
disruption of lymphoid architecture persists and may cause insufficient antigen presentation 
to T cells and also effect lymphocyte trafficking during chronic leishmaniasis (Engwerda 
and Kaye, 2000; Smelt et al., 1997). Dendritic cells also failed to migrate from the marginal 
zone (MZ) to the peri-arteriolar regions (PALs) of the spleen during chronic L. donovani 
infection and showed reduced CCR7 expression, and poor responsiveness to the CCR7 
ligands CCL21 and CCL19 (Ato et al., 2002). The stromal cells were also fewer resulting in 
the associated loss of CCL21 and CCL19 expression and of extracellular matrix 
components (the reticular network) which are produced by the stromal cells in the T cell 
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area (Ato et al., 2002). This stromal cell loss during chronic infection would effect the 
chemokine-mediated interactions between DCs and T cells. So chronic infection of the 
spleen resulting in disruption of the microarchitecture of both the B cell follicles and the 
MZ is considered likely to result in reduced presentation of antigens from other infections 
causing increased susceptibility to concomitant infections (Engwerda and Kaye, 2000; 
Engwerda et al., 2002; Smelt et al., 1997). Other immunosuppressive effects reported 
include disruption to lymphocyte migration (Garside et al., 1998; Sallusto et al., 1999), and 
loss of CD45RO+ memory T cells, a process which is reversed by chemotherapy (Cillari et 
al., 1995). There are also mechanisms resulting in suppression of IFN--y production and it's 
principal inducer, IL-12 (Kaye et al., 1991; Gorak et al., 1998; Reiner et al., 1994; 
Engwerda et al., 1998; Taylor and Murray, 1997; Murray et al., 2000) and of TNF-a 
production (Theodos et al., 1991). Various of these effects are believed to contribute to the 
immuno -compromised status of patients with VL and influence the response to concomitant 
infections. Despite the common acceptance that immuno- suppression is a key feature of L. 
donovani infection in humans and also in mice, there have been no experimental 
investigations to demonstrate this. The superinfection experiments planned in this chapter 
were designed so that the schistosome eggs would be produced at a time when the 
disruption to the splenic architecture and function was known to have occurred i. e. 8 weeks 
post L. donovani infection. 
Another alternative outcome considered possible was that the strong Th2 response 
associated with the eggs might still develop and serve to reduce the protective Thl response 
that normally develops at 2 weeks and peaks at 4 weeks post L. donovani infection, and 
would be expected to have reduced the L. donovani parasite load dramatically by the time 
the eggs were produced. As judged by PCR analysis, IL-4 and IL-10 mRNAs are also 
expressed by week 2 after L. donovani infection and it has been suggested that this Th2 cell 
response might contribute to the logarithmic increase in parasite replication during the first 
weeks after challenge (Murray et al., 1987) before the Thl response dominates. So if the 
strong Th2 cytokine response induced by the incoming S. mansoni eggs could inhibit the 
Thl response controlling the L. donovani infection directly or by restimulating the L. 
donovani specific Th2 component of the immune response there could be a recrudescence 
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of LDU. Furthermore, the S. mansoni egg granulomas containing numerous anti- 
proliferative, alternatively activated marcrophages (Flores Villanueva et al., 1994a) could 
provide additional and favourable sites for L. donovani development as discussed in 
Chapter 5. 
So the aims of this work were: - 
I To study the effect of the predominant Thi cytokine response associated with a pre- 
exsisting L. donovani infection on the establishment of a superimposed S. mansoni 
infection and on the production of schistosome eggs. 
2 To determine if a Th. 2 response induced by the superimposed S. mansoni infection 
could inhibit or reverse the development of Thl mediated control of the L. donovani 
infection leading to enhanced LDU. 
3 To determine if the immune response to the schistosome infection was altered by 
the pre-existing L. donovani infection resulting in altered egg granuloma formation. 
4 To determine if the immune response to the L. donovani infection is altered by the 
superimposed S. mansoni infection 
6.2. Results 
For the experiments described in this chapter it was planned that the L. donovani infection 
would be given and then 2 weeks later the mice superinfected with S. mansoni. This meant 
that the Thl response to the L. donovani infection would (i) be establishing at the time 
when the larval schistosomes were migrating through the lungs (I week post S. mansoni 
and 3 weeks post L. donovani infection) during which stage they are susceptible to Thl 
mediated attrition in immune animals (Coulson, 1997) and (ii) would be fully developed at 
a time when the S. mansoni eggs were first produced (5-6 weeks post S. mansoni infection, 
8 weeks post L. donovani infection) and when they would normally induce a marked Th. 2 
response. This timing also meant that the egg production in the liver would start when the 
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L. donovani infection in the liver was reducing but not resolved and so could be affected by 
a developing Th2 response to the eggs. 
Several problems were encountered in trying to carry out this experiment and four separate 
attempts were made. In the first experiment, using 25 cercariae per mouse there was poor S. 
mansoni infectivity so that at perfusion, insufficient numbers of mice had bisexual 
infections. Therefore in subsequent experiments the number of cercariae given was 
increased to 50 and then to 100. A second experiment had to be terminated because of a 
viral infection in the Biological Services Unit which necessitated all mice being culled. 
Two further experiments were completed and the data for both is presented below but, in 
the first of these, the L. donovani infectivity was low. Eventually two experiments were 
completed. 
Parasitological results - Experiment 1. 
6.2.1. Experimental design - Experiment I 
Thirty two female C57BL/6 mice were divided into 4 groups. Initially 16 mice were each 
infected with Leishmania donovani strain at 2xI 07 amastigotes of LV9/ml ix. via the tail 
vein. Two weeks after the L. donovani infection 8 mice were super-infected with 50 
Schistosoma mansoni cercariae via the percutaneous route (CO-INFECT). The remaining 8 
mice were given the schistosome infection only (SCHISTO). A further group of 8 mice 
were left with the Leishmania infection alone (LEISH). Finally a group of 8 mice were 
untreated (CONTROLS). All mice were sacrificed at +8 weeks post L. donovani infection. 
6.2.2. Parasitological results (Experiment 1) 
6.2.2.1. S. mansoni wonn and eRR burdens. 
Worm and egg burdens from the SCHISTO and CO-INFECT groups are shown in Table 6.1. 
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Table 6.1. Mean adult worm and geometric mean liver egg burdens (±SD) i 
SCHISTO and CO-INFECT groups at +8 week after S. mansoni super- 
infection. 
Group 
Time Mean worm count #Geometric Geometric mean 
mean e e s/ (wk) Total (±SD) Pairs* gg count (±SD) 
gg 
worm pair (±SD) (±SD) 
SCHISTO +8 25 (±2.01) 9.3 (±1.38l :ý ý1.41 (±6922) 22141 8516(±3914) CO-INFECT 1 +8 22.9 (±1.7) 9.6 (±0.4) 
t 
- , 6273 1627 (±3658) 4282(±1197) 
Table 6.1. C57BL/6 mice were infected i. v. with L. donovani and 2 weeks later superinfected 
with 50 S. mansoni cercariae. The mice were perfused at +8 weeks and livers digested for 
egg counting. # Egg count expressed as total for the whole liver. *Estimated from the number 
of mature female and male worms recovered in each animal. Data is based on the mean 
number of animals which developed bisexual, egg producing schistosome infections (6 CO- 
INFECT, 7 SCHISTO mice). 
All mice which had been exposed to schistosome cercariae were found to have adult 
worms. There were no significant differences between the mean total worm or worm pair 
recoveries from the two groups. Despite this the (geometric mean egg count) GECs were 
lower in the CO-INFECT group compared with the SCHISTO group. Consequently, the 
GEC/worm. pair values were lower for the CO-INFECT group compared with the 
SCHISTO giving some suggestion of fecundity suppression/more rapid egg destruction 
following the Leishmania infection. However, these results were not statistically 
significantly different. 
6.2.2.2. L. donovani parasite load. 
The Leishman Donovan units (LDU) are shown in Figure 6.1. 
It was clear from looking at the impression smears in this experiment that amastigotes were 
very scanty and this is reflected in the LDU counts. In spite of this there were no significant 
differences between either the liver or spleen LDU counts in the CO-INFECT and LEISH 
mice. 
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Figure 6.1. Comparison of Leishman Donovan Units (LDU) from Liver 
and Spleen imprints at +8 weeks post S. mansoni superinfection. 
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Figure 6.1. Graphs show the mean (±SE) LDU for 7/8 mice from the CO-INFECT 
and LEISH groups. LEISH and CO-INFECT mice were infected ix. with L. 
donovani and the CO-INFECT mice superinfected with 50 S. mansoni cercariae 2 
weeks later. Mice were sacrificed 8 weeks later (+8 weeks). 
6.2.3 Experimental design - Experiment 11 
This is essentially a repeat experiment with the same experimental design as in Experiment 
1 (6.2.1) except that the S. mansoni infection was doubled to 100 cercariae in order to 
ensure a potent schistosome infection. There were 8 mice per group for CO-INFECT 
SCHISTO and CONTROLS and 5 mice for LEISH. 
6.2.4. Parasitological results (Experiment 11) 
6.2.4.1. S. mansoni wonn and egg burdens. 
Worm and egg burdens from the SCHISTO and CO-INFECT groups are shown in Table 6.2. 
In this repeat experiment, the overall S. mansoni worm burden was higher than in the first 
experiment as expected from the higher number of cercariae in the infection. Unlike the 
first experiment the CO-INFECT mice showed a lower infection rate compared with the 
SCHISTO animals. This was seen with both the total worm burdens (24.5% lower in CO- 
INFECT cf SCHISTO, p= 0.03) and in worm pairs (29.3% lower, p=0.05). The total liver 
egg burden was also reduced by a similar percentage in the CO-INFECT (26%) but this 
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was not statistically significant. The tissue eggs/worm pair were almost exactly comparable 
giving no indication of fecundity suppression. 
Table 6.2. Mean adult worm and geometric mean liver egg burdens (±SD) in 
SCHISTO and CO-INFECT g-roos at +8 week after S. mansoni 
soerinfection. 
Group Mean worm count 
Time Total (±SD) - Pairs (±SD) #Geometric Geometric mean 
(wk) mean egg count eggs/ (±SD) Worm pair (±SD) 
SCHISTO +8 41.3 (±2.4) 18.4*(±1.4) 53823 (±8915) 2925.2 (±6367.9) 
CO-INFECT +8 30.8 (±3.8) 
, 
13 (±2.3) 38789(±10156) 2983.8 (±4415.7) 
Table 6.2. C57BL/6 mice were infected i. v- with L. donovani and 2 weeks later, 
superinfected with 100 S. mansoni cercariae. The mice were perfused at +8 weeks and 
livers digested for egg counting. # Egg count expressed as total for the whole liver. 
*Estimated from the number of mature female and male worms recovered in each 
animal. Data is based on the mean number of animals which developed bisexual, egg 
producing schistosome infections (5 mice/group). 
6.2.4.2. L. donovani parasite load 
The mean Leishman Donovan units (LDU) are shown in Figure 6.2. In this experiment the 
spleen and liver LDU values were more similar to the expected values for a 10 week L. 
donovani infection (e. g. similar to the values in Experiments I and 2, Chapter 3) than in 
Experiment 1 above. Unexpectedly and interestingly the CO-INFECT mice produced 
markedly lower levels of parasitic burden (LDU) in both liver and spleen imprints 
compared to the LEISH animals (9 5.5% lower for the liver values, p= 0.04, and 93.8% 
lower for the spleen values 0.05 respectively). 
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Figure 6.2. Comparison of Leishman Donovan Units (LDU) from Liver and Spleen imprin 
at +8 weeks post S. mansoni sLaperinfection. 
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Figure 6.2. Graphs show the mean (±SE) LDU for 5/8 CO-INFECT mice and 515 mice in LEISH 
groups. LEISH and CO-INFECT mice were infected i. v. with L. donovani and the CO-INFECT 
mice superinfected with 100 S. mansoni cercariae 2 weeks later. Mice were sacrificed 8 weeks later 
(+8 weeks). 
6.2.5. Immunology results - Experiment I 
6.2.5.1. Detection of cNjokine production from spleen lyMphocytes by ELISA 
Cytokine production (IFN--y and IL-4 as markers of Thl and Th2 responsiveness 
respectively), was assessed in supernatants obtained from spleen cells from three individual 
mice per group. Cells were cultured in vitro at a concentration of 5xl 06/ml with medium 
alone, mitogen (ConA), schistosome soluble egg antigen [SEA], and leishmanial antigen 
(formalin fixed arnastigote antigen [FLAA]). 
6.2.5.1.1. Levels of-[L-4 
As shown in Figure 6.3, at 10 weeks (+8+ wks post S. mansoni) the splenocyte in vitro cell 
cultures from both SCHISTO and CO-INFECT groups produced raised levels of IL-4 in the 
presence of mitogen compared with the CONTROLS (p=0.05 and 0.0005 respectively) and 
the LEISH animals (p=0.04 and 0.0004 respectively). Moreover, both CO-INFECT and 
SCHISTO animals produced raised levels of IL-4 in response to SEA although this 
difference was only statistically significant for the CO-INFECT animals relative to the 
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LEISH animals and the CONTROLS (p=0.0003 and 0.0007 respectively). There were no 
significant differences between the IL-4 levels in the CO-INFECT and SCHISTO groups 
stimulated with either ConA or SEA. There was no IL-4 detectable in the presence of 
FLAA from any of the other groups. 
Figure 6.3. CoMparison of the levels of IL-4 in sMematants of spleen cell 
cultures 
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Figure 6.3. Graphs showing the means and standard errors for IL-4 production by spleen 
cells from three mice in each group sacrificed at +8 weeks after the S. mansoni 
superinfection. Cultures of 5xl 06 cells/ml were stimulated with medium alone, ConA at 
5/Lg/ml, SEA at 20jtg/mI or fixed leishmanial amastigote antigen (FLAA) at 107 /ml. LEISH 
and CO-INFECT mice were infected i. v. with L. donovani and the CO-INFECT mice 
superinfected with 100 S. mansoni cercariae 2 weeks later along with a previously 
uninfected group SCHISTO, CONTROL mice were uninfected naYve mice. 
6.2.5.1.2. Levels of IFN--y 
As shown in Figure 6.4, the LEISH and CONTROL animals produced higher levels of 
IFN--y in response to Con A compared with the SCHISTO and CO-INFECT mice but this 
was only significantly higher for the CONTROL animals (p=0.05, and 0.01 relative to CO- 
INFECT and SCHISTO, respectively). 
In the presence of FLAA high IFN-7 responses were seen with both the LEISH and CO- 
INFECT groups and these were significantly higher than the levels in the CONTROL 
(p=0.0002 and 0.008 respectively), and SCHISTO animals (p=0.0002 and 0.008 
respectively). IFN--y production stimulated by FLAA was lower in the CO-12*, TFECT group 
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compared with the LEISH group but this was not significantly significant. Minimal levels 
of IFN--y to SEA were seen in the SCHISTO and CO-INFECT animals. 
Figure 6.4. Comparison of the levels of IFN-j in sLipematants of spleen cell cultures 
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Figure 6.4. Graphs showing the means and standard errors for IFN-7 production by 
spleen cells from three mice in each group sacrificed at +8 weeks after the S. mansoni 
superinfection. Cultures of 5xlO 6 cells/ml were stimulated with medium alone, ConA at 
5[tg/ml, SEA at 201tg/ml or fixed leishmanial amastigote antigen (FLAA), at 107/Ml 
For definition of groups see legend to Figure 6.3. 
6.2.5.1.3. Levels of Nitric Oxide (Nitrite). 
The level of nitrite in the spleen cultures should be a reflection of the balance of the various 
influences acting to activate or modulate activation of the macrophages in the cultures. The 
results are shown in Figure 6.5. 
Although the levels of nitrite were modest, cells from the CO-INFECT animals produced 
the highest level of nitric oxide in response to mitogen (ConA) (p=0.03 relative to 
CONTROLS). The SCHISTO animals showed significantly elevated nitrite levels 
compared to both the LEISH and CONTROL animals (p=0.009 and 0.01 respectively). In 
response to FLAA, the CO-INFECT animals showed the highest 
levels of nitrite but the 
significance of this is uncertain as the SCHISTO animals also showed 
higher levels of 
nitrite than the LEISH animals. 
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Figure 6.5. Comparison of the levels of nitrite in su-pematants of spleen cell cultures 
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Figure 6.5. Graphs showing the means and standard errors for nitrite production by spleen 
cells from three mice in each group sacrificed at +8 weeks after the S. mansoni 
superinfection. Cultures of 5xl 06 cells/ml were stimulated with medium alone, ConA at 
51tg/ml, SEA at 20/ig/ml or fixed leishmanial amastigote antigen (FLAA) at 107 /ml. For 
definition of groups see legend to Figure 6.3. 
6.2.6. Immunology results - Experiment H 
6.2.6.1. Detection of cZokine production from spleen IMphocytes by ELISA 
Levels of IL-4 
As can be seen in Figure 6.6 the pattern of IL-4 production was essentially similar to that in 
Experiment I although the levels of IL-4 were lower than in the above experiment (Figure 
6.3. ) which is surprising given the higher level of worm and egg burdens in this second 
experiment. 
As shown in Figure 6.6, the splenocyte cell cultures from both SCHISTO and CO-INFECT 
groups produced raised levels of IL-4 compared with the CONTROLS in the presence of 
medium alone (P=0.04 and 0.01 respectively), ConA (p=0.009 and 0.007 respectively), and 
SEA (p=0.004 and <0.0001 respectively). Moreover, both the SCHISTO and CO-INFECT 
groups produced raised levels of IL-4 compared with the LEISH animals in the presence of 
medium alone (P=0.01 and 0.005 respectively), mitogen conA (p=0.02 and 0.02 
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respectively), and SEA (p=0.002 and <0.0001 respectively). There was no IL-4 detectable 
in the presence of FLAA for any of the other groups. 
Figure 6.6. Colpparison of the levels of IL-4 in supematants of spleen cell cultures 
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Figure 6.6. Graphs showing the means and standard errors for IL-4 production by spleen cells 
from three mice in each group sacrificed at +8 weeks after the S. mansoni super-infection. 
Cultures of 5x 106 cells/mI were stimulated with medium alone, ConA at 5[tg/ml, SEA at 
20/. tg/ml or fixed leishmanial amastigote antigen (FLAA) at 107/Ml . For definition of groups 
see le2end to Fi2ure 6.3. 
258 
Schisto alone Co-infect Leish alone control 
6.2.6.1.2. Levels ofIL-5 
In view of the low levels of IL-4 recorded, an IL-5 cytokine ELISA was also used on the 
supernatant in this experiment. 
As shown in Figure 6.7, none of the splenocyte in vitro cell cultures showed significant IL- 
5 production in medium alone. However, in response to ConA, both the SCHISTO and CO- 
INFECT groups produced high levels of IL-5, significantly higher than in the CONTROLS 
and LEISH animals (P<0.0001 for all). Similarly SEA induced markedly elevated IL-5 
production by the SCHISTO and CO-INFECT animals which was significantly elevated 
compared with the LEISH and CONTROL groups (p=0.007 and 0.002 respectively for the 
SCHISTO groups and p=0.05 and 0.003 for the CO-INFECT). None of the groups made 
significant levels of IL-5 to FLAA. 
Figure 6.7. Comparison of the levels of EL-5 in sLipematants of spleen cell cultures. 
1800 -o Medium 
1600 - E2 con A 
1400 - SEA 
1200 - FLAA 
E 1000 - 
ch 800 - 
600 - 
400 - 
200 
0 
SCHISTO CO-INFECT LEISH CONTROL 
Figure 6.7. Graphs showing the means and standard errors for IL-5 production by spleen 
cells from three mice in each group sacrificed at +8 weeks after the S. mansoni 
superinfection. Cultures of 5xl 06 cells/ml were stimulated with medium alone, ConA at 
51tg/ml, SEA at 201tg/ml or fixed leishmanial amastigote antigen (FLAA) at 107/Ml . For 
definition of groups see legend to Figure 6.3. 
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6.2.6.1.3. Levels of IFN--y 
As shown Figure 6.8., all groups produced comparable levels of IFN-, y in the presence of 
medium alone. 
In the presence of Con-A, as in the first experiment (Figure 6.4. ) the LEISH animals 
produced the highest levels of IFN--y but this was not statistically significantly different 
from the other groups. However, the CONTROL cells produced somewhat lower IFN-T 
than in the first experiment whereas the SCHISTO and CO-INFECT were similarly low. 
In response to SEA, minimal levels of IFN--y were produced in any of the groups. In the 
presence of FLAA the highest response was from the LEISH group (p=0.05) relative to 
CONTROLS. The CO-INFECT animals showed noticeably lower levels of IFN--y 
compared with LEISH animals although this was also significant compared to CONTROLS 
(p=0.03). The difference in IFN--y production between the CO-INFECT and LEISH groups 
was not significantly significant but did parallel the difference in LDU values (i. e. both 
IFN--y and LDU low in the CO-INFECT). 
Figure 6.8. 
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Figure 6.8. Graphs showing the means and standard errors for IFN-7 production by spleen 
cells from three mice in each group sacrificed at +8 weeks after the S. mansoni 
superinfection. Cultures of 5x 106 cells/ml were stimulated with medium alone, ConA at 
51tg/ml, SEA at 20[tg/ml or fixed leishmanial amastigote antigen (FLAA) at 107/Ml . For 
definition of groups see legend to Figure 6.3. 
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6.2.61.4. Levels of Nitric Oxide (Nitrite). 
The levels of nitrite detected were low and very similar to the first experiment. The CO- 
INFECT animals produced the highest level of NO production in response to ConA, 
significantly higher than in the CONTROLS and LEISH group (p=0.01 and 0.05 
respectively). However, in response to SEA, the SCHISTO animals produced the highest 
nitric oxide production (p=0.0005,0.0009 and <0.0001 respectively compared to CO- 
INFECT, LEISH and CONTROLS). In response to FLAA, the CO-INFECT animals 
produced the highest levels of nitric oxide which was significantly higher than the LEISH 
animals (p=0.02) but as in the earlier experiment SCHISTO alone mice also produced a 
higher response than CONTROLS (p=0.01). 
Figure 6.9. Comparison of the levels of nitric oxide in sllpematants of spleen cell cultures 
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Figure 6.9. Graphs showing the means and standard errors for nitrite production by spleen cells 
from three mice in each group sacrificed at +8 weeks after the S. mansoni superinfection. 
Cultures of 5xlO 6 cells/ml were stimulated with medium alone, ConA at 5, ag/ml, SEA at 
201tg/ml or fixed leishmanial amastigote antigen (FLAA) at 107/ml . For definition of groups 
see legend to Figure 6.3. 
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6.2.7. Pathological responses 
6.2.7.1. Effect on the schistosome granuloma size and cellular coMposition 
r'le 
- JExperiment I 
To assess whether leishmaniasis altered the course of disease in superimposed S. mansoni 
infections histopathology was carried out. For this, tissue from animals with comparable 
numbers of recovered adult worms and geometric egg counts in the liver were chosen for 
sectioning. Histological examination showed there to be no obvious differences in the 
schistosome-induced granulomatous and peri-granulomatous responses. 
Nevertheless granuloma size and cellular composition were measured. As previously, the 
granulomas measured were those containing an identifiable miracidium and the widest 
diameter of each was recorded together with the diameter at right angles to this. The mean 
was then used to calculate the granuloma volume. For each sample 30 granulomas were 
measured. As shown in Figure 6.10. there was no significant difference between the mean 
granuloma volumes of CO-INFECT and SCHISTO animals. 
Analysis of the percentage cellular composition of the egg granulomas showed an 
essentially similar cellular composition in the CO-INFECT and SCHISTO animals 
although the SCHISTO animals showed a slightly higher frequency of eosinophils 
compared to CO-INFECT animals (p=0.05). 
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Figure 6.10. Volume and cellular composition of S. mansoni granulomas 
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Figure 6.10. A. Graphs showing the mean (±SE) volume of S. mansoni egg granulomas from 
livers of SCHISTO and CO-INFECT animals at +8 weeks post S. mansoni superinfection. 
Histological sections were stained with H&E and transverse & longitudinal diameters were 
measured for 30 granulomas/mouse (with visible viable miracidium inside the schistosome 
egg). B. Graphs showing the mean (±SE) cellular composition of the above granulomas 
based on the data from three mice per group. 
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6.2.7.2. Effect on the schistosome granuloma size and cellular compositio 
-Experiment II 
As seen in Figure 6.11. the CO-INFECT animals showed a larger mean egg granuloma 
volume compared to the SCHISTO animals, but this difference was not statistically 
significant. Similarly the cellular composition of the granulomas was very similar in both 
CO-INFECT and SCHISTO mice. 
Figure6.11. Volume and cellular composition of S. mansoni granulomas 
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Figure 6.11. A. Graphs showing the mean (±SE) volume of S. mansoni egg granulomas 
from livers of SCHISTO and CO-INFECT animals at +8 weeks post S. mansoni 
superinfection. Histological sections were stained with H&E and transverse & longitudinal 
diameters were measured from 30 mature granulomas/mouse with visible viable miracidium 
inside the schistosome egg. B. Graphs showing the mean (±SE) cellular composition of the 
above granulomas based on the data from three mice per group. 
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6.3 Discussion 
Owing to variation in infectivity of either the Leishmania or the schistosome infections 
several attempts had to be made before appropriate levels of parasite infection and numbers 
of surviving animals were achieved. Nevertheless the final experiment worked well in this 
regard and gave clear results several of which were supported by data from an earlier 
experiment in which there was a low Leishmania infection. 
The reasons for the variation in L. donovani infection in the two experiments reported are not 
apparent. In the first experiment (Fig 6.1) the LDU in the LEISH alone animals was 
extremely low (0.0122 in liver and 0.0004 in spleen) at the +10 week time point when the 
sampling was done. This was clearly low when compared to the values for the two 
experiments in Chapter 3 which were sampled at +8 weeks, a roughly comparable time, 
(mean liver LDU were 0.09 for Experiment I and 0.276 in Experiment 11 and spleen LDU 
0.032 and 0.067 respectively) and to the second experiment in this Chapter which, like the 
first experiment, was sampled at +10 weeks (mean LDU for liver and spleen 0.18 and 0.02 
respectively). It seems that even with the same strain of mouse and parasite, occasionally 
there is poor infectivity of L. donovani but the reasons for this are unclear (Prof. Paul Kaye, 
6personal conununication'). Prof. Kaye advises that because such low infectivity is unusual, 
the experiments in which it happens are not treated as representative. So the data from the 
second experiment is taken as likely to give a more representative picture. 
Regarding the effect of the superimposed S. mansoni infection on the L. donovani infection, 
the data from Chapter 3 shows that by +10 week post infection the LDUs in LEISH animals 
would have declined to a fraction of the peak parasite burdens due to the development of a 
protective Thl response (Engwerda et al., 2002; Murray, 2001; Murray et al., 1997). It was 
hypothesized at the start of this study that if a strong Th2 response developed following the 
appearance of the schistosome eggs at around 7-8 weeks post L. donovani this might serve to 
reduce the anti-L. donovani Thl response possibly resulting in a recrudescence of the 
infection. However, although it was clear that a strong Th2 response did indeed develop to 
schistosome antigens and to ConA, this did not result in a recrudescence but, on the contrary, 
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the L. donovani infection was markedly and significantly lower in the CO-fNFECT group in 
both the liver (p=0.04) and spleen (p=0.05) in the second experiment. This was particularly 
interesting given the opposite effect seen in Chapter 3 when the L. donovani was given 
second, during the Th2 response established by the prior S. mansoni infection. A major 
difference, therefore between the protocols was that in the S. mansonilL. donovani 
combination the immune response to the L. donovani had to develop in the context of the 
Th2 biased response whereas in the L. donovanilS. mansoni protocol the anti-leishmanial 
response developed in a naive immune context. The crucial question is how the 
superimposed S. mansoni infection might result in lower LDU than the LEISH alone? 
A possible explanation is that the prepatent period of S. mansoni infections in mice are 
characterized by elevation of Thl cytokines. Thus splenocytes from C57BL/6 mice showed 
significantly elevated IL-2 and IFN--y at 1-6 weeks post infection in the presence of both 
ConA and schistosome antigens (larval, adult and egg antigens) (Grzych et al., 1991; Pearce 
et al., 199 1). It was only following the production of eggs at +6 weeks that the Th 1 response 
declined and the Th2 cytokines came to dominate. Such effects were seen with only 10-50 
cercariae (Grzych et al., 199 1; Pearce et al., 199 1) so the 50- 100 cercariae used in the current 
infections should similarly have promoted splenic Thl responses during weeks +3 - +8 of the 
L. donovani infection i. e. during the whole period of development of the protective Thl 
response. More recently, Mountford et al. (2001) have shown that both unirradiated and 
irradiated infections induce IL-12 production in the skin soon after infection and it is 
suggested that this is the cause of the pro-Thl response which develops. So it is possible that 
the S. mansoni induced production of IFN--y and IL-2 could enhance the early development 
of the protective Thl response to L. donovani. However, in the second experiment, in which 
the LDU differences were most pronounced, the levels of IFN--y both to ConA and FLAA 
were lower in the CO-INFECT mice than in the LEISH mice which appears not to support 
the notion that the prepatent Thl response induced by the schistosome infection in the CO- 
INFECT mice boosts the anti-leishmanial response. A possible explanation for this is that 
any boost to the anti-leishmanial immunity would have occurred early after the S. mansoni 
superinfection leading to a rapid and early reduction in the L. donovani parasite loads. In this 
case there would have been a reduction in the level and duration of L. donovani antigen 
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stimulation leading to the lower FLAA specific IFN--y production observed in the CO- 
INFECT mice compared to the LEISH. To investigate this further it would be particularly 
interesting to carry out cytokine analysis earlier during the co-infection i. e. at +2 and +4 
weeks post S. mansoni superinfection. 
Possible boosting of a protective anti-leishmanial immune response by a concurrent infection 
may explain the demonstration by Rousseau et al. (1997) that pre-infection with T spiralis 7 
days before visceral leishmaniasis due to L. infantum, resulted in the hepatic and splenic 
amastigote burden in the co-infected mice being significantly lower than in mice infected 
with L. infantum alone both in the acute (+ 1 8d p. i) and chronic (+70d p. i. ) phases. Despite an 
increase in IFN--y, IL-4 and IL-5 mRNA levels locally (in the liver and spleen) and 
systemically (in the blood) in the co-infected mice, their spleen cells produced significantly 
less IFN-, y than spleen cells from the mice with L. infantum alone. 
Regarding the effect of the pre-existing L. donovani infection on the superimposed S. 
mansoni infection the two experiments showed some differences. In the first experiment 
worm and worm pair numbers were very similar but in the second experiment both were 
significantly lower in the CO-INFECT mice compared with the SCHISTO mice. This 
difference was also reflected in the total schistosome egg count. Obviously this observation 
has to be confirmed but it is conceivable that the Thl response induced by the L. donovani 
infection could enhance the IFN--y response which larval schistosomes induce soon after 
infection (Grzych et al., 1991; Pearce et al., 1991, Mountford et al., 2001). Enhancement of 
this response or its earlier induction could lead to accelerated and enhanced IFN--y mediated 
inflammatory responses to the migrating larvae as have been shown to mediate killing of 
challenge larvae in the lungs of mice sensitized with irradiated cercariae (Coulson, 1997). 
However, there was no evidence of enhanced IFN-7 responses to ConA or SEA in the CO- 
INFECT mice compared with SCHISTO mice at the +8 week sampling time although the 
Th2 bias following the start of egg production would have down-regulated the pre-existing 
Thl responses characteristic of the prepatent period (Grzych et al., 1991; Pearce et al., 
1991). So as with the responses to FLAA it would be interesting to investigate the IFN--y 
267 
responses at +2 and +4 weeks after superinfection and to include larval antigen against 
which there is the strongest Th I response (Pearce et al., 1991). 
Once the worms were established there was no evidence of an effect on the production of 
eggs as there were no significant differences in the mean numbers of eggs/worm pair in the 
SCHISTO and CO-INFECT groups. TNF-a is stimulated during L. donovani infections 
being a key cytokine in mediating leishmanicidal activity in L. donovani granulomas 
(Tumang et al., 1994; Eng-werda et al., 2002; D'Oliveira et al., 2002) and an early study 
implicated TNF-a in enhancing worm fecundity (Amiri et al., 1992) although there has 
since been some problems with confirming this data (Cheever et al., 1999; Davies et al., 
2004). 
Given the finely balanced immune responses controlling schistosome granuloma formation 
(Pearce and MacDonald, 2002; Herbert et al., 2004) it was possible that the Thl envirom-nent 
of the L. donovani-infected liver and spleen would have modulated the developing anti-egg 
response resulting in altered immune responses and so immuno-pathology. For instance, a 
strong pro-inflammatory response to the egg as occurs in IL-4/IL-10 double KO mice results 
in rapid death and up-regulated Thl cytokines (Hoffinann et al., 2000) although a less strong 
Thl inducement by immunizing with eggs and rlL-12, results in less pathology, the 
granulomas being smaller and lacking eosinophils and fibrosis and the animals showing 
enhanced survival (Wynn et al., 1994). However, in the present study there was no evidence 
of alteration of the cytokine response to egg antigens. Thus, L. donovani co-infection had no 
significant effect on the ConA- or schistosome egg antigen (SEA)-specific Th. 2 cytokine 
responses (IL-4 and IL-5) in either experiment. Similarly there was no evidence of 
stimulation of an SEA-specific IFN-Tresponse in the CO-INFECT animals. 
However, although the schistosome egg specific immune response was apparently not altered 
by the co-infection, there was IFN--y production to the L. donovani infection and, in the liver, 
this could have direct bystander effects on macrophage function, for example, counteracting 
the development of AAMOs (by the Th2 cytokines) which are crucial for suppressing 
damaging pro-inflammatory responses (Herbert et al., 2004). Nevertheless, in the current 
268 
study, there was no evidence of either enhanced inflammatory responses to the eggs or 
inhibition of Th2 mediated fibrosis as a consequence of the L. donovani infection as judged 
by granuloma volume, cellular composition or morbidity. 
Little has been done previously on the effects of prior protozoal infections on the 
development of schistosome immuno-pathology. Given the susceptibility of both the L. 
donovani and S. mansoni granulomas to immuno-modulation, it had been considered 
that either or both the L. donovani and S. mansoni parasite counts or disease states 
would have been affected during this co-infection. In fact there was essentially no 
effect of an established L. donovani infection on the establishment of the worms, their 
egg production or the immunological and pathological response to the eggs i. e. a strong 
Th2 response developed in spite of the altered spleen architecture which has been 
shown to develop relatively early during infection in mice and which is considered a 
possible mechanism for the immuno-suppression seen in human visceral leishmaniasis 
(Engwerda et al., 2002). However, in spite of the loss of marginal zone macrophages no 
functional immune deficiency as a consequence has been shown (or tested) previously 
in mice and the relevance of the altered splenic architecture to the severe immuno- 
suppression seen in patients with active kala-azar is uncertain but it is possible that the 
S. mansoni infection in such patients may have a more severe outcome than is 
suggested by these mouse studies. The proposed reactivation of L. donovani infection 
following subsequent S. mansoni infection also did not occur but rather the L. donovani 
seemed to decline more quickly in the CO-INFECT mice. Again the significance of this 
for co-infected humans remains to be elucidated. Finally the observations in this 
chapter were based on limited number of experiments and the experiments need to be 
repeated to confirm some of the tentative conclusions. 
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Chapter 7 
CONCLUSIONS 
Polyparasitism. is a common phenomenon in many parts of the world and due to the wide 
geographical distribution of schistosome infection, schistosomiasis is frequently found 
together with other infectious organisms, viruses, bacteria, protozoa and other worms. The 
aims of this study were to model the effects of prior S. mansoni infection on L. donovani 
infection and vice versa. This was particularly interesting because the schistosome infection 
is characterised by strong Th2 responses and the L. donovani infection is controlled by 
Th 1 -dependent responses. 
The results in Chapter 3 showed that a superimposing L. donovani infection did not 
significantly affect a pre-existing S. mansoni infection as judged by worm burden or egg 
production. However, there was some evidence of an increased granuloma volume at +4 
weeks following the L. donovani super-infection although this difference was not seen at 
+8 weeks. The basis of this increase in size was not apparent Erom the cellular composition 
of the granulomas (percentage of eosinophils, fibroblasts and mononuclear cells) or the 
schistosome antigen specific cytokine responses (EL-4, EL- 10 and IFN--y being comparable 
in the CO-INFECT and SCHISTO mice). In further studies on this aspect it would be 
valuable to determine the granuloma volumes at the +2 week time point. A possible 
explanation for an increased granuloma volume is that, as shown in Chapter 5, L. donovani 
infection was common in macrophages in the periphery of the egg granulomas in CO- 
INFECT mice i. e. there was a higher density of amastigotes than either further inside the 
egg granuloma or in the parenchyma. Although foci of infection in this granuloma 
periphery did not form typical L. donovani granulomas a degree of leishmania- specific 
cellular infiltration is likely and this would have led to an increase in cellular infiltration 
into this area and an apparent increase in egg granuloma diameter. 
In contrast to the lack of effect on the schistosome worm burden it was clear from the 
experiments in Chapter 3 and 4 that the pre-existing schistosome infection resulted in a lack 
of control of the L. donovani infection resulting in significant and marked increases in LDU 
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in both the liver and spleen. This effect was not seen at +2 weeks post super-infection but 
was seen in two out of three experiments at +4 - +5 weeks and in three out of three 
experiments at +8 weeks, when the difference was most marked. No experiments were 
taken beyond this time as, even with the low S. mansoni infections used, the CO-INFECT 
animals showed significant morbidity at the later time points. So it is not known if the L. 
donovani infections would have subsequently resolved or continued to rise. In future work 
it would be interesting in future work to study infections in strains of mice which develop 
weaker Thl responses to L. donovani and show a slower progression and resolution of L. 
donovani infection e. g. BALB/c mice (Murphy et aL, 2001). 
Trying to determine the reasons for this loss of control became the major focus of much of 
the subsequent work. Various hypotheses were put forward to explain this: 
(1) S. mansoni induced hepatosplenomegaly provides additional tissue sites for L. donovani 
proliferation (i. e. there is simply more tissue in general for L. donovani to infect); 
(2) The added tissue would consist of S. mansoni egg granulomas rich in recruited 
macrophages in the liver and, in the Mleen would comprise blood as a result of 
hypertension but also increased numbers of immune cells including recruited macrophages 
responding to the antigenic challenge of the eggs. In both cases there would be more 
suitable host cells [macrophages] to infect. A measurable consequence of this might be a 
higher density of foci of L. donovani infection within the S. mansoni egg granulomas in the 
liver compared with foci in the parenchyma; 
(3) There is a failure to induce a sufficiently strong protective systemic Thl response to L. 
donovani antigens by the spleen i. e. there was a lower IFN--y response to FLAA due to: 
(i) the Th. 2-skewed response to S. mansoni resulting in direct action of EL-4 on Thi 
development (O'Garra, 1998) or 
(ii) indirect effects of schistosome or Leishmania induced EL- 10 (which is produced 
by Th2 cells but also several other cell types and not strictly a Th2 cytokine) on 
antigen presenting cell functions such as down-regulation of costimulatory 
molecules and EL-12 production (Bogdan et al., 1991; Moore et al., 2001) or (iii) 
action of other regulatory cytokines e. g. TGF-0. 
271 
(4) lower EFN--y levels may result in reduced development/reduced rate of maturation of L. 
donovani granulomas (comprising antigen- specific Thl cells and recruited macrophage and 
which are most clearly seen in the liver) i. e. there would be a reduced frequency of 
development of mature L. donovani granulomas; 
(5) L. donovani granulomas may physically fail to form correctly within the context of the 
inflammatory cells of the S. mansoni granulomas and so there may be a lack of control in 
infected macrophages within the egg granuloma; 
(6) even if morphologically normal mature granulomas form, the constituent macrophages 
have a reduced capacity to become activated and so to produce leishmanicidal factors 
[nitric oxide, NO and TNF-a]. This could be due to lower EFN--y (as in (3) above) or to the 
direct suppressive action of IL-4, IL- 13 and EL- 10 on macrophage activation (Vouldoukis et 
al., 1997). If this is true there may be an accumulation of amastigotes within L. donovani 
infected macrophages i. e. there would be higher mean numbers of amastigotes in 
macrophages of CO-INFECT mice compared with LEISH mice. 
(7) As an extension to hypothesis (6) Alternatively Activated Macrophages which 
predominate in the schistosome egg granulomas (Linehan et al., 2003; Hesse et al., 2001; 
Noel et al., 2004) may be infected and may be poor at directing L. donovani granuloma 
formation and/or show poor leishmanicidal activity. In this case amastigotes may 
accumulate within L. donovani infected macrophages in the egg granuloma i. e. there would 
be higher mean numbers of amastigotes in the infected macrophages within the S. mansoni 
granulomas compared with the parenchyma of CO-INFECT mice and/or LEISH mice. 
With regard to (1) and (2), i. e. that greater organ size and availability of macrophage host 
cells for infection in the S. mansoni infected mice simply provide more sites for L. 
donovani infection, comparison of the organ weights (in Chapter 3) shows that the 
percentage differences between organ weights in the LEISH and CO-INFECT groups were 
small and not sufficient to explain the many fold greater LDUs in the CO-INFECT mice at 
+8 weeks. The egg granuloma comprises around 30% macrophages (Oswald et al., 1993; 
Andrade and Cheever, 1995) and this may offer an increased density of potential 
macrophage host cells although of course the granuloma does displace the normal liver 
tissue that is rich in Kiipffer cells. However, it is unlikely that the increase in LDU in CO- 
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INFECT mice anses simply from the greater availability of macrophages in the egg 
infected liver because at the +2 week time point, when the LDUs were similar in the CO- 
INFECT and LEISH animals, egg loads in the CO-INFECT liver were comparable to the 
later +4 and +8 week time points. So there would have been comparable numbers of egg 
granuloma macrophages available for infection at each of these times but this did not result 
in increased LDUs in the CO-INFECT mice relative to the LEISH mice at +2 weeks. 
Furthermore, in the histological studies in Chapter 5, although there was an apparent bias to 
L. donovani infection of the egg granuloma macrophages compared with the parenchymal 
KiApffer cells (60% foci were seen associated with the egg granulomas) this was also 
comparable at +2, +4 and +8 weeks. The histological studies also showed that the density 
of foci in the parenchyma of LEISH animals was actually higher at +2 weeks than in either 
the parenchyma or egg granulomas of the CO-INFECT mice. This indicates that although 
there may be some preference for infection of the granuloma macrophages even early in 
infection this does not lead to an overall higher density of infection in the CO-INFECT 
mice. This supports the notion that there is not a limitation in the availability of suitable 
cells for invasion in the normal liver that can be overcome by the presence of increased egg 
granulomas. 
With regard to the idea (hypothesis 3) that an egg-induced Th2 response inhibits the 
development of the anti-Leishmanial immune response it was clear from the studies in 
Chapter 3 that the S. mansoni infection did induce significant IIL-4 and EL-10 but not IFN-7 
responses to schistosome egg and worm antigens as previously reported (Grzych et al., 
1991) i. e. a Th. 2 biased response. The LEISH infection induced Leishmania antigen 
(FLAA) specific IFN--y production but not EL-4. The level of FLAA-specific IFN-, y which is 
crucial to resolution of L. donovani infection (Murray et al., 1983; 1987; Murray and 
nathan, 1999; Murray et al., 2003) was shown to be markedly lower at +2 weeks post 
infection in the CO-INFECT compared with the LEISH mice indicating a delay in 
development of the response. However, at +4 weeks the IIFN--y levels were comparable or 
even higher in the CO-INFECT animals but by +8 weeks they were again lower. In 
addition there was evidence of a higher FLAA specific IL-10 response at later time points. 
A delay in development of Leishmania-specific EFN--y responses was also seen in S. 
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mansoni in ected mice super-infected with L. major (La Flamme et al., 2002) at +4 weeks 
post infection and this was followed by an increase in parasite burdens in the co-infected 
mice at +8 and +12 weeks relative to the mice infected with L. major alone, despite an 
overshoot at these times in the EFN--y response in the co-infected animals. It appeared that 
the delay in inducing the L. major specific IFN-, y response allowed the infection to 
proliferate to high levels which eventually led to induction of high IFN-'Y levels which were 
then able to control the infection by +16 weeks. So as in the present study there was not a 
direct temporal relationship between the higher IFN--y levels and lower LDU values. The 
immuno-regulatory/immuno-suppressive properties of both EL-4 and IL-10 on Thl 
responses are clearly established and both could have down-regulated the levels of specific 
IFN-, y seen in the CO-INFECT mice and also other aspects of leishmanicidal macrophage 
activation (IL-4 and IL-10 synergise to reduce CMI (Powrie et al., 1993). The above 
studies of cytokine levels do not distinguish which of these cytokines or regulatory 
processes were the most important in this CO-INFECTION model. 
Studies were carried out (Chapter 4) to try to investigate more directly the role of IL-10. 
Two approaches were tried. Firstly similar co-infection experiments were carried out in 
ItMT mice which lack B cells. This was because it has been reported that B cells are a 
major source of EL-10 in S. mansoni infected mice (Ham et al., 1989). The results show that 
the egg glycoproteins were found to stimulate production of B-1 cells (CD5+ B220) which 
appeared in the peritoneal cavity of mice at the time of egg production (Ham et al., 1989), 
and are capable of producing large amounts of EL-10 (O'Garra et al., 1992). Indeed there 
was lower IL-10 production in the ýMT mice and also a relatively lower fold increase in 
LDU in the liver (but not the spleen) of the gMT mice (CO-DTFECT vs. LEISH) compared 
with the WT mice (CO-INFECT vs. LEISH). Although this is consistent with a relative 
lack of B-cell derived IL-10 inhibition of macrophage-mediated killing of L. donovani in 
the CO-INFECT ýtMT mice, this strain of mouse was also much less susceptible to 
infection with L. donovani alone than the C57BL/6 mice. This had been reported previously 
and is believed to be due to the rapid cytotoxic effects of recruited neutrophils (Smelt et al., 
1997). The lowered burdens in the LEISH alone [tMT mice meant that it was not possible 
to directly compare the L. donovani infections in the CO-INFECT ýtMT and WT mice. 
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Given the operation of an additional leishmanicidal mechanism in these mice it is difficult 
to interpret the significance of these results and it is concluded that use of the ýLMT mice 
gave little insight into the role of IL-10 in the CO-INFECT model. In the second approach 
co-infections were set up as above and the mice treated with anti-EL- 10 receptor antibody at 
on day +42 and 0.5mg on days +46, +49, + 52 and +55. Unfortunately the anti-EL-IOR 
treatment resulted in the death of some of the CO-INFIECT mice. Despite this there was 
evidence that the anti-EL-10 treatment was able to reduce the high L. donovani LDU in the 
CO-INFECT mice but it was not possible to conclude with certainty that this was due to 
inhibition of S. mansoni mediated IL- 10 responses as the LEISH infected mice treated with 
anti-EL- 10 mAb also showed a reduction in LDU as previously reported in EL- 10 KO mice 
(Castro et al., 2000) and in IL-10R neutralization (Murray et al., 2002). The anti-IL-IOR 
treatment did not result in increased Leishmania specific IFN-, y production and so this 
shows that the S. mansoni-induced EL-10 can act to inhibit L. donovani immunity in the 
absence of IFN--y effects. This suggests that the prime effect of the EL-10 in the CO- 
INFECT animals is to inhibit macrophage function resulting in reduced granuloma 
formation and leishmanicidal killing within the granulomas (hypothesis 6). 
In order to visualise events in the liver of CO-INFECT and LEISH mice histological and 
immuno-histological studies were carried out (Chapter 5). It was demonstrated that there 
was an increased frequency of mature L. donovani granulomas relative to immature 
granulomas or newly infected KUpffer cells in the LEISH mice as the infection resolved 
(i. e. between weeks +2 and +8) but, in contrast, this ratio was comparable at all time points 
in the CO-INFECT mice. Although this could be taken as evidence that there was a 
relative failure to develop mature granulomas in the CO-INFECT mice it was reasoned that 
the lack of newly infected KCs and immature granulomas in the LEISH animals arose 
because the maturation of an effective immune response meant that there were few 
amastigotes surviving to establish new infections. In contrast, a failure to control the 
infection in the CO-INFECT mice (for whatever reason) would result in continued sources 
of new and immature foci of infection. The demonstration that morphologically normal 
mature granulomas could form in the CO-INFECT mice even at +8 weeks means that the 
loss of control in the CO-INFECT mice is due to a failure in progression of L. donovani 
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granulomas to the mature stage (hypothesis 4). However, the histological studies did show 
that there were higher mean amastigote numbers in the immature and mature granulomas in 
the CO-INFECT mice suggesting a failure of leishmanicidal activity within the granulomas 
(hypothesis 6). 
The histological studies in Chapter 5 also showed that foci of L. donovani infection were 
seen in various locations within the egg granulomas but most commonly in a ring around 
the outside of the granulomas. Typical hepatic L. donovani granulomas did not form around 
these foci of infection and it was often difficult to define the limits of a focus which 
appeared to spread showing satellites of infection around a centre containing just a few 
amastigotes. The difficulty in deciding whether the satellite foci should be considered 
separate foci meant that estimation of the mean amastigote count/focus was not clear-cut. 
Even so, it was concluded that there was a slightly higher mean amastigote count per focus 
within the granuloma compared with either the parenchyma of either CO-INFECT or 
LEISH mice (hypotheses 5 and 7). Nevertheless, there was no evidence of heavy 
accumulation of amastigote numbers within foci of infection in either the parenchyma or 
granulomatous tissue of CO-INFECT mice. So in the livers of the CO-INFECT mice at +8 
weeks there are many more foci of infection and a much higher LDU count but not a 
marked increase in the mean numbers of amastigotes/L. donovani granuloma or even 
evidence of heavy amastigote accumulation in a proportion of foci. It is concluded that 
there must be a lack of killing within the L. donovani granulomas but that this does not 
result in accumulation of amastigotes within the infected cells compared with LEISH mice. 
Rather the infected cells may only be able to accommodate a certain number of amastigotes 
before these escape or the infected cell breaks down releasing the amastigotes to infect new 
cells. 
It is suggested that morphologically normal mature L. donovani granulomas can form in 
CO-INFECT mice but that the leishmanicidal activity of these is low owing to reduced 
Leishmania-specific IFN--y and increased EL-10 as a result of the strongly polarised Th2 
response induced by the S. mansoni infection. IFN--y is crucial for leishmanicidal activity as 
it is essential for macrophage activation in L. donovani infection (Taylor and Murray, 
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1997). EL- 10 could exert its effects in a variety of ways. It has recently been shown to 
inhibit the expression of a large proportion of the genes activated by the Th 1 stimulus, LPS, 
including numerous pro-inflammatory genes e. g. EL-12, EL-6 and TNF-U_ (Lang et al., 
2002) and is known to affect antigen presenting cell functions such as down-regulation of 
costimulatory molecules and IL-12 production (Bogdan et al., 1991; Moore et al., 2001). 
EL-10 has been shown to inhibit IFN--y mediated killing of L. major and L. infanturn by 
macrophages (Barral-Netto et al., 1992; Vouldoukis et al., 1997). L. donovani amastigotes 
infecting human monocytes in vitro can be killed by treatment of the cells with macrophage 
migration inhibition factor (MIF) which, like IFN--y, can also induce NO production but this 
is also prevented by prior exposure of the monocytes to EL-10 (Wu et al., 1993). La 
Flamme et al. (2002) have shown that peritoneal macrophages from 6-8 week S. mansoni 
infected mice activated with IFN--y were markedly less able to kill L. major in vitro as 
judged by increased rates of infected macrophages and this corresponded to impaired 
production of NO. The fact that this effect was seen with peritoneal macrophages shows the 
systemic nature of the inhibition of leishmanicidal activity and it was suggested that IL-10 
was a likely factor in such inhibition. 
Ultimately the mature L. donovani granuloma is able to mediate killing of the surrounded 
amastigotes by the production of nitric oxide and Murphy et al. (2001) demonstrated that in 
IL-10 KO BALB/c mice L. donovani granulomas developed with the same kinetics and 
degree of maturity as in WT BALB/c. However, NOS staining was barely detectable in 
granulomas of WT mice at this time whereas it was readily detected in the granulomas of 
KO mice. This shows that in WT mice, EL-10 can inhibit the leishmanicidal activity in L. 
donovani infection even in morphologically normal mature granulomas. Similarly, 
neutralisation of TNF-a does not affect the granuloma inflammation (Tumang et al., 1994) 
but does prevent control and resolution of infection. So, in the present co-infection studies, 
although the schistosome infection seemed to have little effect on the development of 
morphologically normal L. donovani granulomas, the action of EL-10 may have had marked 
effects on leishmanicidal activity of the granulomas. Despite the difficulties encountered in 
the present studies with immuno-histochemistry owing to the presence of schistosome 
pigment in many of the Leishmania granulomas in CO-INFECT mice it is likely that 
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further attempts to improve the system would provide additional definitive information on 
the leishmanicidal potential of the L. donovani granulomas in the CO-INFECT and LEISH 
mice. Notably, if the technical problems could be overcome, staining for iNOS and TNF-a 
would be of great value as this would show definitively if the leishmanicidal activity of the 
L. donovani granulomas in the parenchyma or foci of infection in the periphery of the egg 
granulomas of CO-INFECT mice was reduced compared to the LEISH mice. 
Such proposed inefficient leishmanicidal activity may be even more pronounced for the L. 
donovani infected macrophages within the egg granulomas. These are likely to be 
alternatively activated macrophages which are induced by the concerted action of EL-4 and 
EL-13 and which can be further promoted by the ability of IL-10 to strongly upregulate 
EL4Ra (Lang et al., 2002). The concentrations of these cytokines would be greatest around 
the egg granulomas owing to the constant stimulation of surrounding T cells by the egg 
antigen released by the egg. These Th-2 cytokines induce arginase-I production which 
competes with inducible NO synthase for L-arginine, the common substrate for both 
enzymes (Modolell et al., 1995) and so they show strongly inhibited microbicidal activities. 
An alternative consequence of arginase I induction in aaMo has also recently been 
demonstrated. Iniesta et al. (2001; 2002), demonstrated that arginase I induction in 
macrophages by Th2-type cytokines results in enhanced proliferation of intracellular 
Leishmania major amastigotes and specific inhibition of arginase I by using N(omega)- 
hydroxy-nor-L-arginine (nor-LOHA) reverted growth of L. major and L. infantum in 
infected macrophages. Arginase I synthesizes L-ornithine which can be used by the parasite 
to generate polyarnines which are required for growth and differentiation of Leishmania 
(Mukhopadhyay and Madhubala, 1995; Fairlamb and Cerami, 1992). Addition of L- 
ornithine and putrescine, to in vitro infected cultures of macrophages could enhance growth 
of intracellular Leishmania amastigotes. It is concluded that arginase induction in the 
context of a Th. 2 predominant response might promote amastigote proliferation through 
increasing the availability of polyamines (Iniesta et al., 2002). It was particularly 
interesting to note heavy L. donovani infection in the giant cells invading the empty 
schistosome egg shell although these were relatively rarely seen and so not likely to 
contribute markedly to the enhanced proliferation in CO-INFECT mice. 
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Future studies on the CO-INFECT livers could investigate if the "spreading" foci of L. 
donovani infection in the periphery of the egg granulomas are associated with AAMo by 
carrying out co-localization experiments using the anti-mannose receptor (MR) antibody 
(MR is a surface marker of AAMo) (Linehan et aL, 2003) and anti-L. donovani infection 
sera to localise amastigotes. 
The final section of these studies was concerned with the effects of an established L. 
donovani infection on a superimposed S. mansoni infection. In view of the susceptibility of 
both the L. donovani and S. mansoni granulomas to immuno-modulation it had been thought 
that either or both the L. donovani and S. mansoni parasite counts or disease states could 
have been modulated. In fact there was no effect on the establishment of the schistosome 
worms, their egg production or the immunological and pathological response to the eggs i. e. 
a strong Th2 response developed. In these experiments the L. donovani infection was around 
8 weeks of duration when the strong Th2 response was induced by the superimposed S. 
mansoni infection and so the L. donovani infection was well controlled by this time and it 
had been thought that the Th2 skewing might result in a recrudescence. In contrast the L. 
donovani seemed to decline even more quickly in the CO-INFECT mice than in the LEISH 
alone and it is suggested that the early phase of the schistosome infection which is 
characterised by Thl responses (Grzych et A, 1991) may have promoted the anti- 
leishmanial response. In these experiments only the +8 week post S. mansoni time point was 
investigated and so it was not known what effect the S. mansoni infection had on L. donovani 
immune responses and proliferation earlier during infection e. g. at +2 weeks post S. mansoni. 
So in future experiments it would be important to look at earlier time points. 
In view of the experimental demonstration of exacerbated L. donovani infection during S. 
mansoni co-infection in mice it would be of interest to carry out epidemiological 
investigations into the existence, prevalence and significance of L. donovani and 
schistosome co-infections in humans. In the South-Eastern regions of Sudan, (Prof. el- 
Hassan 'personal communication' Department of Epidemiology and Clinical Sciences, 
Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan) the likelihood of 
visceral leishmaniasis and schistosomiasis co-infections in humans is thought to be likely 
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particularly due to ongoing displacement and movement of people between endemic areas 
for these infections (el-Hassan and Zijrich, 2001). The likelihood of co-infections occurring 
is heightened by the chronic nature of both L. donovani and schistosome infections. 
Furthermore, nematode infections, both with filarial worms and with gut nematodes are 
also chronic infections associated with high IIL-10 which is proposed to have important 
immuno-regulatory processes in humans (Faulkner et al., 2002; Turner et al., 2003; King et 
al., 1993) and also in mice (Schopf et al., 2002; Lawrence and Devaney, 2001) and also 
with the induction of AAMos (Allen and Loke, 2001). So it is possible that such infections 
may also exacerbate L. donovani infection. Given the high global prevalence of gut 
nematode and filarial infections many co-infections with L. donovani and helminths are 
likely to occur. So epidemiological investigations into L. donovani disease states in relation 
to these co-infecting worms would also be worthy of investigation. 
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